0001331875-26-000026 | 10-K | XBRL Viewer | Fidelity National Financial INC

Ending balance (in shares) at Dec. 31, 2023

518

517

329,000,000

Ending balance at Dec. 31, 2023

7,460

$ 0

5,913

5,244

(2,119)

$ (2,130)

552

Ending balance, Treasury stock (in shares) at Dec. 31, 2023

56,000,000

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Exercise of stock options (in shares)

1,000,000

Exercise of stock options

Purchase of incremental share in consolidated subsidiaries / F&G purchases of treasury stock

(21)

(13)

(8)

Non-controlling interest associated with current period acquisition

139

Issuance of restricted stock (in shares)

1,000,000

Issuance of restricted stock

Other comprehensive earnings - unrealized (loss) gain on investments and other financial instruments

(157)

Other comprehensive earnings — unrealized gain on investments in unconsolidated affiliates

^[1]

Other comprehensive earnings - unrealized (loss) gain on foreign currency translation

(22)

^[2]

(22)

Other comprehensive earnings - minimum pension liability adjustment

Reclassification adjustments for unrealized gains and losses included in net earnings

(8)

^[3]

(8)

Other comprehensive earnings attributable to non-controlling interest

(1)

(7)

Stock-based compensation

Dilution from share issuance by consolidated subsidiary

(24)

Dividends declared

(532)

Shares withheld for taxes and in treasury

(34)

$ (22)

(12)

Change in current discount rate — liability for future policy benefits

224

^[4]

224

Changes in instrument-specific credit risk - market risk benefits

^[5]

Subsidiary dividends declared to non-controlling interests

(48)

Ending balance (in shares) at Dec. 31, 2024

1,391

1,270

121

331,000,000

Ending balance at Dec. 31, 2024

$ 8,532

$ 0

5,976

5,982

(2,052)

$ (2,152)

778

Ending balance, Treasury stock (in shares) at Dec. 31, 2024

56,000,000

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Exercise of stock options (in shares)

Exercise of stock options

$ 4

F&G common stock offering

(117)

(8)

(109)

Purchase of incremental share in consolidated subsidiaries / F&G purchases of treasury stock

(9)

(6)

(3)

Issuance of restricted stock (in shares)

1,000,000

Treasury stock repurchased (in shares)

5,000,000

Treasury stock repurchased

(254)

$ (254)

Other comprehensive earnings - unrealized (loss) gain on investments and other financial instruments

709

Other comprehensive earnings — unrealized gain on investments in unconsolidated affiliates

^[1]

Other comprehensive earnings - unrealized (loss) gain on foreign currency translation

^[2]

Other comprehensive earnings - minimum pension liability adjustment

Reclassification adjustments for unrealized gains and losses included in net earnings

(46)

^[3]

(46)

Other comprehensive earnings attributable to non-controlling interest

(73)

Stock-based compensation

Dilution from share issuance by consolidated subsidiary

(1)

(32)

$ 31

Dividends declared

(549)

Shares withheld for taxes and in treasury (in shares)

(9,000,000)

Shares withheld for taxes and in treasury

(27)

(18)

Noncontrolling interest return of capital

(2)

$ (2)

Change in current discount rate — liability for future policy benefits

(234)

^[4]

(234)

Changes in instrument-specific credit risk - market risk benefits

(24)

^[5]

(24)

Subsidiary dividends declared to non-controlling interests

(62)

(551)

551

Ending balance (in shares) at Dec. 31, 2025

679

602

332,000,000

Ending balance at Dec. 31, 2025

$ 8,972

$ 0

$ 6,042

$ 5,484

$ (1,678)

$ (2,424)

$ 1,548

Ending balance, Treasury stock (in shares) at Dec. 31, 2025

61,000,000

[1]	Net of income tax expense of $2 million, $9 million, and $3 million for the years ended December 31, 2025, 2024, and 2023, respectively.
[2]	Net of income tax expense (benefit) of $4 million and $(6) million, and $2 million for the years ended December 31, 2025 and 2024, and 2023, respectively.
[3]	Net of income tax (benefit) expense of $(13) million, $(1) million, and $34 million for the years ended December 31, 2025, 2024, and 2023, respectively.
[4]	Net of income tax (benefit) expense of $(62) million, $59 million, and $(50) million for the years ended December 31, 2025, 2024, and 2023, respectively
[5]	Net of income tax (benefit) expense of $(6) million, $1 million, and $(9) million for the years ended December 31, 2025, 2024, and 2023, respectively.

Business and Summary of Significant Accounting Policies - Contract Holder Funds, Future Policy Benefits and Secured Trust Deposits (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Accounting Policies [Abstract]
NPR, capped percentage	100.00%
Market risk benefit, attributed fee ratio capped percentage	100.00%
Secured trust deposits	$ 731	$ 551

Business and Summary of Significant Accounting Policies - Owned Distribution Investments (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Related Party Transaction [Line Items]
Commissions	$ 2,518	$ 2,287	$ 2,008
Affiliate
Related Party Transaction [Line Items]
Commissions	$ 55	$ 119	$ 154

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483326/850-10-50-3

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(k)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(k)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 310
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481990/310-10-45-13

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(c)(2)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(c)(2)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(g)(3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Investments, Debt and Equity Securities [Abstract]

F&G Reinsurance - Credit Loss (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Reinsurance Recoverable, Allowance for Credit Loss [Roll Forward]
Balance at Beginning of Period	$ (20)	$ (21)
Changes in the expected credit loss reserve	2	1
Balance at Ending of Period	$ (18)	$ (20)

Investments

12 Months Ended

Dec. 31, 2025

Investments

Our investments in fixed maturity securities have been designated as AFS, and are carried at fair value, net of allowance for expected credit losses, with unrealized gains and losses included within AOCI, net of deferred income taxes. Our preferred and equity securities investments are carried at fair value with unrealized gains and losses included in net earnings.

F&G's investments include assets backing reserves as part of coinsurance with funds withheld agreements. The funds withheld invested assets are reported within their respective line items. See Note N F&G Reinsurance, for more information on the funds withheld agreements. The Company's consolidated AFS investments are summarized as follows:


	December 31, 2025
	Amortized Cost		Allowance for Expected Credit Losses		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
AFS securities	(In millions)
Asset-backed securities	$	18,853	$	(25)	$	166	$	(256)	$	18,738
Commercial mortgage-backed securities	5,341		(61)		58		(139)		5,199
Corporates	26,538		(25)		302		(2,368)		24,447
Hybrids	625		—		6		(22)		609
Municipals	1,604		—		4		(215)		1,393
Residential mortgage-backed securities	2,846		(1)		76		(70)		2,851
U.S. Government	954		—		5		(3)		956
Foreign Governments	400		—		5		(37)		368
Total AFS securities	$	57,161	$	(112)	$	622	$	(3,110)	$	54,561


	December 31, 2024
	Amortized Cost		Allowance for Expected Credit Losses		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
AFS securities	(In millions)
Asset-backed securities	$	15,784	$	(13)	$	202	$	(317)	$	15,656
Commercial mortgage-backed securities	5,379		(49)		53		(201)		5,182
Corporates	24,425		(5)		108		(2,832)		21,696
Hybrids	604		—		6		(29)		581
Municipals	1,638		—		3		(255)		1,386
Residential mortgage-backed securities	2,869		—		32		(105)		2,796
U.S. Government	645		—		2		(10)		637
Foreign Governments	337		—		—		(53)		284
Total AFS securities	$	51,681	$	(67)	$	406	$	(3,802)	$	48,218

Securities held on deposit with various state regulatory authorities had a fair value of $155 million and $997 million at December 31, 2025 and 2024, respectively.

As of December 31, 2025 and 2024, the Company held $54 million and $32 million, respectively, of investments that were non-income producing for a period greater than twelve months.

As of December 31, 2025 and 2024, the Company's accrued interest receivable balance, excluding accrued interest receivable balances related to mortgage loans discussed below under "Mortgage Loans", was $542 million and $476 million, respectively. Accrued interest receivable is classified within Prepaid expenses and other assets within the Consolidated Balance Sheets.

In accordance with our FHLB agreements, the investments supporting the funding agreement liabilities are pledged as collateral to secure the FHLB funding agreement liabilities and are not available to the Company for general purposes. The collateral investments had a fair value of $4,621 million and $4,289 million as of December 31, 2025 and 2024, respectively.

The amortized cost and fair value of fixed maturity securities AFS by contractual maturities, as applicable, are shown below. Actual maturities may differ from contractual maturities because issuers may have the right to call or prepay obligations.


	December 31, 2025				December 31, 2024
	(in millions)				(in millions)
	Amortized Cost		Fair Value		Amortized Cost		Fair Value
Corporates, Non-structured Hybrids, Municipal, Foreign and U.S. Government Securities:
Due in one year or less	$	623	$	619	$	961	$	955
Due after one year through five years	5,597		5,626		4,616		4,544
Due after five years through ten years	5,811		5,812		5,311		5,126
Due after ten years	18,090		15,716		16,761		13,959
Subtotal	30,121		27,773		27,649		24,584
Other securities, which provide for periodic payments:
Asset-backed securities	18,853		18,738		15,784		15,656
Commercial mortgage-backed securities	5,341		5,199		5,379		5,182

Residential mortgage-backed securities	2,846		2,851		2,869		2,796
Subtotal	27,040		26,788		24,032		23,634
Total fixed maturity AFS securities	$	57,161	$	54,561	$	51,681	$	48,218

Allowance for Current Expected Credit Loss

We regularly review AFS securities for declines in fair value that we determine to be credit related. For our fixed maturity securities, we generally consider the following in determining whether our unrealized losses are credit related, and if so, the magnitude of the credit loss:

•The extent to which the fair value is less than the amortized cost basis;

•The reasons for the decline in value (credit event, currency or interest-rate related, including general credit spread widening);

•The financial condition of and near-term prospects of the issuer (including issuer's current credit rating and the probability of full recovery of principal based upon the issuer's financial strength);

•Current delinquencies and non-performing assets of underlying collateral;

•Expected future default rates;

•Collateral value by vintage, geographic region, industry concentration or property type;

•Subordination levels or other credit enhancements as of the balance sheet date as compared to origination; and

•Contractual and regulatory cash obligations and the issuer's plans to meet such obligations.

We recognize an allowance for current expected credit losses on fixed maturity securities in an unrealized loss position when it is determined, using the factors discussed above, a component of the unrealized loss is related to credit. We measure the credit loss using a discounted cash flow model that utilizes the single best estimate cash flow and the recognized credit loss is limited to the total unrealized loss on the security (i.e., the fair value floor). Cash flows are discounted using the implicit yield of bonds at their time of purchase and the current book yield for asset and mortgage backed securities as well as variable rate securities. We recognize the expected credit losses in Recognized gains and losses, net in the Consolidated Statements of Earnings, with an offset for the amount of non-credit impairments recognized in AOCI. We do not measure a credit loss allowance on accrued investment income because we write-off accrued interest through Interest and investment income when collectability concerns arise.

We consider the following in determining whether write-offs of a security’s amortized cost are necessary:

• We believe amounts related to securities have become uncollectible;

• We intend to sell a security; or

• It is more likely than not that we will be required to sell a security prior to recovery.

If we intend to sell a fixed maturity security or it is more likely than not that we will be required to sell the security before recovery of its amortized cost basis and the fair value of the security is below amortized cost, we will write down the security to current fair value, with a corresponding charge, net of any amount previously recognized as an allowance for expected credit

loss, to Recognized gains and losses, net in the Consolidated Statements of Earnings. If we do not intend to sell a fixed maturity security or it is more likely than not that we will not be required to sell a fixed maturity security before recovery of its amortized cost basis but believe amounts related to a security are uncollectible, an impairment is deemed to have occurred and the amortized cost is written down to the estimated recovery value with a corresponding charge, net of any amount previously recognized as an allowance for expected credit loss, to Recognized gains and losses, net in the Consolidated Statements of Earnings. The remainder of unrealized loss is held in AOCI. As of December 31, 2025 and 2024, our allowance for expected credit losses for AFS securities was $112 million and $67 million, respectively.

The fair value and gross unrealized losses of AFS securities, excluding securities in an unrealized loss position with an allowance for expected credit loss, aggregated by investment category and duration of fair value below amortized cost were as follows:


	December 31, 2025
	Less than 12 months				12 months or longer				Total
	Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses
AFS securities	(Dollars in millions)
Asset-backed securities	$	4,756	$	(30)	$	2,160	$	(209)	$	6,916	$	(239)
Commercial mortgage-backed securities	542		(11)		1,051		(106)		1,593		(117)
Corporates	3,419		(55)		10,097		(2,312)		13,516		(2,367)
Hybrids	61		(1)		372		(21)		433		(22)
Municipals	201		(3)		1,050		(212)		1,251		(215)
Residential mortgage-backed securities	208		(2)		390		(67)		598		(69)
U.S. Government	353		(1)		84		(2)		437		(3)
Foreign Government	60		—		148		(37)		208		(37)
Total AFS securities	$	9,600	$	(103)	$	15,352	$	(2,966)	$	24,952	$	(3,069)
Total number of available-for-sale securities in an unrealized loss position less than twelve months											1,962
Total number of available-for-sale securities in an unrealized loss position twelve months or longer											2,194
Total number of available-for-sale securities in an unrealized loss position											4,156


	December 31, 2024
	Less than 12 months				12 months or longer				Total
	Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses
AFS securities
Asset-backed securities	$	1,164	$	(30)	$	2,637	$	(276)	$	3,801	$	(306)
Commercial mortgage-backed securities	727		(11)		1,513		(175)		2,240		(186)
Corporates	6,831		(208)		9,866		(2,624)		16,697		(2,832)
Hybrids	105		(4)		380		(25)		485		(29)
Municipals	261		(12)		1,006		(243)		1,267		(255)
Residential mortgage-backed securities	899		(16)		460		(89)		1,359		(105)
U.S. Government	313		(4)		122		(5)		435		(9)
Foreign Government	120		(5)		157		(48)		277		(53)
Total AFS securities	$	10,420	$	(290)	$	16,141	$	(3,485)	$	26,561	$	(3,775)
Total number of available-for-sale securities in an unrealized loss position less than twelve months											2,005
Total number of available-for-sale securities in an unrealized loss position twelve months or longer											2,305
Total number of available-for-sale securities in an unrealized loss position											4,310

We determined the unrealized losses were caused by higher treasury rates compared to those at the time of the F&G acquisition or the purchase of the security if later. For securities in an unrealized loss position as of December 31, 2025, our allowance for expected credit loss was $112 million. We believe the unrealized loss position for which we have not recorded an allowance for expected credit loss as of December 31, 2025 was primarily attributable to interest rate increases, near-term illiquidity, and other macroeconomic uncertainties as opposed to issuer specific credit concerns.

Mortgage Loans

Our mortgage loans are collateralized by commercial and residential properties.

Commercial Mortgage Loans

Commercial mortgage loans (“CMLs”) represented approximately 4% of our total investments as of December 31, 2025 and 2024. The mortgage loans in our investment portfolio are generally comprised of high quality commercial first lien and mezzanine real estate loans. Mortgage loans are primarily on income producing properties including industrial properties, retail buildings, multifamily properties and office buildings. We diversify our CML portfolio by geographic region and property type to attempt to reduce concentration risk. We continuously evaluate CMLs based on relevant current information to ensure properties are performing at a consistent and acceptable level to secure the related debt. The distribution of CMLs, gross of valuation allowances, by property type and geographic region is reflected in the following tables:


	December 31, 2025				December 31, 2024
	Gross Carrying Value		% of Total		Gross Carrying Value		% of Total
Property Type:	(Dollars in millions)


Hotel	$	9	—	%	$	17	1	%
Industrial	671		21		657		24
Mixed Use	21		1		11		—
Multifamily	1,150		35		1,006		37
Office	345		11		349		13
Retail	327		10		98		4
Student Housing	83		3		83		3
Other	654		19		501		18
Total CMLs, gross of valuation allowance	$	3,260	100	%	$	2,722	100	%
Allowance for expected credit loss	(18)				(17)
Total CMLs, net of valuation allowance	$	3,242			$	2,705

U.S. Region:
East North Central	$	124	4	%	$	98	4	%
East South Central	86		3		75		3
Middle Atlantic	356		11		354		13
Mountain	396		12		409		15
New England	183		6		164		6
Pacific	709		22		706		26
South Atlantic	1,157		34		683		25
West North Central	69		2		62		2
West South Central	180		6		171		6

Total CMLs, gross of valuation allowance	$	3,260	100	%	$	2,722	100	%
Allowance for expected credit loss	(18)				(17)
Total CMLs, net of valuation allowance	$	3,242			$	2,705

An individual loan, or a portion thereof, is charged off when it is determined to be uncollectible. There were no charge offs for CMLs for the years ended December 31, 2025 and 2024. CMLs segregated by aging of the loans (by year of origination), gross of valuation allowances, were as follows for the years ended December 31, 2025 and 2024:


	December 31, 2025

	Amortized Cost by Origination Year
	2025		2024		2023		2022		2021		Prior		Total
CMLs	(In millions)
Current (less than 30 days past due)	$	646	$	295	$	194	$	292	$	1,252	$	569	$	3,248
30-89 days past due	—		—		—		—		—		—		—
90 days or more past due	—		—		—		—		—		12		12
Total CMLs	$	646	$	295	$	194	$	292	$	1,252	$	581	$	3,260


	December 31, 2024

	Amortized Cost by Origination Year
	2024		2023		2022		2021		2020		Prior		Total
CMLs	(In millions)
Current (less than 30 days past due)	$	273	$	227	$	290	$	1,253	$	469	$	201	$	2,713
30-89 days past due	—		—		—		—		—		—		—
90 days or more past due	—		—		—		—		—		9		9
Total CMLs	$	273	$	227	$	290	$	1,253	$	469	$	210	$	2,722

Loan-to-value (“LTV”) and debt service coverage (“DSC”) ratios are measures commonly used to assess the risk and quality of mortgage loans. The LTV ratio is expressed as a percentage of the amount of the loan relative to the value of the underlying property. A LTV ratio in excess of 100% indicates the unpaid loan amount exceeds the underlying collateral. The DSC ratio, based upon the most recently received financial statements, is expressed as a percentage of the amount of a property’s net income to its debt service payments. A DSC ratio of less than 1.00 indicates that a property’s operations do not generate sufficient income to cover debt payments. We normalize our DSC ratios to a 25-year amortization period for purposes of our general loan allowance evaluation.

The following tables present the recorded investment in CMLs by LTV and DSC ratio categories and estimated fair value by the indicated LTV ratios, gross of valuation allowances:


	Debt-Service Coverage Ratios						Total Amount	% of Total		Estimated Fair Value		% of Total
	>1.25		1.00 - 1.25		<1.00
December 31, 2025	(Dollars in millions)
LTV Ratios:
Less than 50.00%	$	594	$	16	$	—		$	610	19	%	$	596	19	%
50.00% to 59.99%	850		36		37			923		28		852		28
60.00% to 74.99%	1,415		288		6			1,709		52		1,560		52
75.00% to 84.99%	—		9		9			18		1		17		1
Total CMLs	$	2,859	$	349	$	52		$	3,260	100	%	$	3,025	100	%

December 31, 2024
LTV Ratios:
Less than 50.00%	$	490	$	34	$	—		$	524	19	%	$	501	21	%
50.00% to 59.99%	803		112		12			927		34		826		34
60.00% to 74.99%	1,238		16		—			1,254		46		1,060		44
75.00% to 84.99%	4		4		9			17		1		17		1
Total CMLs	$	2,535	$	166	$	21		$	2,722	100	%	$	2,404	100	%


	December 31, 2025

	Amortized Cost by Origination Year
	2025		2024		2023		2022		2021		Prior		Total
LTV Ratios:	(In millions)
Less than 50.00%	$	148	$	49	$	66	$	21	$	75	$	251	$	610
50.00% to 59.99%	157		36		53		149		320		208		923
60.00% to 74.99%	341		206		70		113		857		122		1,709
75.00% to 84.99%	—		4		5		9		—		—		18

Total CMLs	$	646	$	295	$	194	$	292	1,252		$	581	3,260
DSC Ratios
Greater than 1.25x	$	469	$	140	$	182	$	283	$	1,240	$	545	$	2,859
1.00x - 1.25x	169		155		12		—		—		13		349
Less than 1.00x	8		—		—		9		12		23		52
Total CMLs	$	646	$	295	$	194	$	292	$	1,252	$	581	$	3,260


	December 31, 2024

	Amortized Cost by Origination Year
	2024		2023		2022		2021		2020		Prior		Total
LTV Ratios:	(In millions)
Less than 50.00%	$	66	$	99	$	19	$	74	$	189	$	77	$	524
50.00% to 59.99%	112		53		149		321		159		133		927
60.00% to 74.99%	91		71		113		858		121		—		1,254
75.00% to 84.99%	4		4		9		—		—		—		17
Total CMLs	$	273	$	227	$	290	$	1,253	$	469	$	210	$	2,722
DSC Ratios
Greater than 1.25x	$	140	$	215	$	278	$	1,241	$	469	$	192	$	2,535
1.00x - 1.25x	133		12		3		—		—		18		166
Less than 1.00x	—		—		9		12		—		—		21
Total CMLs	$	273	$	227	$	290	$	1253	$	469	$	210	$	2,722

We recognize a mortgage loan as delinquent when payments on the loan are greater than 30 days past due. As of December 31, 2025 and 2024, we had one CML that was delinquent in principal or interest payments as shown in the tables above.

Residential Mortgage Loans

Residential mortgage loans (“RMLs”) represented approximately 7% and 5% of our total investments reported on the Condensed Consolidated Balance Sheets as of December 31, 2025 and 2024, respectively. Our RMLs are primarily closed end, amortizing loans and 100% of the properties are located in the United States. We diversify our RML portfolio by state to attempt to reduce concentration risk. The distribution of RMLs by state with highest-to-lowest concentration are reflected in the following tables, gross of valuation allowances:


	December 31, 2025
U.S. States:	Amortized Cost (In millions)		% of Total
California	$	288	6	%
Florida	246		5
New York	232		5




All other states (a)	3,951		84
Total RMLs, gross of valuation allowance	$	4,717	100	%
Allowance for expected credit loss	(68)
Total RMLs, net of valuation allowance	$	4,649

(a) The individual concentration of each state is less than 5% as of December 31, 2025.


	December 31, 2024
U.S. States:	Amortized Cost (In millions)		% of Total
Florida	$	164	5	%






All other states (a)	3,110		95
Total RMLs, gross of valuation allowance	$	3,274	100	%
Allowance for expected credit loss	(53)
Total RMLs, net of valuation allowance	$	3,221

(a) The individual concentration of each state is less than 5% as of December 31, 2024.

RMLs have a primary credit quality indicator of either a performing or non-performing loan. We define non-performing residential mortgage loans as those that are 90 or more days past due or in non-accrual status, which is assessed monthly. The credit quality of RMLs was as follows:


	December 31, 2025				December 31, 2024
	Amortized Cost		% of Total		Amortized Cost		% of Total
Performance indicators:	(In millions)						(In millions)
Performing	$	4,650	99	%	$	3,188	97	%
Non-performing	67		1		86		3
Total RMLs, gross of valuation allowance	$	4,717	100	%	$	3,274	100	%
Allowance for expected loan loss	(68)				(53)
Total RMLs, net of valuation allowance	$	4,649			$	3,221

An individual loan, or a portion thereof, is charged off when it is determined to be uncollectible. There were no charge offs recorded for RMLs during the year ended December 31, 2025. RMLs segregated by aging of the loans (by year of origination) as of December 31, 2025 and 2024 were as follows, gross of valuation allowances:


	December 31, 2025

	Amortized Cost by Origination Year
	2025		2024		2023		2022		2021		Prior		Total
RMLs	(In millions)
Current (less than 30 days past due)	$	1,568	$	736	$	327	$	798	$	731	$	419	$	4,579
30-89 days past due	15		2		17		29		4		3		70
90 days or more past due	2		4		4		12		21		25		68
Total RMLS	$	1,585	$	742	$	348	$	839	$	756	$	447	$	4,717


	December 31, 2024

	Amortized Cost by Origination Year
	2024		2023		2022		2021		2020		Prior		Total
RMLs	(In millions)
Current (less than 30 days past due)	$	610	$	368	$	911	$	805	$	162	$	312	$	3,168
30-89 days past due	1		6		4		6		1		3		21
90 days or more past due	3		2		13		29		13		25		85
Total RMLS	$	614	$	376	$	928	$	840	$	176	$	340	$	3,274

Non-accrual loans by amortized cost as of December 31, 2025 and 2024 were as follows:


	December 31, 2025		December 31, 2024
	(In millions)
Residential mortgage	$	67	$	85
Commercial mortgage	12		9
Total non-accrual mortgages	$	79	$	94

Immaterial interest income was recognized on non-accrual financing receivables for the years ended December 31, 2025 and 2024.

It is our policy to cease to accrue interest on loans that are delinquent for 90 days or more. For loans less than 90 days delinquent, interest is accrued unless it is determined that the accrued interest is not collectible. If a loan becomes 90 days or more delinquent, it is our general policy to initiate foreclosure proceedings unless a workout arrangement to bring the loan current is in place. As of December 31, 2025 and 2024, we had $79 million and $94 million, respectively, of mortgage loans that were over 90 days past due.

As of December 31, 2025 and 2024 we had $111 million and $81 million, respectively, of residential mortgage loans that were in the process of foreclosure.

Loan Modifications

Under certain circumstances, modifications are granted to mortgage loans. Generally, the types of concessions may include interest rate reduction, term extension, payment deferrals, principal forgiveness or a combination of these concessions. We had an immaterial amount of mortgage loans modified during the years ended December 31, 2025 and 2024.

Allowance for Expected Credit Loss

We estimate expected credit losses for our commercial and residential mortgage loan portfolios using a probability of default/loss given default model. Significant inputs to this model include, where applicable, the loans' current performance, underlying collateral type, location, contractual life, LTV, DSC and Debt to Income or FICO. The model projects losses using a two year reasonable and supportable forecast and then reverts over a three year period to market-wide historical loss experience. Changes in our allowance for expected credit losses on mortgage loans are recognized in Recognized gains and losses, net in the Consolidated Statements of Earnings.

The allowances for our mortgage loan portfolio are summarized as follows:


	Year ended December 31, 2025			Year ended December 31, 2024
	( In millions)			( In millions)
		Residential Mortgage		Commercial Mortgage		Total		Residential Mortgage		Commercial Mortgage		Total
Beginning Balance		$	(53)	$	(17)	$	(70)	$	(54)	$	(12)	$	(66)
Provision (expense) benefit for loan losses		(15)		(1)		(16)		1		(5)		(4)




Ending Balance		$	(68)	$	(18)	$	(86)	$	(53)	$	(17)	$	(70)

An allowance for expected credit loss is not measured on accrued interest income for commercial mortgage loans as we have a process to write-off interest on loans that enter into non-accrual status (90 days or more past due). Allowances for expected credit losses are measured on accrued interest income for residential mortgage loans and were immaterial as of December 31, 2025 and 2024.

There were no purchases of purchased credit deteriorated mortgage loans during the years ended December 31, 2025 and 2024.

As of December 31, 2025 and 2024, the accrued interest receivable balance on CMLs totaled $11 million and $8 million, respectively, and the accrued interest receivable on RMLs totaled $45 million and $28 million, respectively. Accrued interest receivable is classified within Prepaid expenses and other assets within the Consolidated Balance Sheets.

Interest and Investment Income

The major sources of Interest and investment income reported on the Consolidated Statements of Earnings were as follows:


	Year ended
		December 31, 2025		December 31, 2024		December 31, 2023
		(In millions)
Fixed maturity securities, available-for-sale		$	2,329	$	2,261	$	1,911
Preferred equity securities		26		34		52
Common equity securities		36		33		33
Mortgage loans		374		273		229

Invested cash and short-term investments		180		238		151

Limited partnerships		305		326		231
Tax deferred property exchange income		122		133		166
Other investments		136		125		91
Gross investment income		3,508		3,423		2,864
Investment expense		(271)		(299)		(257)
Interest and investment income		$	3,237	$	3,124	$	2,607

Interest and investment income is shown net of amounts attributable to certain funds withheld reinsurance agreements, which is passed along to the reinsurer in accordance with the terms of these agreements. Interest and investment income attributable to these agreements, and thus excluded from the totals in the table above, was $816 million, $636 million, and $339 million for the years ended December 31, 2025, 2024, and 2023, respectively.

Recognized Gains and Losses, Net

Details underlying Recognized gains and losses, net reported on the Consolidated Statements of Earnings were as follows:


	Year ended
		December 31, 2025		December 31, 2024		December 31, 2023
		(In millions)
Net realized (losses) on fixed maturity available-for-sale securities		$	(10)	$	(9)	$	(155)
Net realized/unrealized (losses) gains on preferred equity securities (a)		(167)		2		23
Net realized/unrealized (losses) gains on common equity securities (b)		(4)		12		(1)
Net realized gains (losses) on other invested assets		70		61		(25)
Change in allowance for expected credit losses		(60)		(33)		(36)
Derivatives and embedded derivatives:
Realized (losses) gains on certain derivative instruments		(62)		254		(211)
Unrealized gains (losses) on certain derivative instruments		312		(184)		358
Change in fair value of reinsurance related embedded derivatives (c)		(148)		(32)		(128)
Change in fair value of other derivatives and embedded derivatives		9		12		11
Net realized/unrealized gains on derivatives and embedded derivatives		111		50		30
Recognized gains and losses, net		$	(60)	$	83	$	(164)

(a) Includes net valuation (losses) gains of $(8) million, $(131) million, and $47 million for the years ended December 31, 2025, 2024, and 2023, respectively.

(b) Includes net valuation gains (losses) of $(1) million, $13 million, and $80 million for the years ended December 31, 2025, 2024, and 2023, respectively

(c) Change in fair value of reinsurance related embedded derivatives is due to activity related to the reinsurance treaties.

Recognized gains and losses is shown net of amounts attributable to certain funds withheld reinsurance agreements which are passed along to the reinsurer in accordance with the terms of these agreements. Recognized (losses) gains attributable to these agreements, and thus excluded from the totals in the table above, was $(154) million, $(30) million and $(123) million for the years ended December 31, 2025, 2024, and 2023, respectively.

The proceeds from the sale of fixed-maturity securities and the gross gains and losses associated with those transactions were as follows:


	Year ended
		December 31, 2025		December 31, 2024		December 31, 2023
		(In millions)
Proceeds		$	5,720	$	4,414	$	2,698
Gross gains		30		45		18
Gross losses		(27)		(80)		(145)

Variable Interest Entities

Our involvement with VIEs is primarily through investments in entities that provide exposure to a diversified portfolio of investment asset classes. A VIE is an entity that does not have sufficient equity to finance its own activities without additional financial support, where investors lack certain characteristics of a controlling financial interest, or where the entity is structured with non-substantive voting rights. VIEs are consolidated by their ‘primary beneficiary,’ a designation given to an entity that receives both the benefits from the VIE as well as the substantive power to make its key economic decisions. We perform ongoing qualitative assessments of our variable interests in VIEs to determine whether we have a controlling financial interest and are therefore the primary beneficiary of the VIE. We consolidate the assets and liabilities (if applicable) of VIEs for which we are determined to be the primary beneficiary in our consolidated financial statements.

Consolidated variable interest entities

We have concluded that we are the primary beneficiary for certain VIEs where we have both the power to direct the most significant activities of the VIE and the obligation to absorb losses or the right to receive benefits that could potentially be significant to the VIE.

Consolidated VIEs at December 31, 2025 are structured investments that are managed by third parties. These structured investments are established as special purpose vehicles (“SPVs”) designed to hold specific assets which include limited partnerships, middle market loans, short-term investments, and cash and cash equivalents. The assets of each VIE can be used only to settle obligations of the VIE. Asset and liability information held by consolidated VIEs included on the Consolidated Balance Sheets are as follows:


	December 31,
	2025		2024

Assets	(In millions)

Investments in unconsolidated affiliates	$	262		$	—
Other long-term investments	248			—
Short-term investments	116			—
Cash and cash equivalents	2			—
Total assets	$	628		$	—




Total consolidated VIE investments	$	628		$	—

We are not required to provide financial support to these VIEs beyond our contractual obligations. Our maximum exposure to loss related to these consolidated VIEs is limited to our capital invested plus any unfunded capital commitments (refer to unfunded commitments in Note G Commitments and Contingencies). The maximum loss exposure of our consolidated VIEs as of December 31, 2025 was $878 million.

Unconsolidated Variable Interest Entities

The Company owns investments in VIEs that are not consolidated within our financial statements. While the Company participates in the benefits from these VIEs in which the Company invests, but do not consolidate, the substantive power to make the key economic decisions for each respective VIE resides with entities not under the Company's common control. It is for this reason that the Company is not considered the primary beneficiary for the VIE investments that are not consolidated.

We invest in various limited partnerships and limited liability companies primarily as a passive investor. These investments are primarily in credit funds with a bias towards current income, real assets, or private equity. Limited partnership and limited liability company interests are accounted for under the equity method and are included in Investments in unconsolidated affiliates on our Consolidated Balance Sheets. In addition, we invest in structured investments, which may be VIEs, but for which we are not the primary beneficiary. These structured investments typically invest in fixed income investments and are

managed by third parties and include asset-backed securities, commercial mortgage-backed securities and residential mortgage-backed securities included in fixed maturity securities available for sale on our Consolidated Balance Sheets.

Our maximum loss exposure with respect to these VIEs is limited to the investment carrying amounts reported in our Consolidated Balance Sheets for limited partnerships and the amortized costs of certain of our fixed maturity securities, in addition to any required unfunded commitments (refer to Note G Commitments and Contingencies).

The following table summarizes the carrying value and the maximum loss exposure of our unconsolidated VIEs:


	December 31, 2025				December 31, 2024
	Carrying Value		Maximum Loss Exposure		Carrying Value		Maximum Loss Exposure
	(In millions)
Investment in unconsolidated affiliates	$	5,145	$	6,389	$	3,565	$	4,703
Fixed maturity securities	26,419		28,803		23,242		24,242
Total unconsolidated VIE investments	$	31,564	$	35,192	$	26,807	$	28,945

Contractholder Funds (Tables)

12 Months Ended

Dec. 31, 2025

Schedule of Balances and Changes in Contract holder Funds

The following tables summarize balances of and changes in contractholder funds’ account balances:


	December 31, 2025
	Indexed annuities			Fixed rate annuities			Universal life			FABN (b)		FHLB (b)
	(In millions)
Balance, beginning of year	$	30,235		$	17,442		$	2,817		$	2,463	$	2,852
Issuances	6,714			3,801			229			1,148		2,241
Premiums received	31			—			593			—		—
Policy charges (a)	(222)			—			(378)			—		—
Surrenders and withdrawals	(3,831)			(2,485)			(130)			—		—
Benefit payments	(536)			(358)			(21)			(395)		(2,298)

Interest credited	830			866			182			107		103
Other	5			(1)			—			1		—
Balance, end of year	33,226			19,265			3,292			3,324		2,898
Reconciling items (c)	321			2			115			11		—
Gross liability, end of year	33,547			19,267			3,407			3,335		2,898
Less: Reinsurance recoverable	3,198			12,863			887			—		—
Net liability, after reinsurance	$	30,349		$	6,404		$	2,520		$	3,335	$	2,898

Weighted-average crediting rate	2.65		%	4.84		%	6.13		%	N/A		N/A
Net amount at risk (d)	N/A			N/A			$	29,581		N/A		N/A
Cash surrender value (e)	$	30,920		$	18,034		$	2,533		N/A		N/A

(a)Contracts included in the contractholder funds are generally charged a premium and/or monthly assessments on the basis of the account balance.

(b)FABN and FHLB are considered funding agreements that are investment contracts which follow the interest method of accounting, and therefore are not subject to ASU 2018-12 disclosure requirements. However, the Company has elected to present the liability for these agreements within the disaggregated roll forward as we believe it will provide meaningful information for users of the financials.

(c)The reconciling items reconcile the account balance to the gross GAAP liability. For indexed annuities and universal life, the reconciling items represent embedded derivatives and include the combination of the host contracts and the fair value of the embedded derivatives. For FABN, the reconciling items represent basis adjustments due to the impact of fair value hedge accounting.

(d)For those guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date.

(e)These amounts are gross of reinsurance.


	December 31, 2024
	Indexed annuities			Fixed rate annuities			Universal life			FABN (b)		FHLB (b)
	(In millions)
Balance, beginning of year	$	27,164		$	13,443		$	2,391		$	2,613	$	2,539
Issuances	6,649			5,125			208			600		1,804
Premiums received	120			1			495			—		—
Policy charges (a)	(195)			—			(315)			—		—
Surrenders and withdrawals	(3,832)			(1,479)			(101)			—		—
Benefit payments	(495)			(315)			(18)			(820)		(1,606)

Interest credited	821			667			157			71		117
Other	3			—			—			(1)		(2)
Balance, end of year	30,235			17,442			2,817			2,463		2,852
Embedded derivative adjustment (c)	219			—			79			—		—
Gross liability, end of year	30,454			17,442			2,896			2,463		2,852
Less: Reinsurance recoverable	861			11,009			877			—		—
Net liability, after reinsurance	$	29,593		$	6,433		$	2,019		$	2,463	$	2,852

Weighted-average crediting rate	2.90		%	4.42		%	6.20		%	N/A		N/A
Net amount at risk (d)	N/A			N/A			$	74,279		N/A		N/A
Cash surrender value (e)	$	27,865		$	16,266		$	2,177		N/A		N/A

(a)Contracts included in the contractholder funds are generally charged a premium and/or monthly assessments on the basis of the account balance.

(c)The embedded derivative adjustment reconciles the account balance to the gross GAAP liability and represents the combination of the host contract and the fair value of the embedded derivatives.

(e)These amounts are gross of reinsurance.

Schedule of Reconciliation of Policyholder Account Balances to Statement of Financial Position

The following table reconciles contractholder funds’ account balances to the contractholder funds liability in the Consolidated Balance Sheets:


	December 31,
	2025		2024
	(In millions)
Indexed annuities	$	33,547	$	30,454
Fixed rate annuities	19,267		17,442
Immediate annuities	262		286
Universal life	3,407		2,896
Traditional life	4		5
FABN	3,335		2,463
FHLB	2,898		2,852
PRT	6		6
Total	$	62,726	$	56,404

Schedule of Policyholder Account Balance, Guaranteed Minimum Crediting Rate

The following tables present the account values by range of guaranteed minimum crediting rates and the related range of difference, in basis points, between rates being credited to policyholders and the respective guaranteed minimums:


	December 31, 2025
Range of guaranteed minimum crediting rate	At Guaranteed Minimum		1 Basis Point-50 Basis Points Above		51 Basis Points-150 Basis Points Above		Greater Than 150 Basis Points Above		Total
Indexed annuities	(In millions)
Up to 1.50%	$	659	$	464	$	298	$	812	$	2,233
1.51%-2.50%	548		17		633		630		1,828
Greater than 2.50%	212		1		—		1		214
Subtotal	1,419		482		931		1,443		$	4,275
No guaranteed minimum crediting rate									28,951
Total									$	33,226

Fixed rate annuities
Up to 1.50%	$	94	$	75	$	792	$	15,548	$	16,509
1.51%-2.50%	4		6		16		466		492
Greater than 2.50%	727		2		5		1,530		2,264
Total	$	825	$	83	$	813	$	17,544	$	19,265

Universal Life
Up to 1.50%	$	2,898	$	9	$	—	$	31	$	2,938
1.51%-2.50%	—		—		—		—		—
Greater than 2.50%	353		—		1		—		354
Total	$	3,251	$	9	$	1	$	31	$	3,292


	December 31, 2024
Range of guaranteed minimum crediting rate	At Guaranteed Minimum		1 Basis Point-50 Basis Points Above		51 Basis Points-150 Basis Points Above		Greater Than 150 Basis Points Above		Total
Indexed annuities	(In millions)
Up to 1.50%	$	721	$	596	$	309	$	880	$	2,506
1.51%-2.50%	432		1		313		485		1,231
Greater than 2.50%	253		—		—		14		267
Subtotal	$	1,406	$	597	$	622	$	1,379	$	4,004
No guaranteed minimum crediting rate									26,231
Total									$	30,235

Fixed rate annuities
Up to 1.50%	$	57	$	20	$	773	$	14,407	$	15,257
1.51%-2.50%	4		7		20		462		493
Greater than 2.50%	804		2		5		881		1,692
Total	$	865	$	29	$	798	$	15,750	$	17,442

Universal Life
Up to 1.50%	$	2,421	$	7	$	—	$	24	$	2,452
1.51%-2.50%	—		—		—		—		—
Greater than 2.50%	364		—		1		—		365
Total	$	2,785	$	7	$	1	$	24	$	2,817

Goodwill

12 Months Ended

Dec. 31, 2025

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill

A summary of the changes in Goodwill consists of the following:


	Title		F&G		Corporate and Other		Total
	(In millions)
Balance, December 31, 2023	$	2,788	$	1,749	$	293	$	4,830
Goodwill associated with acquisitions	11		430		—		441

Balance, December 31, 2024	$	2,799	$	2,179	$	293	$	5,271
Goodwill associated with acquisitions	—		1		—		1




Balance, December 31, 2025	$	2,799	$	2,180	$	293	$	5,272

The entire disclosure for goodwill.

Revenue Recognition - Narrative (Details)	12 Months Ended
Revenue Recognition - Narrative (Details)	Dec. 31, 2025
Revenue Recognition and Deferred Revenue [Abstract]
Home warranty contract, period	1 year

Investments - Changes in Allowance for Expected Credit Losses on Mortgage Loans (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning Balance	$ (70)	$ (66)
Provision (expense) benefit for loan losses	(16)	(4)
Ending Balance	(86)	(70)
Residential Mortgage
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning Balance	(53)	(54)
Provision (expense) benefit for loan losses	(15)	1
Ending Balance	(68)	(53)
Commercial Mortgage
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning Balance	(17)	(12)
Provision (expense) benefit for loan losses	(1)	(5)
Ending Balance	$ (18)	$ (17)

Business and Summary of Significant Accounting Policies - Trade and Notes Receivable (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Revenue Recognition, Milestone Method [Line Items]
Insurance commissions as percentage of agent premiums	77.50%	77.40%	76.90%
Premium due from agents, net of accrued sales commissions	$ 42	$ 40
Minimum
Revenue Recognition, Milestone Method [Line Items]
Accrual for agency premiums reported within three months, percent	48.00%
Accrual for agency premiums reported within next three months, percent	24.00%
Accrual for agency premiums, remaining period	7 months
Maximum
Revenue Recognition, Milestone Method [Line Items]
Accrual for agency premiums reported within three months, percent	75.00%
Accrual for agency premiums reported within next three months, percent	48.00%
Accrual for agency premiums, remaining period	15 months

Cybersecurity Risk Management and Strategy Disclosure	12 Months Ended
Cybersecurity Risk Management and Strategy Disclosure	Dec. 31, 2025
Cybersecurity Risk Management, Strategy, and Governance [Line Items]
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]	We assess, identify and manage cybersecurity risks through various processes within our Enterprise Risk Management Program and Information Security Program. We focus on all areas of cybersecurity, including threat and vulnerability management, security monitoring, identity and access management, phishing awareness, risk oversight, third-party risk management, disaster recovery and continuity management. We have established policies, including those related to privacy, information security and cybersecurity, and we employ a broad and diversified set of cybersecurity risk monitoring and risk mitigation techniques. Internal audits, external audits and self-assessments are conducted to assess the effectiveness and maturity of our Enterprise Risk Management Program and Information Security Program. Our employees are one of our strongest assets in protecting our customers' information and mitigating cybersecurity risk. We maintain comprehensive and tailored training programs that focus on applicable privacy and cybersecurity requirements. Additionally, we make strategic investments in cybersecurity to protect our customers and information systems, including both capital expenditures and operating expenses for hardware, software, personnel and consulting services. Our processes to assess, identify and manage cybersecurity risks, including cybersecurity risks related to the use of third-party service providers, are fully integrated into our Enterprise Risk Management Program. In some circumstances we use third-party service providers to provide expertise and to monitor utilization of specific cyber tools, and in certain cases, to supplement staffing services. Through our vendor risk management process, these vendors undergo various assessments such as financial, reputational, contractual and informational security. These assessments are performed to ascertain that these vendors meet our policy requirements relative to the services they perform on our behalf. To further reduce the residual risk associated with cybersecurity, we maintain Miscellaneous Professional Liability Insurance, which provides coverage for cybersecurity incidents. The deductible limits on these policies are determined by a corporate insurance risk management group and executive management at least on an annual basis. This group determines appropriate coverage levels and deductibles for each policy based on tolerance and weighs the coverage against the premium for the policy.
Cybersecurity Risk Management Processes Integrated [Flag]	true
Cybersecurity Risk Management Processes Integrated [Text Block]	We assess, identify and manage cybersecurity risks through various processes within our Enterprise Risk Management Program and Information Security Program. We focus on all areas of cybersecurity, including threat and vulnerability management, security monitoring, identity and access management, phishing awareness, risk oversight, third-party risk management, disaster recovery and continuity management. We have established policies, including those related to privacy, information security and cybersecurity, and we employ a broad and diversified set of cybersecurity risk monitoring and risk mitigation techniques. Internal audits, external audits and self-assessments are conducted to assess the effectiveness and maturity of our Enterprise Risk Management Program and Information Security Program. Our employees are one of our strongest assets in protecting our customers' information and mitigating cybersecurity risk. We maintain comprehensive and tailored training programs that focus on applicable privacy and cybersecurity requirements. Additionally, we make strategic investments in cybersecurity to protect our customers and information systems, including both capital expenditures and operating expenses for hardware, software, personnel and consulting services. Our processes to assess, identify and manage cybersecurity risks, including cybersecurity risks related to the use of third-party service providers, are fully integrated into our Enterprise Risk Management Program. In some circumstances we use third-party service providers to provide expertise and to monitor utilization of specific cyber tools, and in certain cases, to supplement staffing services. Through our vendor risk management process, these vendors undergo various assessments such as financial, reputational, contractual and informational security. These assessments are performed to ascertain that these vendors meet our policy requirements relative to the services they perform on our behalf.
Cybersecurity Risk Management Third Party Engaged [Flag]	true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]	true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]	false
Cybersecurity Risk Board of Directors Oversight [Text Block]	Management's Role in Assessing and Managing Cybersecurity Risk Our Corporate Information Security Group is led by our Chief Information Security Officer ("CISO") who is responsible for our information security strategy. This strategy includes policy management, security engineering, identity and access management, vulnerability management and cyber threat detection and response through our Security Operations Center. Our CISO has extensive information technology and program management experience as do many of our employees in our information security group. Our CISO, as well as others in our information security group, hold certifications such the Certified Information System Security Professional certification. We believe cybersecurity is a shared responsibility throughout the organization and thus we also manage cybersecurity risks, through a cross-functional committee of members of senior management known as the Enterprise Risk Steering Committee, which includes the CISO. The diversity of this group allows for identification of key enterprise risks from strategic, operational, financial, legal, information technology and compliance perspectives. These individuals receive reporting on our cybersecurity programs and also participate in table-top exercises relating to potential security incidents. The CISO is also the primary point of contact for reporting information security incidents and for coordinating information security activities including incident response and digital forensics. Our CISO reports to our Chief Security Officer who also has extensive experience in the information security space. Board Oversight of Cybersecurity Our board has a strong focus on cybersecurity. Our approaches to cybersecurity and privacy risk are overseen by the audit committee. At each regular meeting of the audit committee of our Board of Directors, our Chief Risk Officer, Chief Compliance Officer, Chief Security Officer, Chief Information Security Officer, and Chief Audit Officer provide reports relating to existing and emerging cyber and data security risks, as well as reports on the Company’s risk assessments and security incidents. Our audit committee chairman reports on these discussions to our board of directors on a quarterly basis. See Item 1A Risk Factors for discussion of material risks faced by the Company, including risks related to cybersecurity. 2023 Cybersecurity Incident On November 19, 2023, we became aware of a cybersecurity incident that impacted certain of our systems. We promptly commenced an investigation, retained leading experts to assist the Company, notified law enforcement authorities, regulatory authorities and other stakeholders and followed our incident response plans. In addition, we took containment measures such as blocking access to certain of our systems resulting in varying levels of disruption to our businesses. The incident was contained on November 26, 2023. We completed our forensic investigation on December 13, 2023. We determined that an unauthorized third-party accessed certain of our systems, deployed a type of malware that is not self-propagating and exfiltrated certain data. We have no evidence that any customer-owned system was directly impacted in the incident, and no customer has reported that this has occurred. The last confirmed date of unauthorized third-party activity in our network occurred on November 20, 2023. This incident did not have a material impact on the Company.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]	Our approaches to cybersecurity and privacy risk are overseen by the audit committee. At each regular meeting of the audit committee of our Board of Directors, our Chief Risk Officer, Chief Compliance Officer, Chief Security Officer, Chief Information Security Officer, and Chief Audit Officer provide reports relating to existing and emerging cyber and data security risks, as well as reports on the Company’s risk assessments and security incidents. Our audit committee chairman reports on these discussions to our board of directors on a quarterly basis.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]	Our approaches to cybersecurity and privacy risk are overseen by the audit committee. At each regular meeting of the audit committee of our Board of Directors, our Chief Risk Officer, Chief Compliance Officer, Chief Security Officer, Chief Information Security Officer, and Chief Audit Officer provide reports relating to existing and emerging cyber and data security risks, as well as reports on the Company’s risk assessments and security incidents. Our audit committee chairman reports on these discussions to our board of directors on a quarterly basis.
Cybersecurity Risk Role of Management [Text Block]	Our Corporate Information Security Group is led by our Chief Information Security Officer ("CISO") who is responsible for our information security strategy. This strategy includes policy management, security engineering, identity and access management, vulnerability management and cyber threat detection and response through our Security Operations Center. Our CISO has extensive information technology and program management experience as do many of our employees in our information security group. Our CISO, as well as others in our information security group, hold certifications such the Certified Information System Security Professional certification. We believe cybersecurity is a shared responsibility throughout the organization and thus we also manage cybersecurity risks, through a cross-functional committee of members of senior management known as the Enterprise Risk Steering Committee, which includes the CISO. The diversity of this group allows for identification of key enterprise risks from strategic, operational, financial, legal, information technology and compliance perspectives. These individuals receive reporting on our cybersecurity programs and also participate in table-top exercises relating to potential security incidents. The CISO is also the primary point of contact for reporting information security incidents and for coordinating information security activities including incident response and digital forensics. Our CISO reports to our Chief Security Officer who also has extensive experience in the information security space.
Cybersecurity Risk Management Positions or Committees Responsible [Flag]	true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]	At each regular meeting of the audit committee of our Board of Directors, our Chief Risk Officer, Chief Compliance Officer, Chief Security Officer, Chief Information Security Officer, and Chief Audit Officer provide reports relating to existing and emerging cyber and data security risks, as well as reports on the Company’s risk assessments and security incidents. Our audit committee chairman reports on these discussions to our board of directors on a quarterly basis.
Cybersecurity Risk Management Expertise of Management Responsible [Text Block]	Our CISO reports to our Chief Security Officer who also has extensive experience in the information security space.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]	Our board has a strong focus on cybersecurity. Our approaches to cybersecurity and privacy risk are overseen by the audit committee. At each regular meeting of the audit committee of our Board of Directors, our Chief Risk Officer, Chief Compliance Officer, Chief Security Officer, Chief Information Security Officer, and Chief Audit Officer provide reports relating to existing and emerging cyber and data security risks, as well as reports on the Company’s risk assessments and security incidents. Our audit committee chairman reports on these discussions to our board of directors on a quarterly basis.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]	true

Future Policy Benefits - Additional Information, Cohort NPR (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Insurance [Abstract]
NPR before capping	104.00%	108.00%
Reserves before NPR capping	$ 1,145	$ 1,147
Reserves after NPR capping	1,156	1,174
Loss Expense	$ 11	$ 27

Notes Payable - Schedule of Long Term Debt (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024	Oct. 04, 2024	Jun. 04, 2024	Dec. 06, 2023	Jan. 13, 2023	Sep. 17, 2021	Sep. 15, 2020
Debt Instrument [Line Items]
Notes payable	$ 4,400	$ 4,321
4.50% Notes, net of discount \| Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	4.50%
Notes payable	$ 448	447
3.40% Notes, net of discount \| Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	3.40%
Notes payable	$ 646	646
2.45% Notes, net of discount \| Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	2.45%							2.45%
Notes payable	$ 596	595
3.20% Notes, net of discount
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage							3.20%
3.20% Notes, net of discount \| Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	3.20%
Notes payable	$ 445	444
Revolving Credit Facility \| Line of Credit \| Revolving Credit Facility
Debt Instrument [Line Items]
Revolving Credit Facility	(3)	(4)
F&G Credit Agreement \| Line of Credit \| Revolving Credit Facility
Debt Instrument [Line Items]
Notes payable	$ 0	0
5.50% F&G Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	5.50%
Notes payable	$ 0	301
7.40% F&G Notes, net of discount \| Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	7.40%					7.40%
Notes payable	$ 498	497
7.30% F&G Notes
Debt Instrument [Line Items]
Notes payable	$ 364	0
7.95% F&G Notes, net of discount \| Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	7.95%				7.95%
Notes payable	$ 336	336
6.50% F&G Notes, net of discount \| Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	6.50%			6.50%
Notes payable	$ 546	545
6.25% F&G Notes, net of discount \| Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	6.25%		6.25%
Notes payable	$ 493	492
Other
Debt Instrument [Line Items]
Notes payable	$ 31	$ 22

Schedule II - Condensed Financial Information - Balance Sheets (Parent Company) Narrative (Details) - $ / shares	Dec. 31, 2025	Dec. 31, 2024
Condensed Balance Sheet Statements, Captions [Line Items]
Common stock, par value per share (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	600,000,000	600,000,000
Common stock, shares outstanding (in shares)	271,000,000	275,000,000
Common stock, shares issued (in shares)	332,000,000	331,000,000
Preferred stock, par or stated value per share (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	50,000,000	50,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Treasury stock (in shares)	61,000,000	56,000,000
Parent Company
Condensed Balance Sheet Statements, Captions [Line Items]
Common stock, par value per share (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	600,000,000	600,000,000
Common stock, shares outstanding (in shares)	271,000,000	275,000,000
Common stock, shares issued (in shares)	332,000,000	331,000,000
Preferred stock, par or stated value per share (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	50,000,000	50,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Treasury stock (in shares)	61,000,000	56,000,000

Derivative Financial Instruments - Schedule of Exposure to Credit Loss on Call Options Held (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Derivatives, Fair Value [Line Items]
Fair Value	$ 1,596	$ 925
Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Fair Value	1,585	923
Not Designated as Hedging Instrument \| Derivative instruments excluding futures contracts
Derivatives, Fair Value [Line Items]
Fair Value	1,137	782
Collateral	1,185	771
Net Credit Risk	$ 34	$ 34

Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Financial Instruments (Tables)

12 Months Ended

Dec. 31, 2025

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value

The notional and carrying amounts of derivative financial instruments, including derivative instruments embedded in indexed annuities and IUL contracts, and reinsurance are as follows:


	December 31, 2025						December 31, 2024
	Gross Notional		Assets		Liabilities		Gross Notional		Assets		Liabilities
	(In millions)
Derivatives designated as hedging instruments
Interest rate swaps (a)	$	850	$	11	$	1	$	—	$	—	$	—

Foreign currency swaps (a)	21		—		3		39		2		—
Total derivatives designated as hedging instruments	871		11		4		39		2		—

Derivatives not designated as hedging instruments
Equity options (a)	29,651		1,062		—		29,594		773		—
Interest rate swaps (a)	6,453		83		3		5,145		19		10
Foreign currency swaps (a)	503		—		6		—		—		—
Futures contracts (a)	68		—		1		152		—		—
Other derivative investments (a)	93		—		—		118		1		—
Other embedded derivatives (b)	—		41		—		—		32		—
Indexed annuities/IUL embedded derivatives (c)	—		399		6,542		—		98		5,220
Reinsurance related embedded derivatives (d)	—		—		75		—		—		(109)
Total derivatives not designated as hedging instruments	36,768		1,585		6,627		35,009		923		5,121
Total derivatives	$	37,639	$	1,596	$	6,631	$	35,048	$	925	$	5,121

(a)The fair value of derivative assets is reported in Derivative investments, and the fair value of derivative liabilities is reported in Accounts payable and accrued liabilities on the Consolidated Balance Sheets.

(b)The fair value is included in Other long term investments on the Consolidated Balance Sheets.

(c)The fair value of the liability is included in Contractholder funds and the ceded portion is included in Reinsurance recoverable on the Consolidated Balance Sheets.

(d)The fair value of the embedded derivative asset is included in Funds withheld for reinsurance liabilities as a contra-liability on the Consolidated Balance Sheet as of December 31, 2024.

The following amounts are recorded in the Consolidated Balance Sheets related to the carrying amount of hedged assets and (liabilities) and the cumulative basis adjustment included in the carrying amount for fair value hedges:


	Year Ended December 31,
	2025				2024
Line Item in the Consolidated Balance Sheet that includes hedged item	Carrying Amount of Hedged Assets (Liabilities)		Cumulative Amount of Fair Value Hedging Adjustment included in the Carrying Amount of the Hedged Assets (Liabilities)		Carrying Amount of Hedged Assets (Liabilities)		Cumulative Amount of Fair Value Hedging Adjustment included in the Carrying Amount of the Hedged Assets (Liabilities)
	(In millions)
Fixed maturity securities, AFS, at amortized cost	$	21	$	—	$	—	$	—
Contractholder funds	(862)		(11)		—		—

Schedule of Derivative Instruments, Gain (Loss)

The amounts and locations of gains losses, net recognized for derivatives items included in the Consolidated Statements of Earnings are as follows:


	Year Ended December 31,
	2025				2024				2023
	Recognized gains losses, net for derivatives		Benefits and other changes in policy reserves for derivatives		Recognized gains losses, net for derivatives		Benefits and other changes in policy reserves for derivatives		Recognized gains losses, net for derivatives		Benefits and other changes in policy reserves for derivatives
	(In millions)
Derivatives designated as hedging instruments
Interest rate swaps	$	—	$	11	$	—	$	—	$	—	$	—

Foreign currency swaps	(3)		—		—		—		—		—
Total derivatives designated as hedging instruments	(3)		11		—		—		—		—

Derivatives not designated as hedging instruments
Equity options	177		—		145		—		92		—
Interest rate swaps	60		—		(103)		—		48		—
Foreign currency swaps	(6)		—		—		—		—		—
Futures contracts	32		—		18		—		9		—
Other derivative investments	(9)		—		10		—		(2)		—
Other embedded derivatives	9		—		4		—		5		—
Indexed annuities/IUL embedded derivatives	—		402		—		47		—		257
Reinsurance related embedded derivatives	(148)		—		(32)		—		(128)		—
Total derivatives not designated as instruments	115		402		42		47		24		257
Total derivatives	$	112	$	413	$	42	$	47	$	24	$	257

The amounts and locations of gains losses, net recognized for hedged items included in the Consolidated Statements of Earnings are as follows:


	Year Ended December 31,
	2025				2024				2023
	Recognized gains losses, net for hedged item		Benefits and other changes in policy reserves for hedged item		Recognized gains losses, net for hedged item		Benefits and other changes in policy reserves for hedged item		Recognized gains losses, net for hedged item		Benefits and other changes in policy reserves for hedged item
	(In millions)
Derivatives designated as hedging instruments
Interest rate swaps	$	—	$	(11)	$	—	$	—	$	—	$	—

Foreign currency swaps	3		—		—		—		—		—
Total derivatives designated as hedging instruments	$	3	$	(11)	$	—	$	—	$	—	$	—

Schedule of Information Regarding Exposure to Credit Loss on Call Options Held

Information regarding our exposure to credit loss on the derivative instruments we hold, excluding futures contracts, is presented below:


		Fair Value		Collateral		Net Credit Risk
	(In millions)
December 31, 2025		$	1,137	$	1,185	$	34
December 31, 2024		782		771		34

F&G Reinsurance (Tables)

12 Months Ended

Dec. 31, 2025

Reinsurance Disclosures [Abstract]

Schedule of Effect of Reinsurance on Premiums Earned, Benefits Incurred and Reserve Changes

The effects of reinsurance on net premiums earned, net product fees and net benefits incurred (benefits paid and reserve changes) for the years ended December 31, 2025, 2024, and 2023 respectively, were as follows:


	Year Ended December 31,
	2025						2024						2023
	Net Premiums Earned		Net Product Fees		Net Benefits Incurred		Net Premiums Earned		Net Product Fees		Net Benefits Incurred		Net Premiums Earned		Net Product Fees		Net Benefits Incurred
	(In millions)
Direct	$	2,223	$	717	$	4,197	$	2,346	$	655	$	3,987	$	2,112	$	455	$	3,728

Ceded	(85)		(60)		(234)		(94)		(47)		(196)		(105)		(49)		(175)
Net	$	2,138	$	657	$	3,963	$	2,252	$	608	$	3,791	$	2,007	$	406	$	3,553

Schedule of Reinsurance Recoverable

The following summarizes our reinsurance recoverable as of December 31, 2025 and 2024:

Parent Company/
Principal Reinsurers

Reinsurance Recoverable (a)

Agreement Type

Products
Covered

Accounting

December 31, 2025

December 31, 2024

(In millions)

Aspida (b)

8,589

7,844

Coinsurance Funds Withheld

Certain MYGA

Deposit

Somerset Reinsurance Ltd. (c)

5,071

2,822

Coinsurance Funds Withheld

Certain MYGA and deferred annuities

Deposit

Coinsurance Funds Withheld

Certain FIA

Reinsurance

Everlake

1,868

1,168

Coinsurance

Certain MYGA (d)

Deposit

Wilton Reassurance Company

1,032

1,066

Coinsurance

Block of traditional, IUL, and UL (e)

Reinsurance

Fort Greene

502

—

Coinsurance Funds Withheld

Certain FIA

Deposit

Other (f)

501

489

Reinsurance recoverable, gross of allowance

17,563

13,389

Allowance for expected credit loss

(18)

(20)

Reinsurance recoverable, net of allowance for expected credit losses

17,545

13,369

(a)Reinsurance recoverables do not include unearned ceded premiums that would be recovered in the event of early termination of certain traditional life policies.

(b)Includes Aspida Life Re Ltd. and Aspida Re Cayman Ltd.

(c)The balance represents the total reinsurance recoverable for all reinsurance agreements with Somerset.

(d)Reinsurance recoverable is collateralized by assets placed in a statutory comfort trust by the reinsurer and maintained for our sole benefit.

(e)Also includes certain FGL Insurance life insurance policies that are subject to redundant reserves, reported on a statutory basis, under Regulation XXX and Guideline AXXX.

(f)Represents all other reinsurers, with no single reinsurer having a carrying value in excess of 5% of total reinsurance recoverable.

Schedule of Reinsurance Recoverable, Expected Credit Loss Reserves

The expected credit loss reserves were as follows:


	Year Ended December 31,
	2025		2024
	(In millions)
Balance at Beginning of Period	$	(20)	$	(21)
Changes in the expected credit loss reserve	2		1
Balance at End of Period	$	(18)	$	(20)

Schedule of Credit Ratings of Principal Reinsurers

We believe that all amounts

due from Aspida, Somerset Re, Everlake, Wilton Re, and Fort Greene for periodic treaty settlements, net of any applicable credit loss reserves, are collectible as of December 31, 2025:

Parent Company/Principal Reinsurers

Financial Strength Rating

AM Best

S&P

Fitch

Moody's

Aspida

A-

—

Somerset Re

BBB+

—

Everlake

—

Wilton Re

A+

—

A-

—

Fort Greene

—

“—” indicates not rated

Investments - Major Sources of Interest and Investment Income (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Schedule of Investments [Line Items]
Gross investment income	$ 3,508	$ 3,423	$ 2,864
Limited partnerships	305	326	231
Investment expense	(271)	(299)	(257)
Interest and investment income	3,237	3,124	2,607
Fixed maturity securities, available-for-sale
Schedule of Investments [Line Items]
Gross investment income	2,329	2,261	1,911
Preferred equity securities
Schedule of Investments [Line Items]
Gross investment income	26	34	52
Common equity securities
Schedule of Investments [Line Items]
Gross investment income	36	33	33
Mortgage loans
Schedule of Investments [Line Items]
Gross investment income	374	273	229
Invested cash and short-term investments
Schedule of Investments [Line Items]
Gross investment income	180	238	151
Tax deferred property exchange income
Schedule of Investments [Line Items]
Gross investment income	122	133	166
Other investments
Schedule of Investments [Line Items]
Gross investment income	$ 136	$ 125	$ 91

Other Intangible Assets - DAC (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
DAC
DAC at beginning of period	$ 3,031	$ 2,211
Capitalization	954	1,100
Amortization	(357)	(280)	$ (186)
DAC at end of period	3,628	3,031	2,211
Indexed annuities
DAC
DAC at beginning of period	1,874	1,378
Capitalization	530	652
Amortization	(199)	(156)
DAC at end of period	2,205	1,874	1,378
Fixed rate annuities
DAC
DAC at beginning of period	376	288
Capitalization	132	174
Amortization	(106)	(86)
DAC at end of period	402	376	288
Universal Life
DAC
DAC at beginning of period	781	545
Capitalization	292	274
Amortization	(52)	(38)
DAC at end of period	$ 1,021	$ 781	$ 545

Amount of amortization expense (reversal of expense) for deferred policy acquisition costs.

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 944
-SubTopic 605
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477548/944-605-55-14

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 944
-SubTopic 605
-Name Accounting Standards Codification
-Section 55
-Paragraph 11
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477548/944-605-55-11

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 944
-SubTopic 20
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479868/944-20-45-2

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480016/944-40-65-2

Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 944
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479432/944-30-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479432/944-30-50-2B

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 944
-SubTopic 30
-Name Accounting Standards Codification
-Section 55
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479401/944-30-55-2

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-28

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(7)(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479432/944-30-50-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (u)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476148/220-40-50-22

Amount of deferred policy acquisition cost capitalized on contract remaining in force.

Summary of Reserve for Title Claim Losses

12 Months Ended

Dec. 31, 2025

Summary of Reserve for Title Claim Losses

A summary of the reserve for title claim losses follows:


	Year Ended December 31,
	2025			2024			2023
	(Dollars in millions)
Beginning balance	$	1,713		$	1,770		$	1,810

Change in insurance recoverable	(6)			(10)			15
Claim loss provision related to:
Current year	262			232			207
Prior years	—			—			—
Total title claim loss provision	262			232			207
Claims paid, net of recoupments related to:
Current year	(21)			(25)			(22)
Prior years	(248)			(254)			(240)
Total title claims paid, net of recoupments	(269)			(279)			(262)
Ending balance of claim loss reserve for title insurance	$	1,700		$	1,713		$	1,770
Provision for title insurance claim losses as a percentage of title insurance premiums	4.5		%	4.5		%	4.5		%

We continually update loss reserve estimates as new information becomes known, new loss patterns emerge or as other contributing factors are considered and incorporated into the analysis of reserve for claim losses. Estimating future title loss payments is difficult because of the complex nature of title claims, the long periods of time over which claims are paid, significantly varying dollar amounts of individual claims and other factors.

Due to the uncertainty inherent in the process and to the judgment used by management, the ultimate liability may be greater or less than our current reserves. If actual claims loss development varies from what is currently expected and is not offset by other factors, it is possible that additional reserve adjustments may be required in future periods in order to maintain our recorded reserve within a reasonable range of our actuary's central estimate.

Regulation and Equity

Regulation

Title

Our insurance subsidiaries, including title insurers, underwritten title companies and insurance agencies, are subject to extensive regulation under applicable state laws. Each of the insurance underwriters is subject to a holding company act in its state of domicile that regulates, among other matters, the ability to pay dividends and enter into transactions with affiliates. The laws of most states in which we transact business establish supervisory agencies with broad administrative powers relating to issuing and revoking licenses to transact business, regulating trade practices, licensing agents, approving policy forms, accounting practices, financial practices, establishing reserve and capital and surplus as regards policyholders (“capital and surplus”) requirements, defining suitable investments for reserves and capital and surplus and approving rate schedules. The process of state regulation of changes in rates ranges from states that set rates, to states where individual companies or associations of companies prepare rate filings that are submitted for approval, to a few states in which rate changes do not need to be filed for approval.

Since we are regulated by both state and federal governments and the applicable insurance laws and regulations are constantly subject to change, it is not possible to predict the potential effects on our insurance operations, particularly the Title segment, of any laws or regulations that may become more restrictive in the future or if new restrictive laws will be enacted.

Statutory-basis financial statements are prepared in accordance with accounting practices prescribed or permitted by the various state insurance regulatory authorities. The National Association of Insurance Commissioners' Accounting Practices and Procedures manual (“NAIC SAP”) has been adopted as a component of prescribed or permitted practices by each of the states that regulate us. Each of our states of domicile for our title insurance underwriter subsidiaries have adopted a material prescribed accounting practice that differs from that found in NAIC SAP. Specifically, in both years, the timing of amounts released from the statutory unearned premium reserve under NAIC SAP differs from the states' required practice. Statutory surplus at December 31, 2025 and 2024 was lower by approximately $32 million and $33 million than if we had reported such amounts in accordance with NAIC SAP.

Pursuant to statutory accounting requirements of the various states in which our insurers are domiciled, these insurers must defer a portion of premiums earned as an unearned premium reserve for the protection of policyholders and must maintain qualified assets in an amount equal to the statutory requirements. The level of unearned premium reserve required to be maintained at any time is determined by statutory formula based upon either the age, number of policies and dollar amount of policy liabilities underwritten, or the age and dollar amount of statutory premiums written. As of December 31, 2025, the combined statutory unearned premium reserve required and reported for our title insurers was $1,619 million. In addition to statutory unearned premium reserves, each of our insurers maintains reserves for known claims and surplus funds for policyholder protection and business operations.

Each of our insurance subsidiaries is regulated by the insurance regulatory authority in its respective state of domicile, as well as that of each state in which it is licensed. The insurance commissioners of their respective states of domicile are the primary regulators of our title insurance subsidiaries. Each of the insurers is subject to periodic regulatory financial examination by regulatory authorities.

Our insurance subsidiaries are subject to regulations that restrict their ability to pay dividends or make other distributions of cash or property to their immediate parent company without prior approval from the Department of Insurance of their respective states of domicile. As of December 31, 2025, $1,141 million of our net assets are restricted from dividend payments without prior approval from the Departments of Insurance. During 2026, our title insurers can pay or make distributions to us of approximately $437 million, without prior approval.

The combined statutory capital and surplus of our title insurers was approximately $1,273 million and $1,223 million as of December 31, 2025 and 2024, respectively. The combined statutory net earnings of our title insurance subsidiaries were $488 million, $587 million, and $503 million for the years ended December 31, 2025, 2024, and 2023, respectively.

As a condition to continued authority to underwrite policies in the states in which our insurers conduct their business, the insurers are required to pay certain fees and file information regarding their officers, directors and financial condition. In addition, our escrow and trust business is subject to regulation by various state banking authorities.

Pursuant to statutory requirements of the various states in which our insurers are domiciled, such insurers must maintain certain levels of minimum capital and surplus. Required levels of minimum capital and surplus are not significant to the insurers individually or in the aggregate. Each of our insurers has complied with the minimum statutory requirements as of December 31, 2025.

Our underwritten title companies, primarily those domiciled in California, are also subject to certain regulation by insurance regulatory or banking authorities relating to their net worth and working capital. Minimum net worth and working capital requirements for each underwritten title company is less than $1 million. These companies were in compliance with their respective minimum net worth and working capital requirements at December 31, 2025.

There are no restrictions on our retained earnings regarding our ability to pay dividends to shareholders although there are limits on the ability of certain subsidiaries to pay dividends to us, as described above.

F&G

Through our majority owned F&G subsidiary, our insurance subsidiaries, FGL Insurance, FGL NY Insurance, Raven Re and Corbeau Re file financial statements with state insurance regulatory authorities and, except for Raven Re, with the National Association of Insurance Commissioners (“NAIC”) that are prepared in accordance with Statutory Accounting Principles (“SAP”) prescribed or permitted by such authorities. Prescribed SAP includes the Accounting Practices and Procedures Manual of the NAIC as well as state laws, regulations and administrative rules. Permitted SAP encompasses all accounting practices not prescribed but approved by state regulators. The principal differences between SAP financial statements and financial statements prepared in accordance with GAAP are that SAP financial statements do not reflect VOBA, DAC, and DSI, some bond portfolios may be carried at amortized cost, assets and liabilities are presented net of reinsurance, contractholder liabilities are generally valued using more conservative assumptions and certain assets are non-admitted. Accordingly, SAP operating results and SAP capital and surplus may differ substantially from amounts reported in the GAAP basis financial statements for comparable items.

F&G's non-U.S. insurance subsidiaries, F&G Life Re (Bermuda) and F&G Cayman Re (Cayman Islands), file financial statements with their respective regulators.

In our F&G segment, our principal insurance subsidiaries' statutory financial statements are based on a December 31 year end. Statutory net income and statutory capital and surplus of our wholly owned U.S. regulated insurance subsidiaries were as follows:


	Subsidiary (state of domicile) (a)
	FGL Insurance (IA)		FGL NY Insurance (NY)		Raven Re (VT)		Corbeau Re (VT)
Statutory Net (loss) income:	(In millions)
Year ended December 31, 2025	$	(257)	$	29	$	38	$	(201)
Year ended December 31, 2024	150		8		54		(458)
Year ended December 31, 2023	(462)		5		60		(644)

Statutory Capital and Surplus:
December 31, 2025	$	1,735	$	122	$	182	$	236
December 31, 2024	1,654		97		168		178

(a) FGL NY Insurance, Raven Re and Corbeau Re are subsidiaries of FGL Insurance, and the columns should not be added together. Corbeau Re was incorporated on September 1, 2023.

Regulation - U.S. Companies

FGL Insurance, FGL NY Insurance, Raven Re and Corbeau Re’s respective statutory capital and surplus satisfy the applicable minimum regulatory requirements.

To enhance the regulation of insurers’ solvency, the NAIC adopted a model law to implement risk-based capital ("RBC") requirements for life, health and property and casualty insurance companies. All states have adopted the NAIC’s model law or a substantially similar law. RBC is used to evaluate the adequacy of capital and surplus maintained by an insurance company in relation to risks associated with: (i) asset risk, (ii) insurance risk, (iii) interest rate risk, and (iv) business risk. As of the most recent annual statutory financial statements filed with insurance regulators, the RBC ratios for each of our U.S Insurance Companies exceeded the minimum RBC requirements.

Dividends

The insurance laws of Iowa and New York regulate the amount of dividends that may be paid in any year by FGL Insurance and FGL NY Insurance, respectively.

FGL Insurance dividends are paid as declared by its Board of Directors. Pursuant to Iowa insurance law, any proposed payment of a dividend is classified as an "extraordinary dividend" if it, together with the aggregate fair market value of other dividends or distributions made during the preceding twelve months, exceeds the greater of (i) 10% of capital and surplus as of the preceding December 31 or (ii) net gain from operations before realized capital gains or losses for the twelve month period ending December 31 of the preceding year. No extraordinary dividends may be paid without prior approval of the IID. In addition, no ordinary dividends may be paid except from the earned profits arising from FGL Insurance's business, which does not include contributed capital or contributed surplus.

FGL Insurance did not pay dividends to its parent, Fidelity & Guaranty Life Holdings, Inc. ("FGLH"), for the years ended December 31, 2025, 2024, and 2023. Pursuant to the limitations described above, it is estimated that FGL Insurance's maximum ordinary dividend capacity for 2026 is $0.

Each year, FGL NY Insurance may pay a certain limited amount of ordinary dividends or other distributions without being required to obtain the prior consent of the New York State Department of Financial Services (“NYDFS”). However, to pay any dividends or distributions in a calendar year immediately following a calendar year in which the FGL NY's net gain from operations, not including realized capital gains, was negative, approval from the NY Superintendent is required.

FGL NY Insurance has historically not paid dividends. Based on the limitations described above, it's estimated that the maximum amount of ordinary dividends FGL NY Insurance will be permitted to distribute during 2026 is approximately $27 million.

Raven Re and Corbeau Re dividends are paid as declared by their Board of Directors. Under the laws of the State of Vermont, no captive insurance company may pay a dividend out of, or other distribution with respect to, capital or surplus, without the prior approval of the Commissioner.

Prescribed and permitted practices

FGL Insurance - FGL Insurance applies Iowa-prescribed accounting practices prescribed by Iowa Administrative Code (" IAC ") Chapter 97, “Accounting for Certain Derivative Instruments Used to Hedge the Growth in Interest Credited for Indexed Insurance Products and Accounting for the Indexed Insurance Products Reserve”, for its indexed annuities and IUL products. Under these alternative accounting practices, the equity option derivative instruments that hedge the growth in interest credited on index products are accounted for at amortized cost with the corresponding amortization recorded as a decrease to net investment income and indexed annuity reserves are calculated based on Standard Valuation Law and Actuarial Guideline XXXV assuming the market value of the equity options associated with the current index term is zero regardless of the observable market value for such options.

In addition, based on a permitted practice received from the IID, FGL Insurance carries one of its limited partnership interests which qualifies for accounting under SSAP No. 48, “Investments in Joint Ventures, Partnerships and Limited Liability Companies”, on a net asset value per share basis. This is a departure from SSAP No. 48 which requires such investments to be carried based on the investees underlying GAAP equity (prior to any impairment considerations). This limited partnership investment was redeemed as of December 31, 2025. In addition, the financial statements of Raven Re and Corbeau Re include certain permitted practices approved by the Vermont Department of Financial Regulation. Without such permitted statutory accounting practices, Raven Re’s risk-based capital would have been above the minimum regulatory requirements at December 31, 2025, but would have fallen below the minimum regulatory requirements at December 31, 2024. Without such permitted statutory accounting practices, Corbeau Re’s risk-based capital would have fallen below the minimum regulatory requirements as of December 31, 2025 and 2024.

The prescribed and permitted practices resulted in increases to statutory capital and surplus of $249 million and $454 million at December 31, 2025 and 2024, respectively.

FGL Insurance’s statutory carrying value of Raven Re reflects the effect of permitted practices Raven Re received to treat the available amount of a letter of credit as an admitted asset, which increased Raven Re’s statutory capital and surplus by $150 million and $175 million at December 31, 2025 and 2024, respectively. In addition, FGL Insurance’s statutory carrying value of Corbeau Re reflects the effect of permitted practices Corbeau Re received to treat the excess of loss as an admitted asset, which increased Corbeau Re’s statutory capital and surplus by $1,489 million and $1,230 million at December 31, 2025 and 2024, respectively. Refer to Note N F&G Reinsurance for a discussion of the XOL and letter of credit.

Raven Re - Raven Re is also permitted to follow Iowa prescribed statutory accounting practice for its reserves on reinsurance assumed from FGL Insurance and also has approval to include as an admitted asset the value of a letter of credit serving as collateral for reinsurance credit taken by FGL Insurance. Without such permitted statutory accounting practices, Raven Re’s statutory capital and surplus (deficit) would be $29 million and $(13) million as of December 31, 2025 and 2024, respectively, thus its risk-based capital would fall below the minimum regulatory requirements in the prior year. The letter of credit facility is collateralized by NAIC 1 rated debt securities. If the permitted practice was revoked, the letter of credit could be replaced by the collateral assets with Nomura’s consent (refer to discussion of letter of credit in Note N F&G Reinsurance). FGL Insurance’s statutory carrying value of Raven Re was $182 million and $168 million at December 31, 2025 and 2024, respectively.

Corbeau Re - Corbeau Re has four permitted practices pursuant to Vermont Statute, Title 8, Chapter 141 – (8 V.S.A. § 6048k(a)(2), whereby the Vermont Department authorizes the Company to (i) account for the amount equal to the excess of loss amount (“XOL Asset”) as an asset on its statutory financial statements; (ii) that the reserves assumed by Corbeau Re are equal to the reserves ceded by FGL Insurance, which includes application of IAC Insurance 191, Chapter 97, “Accounting for Certain Derivative Instruments Used to Hedge the Growth in Interest Credited for Indexed Insurance Products and Accounting for the Indexed Insurance Products Reserve“ and to (a) calculate the reserves with respect to the Retirement Pro Contracts in accordance with the following reserving methodology: the reserves are calculated as the present value of reinsured benefits when account value equals zero less the present value of reinsurance premiums from the winning integrated stream, floored at zero and capped as necessary to keep the net statutory reserve at the net cash surrender value; and (b) for benefits associated with all other contracts (“the GMWB Riders”), the reserves are calculated as the statutory reserves for the entire contract (i.e., the base contracts plus the GMWB Riders) minus the statutory reserves for the base contracts only (“Reserve Calculation Permitted Practice”); (iii) calculate its company action level risk-based capital as defined in Section 8301(13)(A) and, calculated using the risk-based capital factors and formulas prescribed by the NAIC, applying a factor of 0.62% to the XOL Asset Value; and (iv) annually perform a total company solvency analysis in lieu of cash flow testing and actuarial opinion and memorandum under Section 2010-2 of the Vermont Administrative Code. Without such permitted statutory accounting practices, the Company’s statutory capital deficit would be $1,253 million and $1,052 million as of December 31, 2025 and 2024, respectively, and its risk-based capital would fall below the minimum regulatory requirements. FGL Insurance’s statutory carrying value of Corbeau Re was $236 million and $178 million at December 31, 2025 and 2024, respectively.

FGL NY Insurance - As of December 31, 2025 and 2024, FGL NY Insurance did not follow any prescribed or permitted statutory accounting practices that differ from the NAIC's statutory accounting practices.

Non-U.S. Companies

F&G's non-U.S. insurance subsidiaries, F&G Cayman Re and F&G Life Re, file financial statements with their respective regulators. For the annual period ended December 31, 2023, F&G Cayman Re began to file financial statements that are prepared in accordance with SAP prescribed or permitted by such authorities, which may vary materially from GAAP. Accordingly, SAP operating results and SAP capital and surplus may differ substantially from amounts reported in the GAAP basis financial statements for comparable items.

F&G Cayman Re has two permitted practices which have been approved by the Cayman Islands Monetary Authority (“CIMA”). F&G Cayman Re has a permitted practice approved by CIMA to include, as an admitted asset, the value of the letters of credit (“LOCs”) acquired to support reinsurance transactions. Also, F&G Cayman Re has a permitted practice, approved by CIMA, for PRT reinsurance transactions to use U.S. statutory book value adjusted for best estimate reserve calculations (consistent with GAAP prior to Accounting Standards Update ("ASU") 2018-12, Financial Services-Insurance (Topic 944), Targeted Improvements to the Accounting for Long-Duration Contracts). These reserve calculations will be subject to annual assumption reviews consistent with other GAAP liability balances. If F&G Cayman Re had not been permitted to calculate PRT assumed reserves using best estimate reserve calculations or include the value of the LOCs as an admitted asset, statutory surplus (deficit) would be $20 million and $(64) million as of December 31, 2025 and 2024, respectively. Without such permitted statutory accounting practices, F&G Cayman Re’s risk-based capital would fall below the minimum regulatory requirements as of December 31, 2025 and December 31, 2024.

F&G Life Re files financial statements based on GAAP.

Net income and capital and surplus of our wholly owned Cayman Islands and Bermuda regulated insurance subsidiaries under SAP and GAAP, respectively, were as follows:


	Subsidiary (country of domicile)
	F&G Cayman Re (Cayman Islands)		F&G Life Re (Bermuda)
Statutory Net (loss) income:	(In millions)
Year ended December 31, 2025	$	(30)	$	160
Year ended December 31, 2024	(11)		139
Year ended December 31, 2023	133		151
Statutory Capital and Surplus (Deficit):
December 31, 2025	$	1,134	$	84
December 31, 2024	734		123

Regulation - Bermuda

F&G Life Re is a Bermuda exempted company incorporated under the Companies Act 1981, as amended (the “Bermuda Companies Act”) and registered as a Class E insurer under the Insurance Act 1978, as amended, and its related regulations (the “Bermuda Insurance Act”). F&G Life Re is regulated by the Bermuda Monetary Authority (“BMA”).

In addition to the requirements under the Bermuda Companies Act (as discussed below), the Bermuda Insurance Act limits the maximum amount of annual dividends and distributions that may be paid or distributed by F&G Life Re without prior regulatory approval. F&G Life Re is prohibited from declaring or paying a dividend if it fails to meet its minimum solvency margin, or ECR, or if the declaration or payment of such dividend would cause such breach. If F&G Life Re were to fail to meet its minimum solvency margin on the last day of any financial year, it would be prohibited from declaring or paying any dividends during the next financial year without the approval of the BMA. In addition, as a Class E insurer, F&G Life Re must not declare or pay a dividend to any person other than a policyholder unless the value of the assets of such insurer, as certified by the insurer’s approved actuary, exceeds its liabilities (as so certified) by the greater of its margin of solvency or ECR. In the event a dividend complies with the above, F&G Life Re must ensure the amount of any such dividend does not exceed that excess.

Furthermore, as a Class E insurer, F&G Life Re must not declare or pay a dividend in any financial year which would exceed 25% of its total statutory capital and surplus, as set out in its previous year’s Bermuda statutory financial statements, unless at least seven days before payment of such dividend F&G Life Re files with the BMA an affidavit signed by at least two directors of F&G Life Re and its principal representative under the Bermuda Insurance Act stating that, in the opinion of those signing, declaration of such dividend has not caused the insurer to fail to meet its relevant margins. The Bermuda Companies Act also limits F&G Life Re’s ability to pay dividends and make distributions to its shareholders. F&G Life Re is not permitted

to declare or pay a dividend, or make a distribution out of its contributed surplus, if it is, or would after the payment be, unable to pay its liabilities as they become due or if the realizable value of its assets would be less than its liabilities.

F&G Life Re’s ability to pay dividends in 2026 is subject to the limitations described above.

Regulation - Cayman Islands

F&G Cayman Re is a Cayman Islands exempted company incorporated under the Companies Act, as amended (2023 Revision) and licensed as a Class D insurer in the Cayman Islands under the Insurance Act, 2010 as amended and its related regulation (the “Cayman Islands Insurance Act”). F&G Cayman Re is regulated by CIMA.

F&G Cayman Re dividends are paid as declared by its Board of Directors. The dividends will be in accordance with CIMA regulatory requirements and contractual obligations and any dividends require approval by CIMA. F&G Cayman Re can only request approval for dividends if (i) the ending capital, including considerations for future business plans, will maintain a surplus over the CIMA approved and permitted target modified RBC, and (ii) contractual language pursuant to the PRT reinsurance agreement requiring a US RBC above specified target is met. As of the most recent annual financial statement filed with CIMA, the RBC ratios for F&G Cayman Re exceeded these minimum requirements. Pursuant to the limitations described above, no dividends may be paid in 2026 by F&G Cayman Re without prior regulatory approval.

The prescribed and permitted statutory accounting practices have no impact on our audited Consolidated Financial Statements, which are prepared in accordance with GAAP.

Equity

On August 3, 2021, our Board of Directors approved the 2021 Repurchase Program under which we may purchase up to 25 million shares of our FNF common stock through July 31, 2024 (the "2021 Repurchase Program"). On July 31, 2024, our Board of Directors approved a new three-year stock repurchase program effective July 31, 2024 (the "2024 Repurchase Program") under which we are authorized to purchase up to 25 million shares of our FNF common stock through July 31, 2027. We may make repurchases from time to time in the open market, in block purchases or in privately negotiated transactions, depending on market conditions and other factors. During the year ended December 31, 2024, we did not repurchase any FNF common stock under the 2021 Repurchase Program or the 2024 Repurchase Program. During the year ended December 31, 2025, we repurchased a total of 4,426,224 FNF common shares for approximately $252 million, at an average price of $56.80 per shares under the 2024 Repurchase Program. Subsequent to December 31, 2025 and through market close on February 19, 2026, we repurchased a total of 60,000 shares, for approximately $3 million, or an average of $55.66 under the 2024 Repurchase Program.

The entire disclosure for the types of coverages and products sold, and the assets, obligations, recorded liabilities, revenues and expenses arising therefrom, and the amounts of and methodologies and assumptions used in determining the amounts of such items.

Condensed Financial Information Disclosure [Abstract]

Schedule II - Condensed Financial Information

12 Months Ended

Dec. 31, 2025

Schedule II - Condensed Financial Information

SCHEDULE II

FIDELITY NATIONAL FINANCIAL, INC.

(Parent Company)

BALANCE SHEETS

(In millions)


	December 31,
	2025		2024
ASSETS
Cash	$	396	$	534
Short-term investments	262		252


Investment in unconsolidated affiliates	2		3
Notes receivable	142		212
Investments in and amounts due from subsidiaries	9,245		8,882
Property and equipment, net	15		2
Prepaid expenses and other assets	358		433



Total assets	$	10,420	$	10,318
LIABILITIES AND EQUITY
Liabilities:
Accounts payable and other accrued liabilities	$	424	$	385
Income taxes payable	1		51
Deferred tax liability	439		—
Notes payable	2,132		2,128
Total liabilities	2,996		2,564
Equity:

FNF common stock, $0.0001 par value; authorized 600 shares as of December 31, 2025 and 2024; outstanding of 271 and 275 as of December 31, 2025 and 2024, respectively, and issued of 332 and 331 as of December 31, 2025 and 2024, respectively	—		—

Preferred stock, $0.0001 par value; authorized 50,000,000 shares; issued and outstanding, none	—		—
Additional paid-in capital	6,042		5,976
Retained earnings	5,484		5,982
Accumulated other comprehensive earnings	(1,678)		(2,052)
Less: Treasury stock, 61 and 56 shares as of December 31, 2025 and 2024, at cost	(2,424)		(2,152)
Total equity of Fidelity National Financial, Inc. common shareholders	7,424		7,754


Total liabilities and equity	$	10,420	$	10,318

SCHEDULE II

FIDELITY NATIONAL FINANCIAL, INC.

(Parent Company)

STATEMENTS OF EARNINGS AND RETAINED EARNINGS


	Year Ended December 31,
	2025		2024		2023
	(In millions, except per share data)
Revenues:
Other fees and revenue	$	39	$	38	$	33
Interest and investment income and realized gains	64		76		74
Recognized gains and losses, net	7		2		(31)
Total revenues	110		116		76
Expenses:
Personnel expenses	100		94		70
Other operating expenses	38		28		47
Interest expense	77		76		77
Total expenses	215		198		194
Losses before income tax benefit and equity in earnings of subsidiaries	(105)		(82)		(118)
Income tax expense (benefit)	419		(20)		(29)
Losses before equity in earnings of subsidiaries	(524)		(62)		(89)
Equity in earnings of subsidiaries	1,126		1,332		606


Net earnings attributable to Fidelity National Financial, Inc. common shareholders	$	602	$	1,270	$	517

Retained earnings, beginning of year	$	5,982	$	5,244	$	5,225
Dividends declared	(549)		(532)		(498)
Distribution of F&G to FNF common shareholders	(551)		—		—



Net earnings attributable to Fidelity National Financial, Inc. common shareholders	602		1,270		517
Retained earnings, end of year	$	5,484	$	5,982	$	5,244

SCHEDULE II

FIDELITY NATIONAL FINANCIAL, INC.

(Parent Company)

STATEMENTS OF CASH FLOWS


	Year Ended December 31,
	2025		2024		2023
	(In millions)
Cash Flows From Operating Activities:
Net earnings	$	602	$	1,270	$	517
Adjustments to reconcile net earnings to net cash provided by operating activities:



Equity in earnings of subsidiaries	(1,126)		(1,332)		(606)
Depreciation and amortization	1		1		1
Stock-based compensation	83		82		57

Net change in income taxes	415		5		(262)
Net increase in prepaid expenses and other assets	(3)		(113)		(72)
Net increase in accounts payable and other accrued liabilities	36		27		70
Net cash provided by (used in) operating activities	8		(60)		(295)
Cash Flows From Investing Activities:
Purchase of F&G preferred stock	—		(250)		—
Net (purchases of) proceeds from short-term investment activities	(10)		235		82
Purchase of F&G common stock	(151)		—		—
Additions to notes receivable	(1)		(1)		(12)
Collection of notes receivable	40		55		47


Investments in subsidiaries	(95)		—		—
Net cash provided by (used in) investing activities	(217)		39		117
Cash Flows From Financing Activities:





Dividends paid	(546)		(532)		(500)
Purchases of treasury stock	(251)		—		(6)
Exercise of stock options	4		21		15
Payment for shares withheld for taxes and in treasury	(18)		(22)		(17)

Additional investments in non-controlling interests	(6)		(12)		(12)


Net cash transfers from subsidiaries	888		703		689
Net cash provided by (used in) financing activities	71		158		169
Net change in cash and cash equivalents	(138)		137		(9)
Cash at beginning of year	534		397		406
Cash at end of year	$	396	$	534	$	397
See Notes to Financial Statements

SCHEDULE II

FIDELITY NATIONAL FINANCIAL, INC.

(Parent Company)

NOTES TO FINANCIAL STATEMENTS

A. Summary of Significant Accounting Policies

Fidelity National Financial, Inc. transacts substantially all of its business through its subsidiaries. The Parent Company Financial Statements should be read in connection with the aforementioned Consolidated Financial Statements and Notes thereto included elsewhere herein.

B. Notes Payable

Notes payable consist of the following:


	December 31,
	2025		2024
	(In millions)
4.50% Notes, net of discount	$	448	$	447

3.40% Notes, net of discount	646		646
2.45% Notes, net of discount	596		595
3.20% Notes, net of discount	445		444
Revolving credit facility	(3)		(4)

	$	2,132	$	2,128

C. Supplemental Cash Flow Information


	Year Ended December 31,
	2025		2024		2023
	(In millions)
Cash paid during the year:
Interest paid	$	73	$	73	$	73
Income tax payments	241		229		213

D. Cash Dividends Received

We have received cash dividends from our title insurance underwriters and F&G of $0.6 billion, $0.6 billion, and $0.4 billion during the years ended December 31, 2025, 2024, and 2023, respectively.

Schedule II - Condensed Financial Information - Statement of Cash Flow (Parent Company) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]
Net earnings attributable to FNF common shareholders	$ 602	$ 1,270	$ 517
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	844	739	593
Stock-based compensation	88	82	60
Net change in income taxes	481	83	(50)
Net cash provided by (used in) operating activities	5,828	6,815	6,478
Cash Flows From Investing Activities:
Net (purchases of) proceeds from short-term investment activities	1,298	(1,076)	340
Investments in subsidiaries	(2,493)	(1,131)	(1,296)
Net cash used in investing activities	(8,934)	(7,862)	(9,090)
Cash Flows From Financing Activities:
Dividends paid	(546)	(532)	(500)
Purchases of treasury stock	(251)	0	(6)
Exercise of stock options	4	21	15
Payment for shares withheld for taxes and in treasury	(27)	(34)	(17)
Net cash provided by financing activities	2,263	1,759	3,093
Net change in cash and cash equivalents	(843)	712	481
Cash and cash equivalents at beginning of period	3,479	2,767	2,286
Cash and cash equivalents at end of period	2,636	3,479	2,767
Parent Company
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]
Net earnings attributable to FNF common shareholders	602	1,270	517
Adjustments to reconcile net earnings to net cash provided by operating activities:
Equity in earnings of subsidiaries	(1,126)	(1,332)	(606)
Depreciation and amortization	1	1	1
Stock-based compensation	83	82	57
Net change in income taxes	415	5	(262)
Net increase in prepaid expenses and other assets	(3)	(113)	(72)
Net increase in accounts payable and other accrued liabilities	36	27	70
Net cash provided by (used in) operating activities	8	(60)	(295)
Cash Flows From Investing Activities:
Net (purchases of) proceeds from short-term investment activities	(10)	235	82
Additions to notes receivable	(1)	(1)	(12)
Collections of notes receivable	40	55	47
Investments in subsidiaries	(95)
Net cash used in investing activities	(217)	39	117
Cash Flows From Financing Activities:
Dividends paid	(546)	(532)	(500)
Purchases of treasury stock	(251)	0	(6)
Exercise of stock options	4	21	15
Payment for shares withheld for taxes and in treasury	(18)	(22)	(17)
Additional investments in non-controlling interests	(6)	(12)	(12)
Net cash transfers from subsidiaries	888	703	689
Net cash provided by financing activities	71	158	169
Net change in cash and cash equivalents	(138)	137	(9)
Cash and cash equivalents at beginning of period	534	397	406
Cash and cash equivalents at end of period	396	534	397
Parent Company \| Preferred equity securities
Cash Flows From Investing Activities:
Payments to acquire equity securities	0	(250)	0
Parent Company \| Common equity securities
Cash Flows From Investing Activities:
Payments to acquire equity securities	$ (151)	$ 0	$ 0

Income Taxes - Components Deferred Tax Asset and Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Deferred Tax Assets:
Employee benefit accruals	$ 138	$ 129
Net operating loss carryforwards	119	115
Tax credits	176	204
Investment securities	504	775
Capital loss carryover	2	19
Life insurance and claim related adjustments	539	451
Funds held under reinsurance agreements	1,178	822
Market Risk Benefits	99	56
Bermuda corporate income tax net operating loss carryforward	0	10
Section 263a Costs	30	0
Other	36	42
Total gross deferred tax asset	2,821	2,623
Less: valuation allowance	114	164
Total deferred tax asset	2,707	2,459
Deferred Tax Liabilities:
Title plant	(54)	(53)
Amortization of goodwill and intangible assets	(97)	(71)
Other	(7)	(11)
Depreciation	(21)	(24)
Partnerships	(277)	(198)
Value of business acquired	(251)	(283)
Deferred acquisition costs	(677)	(543)
Outside basis difference in F&G	(404)	0
Funds held under reinsurance agreements	(1,261)	(945)
Title Insurance reserve discounting	(17)	(16)
Total deferred tax liability	(3,066)	(2,144)
Net deferred tax liability	$ (359)
Net deferred tax (liability) asset		$ 315

Business and Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2025

Accounting Policies [Abstract]

Schedule of Changes in Other Comprehensive Earnings (Loss)

Changes in the balance of Other comprehensive earnings (loss) for the years ended December 31, 2025, 2024, and 2023, by component are as follows:


	Unrealized gain (loss) on investments and other financial instruments, net (excluding investments in unconsolidated affiliates)		Change in current discount rate - future policy benefits		Change in instrument-specific credit risk - market risk benefits		Other		Total Accumulated Other Comprehensive Earnings (Loss)
	(In millions)
Balance January 1, 2023	$	(3,583)	$	763	$	(48)	$	(2)	$	(2,870)

Reclassification adjustments	137		—		—		(11)		126
Other comprehensive earnings	961		(189)		(34)		21		759
Non-controlling interest	(170)		31		6		(1)		(134)
Balance December 31, 2023	(2,655)		605		(76)		7		(2,119)

Reclassification adjustments	3		—		—		(11)		(8)
Other comprehensive earnings	(157)		224		5		10		82
Non-controlling interest	14		(21)		—		—		(7)
Balance December 31, 2024	(2,795)		808		(71)		6		(2,052)
Reclassification adjustments	12		—		—		(58)		(46)
Other comprehensive earnings	711		(235)		(24)		25		477
F&G Distribution	16		—		—		—		16
Non-controlling interest	(116)		40		4		(1)		(73)
Balance December 31, 2025	$	(2,172)	$	613	$	(91)	$	(28)	$	(1,678)

Investments - Carrying Value and Maximum Loss Exposure of Unconsolidated VIEs (Details) - Variable Interest Entity, Not Primary Beneficiary - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Schedule of Investments [Line Items]
Carrying Value	$ 31,564	$ 26,807
Maximum Loss Exposure	35,192	28,945
Investments in unconsolidated affiliates
Schedule of Investments [Line Items]
Carrying Value	5,145	3,565
Maximum Loss Exposure	6,389	4,703
Fixed maturity securities
Schedule of Investments [Line Items]
Carrying Value	26,419	23,242
Maximum Loss Exposure	$ 28,803	$ 24,242

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column A)(Footnote 2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(b))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column A)(Footnote 1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column A)(Footnote 2)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column A)(Footnote 2)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column A)(Footnote 4))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 6))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column B)(Footnote 7))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 8))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 8)(b)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 8)(b)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 8)(c))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 9))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-12(Column C)(Footnote 10))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column D))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 1)(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 1)(b))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 4))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 6))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column A)(Footnote 7))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 36: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 9))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 37: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column B)(Footnote 10))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 38: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 11))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 39: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 40: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 41: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 42: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(b)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 43: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(b)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 44: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(c))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 45: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 12))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 46: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-12B(Column C)(Footnote 13))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3

Reference 47: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 48: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 49: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column F))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 50: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 51: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 52: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 53: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 54: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 55: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(4))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 56: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 57: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 58: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column A)(Footnote 3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 59: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column F)(Footnote 4))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 60: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column F)(Footnote 5)(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 61: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column F)(Footnote 7))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 62: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column F)(Footnote 8))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 63: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Subparagraph (SX 210.12-14(Column F)(Footnote 9))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6

Reference 64: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 19
-Subparagraph (1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-19

Reference 65: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 320
-Name Accounting Standards Codification
-Section S99
-Paragraph 19
-Subparagraph (3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477271/946-320-S99-19

Investments - Residential Loans Segregated by Risk Rating Exposure and Non-accrual Loans by Amortized Cost (Details) - Residential mortgage - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Credit Quality Indicator Current Year [Abstract]
Year one	$ 1,585	$ 614
Year two	742	376
Year three	348	928
Year four	839	840
Year five	756	176
Prior	447	340
Total	4,717	3,274
Credit Quality Indicator Prior Year [Abstract]
Year one	1,585	614
Year two	742	376
Year three	348	928
Year four	839	840
Year five	756	176
Prior	447	340
Total	4,717	3,274
Current (less than 30 days past due)
Credit Quality Indicator Current Year [Abstract]
Year one	1,568	610
Year two	736	368
Year three	327	911
Year four	798	805
Year five	731	162
Prior	419	312
Total	4,579	3,168
Credit Quality Indicator Prior Year [Abstract]
Year one	1,568	610
Year two	736	368
Year three	327	911
Year four	798	805
Year five	731	162
Prior	419	312
Total	4,579	3,168
30-89 days past due
Credit Quality Indicator Current Year [Abstract]
Year one	15	1
Year two	2	6
Year three	17	4
Year four	29	6
Year five	4	1
Prior	3	3
Total	70	21
Credit Quality Indicator Prior Year [Abstract]
Year one	15	1
Year two	2	6
Year three	17	4
Year four	29	6
Year five	4	1
Prior	3	3
Total	70	21
90 days or more past due
Credit Quality Indicator Current Year [Abstract]
Year one	2	3
Year two	4	2
Year three	4	13
Year four	12	29
Year five	21	13
Prior	25	25
Total	68	85
Credit Quality Indicator Prior Year [Abstract]
Year one	2	3
Year two	4	2
Year three	4	13
Year four	12	29
Year five	21	13
Prior	25	25
Total	$ 68	$ 85

Derivative Financial Instruments - Schedule of Carrying Amount and Cumulative Adjustment (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Hedged Asset, Statement of Financial Position Flag	Fair Value	Fair Value
Hedged Liability, Statement of Financial Position Flag	Contractholder funds	Contractholder funds
Carrying Amount of Hedged Assets	$ 21	$ 0
Carrying Amount of Hedged (Liabilities)	(862)	0
Cumulative Amount of Fair Value Hedging Adjustment included in the Carrying Amount of the Hedged Assets	0	0
Cumulative Amount of Fair Value Hedging Adjustment included in the Carrying Amount of the Hedged (Liabilities)	$ (11)	$ 0

Property and Equipment (Details) - USD ($) $ in Millions	12 Months Ended
Property and Equipment (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	$ 587	$ 557
Accumulated depreciation and amortization	(398)	(384)
Total property and equipment, net	189	173
Depreciation	53	53	$ 55
Furniture, fixtures and equipment
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	164	161
Data processing equipment
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	164	155
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	131	126
Buildings
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	103	93
Land
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	17	14
Other
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	$ 8	$ 8

Future Policy Benefits - Changes in the Present Value of Expected Net Premiums and Present Value (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Liability for Future Policy Benefit, Expected Future Policy Benefit
Future policy benefits	$ 10,755	$ 8,749
Traditional life
Liability for Future Policy Benefit, Expected Net Premium
Balance, beginning of year	631	722
Beginning balance at original discount rate	780	874
Effect of actual variances from expected experience		1	$ (4)
Balance adjusted for variances from expectation		781	870
Interest accrual	15	17
Net premiums collected	(96)	(107)
Ending balance at original discount rate	700	780
Effect of actual variances from expected experience		1	(4)
Effect of changes in discount rate assumptions	(115)	(149)
Balance, end of year	585	631
Liability for Future Policy Benefit, Expected Future Policy Benefit
Balance, beginning of year	1,933	2,071
Beginning balance at original discount rate	2,368	2,492
Effect of actual variances from expected experience		(21)	44
Balance adjusted for variances from expectation		2,347	2,536
Interest accrual	50	54
Benefits payments	(230)	(222)
Ending balance at original discount rate	2,167	2,368
Effect of actual variances from expected experience		(21)	44
Balance adjusted for variances from expectation		2,347	2,536
Interest accrual	50	54
Benefits payments	(230)	(222)
Effect of changes in discount rate assumptions	(312)	(435)
Balance, end of year	1,855	1,933
Future policy benefits	1,270	1,302
Less: Reinsurance recoverable	489	513
Net liability for future policy benefits, after reinsurance recoverable	$ 781	$ 789
Weighted-average duration of liability for future policyholder benefits (years)	6 years 10 months 2 days	6 years 3 months 10 days
PRT
Liability for Future Policy Benefit, Expected Future Policy Benefit
Balance, beginning of year	$ 6,054	$ 4,189
Beginning balance at original discount rate	6,417	4,351
Effect of changes in cash flow assumptions		(36)	(3)
Effect of actual variances from expected experience		13	(11)
Balance adjusted for variances from expectation		6,394	4,337
Issuances	2,206	2,324
Interest accrual	331	240
Benefits payments	(663)	(484)
Ending balance at original discount rate	8,268	6,417
Effect of changes in cash flow assumptions		(36)	(3)
Effect of actual variances from expected experience		13	(11)
Balance adjusted for variances from expectation		6,394	4,337
Issuances	2,206	2,324
Interest accrual	331	240
Benefits payments	(663)	(484)
Effect of changes in discount rate assumptions	(156)	(363)
Balance, end of year	8,112	6,054
Net liability for future policy benefits, after reinsurance recoverable	$ 8,112	$ 6,054
Weighted-average duration of liability for future policyholder benefits (years)	7 years 9 months 18 days	7 years 9 months 10 days
Immediate annuities
Liability for Future Policy Benefit, Expected Future Policy Benefit
Balance, beginning of year	$ 1,297	$ 1,415
Beginning balance at original discount rate	1,732	1,788
Effect of actual variances from expected experience		(11)	(27)
Balance adjusted for variances from expectation		1,721	1,761
Issuances	17	30
Interest accrual	54	59
Benefits payments	(113)	(118)
Ending balance at original discount rate	1,679	1,732
Effect of actual variances from expected experience		(11)	(27)
Balance adjusted for variances from expectation		1,721	$ 1,761
Issuances	17	30
Interest accrual	54	59
Benefits payments	(113)	(118)
Effect of changes in discount rate assumptions	(403)	(435)
Balance, end of year	1,276	1,297
Future policy benefits	1,276	1,297
Less: Reinsurance recoverable	106	109
Net liability for future policy benefits, after reinsurance recoverable	$ 1,170	$ 1,188
Weighted-average duration of liability for future policyholder benefits (years)	12 years 3 months 25 days	12 years 7 months 17 days

Revenue Recognition - Premium and Annuity Deposits (Details) - F&G - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Disaggregation of Revenue [Line Items]
Premium and annuity deposits, net of reinsurance	$ 11,575	$ 10,147	$ 7,787
Fixed indexed annuities
Disaggregation of Revenue [Line Items]
Premium and annuity deposits, net of reinsurance	5,341	5,828	4,738
Fixed rate annuities
Disaggregation of Revenue [Line Items]
Premium and annuity deposits, net of reinsurance	1,637	1,277	1,147
Funding agreements (FABN/FHLB)
Disaggregation of Revenue [Line Items]
Premium and annuity deposits, net of reinsurance	3,748	2,404	1,256
Life insurance and other
Disaggregation of Revenue [Line Items]
Premium and annuity deposits, net of reinsurance	$ 849	$ 638	$ 646

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-7

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Future Policy Benefits

12 Months Ended

Dec. 31, 2025

Property, Plant and Equipment [Abstract]

Future Policy Benefits

The following table summarizes balances and changes in the present value of expected net premiums and the present value of the expected FPB for nonparticipating traditional contracts:


	Traditional life
	December 31, 2025		December 31, 2024
Expected net premiums	(In millions)
Balance, beginning of year	$	631	$	722
Beginning balance at original discount rate	780		874

Effect of actual variances from expected experience	1		(4)
Balance adjusted for variances from expectation	781		870

Interest accrual	15		17
Net premiums collected	(96)		(107)

Ending balance at original discount rate	700		780
Effect of changes in discount rate assumptions	(115)		(149)
Balance, end of year	$	585	$	631

Expected FPB
Balance, beginning of year	$	1,933	$	2,071
Beginning balance at original discount rate	2,368		2,492

Effect of actual variances from expected experience	(21)		44
Balance adjusted for variances from expectation	2,347		2,536

Interest accrual	50		54
Benefits payments	(230)		(222)

Ending balance at original discount rate	2,167		2,368
Effect of changes in discount rate assumptions	(312)		(435)
Balance, end of year	$	1,855	$	1,933

Net liability for future policy benefits	$	1,270	$	1,302
Less: Reinsurance recoverable	489		513
Net liability for future policy benefits, after reinsurance recoverable	$	781	$	789

Weighted-average duration of liability for future policyholder benefits (years)	6.84		6.28

The following tables summarize balances and changes in the present value of the expected FPB for limited-payment contracts:


	PRT
	December 31, 2025		December 31, 2024
	(In millions)
Balance, beginning of year	$	6,054	$	4,189
Beginning balance at original discount rate	6,417		4,351
Effect of changes in cash flow assumptions	(36)		(3)
Effect of actual variances from expected experience	13		(11)
Balance adjusted for variances from expectation	6,394		4,337
Issuances	2,206		2,324
Interest accrual	331		240
Benefits payments	(663)		(484)

Ending balance at original discount rate	8,268		6,417
Effect of changes in discount rate assumptions	(156)		(363)
Balance, end of year	$	8,112	$	6,054



Net liability for future policy benefits, after reinsurance recoverable	$	8,112	$	6,054

Weighted-average duration of liability for future policyholder benefits (years)	7.80		7.78


	Immediate annuities
	December 31, 2025		December 31, 2024
	(In millions)
Balance, beginning of year	$	1,297	$	1,415
Beginning balance at original discount rate	1,732		1,788

Effect of actual variances from expected experience	(11)		(27)
Balance adjusted for variances from expectation	1,721		1,761
Issuances	17		30
Interest accrual	54		59
Benefits payments	(113)		(118)

Ending balance at original discount rate	1,679		1,732
Effect of changes in discount rate assumptions	(403)		(435)
Balance, end of year	$	1,276	$	1,297

Net liability for future policy benefits	$	1,276	$	1,297
Less: Reinsurance recoverable	106		109
Net liability for future policy benefits, after reinsurance recoverable	$	1,170	$	1,188

Weighted-average duration of liability for future policyholder benefits (years)	12.32		12.63

The following tables summarize balances and changes in the liability for DPL for limited-payment contracts:


	December 31, 2025				December 31, 2024
	Immediate annuities		PRT		Immediate annuities		PRT
	(In millions)
Balance, beginning of year	$	90	$	6	$	87	$	10

Effect of changes in cash flow assumptions	—		—		—		(8)
Effect of actual variances from expected experience	2		1		8		—
Balance adjusted for variances from expectation	92		7		95		2
Issuances	6		1		3		1
Interest accrual	1		—		1		4
Amortization	(9)		(1)		(9)		(1)
Balance, end of year	$	90	$	7	$	90	$	6

The following table reconciles the net FPB to the FPB in the Consolidated Balance Sheets. The DPL for Immediate Annuities and PRT is presented together with the FPB in the Consolidated Balance Sheets and has been included as a reconciling item in the table below:


	December 31,
	2025		2024
	(In millions)
Traditional life	$	1,270	$	1,302
Immediate annuities	1,276		1,297
PRT	8,112		6,054
Immediate annuities DPL	90		90
PRT DPL	7		6
Total	$	10,755	$	8,749

The following table provides the amount of undiscounted and discounted expected gross premiums and expected future benefits and expenses for nonparticipating traditional and limited-payment contracts:


	Undiscounted					Discounted
	December 31, 2025		December 31, 2024			December 31, 2025		December 31, 2024
Traditional life	(In millions)
Expected future benefit payments	$	2,511	$	2,705		$	1,857	$	1,948
Expected future gross premiums	848		914			630		681
Immediate annuities
Expected future benefit payments	$	3,095	$	3,189		$	1,276	$	1,297
Expected future gross premiums	—		—		—	—		—
PRT
Expected future benefit payments	$	13,074	$	10,038		$	8,112	$	6,054
Expected future gross premiums	—		—			—		—

The following table summarizes the amount of revenue and interest related to nonparticipating traditional and limited-payment contracts recognized in the Consolidated Statements of Earnings:


	Gross Premiums (a)						Interest Expense (b)
	December 31,						December 31,
	2025		2024		2023		2025		2024		2023
	(In millions)
Traditional life	$	99	$	111	$	123	$	35	$	37	$	37
Immediate annuities	17		18		24		54		59		51
PRT	2,107		2,217		1,964		331		240		109
Total	$	2,223	$	2,346	$	2,111	$	420	$	336	$	197

(a) Included in Life insurance premiums and other fees on the Consolidated Statements of Earnings.

(b) Included in Benefits and other changes in policy reserves (remeasurement gains (a)) on the Consolidated Statements of Earnings.

The following table presents the weighted-average interest rate:


	December 31,
	2025		2024		2023
Traditional life
Interest accretion rate	2.35	%	2.34	%	2.33	%
Current discount rate	4.77	%	5.44	%	5.03	%
Immediate annuities
Interest accretion rate	3.20	%	3.17	%	3.14	%
Current discount rate	5.29	%	5.45	%	4.98	%
PRT
Interest accretion rate	4.87	%	4.72	%	4.61	%
Current discount rate	4.98	%	5.54	%	5.03	%

The following tables summarize the actual experience and expected experience for mortality and lapses of the FPB:


	December 31,
	2025						2024						2023
	Traditional life		Immediate annuities		PRT		Traditional life		Immediate annuities		PRT		Traditional life		Immediate annuities		PRT
Mortality
Actual experience	2.4	%	2.4	%	2.6	%	1.4	%	2.7	%	2.7	%	1.7	%	3.2	%	3.2	%
Expected experience	1.6	%	1.7	%	2.5	%	1.5	%	1.9	%	2.5	%	1.4	%	1.8	%	2.3	%
Lapses
Actual experience	—	%	—	%	—	%	0.1	%	—	%	—	%	—	%	—	%	—	%
Expected experience	0.6	%	—	%	—	%	0.5	%	—	%	—	%	0.3	%	—	%	—	%

The following table provides additional information for periods in which a cohort has a net premium ratio (“NPR”) greater than 100% (and therefore capped at 100%) (dollars in millions):


	December 31, 2025				December 31, 2024
	Cohort X			Description	Cohort X			Description
NPR before capping	104		%	Term with return of premium Non-NY Cohort	108		%	Term with return of premium Non-NY Cohort
Reserves before NPR capping	$	1,145		Term with return of premium Non-NY Cohort	$	1,147		Term with return of premium Non-NY Cohort
Reserves after NPR capping	1,156			Term with return of premium Non-NY Cohort	1,174			Term with return of premium Non-NY Cohort
Loss Expense	11			Term with return of premium Non-NY Cohort	27			Term with return of premium Non-NY Cohort

F&G made changes to assumptions during the years ended December 31, 2025 and 2024. Significant assumption inputs used in the calculation of our FPB are described below. Refer to the tables above for further details on changes to our FPB.

Traditional life

The traditional life line of business primarily consists of policies that were sold prior to 2010. As this line of business continues to age, benefit payments made from these contracts will be the primary driver of the emergence of reserves, decreasing the reserve balance.

Significant assumption inputs to the calculation of the FPB for traditional life include mortality, lapses (including lapses due to nonpayment of premium and surrenders for cash surrender value), and discount rates (both accretion and current). F&G reviews the cash flow assumptions annually, typically in the third quarter. In 2025, F&G updated the assumptions for surrenders and lapses. Updates to these assumptions brought F&G more in line with internal and overall industry experience since the prior assumption updates. These assumption updates resulted in a decrease to the FPB liability for the year ended December 31, 2025. In 2024, F&G made an adjustment to the calculation to reflect additional actuarial precision, unrelated to the assumptions, driving an increase to the FPB liability.

Market data that underlies current discount rates was updated in 2025 from that utilized in 2024 resulting in decreased discount rates that drove an increase to the FPB. Market data that underlies current discount rates was updated in 2024 from that utilized in 2023 resulting in increased discount rates that drove a decrease to the FPB.

Immediate annuities (life contingent)

Significant assumption inputs to the calculation of the FPB for immediate annuities (life contingent) include mortality and discount rates (both accretion and current). F&G reviews the cash flow assumptions annually, typically in the third quarter. In 2024, F&G undertook a review of the significant cash flow assumptions and did not make any changes to mortality. Market data that underlies current discount rates was updated in 2025 from that utilized in 2024 resulting in decreased discount rates that drove an increase to the FPB. Market data that underlies current discount rates was updated in 2024 from that utilized in 2023 resulting in increased discount rates that drove a decrease to the FPB.

PRT (life contingent)

The PRT line of business has issued a significant volume of contracts for 2025 and 2024, which is the primary impact in increasing the reserve balance in each of those periods.

Significant assumption inputs to the calculation of the FPB for PRT (life contingent) include mortality and discount rates (both accretion and current). Additionally, for PRT contracts with deferred payment streams, retirement age and elected payment form are significant assumptions. F&G reviews the cash flow assumptions annually, typically in the third quarter. In 2024, F&G undertook a review of the significant cash flow assumptions and did not make any changes to any significant assumptions. Market data that underlies current discount rates was updated in 2025 from that utilized in 2024 resulting in decreased discount rates that drove an increase to the FPB. Market data that underlies current discount rates was updated in 2024 from that utilized in 2023 resulting in increased discount rates that drove a decrease to the FPB.

Premium deficiency testing

F&G conducts annual premium deficiency testing for its long-duration contracts except for the FPB for nonparticipating traditional and limited-payment contracts. F&G also conducts annual premium deficiency testing for the VOBA of all long-duration contracts. Premium deficiency testing is performed by reviewing assumptions used to calculate the insurance liabilities and determining whether the sum of the existing contract liabilities and the present value of future gross premiums is sufficient to cover the present value of future benefits to be paid to or on behalf of policyholders and settlement costs and recover unamortized present value of future profits. Anticipated investment income, based on F&G’s experience, is considered when performing premium deficiency testing for long-duration contracts. During 2024, F&G did not pass premium deficiency testing for the traditional life block of business, related to the recoverability of VOBA. Due to that result, F&G began accruing a liability in the fourth quarter of 2024 that increases the amortization of traditional life VOBA. The liability balance was immaterial at December 31, 2025 and December 31, 2024.

Income Taxes - Narrative (Details) - USD ($)	12 Months Ended
Income Taxes - Narrative (Details) - USD ($)	Dec. 31, 2025	Dec. 31, 2024
Valuation Allowance [Line Items]
Deferred tax liability	$ (359,000,000)
Deferred tax assets, net		$ 315,000,000
Decrease in deferred tax liability due to investments unrealized gains	271,000,000
Increase in deferred tax asset, reinsurance receivable	356,000,000
Increase in deferred tax asset related to life insurance receivables	88,000,000
Deferred tax liability, increase (decrease), amount	404,000,000
Investment tax credits	471,000,000
Operating loss carryforwards	25,000,000
Tax credits	176,000,000	204,000,000
Valuation allowance	114,000,000	164,000,000
Unrecognized tax benefits	0	0
Income taxes receivable	82,000,000	20,000,000
Deferred Tax Liability, Unrealized Gain
Valuation Allowance [Line Items]
Deferred tax liability, increase (decrease), amount	79,000,000
F& G Subsidiaries
Valuation Allowance [Line Items]
Deferred tax assets, net		295,000,000
Income taxes receivable	84,000,000	$ 6,000,000
General Business Credit Carryforward
Valuation Allowance [Line Items]
Valuation allowance	31,000,000
Deferred Tax Asset, Capital Loss
Valuation Allowance [Line Items]
Valuation allowance	71,000,000
Valuation allowance, decrease	48,000,000
Begin to expire in 2023
Valuation Allowance [Line Items]
Operating loss carryforwards	548,000,000
Title
Valuation Allowance [Line Items]
Decrease in deferred tax liability due to investments unrealized gains	29,000,000
Deferred tax liability, increase (decrease), amount	30,000,000
Operating loss carryforwards	42,000,000
Operating loss carryforwards, valuation allowance	25,000,000
Title \| Deferred Tax Asset, Capital Loss
Valuation Allowance [Line Items]
Valuation allowance	34,000,000
Title \| General Business Credit Carryforward
Valuation Allowance [Line Items]
Tax credits	31,000,000
F&G
Valuation Allowance [Line Items]
Decrease in deferred tax liability due to investments unrealized gains	242,000,000
Increase in deferred tax liability, deferred acquisition costs	134,000,000
Increase deferred tax liability, reinsurance receivable	316,000,000
Deferred tax liability, increase (decrease), amount	49,000,000
Operating loss carryforwards	506,000,000
F&G \| Deferred Tax Asset, Capital Loss
Valuation Allowance [Line Items]
Valuation allowance	37,000,000
F&G \| General Business Credit Carryforward
Valuation Allowance [Line Items]
Tax credits	$ 124,000,000

F&G Reinsurance - Narrative (Details) $ in Millions	12 Months Ended
F&G Reinsurance - Narrative (Details) $ in Millions	Dec. 31, 2025 USD ($) policy	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)
Effects of Reinsurance [Line Items]
Number of policies reinsured by foreign company not engaged in insurance \| policy	0
Deposit assets	$ 13,279	$ 11,039
Reinsurance risk charge fee	42	$ 42	$ 39
Raven Re (VT) \| Intercompany Reinsurance Agreements \| Affiliate
Effects of Reinsurance [Line Items]
Remaining borrowing capacity	150
F&G Cayman Re Ltd \| Intercompany Reinsurance Agreements \| Affiliate
Effects of Reinsurance [Line Items]
Remaining borrowing capacity	610
Corbeau Re (VT) \| Affiliate
Effects of Reinsurance [Line Items]
Excess of loss agreement, maximum loss coverage	$ 2,400

Schedule II - Condensed Financial Information - Statement of Earnings (Parent Company) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Revenues:
Other fees and revenue	$ 5,444	$ 5,321	$ 4,717
Recognized gains and losses, net	(60)	83	(164)
Total revenues	14,445	13,681	11,752
Expenses:
Personnel costs	3,437	3,148	2,908
Other operating expenses	1,615	1,558	1,521
Total expenses	13,048	11,939	11,059
Earnings before income taxes and equity in earnings of unconsolidated affiliates	1,397	1,742	693
Income tax expense	753	367	192
Net earnings attributable to FNF common shareholders	602	1,270	517
Beginning balance	8,532	7,460	6,569
Dividends declared	(549)	(532)	(498)
Ending balance	8,972	8,532	7,460
Retained Earnings
Expenses:
Beginning balance	5,982	5,244	5,225
Dividends declared	(549)	(532)	(498)
Ending balance	5,484	5,982	5,244
Parent Company
Revenues:
Other fees and revenue	39	38	33
Interest and investment income and realized gains	64	76	74
Recognized gains and losses, net	7	2	(31)
Total revenues	110	116	76
Expenses:
Personnel costs	100	94	70
Other operating expenses	38	28	47
Interest expense	77	76	77
Total expenses	215	198	194
Earnings before income taxes and equity in earnings of unconsolidated affiliates	(105)	(82)	(118)
Income tax expense	419	(20)	(29)
Losses before equity in earnings of subsidiaries	(524)	(62)	(89)
Equity in earnings of subsidiaries	1,126	1,332	606
Net earnings attributable to FNF common shareholders	602	1,270	517
Parent Company \| Retained Earnings
Expenses:
Net earnings attributable to FNF common shareholders	602	1,270	517
Beginning balance	5,982	5,244	5,225
Dividends declared	(549)	(532)	(498)
Distribution of F&G to FNF common shareholders	(551)	0	0
Ending balance	$ 5,484	$ 5,982	$ 5,244

Property and Equipment (Tables)

12 Months Ended

Dec. 31, 2025

Schedule of Property and Equipment


Property and equipment consist of the following:
	December 31,
	2025		2024
	(In millions)
Furniture, fixtures and equipment	$	164	$	161
Data processing equipment	164		155
Leasehold improvements	131		126
Buildings	103		93
Land	17		14
Other	8		8
Total property and equipment, gross	587		557
Accumulated depreciation and amortization	(398)		(384)
Total property and equipment, net	$	189	$	173

Contractholder Funds - Reconciliation to Condensed Consolidated Balance Sheets (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Policyholder Account Balance [Line Items]
Contractholder funds	$ 62,726	$ 56,404
Indexed annuities
Policyholder Account Balance [Line Items]
Contractholder funds	33,547	30,454
Fixed rate annuities
Policyholder Account Balance [Line Items]
Contractholder funds	19,267	17,442
Immediate annuities
Policyholder Account Balance [Line Items]
Contractholder funds	262	286
Universal Life
Policyholder Account Balance [Line Items]
Contractholder funds	3,407	2,896
Traditional life
Policyholder Account Balance [Line Items]
Contractholder funds	4	5
FABN
Policyholder Account Balance [Line Items]
Contractholder funds	3,335	2,463
FHLB
Policyholder Account Balance [Line Items]
Contractholder funds	2,898	2,852
PRT
Policyholder Account Balance [Line Items]
Contractholder funds	$ 6	$ 6

CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (Parenthetical) - USD ($)
$ in Millions

12 Months Ended

Dec. 31, 2025

Dec. 31, 2024

Dec. 31, 2023

Statement of Comprehensive Income [Abstract]

Unrealized (loss) gain on investments and other financial instruments, net of adjustments to intangible assets and unearned revenue (excluding investments in unconsolidated affiliates), tax expense (benefit)

^[1]

$ 171

$ (43)

$ 238

Unrealized gain on investments in unconsolidated affiliates, tax expense

^[2]

Unrealized (loss) gain (benefit) expense

(6)

^[3]

Reclassification adjustments for change in unrealized gains and losses included in net earnings, tax (benefit) expense

(13)

(1)

Changes in current discount rate - future policy benefits , tax expense (benefit)

^[4]

(62)

(50)

Changes in instrument-specific credit risk - market risk benefits, tax expense (benefit)

^[5]

(6)

(9)

Other comprehensive (loss) earnings attributable to non-controlling interest, tax (benefit) expense

$ (18)

$ (3)

$ (35)

[1]	Net of income tax expense (benefit) of $171 million, $(43) million, and $238 million for the years ended December 31, 2025, 2024, and 2023, respectively.
[2]	Net of income tax expense of $2 million, $9 million, and $3 million for the years ended December 31, 2025, 2024, and 2023, respectively.
[3]	Net of income tax expense (benefit) of $4 million and $(6) million, and $2 million for the years ended December 31, 2025 and 2024, and 2023, respectively.
[4]	Net of income tax (benefit) expense of $(62) million, $59 million, and $(50) million for the years ended December 31, 2025, 2024, and 2023, respectively
[5]	Net of income tax (benefit) expense of $(6) million, $1 million, and $(9) million for the years ended December 31, 2025, 2024, and 2023, respectively.

Contractholder Funds - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Insurance [Abstract]
Change in total benefits and other changes in policy reserves (decrease) increase	$ (22)	$ (89)

Income Taxes - Income Taxes Paid (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Federal	$ 198
State & Foreign	52
Total	$ 250	$ 237	$ 216

Recent Accounting Pronouncements	12 Months Ended
Recent Accounting Pronouncements	Dec. 31, 2025
Accounting Changes and Error Corrections [Abstract]
Recent Accounting Pronouncements	Recent Accounting Pronouncements Adopted Pronouncements In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amendments in this update enhance the transparency of the income tax disclosures by expanding on the disclosures required annually. The amendments require entities to disclose in their rate reconciliation table additional categories of information about federal, state, and foreign income taxes, in addition to providing details about the reconciling items in some categories if above a quantitative threshold. Additionally, the amendments require annual disclosure of income taxes paid (net of refunds received) disaggregated by jurisdiction based on a quantitative threshold. We adopted this standard as of December 31, 2025 and are applying this guidance on a prospective basis. Refer to Note S Income Taxes for further information. Pronouncements Not Yet Adopted In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. The amendments in this update enhance transparency of certain expense captions by disclosing more granular information of specific expenses within those captions such as personnel costs, depreciation, and amortization. The amendments also require disclosure of qualitative description of amounts remaining in relevant expense captions that are not separately disaggregated. The amendments in this update are effective for all public companies for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted, and the amendments should be applied either prospectively to financial statements issued for reporting periods after the effective date or retrospectively to all prior periods presented in the financial statements. We do not expect to early adopt this standard and are in the process of assessing its impact on our disclosures upon adoption. In September 2025, the FASB issued ASU 2025-06, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software. The amendments in this update refine capitalization thresholds by removing all references to project stages. The amendments require that an entity capitalize software costs when management has authorized and committed to funding the software project and when it is probable that the project will be completed and the software will be used to perform the function intended (“probable-to-complete recognition threshold”). Additionally, the amendments clarify the disclosure requirements for internal-use software costs. The amendments in this update are effective for all companies for annual and interim reporting periods beginning after December 15, 2027. Early adoption is permitted, and the amendments should be applied using a prospective, retrospective, or modified transition approach. We are in the process of assessing this standard and its impact upon adoption. In November 2025, the FASB issued ASU 2025-09, Derivatives and Hedging (Topic 815): Hedge Accounting Improvements. The amendments in this update make improvements to the hedge accounting guidance, with the overall goal of simplifying the application of hedge accounting guidance. The main amendments in this Update include: Issue 1) Similar Risk Assessment for Cash Flow Hedges: expands the hedged risks permitted to be aggregated in a group of individual forecasted transactions in a cash flow hedge, enabling entities to apply hedge accounting to potentially broader portfolios of forecasted transactions, Issue 2) Hedging Forecasted Interest Payments on Choose-Your-Rate Debt Instruments: establishes a model that enables hedge accounting to be applied more broadly to choose-your-rate debt and address existing diversity in practice, Issue 3) Cash Flow Hedges of Nonfinancial Forecasted Transactions: expands hedge accounting for forecasted purchases and sales of nonfinancial assets subject to certain criteria, Issue 4) Net Written Options as Hedging Instruments: accommodates differences in the loan and swap markets that resulted from reference rate reform, eliminating the requirement for the net written option test in certain instances, and Issue 5) Foreign-Currency-Denominated Debt Instrument as Hedging Instrument and Hedged Item (Dual Hedge): eliminates the recognition and presentation mismatch related to a dual hedge strategy. The amendments in this update are effective for public companies for annual and interim reporting periods beginning after December 15, 2026. Early adoption is permitted, and the amendments should be applied using a prospective basis for all hedging relationships. We are in the process of assessing this standard and its impact upon adoption.

The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 9
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479343/105-10-65-9

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 17
-Subparagraph (d)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480336/718-10-65-17

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 17
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480336/718-10-65-17

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476173/280-10-65-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 7
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479343/105-10-65-7

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 60
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476176/805-60-65-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 848
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483550/848-10-65-2

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 323
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478666/740-323-65-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 848
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483550/848-10-65-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 848
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483550/848-10-65-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480016/944-40-65-2

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480016/944-40-65-2

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480016/944-40-65-2

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(iv)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480016/944-40-65-2

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (h)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480016/944-40-65-2

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 5
-Subparagraph (SAB Topic 11.M.Q2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480530/250-10-S99-5

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 6
-Subparagraph (i)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480528/815-20-65-6

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 326
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479654/326-10-65-4

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 326
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (e)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479654/326-10-65-4

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480530/250-10-S99-6

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (f)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481538/470-20-65-4

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481538/470-20-65-4

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-1

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Topic 250
-Publisher FASB
-URI https://asc.fasb.org/250/tableOfContent

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480175/815-40-65-1

SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Abstract]

F&G Reinsurance - Reinsurance Recoverable (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Effects of Reinsurance [Line Items]
Allowance for expected credit loss	$ (18)	$ (20)	$ (21)
Reinsurance recoverable, net of allowance for expected credit losses	17,551	13,380
F&G
Effects of Reinsurance [Line Items]
Reinsurance recoverable	17,563	13,389
Allowance for expected credit loss	(18)	(20)
Reinsurance recoverable, net of allowance for expected credit losses	17,545	13,369
Aspida \| Certain MYGA \| F&G
Effects of Reinsurance [Line Items]
Reinsurance recoverable	8,589	7,844
Somerset Reinsurance Ltd. \| Certain MYGA and deferred annuities \| F&G
Effects of Reinsurance [Line Items]
Reinsurance recoverable	5,071	2,822
Everlake \| Certain MYGA \| F&G
Effects of Reinsurance [Line Items]
Reinsurance recoverable	1,868	1,168
Wilton Reassurance Company \| Block of traditional, IUL, and UL \| F&G
Effects of Reinsurance [Line Items]
Reinsurance recoverable	1,032	1,066
Fort Greene \| Block of traditional, IUL, and UL \| F&G
Effects of Reinsurance [Line Items]
Reinsurance recoverable	502	0
Other \| F&G
Effects of Reinsurance [Line Items]
Reinsurance recoverable	$ 501	$ 489

Schedule III - F&G Supplementary Insurance Information

12 Months Ended

Dec. 31, 2025

Schedule III - F&G Supplementary Insurance Information

Schedule III

FIDELITY NATIONAL FINANCIAL, INC.

F&G Supplementary Insurance Information

(in millions)


	Year Ended
	December 31, 2025		December 31, 2024		December 31, 2023

F&G Segment:
Deferred acquisition costs	$	3,637	$	3,036	$	2,215
Future policy benefits, losses, claims and loss expenses	10,755		8,749		7,050
Other policy claims and benefits payable	100		102		92
Life insurance premiums and other fees	2,795		2,860		2,413
Interest and investment income	2,837		2,719		2,211
Benefits, claims, losses and settlement expenses	(3,963)		(3,791)		(3,553)
Amortization of deferred policy acquisition costs	(357)		(280)		(191)
Other operating expenses, net of deferrals	(156)		(203)		(146)

Investments - Proceeds From the Sale of Fixed-Maturity Available-For-Sale Securities (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Proceeds	$ 5,720	$ 4,414	$ 2,698
Gross gains	30	45	18
Gross losses	$ (27)	$ (80)	$ (145)

Fair Value of Financial Instruments - Carrying Value and Estimated Fair Value of Financial Instruments (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Assets
Investments in unconsolidated affiliates	$ 5,166	$ 3,731
Trade and notes receivables, net of allowance	473	471
Total Estimated Fair Value
Assets
FHLB common stock	155	153
Commercial mortgage loans	3,025	2,404
Residential mortgage loans	4,424	2,916
Investments in unconsolidated affiliates	4,608	3,293
Policy loans	147	104
Other invested assets	93	90
Company-owned life insurance	887	431
Trade and notes receivables, net of allowance	473	471
Total	13,812	9,862
Liabilities
Investment contracts, included in Contractholder funds	51,027	46,339
Debt	4,204	3,781
Total	55,231	50,120
Carrying Amount
Assets
FHLB common stock	155	153
Commercial mortgage loans	3,242	2,705
Residential mortgage loans	4,649	3,221
Investments in unconsolidated affiliates	4,608	3,293
Policy loans	147	104
Other invested assets	93	90
Company-owned life insurance	887	431
Trade and notes receivables, net of allowance	473	471
Total	14,254	10,468
Liabilities
Investment contracts, included in Contractholder funds	56,184	51,184
Debt	4,400	4,321
Total	60,584	55,505
Level 1
Assets
FHLB common stock	0	0
Commercial mortgage loans	0	0
Residential mortgage loans	0	0
Investments in unconsolidated affiliates	0	0
Policy loans	0	0
Other invested assets	18	42
Company-owned life insurance	0	0
Trade and notes receivables, net of allowance	0	0
Total	18	42
Liabilities
Investment contracts, included in Contractholder funds	0	0
Debt	0	0
Total	0	0
Level 2
Assets
FHLB common stock	155	153
Commercial mortgage loans	0	0
Residential mortgage loans	0	0
Investments in unconsolidated affiliates	0	0
Policy loans	0	0
Other invested assets	0	0
Company-owned life insurance	0	0
Trade and notes receivables, net of allowance	0	0
Total	155	153
Liabilities
Investment contracts, included in Contractholder funds	0	0
Debt	4,204	3,781
Total	4,204	3,781
Level 3
Assets
FHLB common stock	0	0
Commercial mortgage loans	3,025	2,404
Residential mortgage loans	4,424	2,916
Investments in unconsolidated affiliates	0	5
Policy loans	147	104
Other invested assets	0	0
Company-owned life insurance	887	431
Trade and notes receivables, net of allowance	473	471
Total	8,956	6,331
Liabilities
Investment contracts, included in Contractholder funds	51,027	46,339
Debt	0	0
Total	51,027	46,339
NAV
Assets
Investments in unconsolidated affiliates	4,608	3,288
Other invested assets	75	48
Total	$ 4,683	$ 3,336

Leases - Future Payments Under Operating Lease Arrangements (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Leases [Abstract]
2026	$ 130
2027	101
2028	76
2029	52
2030	29
Thereafter	20
Total operating lease payments, undiscounted	408
Less: present value discount	40
Lease liability, at present value	$ 368	$ 385

Other Intangible Assets - DSI (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Movement in Deferred Sales Inducements [Roll Forward]
DSI at beginning of period	$ 625	$ 346
Capitalization	332	319
Amortization	(66)	(40)	$ (22)
DSI at end of period	$ 891	$ 625	$ 346

CONSOLIDATED STATEMENTS OF EARNINGS - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Revenues:
Direct title insurance premiums	$ 2,574	$ 2,200	$ 1,982
Agency title insurance premiums	3,250	2,953	2,610
Escrow, title-related and other fees	5,444	5,321	4,717
Interest and investment income	3,237	3,124	2,607
Recognized gains and losses, net	(60)	83	(164)
Total revenues	14,445	13,681	11,752
Expenses:
Personnel costs	3,437	3,148	2,908
Agent commissions	2,518	2,287	2,008
Other operating expenses	1,615	1,558	1,521
Benefits and other changes in policy reserves	3,963	3,791	3,553
Market risk benefit (gains) losses	167	(25)	95
Depreciation and amortization	844	739	593
Provision for title claim losses	262	232	207
Interest expense	242	209	174
Total expenses	13,048	11,939	11,059
Earnings before income taxes and equity in earnings of unconsolidated affiliates	1,397	1,742	693
Income tax expense	753	367	192
Earnings before equity in earnings of unconsolidated affiliates	644	1,375	501
Equity in earnings of unconsolidated affiliates	35	16	17
Net earnings	679	1,391	518
Less: Net earnings attributable to non-controlling interests	77	121	1
Net earnings attributable to Fidelity National Financial, Inc. common shareholders	$ 602	$ 1,270	$ 517
Earnings per share
Net earnings per share attributable to FNF common shareholders, basic (in dollars per share)	$ 2.22	$ 4.69	$ 1.91
Net earnings per share attributable to FNF common shareholders, diluted (in dollars per share)	$ 2.21	$ 4.65	$ 1.91
Weighted average shares outstanding FNF common stock, basic basis (in shares)	271	271	270
Weighted average shares outstanding FNF common stock, diluted basis (in shares)	272	273	271

Financial Instruments with Off-Balance Sheet Risk and Concentration of Risk

12 Months Ended

Dec. 31, 2025

Risks and Uncertainties [Abstract]

Financial Instruments with Off-Balance Sheet Risk and Concentration of Risk

In the normal course of business, we and certain of our subsidiaries enter into off-balance sheet credit arrangements associated with certain aspects of the title insurance business and other activities.

We generate a significant amount of title insurance premiums in Texas, California, Florida, Pennsylvania and Illinois. Title insurance premiums as a percentage of the total title insurance premiums written from those five states are detailed as follows:


	2025		2024		2023
Texas	14.1	%	13.8	%	14.3	%
California	12.2	%	12.9	%	13.0	%
Florida	9.4	%	10.2	%	10.7	%
Illinois	5.8	%	5.8	%	6.0	%
Pennsylvania	5.4	%	5.2	%	4.9	%

Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash equivalents, short-term investments, and trade receivables.

We place cash equivalents and short-term investments with high credit quality financial institutions and, by policy, limit the amount of credit exposure with any one financial institution. Investments in commercial paper of industrial firms and financial institutions are rated investment grade by nationally recognized rating agencies.

Concentrations of credit risk with respect to trade receivables are limited because a large number of geographically diverse customers make up our customer base, thus spreading the trade receivables credit risk. We control credit risk through monitoring procedures.

The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (d)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-21

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (d)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-21

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (c)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-21

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-21

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-21

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 3A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482836/275-10-55-3A

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-2A

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-1

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 275
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/275/tableOfContent

Investments - Narrative (Details)	12 Months Ended
Investments - Narrative (Details)	Dec. 31, 2025 USD ($) loan	Dec. 31, 2024 USD ($) loan	Dec. 31, 2023 USD ($)
Debt Securities, Available-for-sale [Line Items]
Non-income producing investment fair value	$ 54,000,000	$ 32,000,000
Accrued interest receivable	$ 542,000,000	476,000,000
Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss, Statement of Financial Position [Extensible Enumeration]	Prepaid expenses and other assets
FHLB collateral pledged	$ 4,621,000,000	4,289,000,000
Available for sale securities, allowance for credit losses	112,000,000	$ 67,000,000
Available-for-sale, securities in unrealized loss position, allowance for credit loss	$ 0
Commercial mortgage loans, percentage of investments	4.00%	4.00%
DSC ratio, amortization period	25 years
Mortgage loans past due 90 days	$ 79,000,000	$ 94,000,000
Mortgage loans in process of foreclosure	111,000,000	81,000,000
Purchased mortgage loans with credit deterioration	0	0
Gross investment income	3,508,000,000	3,423,000,000	$ 2,864,000,000
Reinsurance agreement, recognized gains (losses)	(154,000,000)	(30,000,000)	(123,000,000)
90 days or more past due
Debt Securities, Available-for-sale [Line Items]
Mortgage loans past due 90 days	79,000,000
Variable Interest Entity, Primary Beneficiary
Debt Securities, Available-for-sale [Line Items]
Maximum loss exposure	878,000,000
Funds Withheld for Reinsurance
Debt Securities, Available-for-sale [Line Items]
Gross investment income	$ 816,000,000	$ 636,000,000	$ 339,000,000
United States
Debt Securities, Available-for-sale [Line Items]
Residential mortgage loans, location percentage	100.00%
Commercial mortgage
Debt Securities, Available-for-sale [Line Items]
Number of loans delinquent in principal or interest payments \| loan	1	1
Mortgage loans past due 90 days	$ 12,000,000	$ 9,000,000
Interest receivable	$ 11,000,000	$ 8,000,000
Residential mortgage
Debt Securities, Available-for-sale [Line Items]
Percentage of total investments	7.00%	5.00%
Loan charge offs	$ 0
Mortgage loans past due 90 days	67,000,000	$ 85,000,000
Interest receivable	$ 45,000,000	28,000,000
Mortgage loans \| Commercial mortgage
Debt Securities, Available-for-sale [Line Items]
Allowance for expected credit loss, probability of loss/default model, projected loss, forecast period	2 years
Allowance for credit loss, probability of loss/default, using market historical loss experience, period	3 years
Mortgage loans \| Residential mortgage
Debt Securities, Available-for-sale [Line Items]
Allowance for expected credit loss, probability of loss/default model, projected loss, forecast period	2 years
Allowance for credit loss, probability of loss/default, using market historical loss experience, period	3 years
Fixed maturity securities, available-for-sale
Debt Securities, Available-for-sale [Line Items]
Assets held by insurance regulators	$ 155,000,000	$ 997,000,000

Dividends	12 Months Ended
Dividends	Dec. 31, 2025
Equity [Abstract]
Dividends	Dividends On February 19, 2026, our Board of Directors declared cash dividends of $0.52 per share, payable on March 31, 2026, to FNF common shareholders of record as of March 17, 2026. During the years ended December 31, 2025, 2024 and 2023, we declared dividends on our common stock of $2.02, $1.94 and $1.83, respectively.

The entire disclosure for equity.

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies - Narrative (Details) $ in Millions			12 Months Ended
	Jan. 02, 2024 USD ($)	Sep. 07, 2023 defendant	Dec. 31, 2025 USD ($) lawsuit	Dec. 31, 2024 USD ($)	Oct. 31, 2021 USD ($)
Other Commitments [Line Items]
Estimated litigation liability			$ 7	$ 17
Escrow balances			16,200	14,400
Kubera
Other Commitments [Line Items]
Note funding, maximum					$ 435
Roar Joint Venture, LLC
Other Commitments [Line Items]
Contingent consideration liability payment period	3 years
Roar Joint Venture, LLC \| Loan Commitment
Other Commitments [Line Items]
Loan principal outstanding			24	11
Roar Joint Venture, LLC \| Maximum \| Loan Commitment
Other Commitments [Line Items]
Unfunded investment commitment				$ 40
Roar Joint Venture, LLC \| F&G
Other Commitments [Line Items]
Contingent consideration obligation, payments (up to)	$ 90
Breach Of Contract \| Insurance Distribution Consulting, LLC v. Fidelity & Guaranty Life Insurance Company
Other Commitments [Line Items]
Plaintiffs claim losses amount			162
Failure To Purchase Interest In Contracts \| Insurance Distribution Consulting, LLC v. Fidelity & Guaranty Life Insurance Company
Other Commitments [Line Items]
Plaintiffs claim losses amount			$ 11
Pending Litigation \| Damages from Product Defects
Other Commitments [Line Items]
Number of class action lawsuits \| lawsuit			2
Number of similar lawsuits filed against other entities (over) \| lawsuit			150
Pending Litigation \| Damages from Product Defects \| Cooper v. Progress Software Corp., No. 1:23-cv-12067
Other Commitments [Line Items]
Number of defendants \| defendant		5

Business and Summary of Significant Accounting Policies - Other Intangible Assets and Goodwill, Intangible Assets and Property and Equipment (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Goodwill [Line Items]
Impairment related to property and equipment	$ 0	$ 0	$ 0
Minimum \| Buildings
Goodwill [Line Items]
Property and equipment, useful life (in years)	20 years
Minimum \| Furniture Fixture and Equipment
Goodwill [Line Items]
Property and equipment, useful life (in years)	3 years
Maximum \| Buildings
Goodwill [Line Items]
Property and equipment, useful life (in years)	30 years
Maximum \| Furniture Fixture and Equipment
Goodwill [Line Items]
Property and equipment, useful life (in years)	25 years
Title Plant
Goodwill [Line Items]
Impairment of indefinite-lived intangible asset	$ 0	$ 2	$ 0
Trademarks, tradenames, and other
Goodwill [Line Items]
Finite-lived intangible asset, useful life (years)	10 years

Regulation and Equity - Equity (Details) - USD ($) $ / shares in Units, $ in Millions		2 Months Ended	12 Months Ended
	Jul. 31, 2024	Feb. 19, 2026	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023	Aug. 03, 2021
Class of Stock [Line Items]
Treasury stock repurchased			$ 254		$ 4
2021 Repurchase Program
Class of Stock [Line Items]
Stock repurchase program number of shares authorized (in shares)						25,000,000
2024 Repurchase Program
Class of Stock [Line Items]
Stock repurchase program number of shares authorized (in shares)	25,000,000
Stock repurchase program, period	3 years
FNF Common Stock \| 2021 Repurchase Program
Class of Stock [Line Items]
Treasury stock repurchased (in shares)				0
FNF Common Stock \| 2024 Repurchase Program
Class of Stock [Line Items]
Treasury stock repurchased (in shares)			4,426,224	0
Treasury stock repurchased			$ 252
Treasury stock acquired (in usd per share)			$ 56.80
FNF Common Stock \| 2024 Repurchase Program \| Subsequent Event
Class of Stock [Line Items]
Treasury stock repurchased (in shares)		60,000
Treasury stock repurchased		$ 3
Treasury stock acquired (in usd per share)		$ 55.66

Market Risk Benefits - Schedule of Reconciliation of Asset and Liability (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Market Risk Benefit [Line Items]
Market risk benefits assets	$ 285	$ 189
Market risk benefits liability	903	549
Direct
Market Risk Benefit [Line Items]
Market risk benefits assets	88	128
Market risk benefits liability	901	549
Reinsured
Market Risk Benefit [Line Items]
Market risk benefits assets	197	61
Market risk benefits liability	2	0
Indexed annuities
Market Risk Benefit [Line Items]
Market risk benefits assets	285	189
Market risk benefits liability	902	548
Indexed annuities \| Direct
Market Risk Benefit [Line Items]
Market risk benefits assets	88	128
Market risk benefits liability	900	548
Indexed annuities \| Reinsured
Market Risk Benefit [Line Items]
Market risk benefits assets	197	61
Market risk benefits liability	2	0
Fixed rate annuities
Market Risk Benefit [Line Items]
Market risk benefits assets	0	0
Market risk benefits liability	1	1
Fixed rate annuities \| Direct
Market Risk Benefit [Line Items]
Market risk benefits assets	0	0
Market risk benefits liability	1	1
Fixed rate annuities \| Reinsured
Market Risk Benefit [Line Items]
Market risk benefits assets	0	0
Market risk benefits liability	$ 0	$ 0

Commitments and Contingencies (Tables)

12 Months Ended

Dec. 31, 2025

Summary of Unfunded Commitments

A summary of unfunded commitments by commitment type is included below:


	December 31, 2025

Commitment Type	(In millions)
Other fixed maturity securities, AFS	$	126
Commercial mortgage loans	74
Residential mortgage loans	300
Other assets	122

Consolidated VIEs:
Other long-term investments	250
Unconsolidated VIEs:
Limited partnerships	$	1,224
Asset-backed lending	263
Fixed maturity securities, asset-backed securities	684
Direct Lending	1,199
Total	$	4,242

Notes Payable (Tables)

12 Months Ended

Dec. 31, 2025

Debt Disclosure [Abstract]

Schedule of Notes Payable

Notes payable consists of the following:


	December 31, 2025		December 31, 2024
	(In millions)
4.50% Notes, net of discount	$	448	$	447

3.40% Notes, net of discount	646		646





2.45% Notes, net of discount	596		595
3.20% Notes, net of discount	445		444
Revolving Credit Facility	(3)		(4)
F&G Credit Agreement	—		—
5.50% F&G Notes	—		301

7.40% F&G Notes, net of discount	498		497
7.30% F&G Notes	364		—




7.95% F&G Notes, net of discount	336		336
6.50% F&G Notes, net of discount	546		545
6.25% F&G Notes, net of discount	493		492
Other	31		22
	$	4,400	$	4,321

B. Notes Payable

Notes payable consist of the following:


	December 31,
	2025		2024
	(In millions)
4.50% Notes, net of discount	$	448	$	447

3.40% Notes, net of discount	646		646
2.45% Notes, net of discount	596		595
3.20% Notes, net of discount	445		444
Revolving credit facility	(3)		(4)

	$	2,132	$	2,128

Schedule of Principal Maturities of Notes Payable


Gross principal maturities of notes payable at December 31, 2025, are as follows:	(In millions)
2026	$	32
2027	—
2028	950
2029	550
2030	650
Thereafter	2,270
	$	4,452

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-SubTopic 10
-Topic 210
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69E
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482925/835-30-45-2

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477734/942-470-50-3

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-8

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-6

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-7

Notes Payable - Narrative (Details) - USD ($)									12 Months Ended
Notes Payable - Narrative (Details) - USD ($)	Oct. 04, 2024	Jun. 04, 2024	Feb. 21, 2023	Nov. 22, 2022	Sep. 17, 2021	Sep. 15, 2020	Jun. 12, 2020	Apr. 20, 2018	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023	Feb. 01, 2025	Jan. 13, 2025	Feb. 16, 2024	Dec. 06, 2023	Jan. 13, 2023	Apr. 22, 2020	May 16, 2019	Aug. 13, 2018
Debt Instrument [Line Items]
Repayments of senior debt									$ 300,000,000	$ 250,000,000	$ 0
Total long term debt									$ 4,452,000,000
Senior Notes
Debt Instrument [Line Items]
Debt instrument, unamortized premium								$ 39,000,000
7.300% Junior Subordinated Notes due 2065 \| Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage													7.30%
5.50% F&G Senior Notes due May 2025 \| Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage		5.50%						5.50%				5.50%
Repurchased amount												$ 300,000,000
Aggregate principal amount								$ 550,000,000
Price as percent of par on offering of unsecured notes								99.50%
Repayments of senior debt		$ 250,000,000
Proceeds from issuance of senior notes								$ 547,000,000
6.25% F&G Notes, net of discount \| Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	6.25%								6.25%
Aggregate principal amount	$ 500,000,000
Price as percent of par on offering of unsecured notes	99.36%
Debt issuance costs, net	$ 8,000,000
Credit Agreement November 2022 \| Line of Credit \| Revolving Credit Facility
Debt Instrument [Line Items]
Repayment of remaining outstanding principal	$ 365,000,000
6.50% F&G Notes, net of discount \| Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage		6.50%							6.50%
Aggregate principal amount		$ 550,000,000
Price as percent of par on offering of unsecured notes		99.74%
Debt issuance costs, net		$ 6,000,000
7.95% F&G Notes, net of discount \| Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage									7.95%						7.95%
Aggregate principal amount															$ 345,000,000
Debt issuance costs, net															$ 9,000,000
7.40% F&G Notes, net of discount \| Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage									7.40%							7.40%
Aggregate principal amount																$ 500,000,000
Debt issuance costs, net																$ 6,000,000
F&G Credit Agreement \| Line of Credit
Debt Instrument [Line Items]
Basis spread on variable rate				1.00%
F&G Credit Agreement \| Line of Credit \| Revolving Credit Facility
Debt Instrument [Line Items]
Line of credit facility			$ 665,000,000	$ 550,000,000										$ 750,000,000
Credit facility increase in borrowing capacity			$ 115,000,000
Basis spread on variable rate				0.50%
Average variable interest rate									0.00%	7.06%
Revolving credit outstanding									$ 0	$ 0
Remaining borrowing capacity									$ 750,000,000
F&G Credit Agreement \| Line of Credit \| Revolving Credit Facility \| Minimum
Debt Instrument [Line Items]
Facility fee, rate				0.20%
F&G Credit Agreement \| Line of Credit \| Revolving Credit Facility \| Maximum
Debt Instrument [Line Items]
Facility fee, rate				0.45%
F&G Credit Agreement \| Line of Credit \| Revolving Credit Facility \| Condition One \| Minimum
Debt Instrument [Line Items]
Basis spread on variable rate				0.30%
F&G Credit Agreement \| Line of Credit \| Revolving Credit Facility \| Condition One \| Maximum
Debt Instrument [Line Items]
Basis spread on variable rate				0.80%
F&G Credit Agreement \| Line of Credit \| Revolving Credit Facility \| Condition Two \| Minimum
Debt Instrument [Line Items]
Basis spread on variable rate				1.30%
F&G Credit Agreement \| Line of Credit \| Revolving Credit Facility \| Condition Two \| Maximum
Debt Instrument [Line Items]
Basis spread on variable rate				1.80%
3.20% Notes, net of discount
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage					3.20%
Aggregate principal amount					$ 450,000,000
Proceeds from issuance debt					$ 443,000,000
3.20% Notes, net of discount \| Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage									3.20%
Revolving Credit Facility \| Line of Credit \| Revolving Credit Facility
Debt Instrument [Line Items]
Debt issuance costs, net									$ 3,000,000
Remaining borrowing capacity									800,000,000
Total long term debt									$ 0
2.45% Notes, net of discount
Debt Instrument [Line Items]
Proceeds from issuance debt						$ 593,000,000
2.45% Notes, net of discount \| Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage						2.45%			2.45%
Aggregate principal amount						$ 600,000,000
Term Loan Credit Agreement \| Term Loan
Debt Instrument [Line Items]
Line of credit facility																	$ 1,000,000,000.0
Repayments of all outstanding indebtedness under term loan credit agreement						$ 260,000,000
Repayment of principal borrowed							$ 640,000,000
3.40% Notes due June 15, 2030 \| Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage							3.40%
Aggregate principal amount							$ 650,000,000
Proceeds from issuance debt							$ 642,000,000
4.50% Notes Due August 2028
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage																		4.50%	4.50%
4.50% Notes Due August 2028 \| Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage																		4.50%	4.50%
Aggregate principal amount																			$ 450,000,000
Price as percent of par on offering of unsecured notes																			99.252%
Annual interest rate																			4.594%

Schedule IV - F&G Reinsurance (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Life insurance in force
Gross Amount	$ 13,148	$ 10,906	$ 8,448
Ceded to other companies	(1,306)	(1,370)	(1,436)
Assumed from other companies	0	0	0
Net Amount	$ 11,842	$ 9,536	$ 7,012
Percentage of amount assumed to net	0.00%	0.00%	0.00%
Net Premiums Earned
Gross Amount	$ 2,940	$ 3,001	$ 2,567
Ceded to other companies	(145)	(141)	(154)
Assumed from other companies	0	0	0
Net Amount	$ 2,795	$ 2,860	$ 2,413
Percentage of amount assumed to net	0.00%	0.00%	0.00%
Traditional life insurance premiums
Net Premiums Earned
Gross Amount	$ 115	$ 129	$ 148
Ceded to other companies	(85)	(94)	(105)
Assumed from other companies	0	0	0
Net Amount	$ 30	$ 35	$ 43
Percentage of amount assumed to net	0.00%	0.00%	0.00%
Life-contingent PRT premiums
Net Premiums Earned
Gross Amount	$ 2,108	$ 2,217	$ 1,964
Ceded to other companies	0	0	0
Assumed from other companies	0	0	0
Net Amount	$ 2,108	$ 2,217	$ 1,964
Percentage of amount assumed to net	0.00%	0.00%	0.00%
Annuity product charges and other fees
Net Premiums Earned
Gross Amount	$ 717	$ 655	$ 455
Ceded to other companies	(60)	(47)	(49)
Assumed from other companies	0	0
Net Amount	$ 657	$ 608	$ 406
Percentage of amount assumed to net	0.00%	0.00%	0.00%

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Investments:
Fixed maturity securities available for sale, at fair value, as of December 31, 2025 and 2024, at an amortized cost of $57,161 and $51,681, respectively, net of allowance for credit losses of $112 and $67, respectively, and includes pledged fixed maturity securities of $446 and $495, respectively, related to secured trust deposits	$ 54,561	$ 48,218
Derivative investments	1,156	794
Mortgage loans, net of allowance for credit losses of $86 and $70 as of December 31, 2025 and 2024, respectively	7,891	5,926
Investments in unconsolidated affiliates (2025 includes $262 related to investments held by consolidated variable interest entities (“VIEs”) and 2025 and 2024 include certain investments at fair value of $270 and $272, respectively)	5,166	3,731
Other long-term investments (2025 includes $248 related to investments held by consolidated VIEs)	1,572	811
Short-term investments (2025 includes $116 related to investments held by consolidated VIEs)	1,920	3,050
Total investments	73,195	63,615
Cash and cash equivalents, as of December 31, 2025 and 2024 includes $261 and $69, respectively, of pledged cash related to secured trust deposits	2,636	3,479
Trade and notes receivables, net of allowance of $31 and $32 as of December 31, 2025 and 2024, respectively	473	471
Reinsurance recoverable, net of allowance for credit losses of $18 and $20 at December 31, 2025 and 2024, respectively	17,551	13,380
Goodwill	5,272	5,271
Prepaid expenses and other assets	2,012	1,938
Market risk benefits assets	285	189
Lease assets	336	351
Other intangible assets, net	6,641	5,976
Title plants	424	420
Property and equipment, net	189	173
Total assets	109,014	95,263
Liabilities:
Contractholder funds	62,726	56,404
Future policy benefits	10,755	8,749
Accounts payable and accrued liabilities	3,828	3,249
Market risk benefits liability	903	549
Notes payable	4,400	4,321
Reserve for title claim losses	1,700	1,713
Funds withheld for reinsurance liabilities	14,191	10,758
Secured trust deposits	731	551
Lease liabilities	368	385
Income taxes payable	1	52
Deferred tax liability	439	0
Total liabilities	100,042	86,731
Equity:
FNF common stock, $0.0001 par value; authorized 600 shares as of December 31, 2025 and 2024, respectively; outstanding of 271 and 275 as of December 31, 2025 and 2024, respectively, and issued of 332 and 331 as of December 31, 2025 and 2024, respectively	0	0
Preferred stock, $0.0001 par value; authorized 50 shares; issued and outstanding, none	0	0
Additional paid-in capital	6,042	5,976
Retained earnings	5,484	5,982
Accumulated other comprehensive earnings	(1,678)	(2,052)
Less: Treasury stock, 61 and 56 shares as of December 31, 2025 and 2024, at cost	(2,424)	(2,152)
Total Fidelity National Financial, Inc. shareholders’ equity	7,424	7,754
Non-controlling interests	1,548	778
Total equity	8,972	8,532
Total liabilities and equity	109,014	95,263
Preferred equity securities
Investments:
Securities, at fair value	436	443
Equity securities
Investments:
Securities, at fair value	$ 493	$ 642

Segment Information

12 Months Ended

Dec. 31, 2025

Segment Reporting [Abstract]

Segment Information

As of and for the year ended December 31, 2025:


	Title		F&G		Corporate and Other		Elimination		Total
Segment revenues:	(In millions)
Direct title insurance premiums	$	2,574	$	—	$	—	$	—	$	2,574
Agency title insurance premiums	3,250		—		—		—		3,250
Escrow, title related and other fees	2,381		2,884		179		—		5,444
Interest and investment income	363		2,837		154		(117)		3,237
Recognized gains and losses, net	(78)		10		8		—		(60)
Total segment revenues	8,490		5,731		341		(117)		14,445
Significant segment expenses:
Personnel costs	2,983		293		161		—		3,437
Agent commissions	2,518		—		—		—		2,518
Other operating expenses	1,353		156		106		—		1,615
Benefits and other changes in policy reserves	—		3,963		—		—		3,963
Total significant segment expenses	6,854		4,412		267		—		11,533
Other segment items:
Depreciation and amortization	147		665		32		—		844
Provision for title claim losses	262		—		—		—		262
Market risk benefit gains	—		167		—		—		167
Interest expense	—		164		78		—		242
Total other segment items	409		996		110		—		1,515
Total segment expenses	7,263		5,408		377		—		13,048
Earnings (loss) before income taxes and equity in earnings of unconsolidated affiliates	1,227		323		(36)		(117)		1,397
Income tax expense (benefit)	283		52		418		—		753
Earnings (loss) before equity in earnings (loss) of unconsolidated affiliates	944		271		(454)		(117)		644
Equity in earnings of unconsolidated affiliates	39		—		(4)		—		35
Net earnings (loss) from continuing operations	$	983	$	271	$	(458)	$	(117)	$	679
Assets	$	8,093	$	98,432	$	2,489	$	—	$	109,014
Goodwill	2,799		2,180		293		—		5,272

As of and for the year ended December 31, 2024:


	Title		F&G		Corporate and Other		Elimination		Total
Segment revenues:	(In millions)
Direct title insurance premiums	$	2,200	$	—	$	—	$	—	$	2,200
Agency title insurance premiums	2,953		—		—		—		2,953
Escrow, title related and other fees	2,196		2,941		184		—		5,321
Interest and investment income	359		2,719		154		(108)		3,124
Recognized gains and losses, net	(6)		84		5		—		83
Total segment revenues	7,702		5,744		343		(108)		13,681
Significant segment expenses:
Personnel costs	2,695		296		157		—		3,148
Agent commissions	2,287		—		—		—		2,287
Other operating expenses	1,251		203		104		—		1,558
Benefits and other changes in policy reserves	—		3,791		—		—		3,791
Total significant segment expenses	6,233		4,290		261		—		10,784
Other segment items:
Depreciation and amortization	141		569		29		—		739
Provision for title claim losses	232		—		—		—		232
Market risk benefit losses	—		(25)		—		—		(25)
Interest expense	—		132		77		—		209
Total other segment items	373		676		106		—		1,155
Total segment expense	6,606		4,966		367		—		11,939
Earnings (loss) before income taxes and equity in earnings of unconsolidated affiliates	1,096		778		(24)		(108)		1,742
Income tax expense (benefit)	265		136		(34)		—		367
Earnings (loss) before equity in earnings of unconsolidated affiliates	831		642		10		(108)		1,375
Equity in earnings of unconsolidated affiliates	16		—		—		—		16
Net earnings (loss)	$	847	$	642	$	10	$	(108)	$	1,391
Assets	$	7,627	$	84,938	$	2,698	$	—	$	95,263
Goodwill	2,799		2,179		293		—		5,271

As of and for the year ended December 31, 2023:


	Title		F&G		Corporate and Other		Elimination		Total
Segment revenues:	(In millions)
Direct title insurance premiums	$	1,982	$	—	$	—	$	—	$	1,982
Agency title insurance premiums	2,610		—		—		—		2,610
Escrow, title related and other fees	2,117		2,413		187		—		4,717
Interest and investment income	338		2,211		123		(65)		2,607
Recognized gains and losses, net	(9)		(124)		(31)		—		(164)
Total segment revenues	7,038		4,500		279		(65)		11,752
Significant segment expenses:
Personnel costs	2,544		232		132		—		2,908
Agent commissions	2,008		—		—		—		2,008
Other operating expenses	1,242		146		133		—		1,521
Benefits and other changes in policy reserves	—		3,553		—		—		3,553
Total significant segment expenses	5,794		3,931		265		—		9,990
Other segment items:
Depreciation and amortization	154		412		27		—		593
Provision for title claims losses	207		—		—		—		207
Market risk benefit gains	—		95		—		—		95
Interest expense	—		97		77		—		174
Total other segment items	361		604		104		—		1,069
Total segment expenses	6,155		4,535		369		—		11,059
Earnings (loss) before income taxes and equity in earnings of unconsolidated affiliates	883		(35)		(90)		(65)		693
Income tax expense (benefit)	181		23		(12)		—		192
Earnings (loss) before equity in earnings of unconsolidated affiliates	702		(58)		(78)		(65)		501
Equity in earnings of unconsolidated affiliates	17		—		—		—		17
Net earnings (loss)	$	719	$	(58)	$	(78)	$	(65)	$	518
Assets	$	7,949	$	70,186	$	2,479	$	—	$	80,614
Goodwill	2,788		1,749		293		—		4,830

The activities in our segments include the following:

Title. This segment consists of the operations of our title insurance underwriters and related businesses. This segment provides core title insurance and escrow and other title-related services including loan sub-servicing, valuations, default services and home warranty.

F&G. This segment primarily consists of the operations of our annuities and life insurance related businesses. This segment issues a broad portfolio of annuity and life products, including deferred annuities (fixed indexed and fixed rate annuities), immediate annuities and indexed universal life insurance. This segment also provides funding agreements and pension risk transfer solutions.

Corporate and Other. This segment consists of the operations of the parent holding company, our real estate technology subsidiaries and our remaining real estate brokerage businesses. This segment also includes certain other unallocated corporate overhead expenses and eliminations of revenues and expenses between it and our Title segment.

Refer to Note K Revenue Recognition for a description of our accounting for our various revenue streams.

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-21

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-21

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-31

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-15

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-42

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 48
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-48

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 12: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 13: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 14: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 15: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 16: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 17: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 34
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-34

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-40

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/280/tableOfContent

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

Other Intangible Assets - Reconciliation of DAC to the Condensed Consolidated Balance Sheets (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Finite-Lived Intangible Assets [Line Items]
DAC	$ 3,637	$ 3,036
Indexed annuities
Finite-Lived Intangible Assets [Line Items]
DAC	2,205	1,874
Fixed rate annuities
Finite-Lived Intangible Assets [Line Items]
DAC	402	376
Universal Life
Finite-Lived Intangible Assets [Line Items]
DAC	1,021	781
FABN
Finite-Lived Intangible Assets [Line Items]
DAC	5	4
PRT
Finite-Lived Intangible Assets [Line Items]
DAC	$ 4	$ 1

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 20
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-20

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 20
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-20

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 38
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-38

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 38
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-38

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 38
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-38

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 38
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-38

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 38
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-38

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 38
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-38

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 12: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 13: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 14: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 15: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 16: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 17: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 18: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 19: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 29
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-29

Reference 20: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 29
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-29

Reference 21: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 20
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-20

Reference 22: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 20
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-20

Reference 23: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-14

Reference 24: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-14

Reference 25: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-14

Reference 26: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-14

Reference 27: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-14

Reference 28: http://www.xbrl.org/2003/role/exampleRef
-Name Accounting Standards Codification
-Section 55
-Paragraph 40
-SubTopic 30
-Topic 350
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482640/350-30-55-40

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482665/350-30-50-2

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482665/350-30-50-2

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482686/350-30-45-1

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482665/350-30-50-2

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482665/350-30-50-3

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Topic 985
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481283/985-20-50-2

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Topic 926
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483154/926-20-50-5

Accounts Payable and Other Accrued Liabilities

Accounts Payable and Other Accrued Liabilities

12 Months Ended

Dec. 31, 2025

Payables and Accruals [Abstract]

Accounts payable and other accrued liabilities consist of the following:


	December 31,
	2025		2024
	(In millions)
Salaries and incentives	$	469	$	433
Accrued benefits	491		454
URL	551		401
Deferred revenue	95		92
Contingent consideration - acquisitions	95		110
Trade accounts payable	246		191

Accrued recording fees and transfer taxes	8		7
Accrued premium taxes	37		30
Liability for policy and contract claims	100		102
Retained asset account	48		60
Remittances and items not allocated	267		224
Option collateral liabilities	928		680

Other accrued liabilities	493		465
	$	3,828	$	3,249

The following tables roll forward URL for the universal life product for the years ended December 31, 2025 and 2024:


	December 31,
	2025		2024
	(In millions)
Balance at January 1,	$	401	$	270
Capitalization	178		151
Amortization	(28)		(20)
Balance at December 31,	$	551	$	401

For IUL the cash flow assumptions used to amortize URL reflect the Company’s best estimates for policyholder behavior. F&G reviews cash flow assumptions annually, generally in the third quarter. In 2024 and 2025, F&G undertook a review of all significant assumptions. For the year ended December 31, 2025, F&G updated the assumptions for surrenders, lapses, and mortality. For the year ended December 31, 2024, F&G updated assumptions including premium persistency and mortality improvement. All updates to these assumptions brought F&G more in line with our Company and overall industry experience since the prior assumption update.

Fair Value of Financial Instruments

12 Months Ended

Dec. 31, 2025

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

Our measurement of fair value is based on assumptions used by market participants in pricing the asset or liability, which may include inherent risk, restrictions on the sale or use of an asset, or non-performance risk, which may include our own credit risk. We estimate an exchange price is the price in an orderly transaction between market participants to sell the asset or transfer the liability (“exit price”) in the principal market, or the most advantageous market for that asset or liability in the absence of a principal market as opposed to the price that would be paid to acquire the asset or assume a liability (“entry price”). We categorize financial instruments carried at fair value into a three-level fair value hierarchy, based on the priority of inputs to the respective valuation technique, along with net asset value. The three-level hierarchy for fair value measurement is defined as follows:

Level 1 – Values are unadjusted quoted prices for identical assets and liabilities in active markets accessible at the measurement date.

Level 2 – Inputs include quoted prices for similar assets or liabilities in active markets, quoted prices from those willing to trade in markets that are not active, or other inputs that are observable or can be corroborated by market data for the term of the instrument. Such inputs include market interest rates and volatilities, spreads, and yield curves.

Level 3 – Certain inputs are unobservable (supported by little or no market activity) and significant to the fair value measurement. Unobservable inputs reflect the Company’s best estimate of what hypothetical market participants would use to determine a transaction price for the asset or liability at the reporting date based on the best information available in the circumstances.

Net Asset Value ("NAV") – Certain equity investments are measured using NAV as a practical expedient in determining fair value. In addition, our unconsolidated affiliates (primarily limited partnerships) are primarily accounted for using the equity method of accounting with fair value determined using NAV as a practical expedient. Our carrying value reflects our pro rata ownership percentage as indicated by NAV in the unconsolidated affiliate’s financial statements, which we may adjust if we determine NAV is not calculated consistent with investment company fair value principles. The underlying investments of the unconsolidated affiliates may have significant unobservable inputs, which may include, but are not limited to, comparable multiples and weighted average cost of capital rates applied in valuation models or a discounted cash flow model. Additionally, management inquires quarterly with the general partner to determine whether any credit or other market events have occurred since prior period financial statements to ensure any material events are properly included in current period valuation and investment income.

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment’s level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment.

When a determination is made to classify an asset or liability within Level 3 of the fair value hierarchy, the determination is based upon the significance of the unobservable inputs to the overall fair value measurement. Because certain securities trade in less liquid or illiquid markets with limited or no pricing information, the determination of fair value for these securities is inherently more difficult. In addition to the unobservable inputs, Level 3 fair value investments may include observable components, which are components that are actively quoted or can be validated to market-based sources.

Our assets and liabilities measured and carried at fair value on a recurring basis, summarized according to the hierarchy previously described, are as follows:


	December 31, 2025
	Level 1		Level 2		Level 3		NAV		Fair Value
Assets	(In millions)
Cash and cash equivalents	$	2,636	$	—	$	—	$	—	$	2,636
Fixed maturity securities, available-for-sale:
Asset-backed securities	—		8,644		10,094		—		18,738
Commercial mortgage-backed securities	—		5,200		—		—		5,200
Corporates	40		21,263		3,145		—		24,448
Hybrids	36		558		15		—		609
Municipals	—		1,390		3		—		1,393
Residential mortgage-backed securities	—		2,848		3		—		2,851
U.S. Government	938		15		—		—		953
Foreign Governments	107		238		23		—		368
Equity securities:
Preferred equity securities	174		254		8		—		436
Common equity securities	441		—		17		35		493
Derivative investments	—		1,156		—		—		1,156
Investments in unconsolidated affiliates	—		—		270		—		270
Other long-term investments (a)	—		248		41		—		289
Short term investments	1,764		82		74		—		1,920
Indexed annuities/IUL ceded embedded derivatives, included in Reinsurance recoverable	—		—		399		—		399
Loan receivable, included in Prepaid expenses and other assets	—		—		24		—		24


Market risk benefits asset	—		—		285		—		285
Other assets	—		—		129		—		129

Total financial assets at fair value	$	6,136	$	41,896	$	14,530	$	35	$	62,597
Liabilities

Derivatives:
Indexed annuities/indexed universal life insurance ("IUL") embedded derivatives, included in Contractholder funds	$	—	$	—	$	6,542	$	—	$	6,542
Interest rate and foreign currency swaps, included in Accounts payable and accrued liabilities	—		3		9		—		12
Reinsurance related embedded derivatives, included in Funds withheld for reinsurance liabilities	—		75		—		—		75
Equity options	1		—		—		—		1
Contingent consideration, included in Accounts payable and accrued liabilities	—		—		72		—		72
Market risk benefits liability	—		—		903		—		903

Total financial liabilities at fair value	$	1	$	78	$	7,526	$	—	$	7,605

(a) Includes certain interests in VIEs for which the fair value option has been elected. Refer to Note D - Investments for further details.


	December 31, 2024
	Level 1		Level 2		Level 3		NAV		Fair Value
Assets	(In millions)
Cash and cash equivalents	$	3,479	$	—	$	—	$	—	$	3,479
Fixed maturity securities, available-for-sale:
Asset-backed securities	—		7,513		8,143		—		15,656
Commercial mortgage-backed securities	—		5,182		—		—		5,182
Corporates	41		18,698		2,957		—		21,696
Hybrids	35		546		—		—		581
Municipals	—		1,386		—		—		1,386
Residential mortgage-backed securities	—		2,793		3		—		2,796
U.S. Government	631		6		—		—		637
Foreign Governments	—		280		4		—		284



Equity securities:
Preferred equity securities	189		246		8		—		443
Common equity securities	575		—		10		57		642
Derivative investments	—		791		3		—		794

Investments in unconsolidated affiliates	—		—		272		—		272
Other long-term investments	—		—		32		—		32
Short term investments	2,995		18		37		—		3,050
Indexed annuities/IUL ceded embedded derivatives, included in Reinsurance recoverable	—		—		98		—		98
Loan receivable, included in Prepaid expenses and other asset	—		—		11		—		11
Market risk benefits asset	—		—		189		—		189
Other assets	—		—		65		—		65

Total financial assets at fair value	$	7,945	$	37,459	$	11,832	$	57	$	57,293
Liabilities

Derivatives:
Indexed annuities/IUL embedded derivatives, included in Contractholder funds	$	—	$	—	$	5,220	$	—	$	5,220
Interest rate swaps, included in Accounts payable and accrued liabilities	—		10		—		—		10
Equity options	1		—		—		—		1
Reinsurance related embedded derivatives, included in Funds withheld for reinsurance liabilities	—		(109)		—		—		(109)
Contingent consideration, included in Accounts payable and accrued liabilities	—		—		74		—		74
Market risk benefits liability	—		—		549		—		549


Total financial liabilities at fair value	$	1	$	(99)	$	5,843	$	—	$	5,745

Valuation Methodologies

Cash and Cash Equivalents

The carrying amounts reported in the Consolidated Balance Sheets for these instruments approximate fair value.

Fixed Maturity, Preferred and Equity Securities

We measure the fair value of our securities based on assumptions used by market participants in pricing the security. The most appropriate valuation methodology is selected based on the specific characteristics of the fixed maturity, preferred or equity security, and we will then consistently apply the valuation methodology to measure the security’s fair value. Our fair value measurement is based on a market approach, which utilizes prices and other relevant information generated by market transactions involving identical or comparable securities. Sources of inputs to the market approach include third-party pricing services, independent broker quotations, or pricing matrices. We use observable and unobservable inputs in our valuation methodologies. Observable inputs include benchmark yields, reported trades, broker-dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, and reference data including market research publications. In addition, market indicators and industry and economic events are monitored and further market data will be acquired when certain thresholds are met.

For certain security types, additional inputs may be used, or some of the inputs described above may not be applicable. The significant input used in the fair value measurement of equity securities for which the market approach valuation technique is employed is yield for comparable securities. Increases or decreases in the yields would result in lower or higher, respectively,

fair value measurements. For broker-quoted only securities, quotes from market makers or broker-dealers are obtained from sources recognized to be market participants. We believe the broker quotes are prices at which trades could be executed based on historical trades executed at broker-quoted or slightly higher prices.

We analyze the third-party valuation methodologies and related inputs to perform assessments to determine the appropriate level within the fair value hierarchy. However, we did not adjust prices received from third parties as of December 31, 2025 or 2024.

Certain equity investments are measured using NAV as a practical expedient in determining fair value.

Derivative Financial Instruments

Derivative contracts can either be exchange traded or traded over the counter. Exchange traded derivatives typically fall within Level 1 of the fair value hierarchy if there is active trading activity. Two methods are used to value over-the-counter derivatives. When required inputs are available, certain derivatives are valued using valuation pricing models, which represent what we would expect to receive or pay at the balance sheet date if we cancelled or exercised the derivative or entered into offsetting positions. Valuation models require a variety of inputs, which include the use of market-observable inputs, including interest rate, yield curve volatilities, foreign currency exchange rates and other factors. These over-the-counter derivatives are typically classified within Level 2 of the fair value hierarchy as the majority trade in liquid markets, we can verify model inputs and model selection does not involve significant management judgment. When inputs are not available for valuation models, certain over-the-counter derivatives are valued using independent broker quotes, which are based on unobservable market data and classified within Level 3. Effective September 30, 2024, pricing for certain derivatives was obtained from internal models using substantially all market observable inputs, and those derivatives were transferred out of Level 3 to Level 2.

The fair value of the reinsurance-related embedded derivatives in our funds withheld reinsurance agreements are estimated based upon the change in fair value (for total return swaps), or the fair value (for the index credit obligation due the reinsurer), of the assets supporting the funds withheld from reinsurance liabilities. The fair value of the assets is based on a quoted market price of similar assets or is obtained from models using substantially all market observable inputs (Level 2), and therefore the fair value of the embedded derivatives are based on market-observable inputs and are classified as Level 2.

The fair value measurement of the indexed annuities/IUL embedded derivatives, representing the indexed crediting feature of the policies included in Contractholder funds, and the ceded portion, the reinsured indexed crediting feature embedded derivatives recorded as a component of the Reinsurance recoverable, is determined through a combination of market observable information and significant unobservable inputs using the option budget method. The market observable inputs are the market value of option and treasury rates. The significant unobservable inputs are the budgeted option cost (i.e., the expected cost to purchase equity options in future periods to fund the equity indexed linked feature), surrender rates, mortality multiplier and non-performance spread. The mortality multiplier at December 31, 2025 and 2024 was applied to the 2012 Individual Annuity mortality tables. Increases or decreases in the market value of an option in isolation would result in a higher or lower, respectively, fair value measurement. Increases or decreases in treasury rates, mortality multiplier, surrender rates, or non-performance spread in isolation would result in a lower or higher fair value measurement, respectively. Generally, a change in any one unobservable input would not directly result in a change in any other unobservable input. Also refer to Management's Estimates in Note A Business and Summary of Significant Accounting Policies regarding certain assumption updates.

Investments in Unconsolidated affiliates

We have elected the fair value option (“FVO”) for certain investments in unconsolidated affiliates as we believe this better aligns them with other investments in unconsolidated affiliates that are measured using NAV as a practical expedient in determining fair value. Investments measured using the FVO are included in Level 3 and the fair values of these investments are determined using a multiple of the affiliates’ earnings before interest, taxes, depreciation and amortization (“EBITDA”). The EBITDA is based on the affiliates’ financial information. The multiple is derived from market analysis of transactions involving comparable companies. The inputs are considered unobservable, as not all market participants have access to this data.

Short-term Investments

The carrying amounts reported in the Consolidated Balance Sheets for these instruments approximate fair value. Certain short-term investments are valued based on third-party pricing services or broker quotes and are classified as Level 2 or 3.

Loan receivable

Concurrent with the Roar purchase agreement, F&G executed a separate loan agreement with the sellers of Roar. The loan is collateralized by the sellers’ minority equity stake in Roar. The loan receivable is measured at fair value using a discounted cash flow model applied using a Monte Carlo simulation of estimated cash flows at each measurement period and for each

simulated path relative to the estimated collateral value. The Monte Carlo simulation utilizes the outstanding principal balance, a risk-adjusted discount rate, and risk-free rates to discount the expected cash flows and compare to the estimated collateral value for each payment period and simulated path. The discounted cash flow approach applies a company-specific discount rate to future expected interest and payoff payments to calculate the estimated fair value based on the average outcome from the simulation. This loan receivable is included in Level 3 and the inputs are considered unobservable, as not all market participants have access to this data.

Other long-term Investments

We have elected the fair value option (“FVO”) for certain loans held by consolidated VIEs to better align measurement with the economic characteristics of the underlying structures and to reduce accounting mismatches that would otherwise result from measuring the assets and liabilities using different attributes. We have also elected to apply the collateralized financing entity guidance in ASC 810 to measure both the financial assets and the financial liabilities of the VIE using the more observable of the fair value of the financial assets and the fair value of the financial liabilities. We believe that the value of the debt securities, that trade in the secondary market, are more observable than the pricing of the individual loans and will use the fair value of the debt securities issued by the VIE as a practical expedient in determining the fair value of the loans. Based on the market-observable inputs of the debt securities, the fair value of the loans are included in Level 2.

We hold a fund-linked note, which provides for an additional payment at maturity based on the value of an embedded derivative based on the actual return of a dedicated return fund. Fair value of the embedded derivative is based on an unobservable input, the NAV of the fund at the balance sheet date. The embedded derivative is similar to an equity option on the NAV of the fund with a strike price of zero since F&G will not be required to make any additional payments at maturity of the fund-linked note in order to receive the NAV of the fund on the maturity date. A Black-Scholes model determines the NAV of the fund as the fair value of the equity option regardless of the values used for the other inputs to the option pricing model. The NAV of the fund is provided by the fund manager at the end of each calendar month and represents the value an investor would receive if it withdrew its investment on the balance sheet date. Therefore, the key unobservable input used in the Black-Scholes model is the value of the fund. As the value of the fund increases or decreases, the fair value of the embedded derivative will increase or decrease. See further discussion on the available-for-sale embedded derivative in Note E Derivative Financial Instruments.

Other Assets

Mortgage servicing rights are measured at fair value using a discounted cash flow model, which incorporates assumptions that market participants use in estimating future net servicing income cash flows. These assumptions include estimates of prepayment rates, discount rates, cost to service (including delinquency and foreclosure costs), escrow account earnings, contractual servicing fee income, and ancillary income.

Contingent Consideration

We have recorded contingent consideration pursuant to the terms of the purchase agreement for the acquisition of Roar. The contingent consideration is measured at fair value using a discounted cash flow model applied using a Monte Carlo simulation of estimated EBITDA at each measurement period and for each simulated path relative to contractual EBITDA milestones. The Monte Carlo simulation utilizes a risk-adjusted discount rate, volatility assumption, and risk-free rates to assess the probability Roar's EBITDA trajectory reaches required milestones for the earn out payments to be made. The discounted cash flow approach applies a company-specific discount rate based on F&G credit profile to future expected earn out payments to calculate the estimated fair value based on the average outcome from the simulation. This contingent consideration is included in Level 3 and the inputs are considered unobservable, as not all market participants have access to this data. See further discussion on the contingent consideration in Note G Commitments and Contingencies.

Market Risk Benefits ("MRBs")

Quantitative information regarding significant unobservable inputs used for recurring Level 3 fair value measurements of financial instruments carried at fair value as of December 31, 2025 and 2024, excluding assets and liabilities for which significant quantitative unobservable inputs are not developed internally and not readily available to the Company (primarily those valued using broker quotes and certain third-party pricing services), are as follows:

Fair Value at

Valuation Technique

Unobservable Input(s)

Range (Weighted average)

December 31, 2025

(in millions)

December 31, 2025

Assets

Asset-backed securities

Third-Party Valuation

Discount Rate

4.36% - 7.15% (5.80%)

Corporates

Discounted Cash Flow

Discount Rate

5.50% - 100.00% (98.73%)

Corporates

661

Third-Party Valuation

Discount Rate

3.45% - 8.68% (5.84%)

Residential mortgage-backed securities

Third-Party Valuation

Discount Rate

5.41%-5.41% (5.41%)

Foreign Governments

Third-Party Valuation

Discount Rate

5.73% - 5.73% (5.73%)

Municipals

Third-Party Valuation

Discount Rate

4.94% - 4.94% (4.94%)

Investments in unconsolidated affiliates

270

Market Comparable Company Analysis

EBITDA Multiple

7.4x - 15.5x (12.10x)

Equity securities:

Preferred equity securities

Discounted Cash Flow

Discount rate

100.00% - 100.00% (100.00%)

Common equity securities

Discounted Cash Flow

Discount rate

8.10% - 14.00% (14.29%)

Market Comparable Company Analysis

EBITDA multiple

4.8x - 6.7x (5.5x)

MSRs

129

Discounted Cash Flow

Discount Rate

6.38% - 10.69% (8.00%)

Conditional Prepayment Rate

5.85% -13.65% (7.77%)

Other long-term investments:

Available-for-sale embedded derivative

Black Scholes Model

Market Value of AnchorPath Fund

100.00%

Reinsurance recoverable:

Indexed annuities/IUL ceded embedded derivatives

399

Discounted Cash Flow

Market Value of Option

0.00% - 31.77% (2.74%)

Mortality Multiplier

80.00% - 115.00% (100.00%)

Surrender Rates

0.25% - 50.00% (3.33%)

Partial Withdrawals

2.00% - 6.50% (2.22%)

Non-Performance Spread

0.53% - 1.15% (0.90%)

Option Cost

1.39% - 5.30% (1.98%)

Prepaid expenses and other assets:

Loan receivable

Discounted Cash Flow

Risk-Adjusted Discount Rate

6.35% - 6.35% (6.35%)

Collateral Volatility

35.00% - 35.00% (35.00%)

Market risk benefits asset

285

Discounted Cash Flow

Mortality

80.00% - 115.00% (100.00%)

Surrender Rates

0.25% - 30.00% (5.33%)

Partial Withdrawal Rates

0.00% - 25.64% (2.47%)

Non-Performance Spread

0.43% - 0.85% (0.64%)

GMWB Utilization

50.00% - 75.00% (63.03%)

Total financial assets at fair value (a)

1,933

Liabilities

Derivatives:

Indexed annuities/ IUL embedded derivatives, included in Contractholder funds

6,542

Discounted Cash Flow

Market Value of Option

0.00% - 40.13% (3.84%)

Mortality Multiplier

80.00% - 115.00% (100.00%)

Surrender Rates

0.25% - 50.00% (6.68%)

Partial Withdrawals

2.00% - 35.71% (2.69%)

Non-Performance Spread

0.43% - 0.85% (0.64%)


				Option Cost	0.50% - 6.09% (2.78%)


Contingent consideration	72		Discounted Cash Flow	Risk-Adjusted Discount Rate	11.50% - 11.50% (11.50%)
				EBITDA Volatility	35% - 35% (35%)
				Counterparty Discount Rate	6.30% - 6.30% (6.30%)
Market risk benefits liability	903		Discounted Cash Flow	Mortality	80.00% - 115.00% (100.00%)
				Surrender Rates	0.25% - 30.00% (5.33%)
				Partial Withdrawal Rates	0.00% - 25.64% (2.47%)
				Non-Performance Spread	0.43% - 0.85% (0.64%)
				GMWB Utilization	50.00% - 75.00% (63.03%)
Total financial liabilities at fair value	$	7,517

(a) Assets of $12,597 million and liabilities of $9 million for which significant quantitative unobservable inputs are not developed internally and not readily available to the Company (primarily those valued using broker quotes and certain third-party pricing services) are excluded from the respective totals in the table above.

Fair Value at

Valuation Technique

Unobservable Input(s)

Range (Weighted average)

December 31, 2024

(In millions)

December 31, 2024

Assets

Asset-backed securities

Third-Party Valuation

Discount Rate

4.83% - 7.15% (6.33%)

Corporates

750

Third-Party Valuation

Discount Rate

2.00% - 22.53% (6.76%)

Corporates

Discounted Cash Flow

Discount Rate

13.33% - 100.00% (96.45%)

Residential mortgage-backed securities

Third-Party Valuation

Discount Rate

5.89% - 5.89% (5.89%)

Foreign Governments

Third-Party Valuation

Discount Rate

12.14% - 12.14% (12.14%)

Investments in unconsolidated affiliates

272

Market Comparable Company Analysis

EBITDA Multiple

8.7x - 23.6x (14.6x)

Equity securities:

Preferred equity securities

Discounted Cash Flow

Discount rate

100.00% -100.00% (100.00%)

Common equity securities

Discounted Cash Flow

Discount rate

4.80% - 14.10% (9.40%)

Market Comparable Company Analysis

EBITDA multiple

5.8x - 7.5x (7.0x)

Other assets

Discounted Cash Flow

Discount Rate

10.60% - 12.00% (11.30%)

Conditional Prepayment Rate

6.24% - 11.99% (9.12%)

Other long-term investments:

Available-for-sale embedded derivative

Black Scholes Model

Market Value of AnchorPath Fund

100%

Reinsurance recoverable:

Indexed annuities/IUL ceded embedded derivatives

Discounted Cash Flow

Market Value of Option

0.35% - 2.53% (1.39%)

Mortality Multiplier

80.00% - 115.00% (100.00%)

Surrender Rates

0.25% - 50.00% (3.24%)

Partial Withdrawals

2.00% - 5.00% (2.13%)

Non-Performance Spread

0.48% - 0.95% (0.75%)

Option Cost

1.40% - 1.40% (1.40%)

Prepaid expenses and other assets:

Loan receivable

Discounted Cash Flow

Risk-Adjusted Discount Rate

7.22% - 7.22% (7.22%)

Collateral Volatility

35.00% -35.00% (35.00%)

Market risk benefits asset

189

Discounted Cash Flow

Mortality

80.00% - 115.00% (100.00%)

Surrender Rates

0.25% - 30.00% (5.05%)


				Partial Withdrawal Rates	2.00% - 24.39% (2.48%)
				Non-Performance Spread	0.48% - 0.95% (0.75%)
				GMWB Utilization	50.00% - 75.00% (61.77%)
Total financial assets at fair value (a)	$	1,531
Liabilities
Derivatives:
Indexed annuities/IUL embedded derivatives, included in Contractholder funds	$	5,220	Discounted Cash Flow	Market Value of Option	0.00% - 20.81% (2.92%)

				Mortality Multiplier	80.00% - 115.00% (100.00%)
				Surrender Rates	0.25% - 50.00% (6.94%)
				Partial Withdrawals	2.00% - 35.71% (2.72%)
				Non-Performance Spread	0.48% - 0.95% (0.75%)
				Option Cost	0.07% - 5.70% (2.68%)
Contingent consideration	74		Discounted Cash Flow	Risk-Adjusted Discount Rate	13.50% - 13.50% (13.50%)
				EBITDA Volatility	35.00% - 35.00% (35.00%)
				Counterparty Discount Rate	6.50% - 6.50% (6.50%)
Market risk benefits liability	549		Discounted Cash Flow	Mortality	80.00% - 115.00% (100.00%)
				Surrender Rates	0.25% - 30.00% (5.05%)
				Partial Withdrawal Rates	2.00% - 24.39% 2.48%
				Non-Performance Spread	0.48% - 0.95% (0.75%)
				GMWB Utilization	50.00% - 75.00% (61.77%)
Total financial liabilities at fair value	$	5,843

(a) Assets of $10,301 million for which significant quantitative unobservable inputs are not developed internally and not readily available to the Company (primarily those valued using broker quotes and certain third-party pricing services) are excluded from the respective totals in the table above.

The following tables summarize changes to the Company’s financial instruments carried at fair value and classified within Level 3 of the fair value hierarchy for the years ended December 31, 2025 and 2024, respectively. The gains and losses below may include changes in fair value due in part to observable inputs that are a component of the valuation methodology.


	Year ended December 31, 2025
	(in millions)
	Balance at Beginning of Period			Total Gains (Losses)					Purchases		Sales		Settlements		Net transfer In (Out) of Level 3 (a)		Balance at End of Period		Change in Unrealized Incl in OCI
			Included in Earnings			Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	8,143		$	(5)		$	80	$	3,688	$	(433)	$	(1,228)	$	(151)	$	10,094	$	73
Commercial mortgage-backed securities	—			—			—		46		—		—		(46)		—		—
Corporates	2,957			(12)			72		1,490		(889)		(407)		(66)		3,145		73
Hybrids	—			—			—		15		—		—		—		15		—
Municipals	—			—			—		4		—		(1)		—		3		—
Residential mortgage-backed securities	3			—			—		2		—		—		(2)		3		—
Foreign Governments	4			—			2		19		—		(2)		—		23		1
Equity securities:
Preferred equity securities	8			(1)			1		—		—		—		—		8		—
Common equity securities	10			2			—		5		—		—		—		17		—
Derivative investments	3			(2)			(2)		1		—		—		—		—		(2)
Investments in unconsolidated affiliates	272			(2)			—		—		—		—		—		270		—
Other assets	65			(4)			—		85		(17)		—		—		129		—
Short-term investments	37			—			—		75		—		(38)		—		74		—

Other long-term assets:

Available-for-sale embedded derivative	32			—			9		—		—		—		—		41		9





Reinsurance recoverable:
Indexed annuities/IUL ceded embedded derivatives	98			48			—		256		—		(3)		—		399		—
Prepaid expenses and other assets:
Loan receivable (b)	11			—			—		13		—		—		—		24		—
Subtotal Level 3 assets at fair value	$	11,643		$	24		$	162	$	5,699	$	(1,339)	$	(1,679)	$	(265)	$	14,245	$	154
Market risk benefits asset (c)	189																285
Total Level 3 assets at fair value	$	11,832															$	14,530
Liabilities
Indexed annuities/ IUL embedded derivatives, included in Contractholder funds	$	5,220		$	450		$	—	$	1,357	$	—	$	(485)	$	—	$	6,542	$	—
Foreign currency swaps, included in Accounts payable and accrued liabilities	—			9			—		—		—		—		—		9		—
Contingent consideration, included in Accounts payable and accrued liabilities	74			10			—		—		—		(12)		—		72		—

Subtotal Level 3 liabilities at fair value	$	5,294		$	469		$	—	$	1,357	$	—	$	(497)	$	—	$	6,623	$	—
Market Risk benefits liability (c)	549																903
Total Level 3 liabilities at fair value	$	5,843															$	7,526

(a)The net transfers out of Level 3 during the year ended December 31, 2025 were exclusively to Level 2.

(b)Purchases represent advances on the loan commitment to Roar. Refer to Note G Commitments and Contingencies for further details.

(c)Refer to Note W Market Risk Benefits for roll forward activity of the net Market Risk Benefits Asset and Liability.



	Year ended December 31, 2024
	Balance at Beginning of Period		Total Gains (Losses)				Purchases		Sales		Settlements		Net transfer In (Out) of Level 3 (a)		Balance at End of Period		Change in Unrealized Incl in OCI
			Included in Earnings		Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	7,122	$	19	$	128	$	5,104	$	(2,825)	$	(1,210)	$	(195)	$	8,143	$	130
Commercial mortgage-backed securities	18		—		—		58		—		—		(76)		—		—
Corporates	1,979		(3)		81		1,148		(100)		(139)		(9)		2,957		80

Municipals	49		—		1		—		(50)		—		—		—		1
Residential mortgage-backed securities	3		—		—		1		—		—		(1)		3		—
Foreign Governments	16		—		(1)		—		—		(11)		—		4		(1)
Preferred securities	8		—		—		—		—		—		—		8		—
Equity securities	15		(5)		—		—		—		—		—		10		—
Derivative investments	57		(50)		3		—		—		—		(7)		3		1
Investments in unconsolidated affiliates	285		79		—		—		—		—		(92)		272		—
Other assets	—		—		—		65		—		—		—		65		—
Short-term investments	—		—		—		236		(190)		(9)		—		37		—
Other long-term assets:

Available-for-sale embedded derivative	27		—		5		—		—		—		—		32		5

Credit linked note	10		1		—		—		—		(11)		—		—		—
Reinsurance recoverable:
Indexed annuities/IUL ceded embedded derivatives	20		(2)		—		81		—		(1)		—		98		—
Prepaid expenses and other assets:
Loan receivable (b)	—		—		—		11		—		—		—		11		—
Subtotal Level 3 assets at fair value	$	9,609	$	39	$	217	$	6,704	$	(3,165)	$	(1,381)	$	(380)	$	11,643	$	216
Market risk benefits asset (c)	88														189
Total Level 3 assets at fair value	$	9,697													$	11,832
Liabilities

Indexed annuities embedded derivatives, included in Contractholder funds	$	4,258	$	45	$	—	$	1,351	$	—	$	(434)	$	—	$	5,220	$	—
Interest rate swaps	—		28		—		—		—		—		(28)		—		—
Contingent consideration, included in Accounts payable and accrued liabilities	—		26		—		48		—		—		—		74		—
Subtotal Total liabilities at Level 3 fair value	$	4,258	$	99	$	—	$	1,399	$	—	$	(434)	$	(28)	$	5,294	$	—
Market risk benefits liability (c)	403														549
Total Level 3 liabilities at fair value	$	4,661													$	5,843

(a) The net transfers out of Level 3 during the year ended December 31, 2024 were exclusively to Level 2.

(b) Purchases represent advances on the loan commitment to Roar. Refer to Note G Commitments and Contingencies for further details.

Fair Value Option

F&G has elected the FVO for certain investments held by consolidated VIEs, including certain loans reported in other long term investments. See Note D Investments for additional information on our investments in VIEs. As discussed above, we have also elected the FVO for certain other investments in unconsolidated affiliates and for a loan receivable.

The following table presents information regarding the assets for which the fair value option was elected.


	December 31,
	2025		2024

Assets

Investments in unconsolidated affiliates	$	270		$	272
Other loans, within other long-term investments (a)
Fair Value	$	248		$	—
Aggregate unpaid principal	250			—
Loan receivable, within prepaid expenses and other assets (a)
Fair Value	$	24		$	11
Aggregate unpaid principal	24			11

(a) No loans are 90 days or more past due or on nonaccrual status

The following table presents information regarding the impact of changes in fair value of assets for which the fair value option was elected which are reported within Recognized gains and losses, net on the Consolidated Statements of Earnings.


	December 31,
	2025	2024


Investments in unconsolidated affiliates	(2)		79

Valuation Methodologies and Associated Inputs for Financial Instruments Not Carried at Fair Value

The following discussion outlines the methodologies and assumptions used to determine the fair value of our financial instruments not carried at fair value. Considerable judgment is required to develop these assumptions used to measure fair value. Accordingly, the estimates shown are not necessarily indicative of the amounts that would be realized in a one-time, current market exchange of all of our financial instruments.

Mortgage Loans

The fair value of mortgage loans is established using a discounted cash flow method based on internal credit rating, maturity, and future income. This yield-based approach is sourced from our third-party vendor. The internal ratings for mortgages in good standing are based on property type, location, market conditions, occupancy, debt service coverage, loan-to-value, quality of tenancy, borrower, and payment record. The inputs used to measure the fair value of our mortgage loans are classified as Level 3 within the fair value hierarchy.

Investments in Unconsolidated affiliates

In our F&G segment, the fair value of Investments in unconsolidated affiliates is determined using NAV as a practical expedient and are included in the NAV column in the table below. In our Title segment, Investments in unconsolidated affiliates are accounted for under the equity method of accounting. In our Title segment, Investments in unconsolidated affiliates were $288 million and $166 million as of December 31, 2025 and 2024, respectively.

Policy Loans (included within Other long-term investments)

Policy loans are reported at the unpaid principal balance and are fully collateralized by the cash surrender value of underlying insurance policies. The carrying value of the policy loans approximates the fair value and are classified as Level 3 in the fair value hierarchy.

Company Owned Life Insurance (included within Other long-term investments)

Company owned life insurance ("COLI") is a life insurance program used to finance certain employee benefit expenses. The fair value of COLI is based on net realizable value, which is generally cash surrender value. COLI is classified as Level 3 within the fair value hierarchy.

Other Invested Assets (included within Other long-term investments)

The fair value of bank loans is estimated using a discounted cash flow method with the discount rate based on weighted average cost of capital ("WACC"). This yield-based approach is sourced from a third-party vendor and the WACC establishes a market participant discount rate by determining the hypothetical capital structure for the asset should it be underwritten as of each period end. Bank loans are classified as Level 3 within the fair value hierarchy. For cost method investments, our carrying value approximates fair value. Cost method investments are classified as Level 1 within the fair value hierarchy.

Investment Contracts

Investment contracts include deferred annuities (indexed annuities and fixed rate annuities), IUL policies, funding agreements and PRT, and immediate annuity contracts without life contingencies. The indexed annuities/IUL embedded derivatives, included in contractholder funds, are excluded as they are carried at fair value. The fair value of the deferred annuities (indexed annuities and fixed rate annuities) and IUL contracts is based on their cash surrender value (i.e., the cost the Company would incur to extinguish the liability) as these contracts are generally issued without an annuitization date. The fair value of funding agreements and PRT and immediate annuity contracts without life contingencies is derived by calculating a new fair value interest rate using the updated yield curve and treasury spreads as of the respective reporting date. The Company is not required to, and has not, estimated the fair value of the liabilities under contracts that involve significant mortality or morbidity risks, as these liabilities fall within the definition of insurance contracts that are exceptions from financial instruments that require disclosures of fair value.

Other

Federal Home Loan Bank of Atlanta ("FHLB") common stock, Accounts receivable, and Notes receivable are carried at cost, which approximates fair value. The carrying amount of FHLB common stock represents the value it can be sold back to the FHLB and is classified as Level 2 within the hierarchy. Accounts receivable and Notes receivable are classified as Level 3 within the fair value hierarchy.

Debt

The fair value of debt, with the exception of the F&G Credit Agreement is based on quoted market prices. The carrying value of the F&G Credit Agreement would approximate fair value as the rates are comparable to those at which we could currently borrow under similar terms. As of December 31, 2025 and 2024, there were no outstanding balance on the F&G Credit Agreement. The inputs used to measure the fair value of our outstanding debt are classified as Level 2 within the fair value hierarchy.

The following tables provide the carrying value and estimated fair value of our financial instruments that are carried on the Consolidated Balance Sheets at amounts other than fair value, summarized according to the fair value hierarchy previously described.


	December 31, 2025
	(in millions)
	Level 1		Level 2		Level 3		NAV		Total Estimated Fair Value		Carrying Amount
Assets
FHLB common stock	$	—	$	155	$	—	$	—	$	155	$	155
Commercial mortgage loans	—		—		3,025		—		3,025		3,242
Residential mortgage loans	—		—		4,424		—		4,424		4,649
Investments in unconsolidated affiliates	—		—		—		4,608		4,608		4,608
Policy loans	—		—		147		—		147		147
Other invested assets	18		—		—		75		93		93
Company-owned life insurance	—		—		887		—		887		887

Trade and notes receivables, net of allowance	—		—		473		—		473		473
Total	$	18	$	155	$	8,956	$	4,683	$	13,812	$	14,254

Liabilities
Investment contracts, included in Contractholder funds	$	—	$	—	$	51,027	$	—	$	51,027	$	56,184
Debt	—		4,204		—		—		4,204		4,400

Total	$	—	$	4,204	$	51,027	$	—	$	55,231	$	60,584



	December 31, 2024
	(in millions)
	Level 1		Level 2		Level 3		NAV		Total Estimated Fair Value		Carrying Amount
Assets
FHLB common stock	$	—	$	153	$	—	$	—	$	153	$	153
Commercial mortgage loans	—		—		2,404		—		2,404		2,705
Residential mortgage loans	—		—		2,916		—		2,916		3,221
Investments in unconsolidated affiliates	—		—		5		3,288		3,293		3,293
Policy loans	—		—		104		—		104		104
Other invested assets	42		—		—		48		90		90
Company-owned life insurance	—		—		431		—		431		431
Trade and notes receivables, net of allowance	—		—		471		—		471		471
Total	$	42	$	153	$	6,331	$	3,336	$	9,862	$	10,468

Liabilities
Investment contracts, included in Contractholder funds	$	—	$	—	$	46,339	$	—	$	46,339	$	51,184
Debt	—		3,781		—		—		3,781		4,321
Total	$	—	$	3,781	$	46,339	$	—	$	50,120	$	55,505

For investments for which NAV is used, we do not have any significant restrictions in our ability to liquidate our positions in these investments, other than obtaining general partner approval, nor do we believe it is probable a price less than NAV would be received in the event of a liquidation.

We review the fair value hierarchy classifications each reporting period. Changes in the observability of the valuation attributes may result in a reclassification of certain financial assets or liabilities. Such reclassifications are reported as transfers in and out of Level 3, or between other levels, at the beginning fair value for the reporting period in which the changes occur. The transfers into and out of Level 3 were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value.

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 107
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482078/820-10-55-107

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 100
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482078/820-10-55-100

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2E
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6A
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 940
-SubTopic 820
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478119/940-820-50-1

Goodwill and Intangible Assets Disclosure [Abstract]

Investments - Commercial Mortgage Loan, Gross of Valuation Allowance, By Property Type and Region (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Schedule of Investments [Line Items]
Allowance for expected credit loss	$ (86)	$ (70)	$ (66)
Loans, net	7,891	5,926
Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	3,260	2,722
Allowance for expected credit loss	(18)	(17)	$ (12)
Loans, net	$ 3,242	$ 2,705
% of Total	100.00%	100.00%
Loans	$ 3,260	$ 2,722
Commercial mortgage \| Total Estimated Fair Value
Schedule of Investments [Line Items]
% of Total	100.00%	100.00%
Loans	$ 3,025	$ 2,404
Commercial mortgage \| Less than 50.00%
Schedule of Investments [Line Items]
% of Total	19.00%	19.00%
Loans	$ 610	$ 524
Commercial mortgage \| Less than 50.00% \| Total Estimated Fair Value
Schedule of Investments [Line Items]
% of Total	19.00%	21.00%
Loans	$ 596	$ 501
Commercial mortgage \| 50.00% to 59.99%
Schedule of Investments [Line Items]
% of Total	28.00%	34.00%
Loans	$ 923	$ 927
Commercial mortgage \| 50.00% to 59.99% \| Total Estimated Fair Value
Schedule of Investments [Line Items]
% of Total	28.00%	34.00%
Loans	$ 852	$ 826
Commercial mortgage \| 60.00% to 74.99%
Schedule of Investments [Line Items]
% of Total	52.00%	46.00%
Loans	$ 1,709	$ 1,254
Commercial mortgage \| 60.00% to 74.99% \| Total Estimated Fair Value
Schedule of Investments [Line Items]
% of Total	52.00%	44.00%
Loans	$ 1,560	$ 1,060
Commercial mortgage \| 75.00% to 84.99%
Schedule of Investments [Line Items]
% of Total	1.00%	1.00%
Loans	$ 18	$ 17
Commercial mortgage \| 75.00% to 84.99% \| Total Estimated Fair Value
Schedule of Investments [Line Items]
% of Total	1.00%	1.00%
Loans	$ 17	$ 17
Commercial mortgage \| Greater than 1.25
Schedule of Investments [Line Items]
Loans	2,859	2,535
Commercial mortgage \| Greater than 1.25 \| Less than 50.00%
Schedule of Investments [Line Items]
Loans	594	490
Commercial mortgage \| Greater than 1.25 \| 50.00% to 59.99%
Schedule of Investments [Line Items]
Loans	850	803
Commercial mortgage \| Greater than 1.25 \| 60.00% to 74.99%
Schedule of Investments [Line Items]
Loans	1,415	1,238
Commercial mortgage \| Greater than 1.25 \| 75.00% to 84.99%
Schedule of Investments [Line Items]
Loans	0	4
Commercial mortgage \| Greater than 1.00 but less than 1.25
Schedule of Investments [Line Items]
Loans	349	166
Commercial mortgage \| Greater than 1.00 but less than 1.25 \| Less than 50.00%
Schedule of Investments [Line Items]
Loans	16	34
Commercial mortgage \| Greater than 1.00 but less than 1.25 \| 50.00% to 59.99%
Schedule of Investments [Line Items]
Loans	36	112
Commercial mortgage \| Greater than 1.00 but less than 1.25 \| 60.00% to 74.99%
Schedule of Investments [Line Items]
Loans	288	16
Commercial mortgage \| Greater than 1.00 but less than 1.25 \| 75.00% to 84.99%
Schedule of Investments [Line Items]
Loans	9	4
Commercial mortgage \| Greater than 1.00
Schedule of Investments [Line Items]
Loans	52	21
Commercial mortgage \| Greater than 1.00 \| Less than 50.00%
Schedule of Investments [Line Items]
Loans	0	0
Commercial mortgage \| Greater than 1.00 \| 50.00% to 59.99%
Schedule of Investments [Line Items]
Loans	37	12
Commercial mortgage \| Greater than 1.00 \| 60.00% to 74.99%
Schedule of Investments [Line Items]
Loans	6	0
Commercial mortgage \| Greater than 1.00 \| 75.00% to 84.99%
Schedule of Investments [Line Items]
Loans	9	9
East North Central \| Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	$ 124	$ 98
% of Total	4.00%	4.00%
East South Central \| Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	$ 86	$ 75
% of Total	3.00%	3.00%
Middle Atlantic \| Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	$ 356	$ 354
% of Total	11.00%	13.00%
Mountain \| Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	$ 396	$ 409
% of Total	12.00%	15.00%
New England \| Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	$ 183	$ 164
% of Total	6.00%	6.00%
Pacific \| Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	$ 709	$ 706
% of Total	22.00%	26.00%
South Atlantic \| Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	$ 1,157	$ 683
% of Total	34.00%	25.00%
West North Central \| Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	$ 69	$ 62
% of Total	2.00%	2.00%
West South Central \| Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	$ 180	$ 171
% of Total	6.00%	6.00%
Hotel \| Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	$ 9	$ 17
% of Total	0.00%	1.00%
Industrial \| Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	$ 671	$ 657
% of Total	21.00%	24.00%
Mixed Use \| Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	$ 21	$ 11
% of Total	1.00%	0.00%
Multifamily \| Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	$ 1,150	$ 1,006
% of Total	35.00%	37.00%
Office \| Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	$ 345	$ 349
% of Total	11.00%	13.00%
Retail \| Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	$ 327	$ 98
% of Total	10.00%	4.00%
Student Housing \| Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	$ 83	$ 83
% of Total	3.00%	3.00%
Other \| Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	$ 654	$ 501
% of Total	19.00%	18.00%

Other Intangible Assets

12 Months Ended

Dec. 31, 2025

Other Intangible Assets

The following table reconciles to Other intangible assets, net, on the Consolidated Balance Sheets as of December 31, 2025 and 2024:


	December 31, 2025		December 31, 2024
	(In millions)
Customer relationships and contracts	$	349	$	435
VOBA	1,196		1,349
DAC	3,637		3,036
DSI	891		625
Value of distribution asset	62		74
Computer software	289		277
Trademarks, tradenames, and other	217		180
Total Other intangible assets, net	$	6,641	$	5,976

The following tables roll forward VOBA by product for the years ended December 31, 2025 and 2024:


	Indexed Annuities		Fixed Rate Annuities		Immediate Annuities		Universal Life		Traditional Life		Total
	(In millions)
Balance at January 1, 2025	$	892	$	22	$	184	$	126	$	125	$	1,349

Amortization	(122)		(4)		(6)		(7)		(14)		(153)

Balance at December 31, 2025	$	770	$	18	$	178	$	119	$	111	$	1,196


	Indexed Annuities		Fixed Rate Annuities		Immediate Annuities		Universal Life		Traditional Life		Total
	(In millions)
Balance at January 1, 2024	$	1,025	$	27	$	191	$	134	$	69	$	1,446

Amortization	(133)		(5)		(7)		(8)		(7)		(160)
Actuarial model updates and refinements (a)	—		—		—		—		63		63

Balance at December 31, 2024	$	892	$	22	$	184	$	126	$	125	$	1,349

(a)net of amortization of ($15 million).

VOBA amortization expense of $153 million, $175 million, and $169 million, was recorded in Depreciation and amortization on the Consolidated Statements of Earnings for the years ended December 31, 2025, 2024, and 2023, respectively.

The following tables roll forward DAC by product for the years ended December 31, 2025 and 2024:


	Indexed Annuities		Fixed Rate Annuities		Universal Life		Total (a)
	(In millions)
Balance at January 1, 2025	$	1,874	$	376	$	781	$	3,031
Capitalization	530		132		292		954
Amortization	(199)		(106)		(52)		(357)

Balance at December 31, 2025	$	2,205	$	402	$	1,021	$	3,628

	Indexed Annuities		Fixed Rate Annuities		Universal Life		Total (a)
	(In millions)
Balance at January 1, 2024	$	1,378	$	288	$	545	$	2,211
Capitalization	652		174		274		1,100
Amortization	(156)		(86)		(38)		(280)

Balance at December 31, 2024	$	1,874	$	376	$	781	$	3,031

(a) Excludes insignificant amounts of DAC related to FABN and PRT.

DAC amortization expense of $357 million, $280 million, and $186 million, was recorded in Depreciation and amortization on the Consolidated Statements of Earnings for the years ended December 31, 2025, 2024, and 2023, respectively, excluding insignificant amounts related to FABN and PRT.

The following table presents a reconciliation of DAC to the table above which is reconciled to the Consolidated Balance Sheets as of December 31, 2025 and 2024:


	December 31, 2025		December 31, 2024
	(In millions)
Indexed Annuities	$	2,205	$	1,874
Fixed Rate Annuities	402		376

Universal Life	1,021		781

FABN	5		4
PRT	4		1
Total	$	3,637	$	3,036

The following tables roll forward DSI for our indexed annuity products for the years ended December 31, 2025 and 2024:


	Years Ended December 31,
	2025		2024
	(In millions)
Balance at January 1,	$	625	$	346
Capitalization	332		319
Amortization	(66)		(40)
Balance at December 31,	$	891	$	625

DSI amortization expense of $66 million, $40 million, and $22 million, was recorded in Depreciation and amortization on the Consolidated Statements of Earnings for the years ended December 31, 2025, 2024, and 2023, respectively.

The cash flow assumptions used to amortize VOBA and DAC were consistent with the assumptions used to estimate the future policy benefits (“FPB”) for life contingent immediate annuities and PRT. Those assumptions will be reviewed and unlocked, if applicable, in the same period as those balances. For nonparticipating traditional life contracts, the VOBA amortization is straight-line, without the use of cash flow assumptions. For indexed annuity contracts, the cash flow assumptions used to amortize VOBA, DAC, and DSI were consistent with the assumptions used to estimate the value of the embedded derivative and MRBs, and will be reviewed and unlocked, if applicable, in the same period as those balances. For fixed rate annuities and IUL the cash flow assumptions used to amortize VOBA and DAC reflect the Company’s best estimates for policyholder behavior, consistent with the development of assumptions for indexed annuities and immediate annuities. Refer to Note A Business and Summary of Significant Accounting Policies for further information about accounting policies for amortization of VOBA, DAC and DSI.

F&G reviews cash flow assumptions annually, generally in the third quarter. In 2024 and 2025, F&G undertook a review of all significant assumptions and revised several assumptions relating to their deferred annuity (indexed annuity and fixed rate annuity) and IUL products. For the year ended December 31, 2025, F&G updated the assumption for option budgets, surrenders, lapses, mortality and mortality improvement, and free partial withdrawals. For the year ended December 31, 2024, F&G updated assumptions including surrender rates, GMWB election timing, premium persistency, mortality improvement, and option budgets. For both periods, these assumption updates resulted in increased amortization rates on some DAC and DSI balances, primarily for indexed annuities. All updates to these assumptions brought F&G more in line with internal and overall industry experience since the prior assumption update.

For the in-force liabilities as of December 31, 2025, the estimated amortization expense for VOBA in future fiscal periods is as follows:


	Estimated Amortization Expense
	(In millions)
2026	$	133
2027	120
2028	109
2029	99
2030	90
Thereafter	645
Total	$	1,196

Definite and Indefinite Lived Other Intangible Assets

Other intangible assets as of December 31, 2025, consist of the following:


	Cost		Accumulated amortization		Net carrying amount		Weighted average useful life (years)
	(In millions)
Customer relationships and contracts (a)	$	760	$	(411)	$	349	10 to 20
Computer software	747		(458)		289		2 to 10
Value of distribution asset (VODA)	140		(78)		62		15
Trademarks, tradenames, and other	289		(72)		217		Varies
Total					$	917

Other intangible assets as of December 31, 2024, consist of the following:


	Cost		Accumulated amortization		Net carrying amount		Weighted average useful life (years)
	(In millions)
Customer relationships and contracts	$	795	$	(360)	$	435	10 to 20
Computer software	723		(446)		277		2 to 10
Value of distribution Asset (VODA)	140		(66)		74		15
Trademarks, tradenames, and other	234		(54)		180		Varies
Total					$	966

Amortization expense for amortizable intangible assets, which consist primarily of VODA, customer relationships, computer software and definite lived trademarks, tradenames and other, was $203 million, $187 million, and $152 million for the years ended December 31, 2025, 2024, and 2023, respectively. For the amortizable intangible assets as of December 31, 2025, the estimated amortization expense in future fiscal periods is $174 million in 2026, $141 million in 2027, $109 million in 2028, $91 million in 2029, and $64 million in 2030.

Within definite lived trademarks, tradenames, and other is an amount established to offset MRBs with no explicit rider charges, which had a balance of $145 million and $94 million as of December 31, 2025 and 2024, respectively. Amortization of $9 million, $5 million, and $1 million was recorded in Depreciation and amortization on the Consolidated Statements of Earnings for the years ended December 31, 2025, 2024, and 2023, respectively.

Leases (Tables)

12 Months Ended

Dec. 31, 2025

Leases [Abstract]

Schedule of Future Payments Under Operating Lease Arrangements

Future payments under operating lease arrangements accounted for under ASC Topic 842 as of December 31, 2025, are as follows (in millions):


2026	$	130
2027	101
2028	76
2029	52
2030	29
Thereafter	20
Total operating lease payments, undiscounted	$	408
Less: present value discount	40
Lease liability, at present value	$	368

Notes Payable

12 Months Ended

Dec. 31, 2025

Debt Disclosure [Abstract]

Notes Payable

Notes payable consists of the following:


	December 31, 2025		December 31, 2024
	(In millions)
4.50% Notes, net of discount	$	448	$	447

3.40% Notes, net of discount	646		646





2.45% Notes, net of discount	596		595
3.20% Notes, net of discount	445		444
Revolving Credit Facility	(3)		(4)
F&G Credit Agreement	—		—
5.50% F&G Notes	—		301

7.40% F&G Notes, net of discount	498		497
7.30% F&G Notes	364		—




7.95% F&G Notes, net of discount	336		336
6.50% F&G Notes, net of discount	546		545
6.25% F&G Notes, net of discount	493		492
Other	31		22
	$	4,400	$	4,321

On January 13, 2025, F&G completed its public offering of the 7.30% F&G Junior Notes. F&G used a portion of the net proceeds of this offering to redeem the outstanding $300 million aggregate principal amount of its 5.50% F&G Senior Notes.

F&G used the remaining net proceeds for general corporate purposes. The 7.30% F&G Junior Notes are junior, unsecured subordinated obligations of F&G. Interest is payable quarterly in arrears beginning on April 15, 2025, and the 7.30% F&G Junior Notes mature on January 15, 2065, unless earlier repurchased or redeemed. The 7.30% F&G Junior Notes become redeemable in whole or in part, any time and from time to time on or after January 15, 2030 or within 90 days of the occurrence of certain events as described in the indenture. The 7.30% F&G Junior Notes were registered under the Securities Act of 1933 (as amended) (the “Securities Act”).

On October 4, 2024, F&G issued $500 million of its 6.25% Senior Notes due 2034. The 6.25% F&G Notes were issued at 99.36% of face value, net of deferred issuance costs of approximately $8 million The 6.25% F&G Notes are senior unsecured, unsubordinated obligations of F&G and are guaranteed by each of F&G's subsidiaries that are guarantors of F&G's obligations under its existing credit agreement. The 6.25% F&G Notes mature on October 4, 2034, and become callable on July 4, 2034. Interest is payable semi-annually at a fixed rate of 6.25%, and if the 6.25% F&G Notes are downgraded, the interest rate payable is subject to adjustment from time to time per the terms of the indenture. A portion of the net proceeds were used to pay off the outstanding balance of $365 million on the F&G Credit Agreement described below. The remaining net proceeds of this offering were used for general corporate purposes, including the support of organic growth opportunities.

On June 4, 2024, F&G issued $550 million of its 6.50% Senior Notes due 2029. The 6.50% F&G Notes were issued at 99.74% of face value, net of deferred issuance costs of approximately $6 million. The 6.50% F&G Notes are senior unsecured, unsubordinated obligations of F&G and are guaranteed by each of F&G's subsidiaries that are guarantors of F&G's obligations under its existing credit agreement. The 6.50% F&G Notes mature on June 4, 2029, and become callable on May 4, 2029. Interest is payable semi-annually at a fixed rate of 6.50%, and if the 6.50% F&G Notes are downgraded, the interest rate payable is subject to adjustment from time to time per the terms of the indenture. A portion of the net proceeds were used to finance a cash tender offer by its wholly owned subsidiary Fidelity & Guaranty Life Holdings, Inc. (“FGLH”) for an aggregate principal amount of $250 million of FGLH’s 5.50% Senior Notes due 2025 (the “5.50% F&G Notes”). The remaining net proceeds of this offering were used for for general corporate purposes, including the repurchase, redemption or repayment at maturity of outstanding indebtedness.

On December 6, 2023, F&G issued $345 million of its 7.95% Senior Notes due 2053 (the "7.95% F&G Notes"). The 7.95% F&G Notes were issued at par, net of deferred issuance costs of approximately $9 million. The 7.95% F&G Notes are senior unsecured, unsubordinated obligations of F&G and are guaranteed by each of F&G’s subsidiaries that are guarantors of F&G’s obligations under its existing credit agreement. The 7.95% F&G Notes mature on December 15, 2053, and become callable on or after December 15, 2028. Interest is payable quarterly at a fixed rate of 7.95%, and, if the 7.95% F&G Notes are downgraded, the interest rate payable is subject to adjustment from time to time per the terms of the indenture.

On January 13, 2023, F&G issued $500 million of its 7.40% F&G Notes due 2028 (the 7.40% F&G Notes"). The 7.40% F&G Notes were issued at par, net of deferred issuance costs of approximately $6 million. The 7.40% F&G Notes are senior, unsecured unsubordinated obligations of F&G and are fully and unconditionally guaranteed on an unsecured, unsubordinated basis by each of F&G’s subsidiaries that are guarantors of F&G’s obligations under its existing credit agreement. The 7.40% F&G Notes mature on January 13, 2028, and become callable on or after December 13, 2027. Interest is payable semi-annually at a fixed rate of 7.40%, and if, the 7.40% F&G Notes are downgraded, the interest rate payable is subject to adjustment from time to time per the terms of the indenture.

On April 20, 2018, Fidelity & Guaranty Life Holdings, Inc. (“FGLH”), F&G's indirect wholly owned subsidiary, completed a debt offering of $550 million of 5.50% F&G Notes due May 1, 2025 at 99.5% of face value for proceeds of $547 million. As a result of our acquisition of F&G in 2020, a premium of $39 million was established for these notes and is being amortized over the remaining life of the debt through 2025. In conjunction with the acquisition, we became a guarantor of FGLH's obligations under the 5.50% F&G Notes and agreed to fully and unconditionally guarantee the 5.50% F&G Notes, on a joint and several basis. A portion of the net proceeds of the 6.50% F&G Notes were used for a $250 million cash tender offer of the 5.50% F&G Notes in June 2024. On February 1, 2025, F&G redeemed the outstanding $300 million aggregate principal amount of the 5.50% F&G Senior Notes. The notes were redeemed for a redemption price equal to 100% of the principal amount of the notes plus accrued and unpaid interest to, but excluding, the redemption date. Refer to Note A Business and Summary of Significant Accounting Policies for a discussion of the redemption of the 5.50% F&G Notes.

On November 22, 2022, F&G entered into the F&G Credit Agreement pursuant to which the Lenders have made available the F&G Credit Facility in an aggregate principal amount of $550 million to be used for working capital and general corporate purposes. On February 21, 2023, F&G entered into the Amended F&G Credit Agreement with the Lenders and the Administrative Agent, swing line lender and issuing bank. The Amended F&G Credit Agreement increased the aggregate principal amount of commitments under the F&G Credit Facility by $115 million to $665 million. On February 16, 2024, F&G entered into a Second Amended and Restated F&G Credit Agreement. Among other changes, the Second Amended and Restated F&G Credit Agreement amends the Amended F&G Credit Agreement to extend the maturity date to November 22,

2027, and increase the aggregate principal amount of commitments under the revolving credit facility to $750 million.

Revolving loans under the Credit Agreement generally bear interest at a variable rate based on either (i) the base rate (which is the highest of (a) one-half of one percent in excess of the federal funds rate, (b) the Administrative Agent’s “prime rate”, or (c) the sum of one percent plus Term The Secured Overnight Financing Rate (“SOFR”) plus a margin of between 30.0 and 80.0 basis points depending on the non-credit-enhanced, senior unsecured long-term debt ratings of F&G or (ii) Term SOFR plus a margin of between 130.0 and 180.0 basis points depending on the non-credit-enhanced, senior unsecured long-term debt ratings of F&G. In addition, F&G pays a facility fee of between 20.0 and 45.0 basis points on the entire facility, also depending on the non-credit-enhanced, senior unsecured long-term debt ratings, which is payable quarterly in arrears. The average variable interest rate on the revolving credit facility for the period the debt was outstanding in 2025 was 0.00% compared to 7.06% for the year ended December 31, 2024.

As of December 31, 2025 and 2024, $0 million and $0 million, respectively, of gross principal balance, was outstanding under the F&G Credit Agreement. As of December 31, 2025, we had $750 million of remaining borrowing availability.

On September 17, 2021, we completed our underwritten public offering of $450 million aggregate principal amount of our 3.20% Notes due 2051, pursuant to our registration statement on Form S-3 ASR (File No. 333-239002) and the related prospectus supplement. The net proceeds from the registered offering of the 3.20% Notes were approximately $443 million, after deducting underwriting discounts, commissions and offering expenses. We plan to use the net proceeds from the offering for general corporate purposes.

On October 29, 2020, we entered into the Fifth Restated Credit Agreement for our Amended Revolving Credit Facility with Bank of America, N.A., as administrative agent and the other agents party thereto. Among other changes, the Fifth Restated Credit Agreement amends the Fourth Restated Credit Agreement to extend the maturity date from April 27, 2022 to October 29, 2025. The material terms of the Fourth Restated Credit Agreement are set forth in our Annual Report for the year ended December 31, 2019. As of December 31, 2025, there was no principal outstanding, $3 million of unamortized debt issuance costs, and $800 million of available borrowing capacity under the Revolving Credit Facility. On February 16, 2024, we entered into a Sixth Amended and Restated Credit Agreement. Among other changes, the Sixth Amended and Restated Credit Agreement amends the Fifth Restated Credit Agreement to extend the maturity date from October 29, 2025 to February 16, 2029.

On September 15, 2020, we completed our underwritten public offering of $600 million aggregate principal amount of our 2.45% Notes due March 15, 2031 (the "2.45% Notes") pursuant to an effective registration statement filed with the Securities and Exchange Commission ("SEC"). The net proceeds from the registered offering of the 2.45% Notes were approximately $593 million, after deducting underwriting discounts and commissions and offering expenses. We used the net proceeds from the offering (i) to repay the remaining $260 million outstanding indebtedness under our prior term loan credit agreement dated April 22, 2020, among us, as borrower, various lenders, and Bank of American N.A., as administrative agent (the "Term Loan"), which provided for an aggregate principal borrowing of $1.0 billion that we entered into to fund a portion of the acquisition of F&G and (ii) for general corporate purposes.

On June 12, 2020, we completed our underwritten public offering of $650 million aggregate principal amount of the 3.40% Notes due 2030 (the “3.40% Notes”) pursuant to an effective registration statement filed with the SEC. The net proceeds from the registered offering of the 3.40% Notes were approximately $642 million, after deducting underwriting discounts, and commissions and offering expenses. We used the net proceeds from the offering (i) to repay $640 million of the then outstanding principal amount under the Term Loan, and (ii) for general corporate purposes.

On August 13, 2018, we completed an offering of $450 million in aggregate principal amount of 4.50% notes due August 2028 (the "4.50% Notes"), pursuant to Rule 144A and Regulation S under the Securities Act of 1933, as amended. The 4.50% Notes were priced at 99.252% of par to yield 4.594% annual interest. We pay interest on the 4.50% Notes semi-annually on the 15th of February and August, beginning February 15, 2019. The 4.50% Notes contain customary covenants and events of default for investment grade public debt, which primarily relate to failure to make principal or interest payments. On May 16, 2019, we completed an offering to exchange the 4.50% Notes for substantially identical notes registered pursuant to Rule 424 under the Securities Act of 1933 (the "4.50% Notes Exchange"). There were no material changes to the terms of the 4.50% Notes as a result of the 4.50% Notes Exchange and all holders of the 4.50% Notes accepted the offer to exchange.


Gross principal maturities of notes payable at December 31, 2025, are as follows:	(In millions)
2026	$	32
2027	—
2028	950
2029	550
2030	650
Thereafter	2,270
	$	4,452

Schedule II - Condensed Financial Information - Balance Sheets (Parent Company) (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
ASSETS
Cash	$ 2,636	$ 3,479
Investments in unconsolidated affiliates	5,166	3,731
Notes receivable	473	471
Property and equipment, net	189	173
Prepaid expenses and other assets	2,012	1,938
Total assets	109,014	95,263	$ 80,614
Liabilities:
Accounts payable and other accrued liabilities	3,828	3,249
Income taxes payable	1	52
Deferred tax liability	439	0
Notes payable	4,400	4,321
Total liabilities	100,042	86,731
Equity [Abstract]
FNF common stock, $0.0001 par value; authorized 600 shares as of December 31, 2025 and 2024; outstanding of 271 and 275 as of December 31, 2025 and 2024, respectively, and issued of 332 and 331 as of December 31, 2025 and 2024, respectively	0	0
Preferred stock, $0.0001 par value; authorized 50,000,000 shares; issued and outstanding, none	0	0
Additional paid-in capital	6,042	5,976
Retained earnings	5,484	5,982
Accumulated other comprehensive earnings	(1,678)	(2,052)
Treasury stock	(2,424)	(2,152)
Total Fidelity National Financial, Inc. shareholders’ equity	7,424	7,754
Total liabilities and equity	109,014	95,263
Parent Company
ASSETS
Cash	396	534
Short-term investments	262	252
Investments in unconsolidated affiliates	2	3
Notes receivable	142	212
Investments in and amounts due from subsidiaries	9,245	8,882
Property and equipment, net	15	2
Prepaid expenses and other assets	358	433
Total assets	10,420	10,318
Liabilities:
Accounts payable and other accrued liabilities	424	385
Income taxes payable	1	51
Deferred tax liability	439	0
Notes payable	2,132	2,128
Total liabilities	2,996	2,564
Equity [Abstract]
Preferred stock, $0.0001 par value; authorized 50,000,000 shares; issued and outstanding, none	0	0
Additional paid-in capital	6,042	5,976
Retained earnings	5,484	5,982
Accumulated other comprehensive earnings	(1,678)	(2,052)
Treasury stock	(2,424)	(2,152)
Total Fidelity National Financial, Inc. shareholders’ equity	7,424	7,754
Total liabilities and equity	10,420	10,318
Parent Company \| FNF Common Stock
Equity [Abstract]
FNF common stock, $0.0001 par value; authorized 600 shares as of December 31, 2025 and 2024; outstanding of 271 and 275 as of December 31, 2025 and 2024, respectively, and issued of 332 and 331 as of December 31, 2025 and 2024, respectively	$ 0	$ 0

Employee Benefit Plans - Stock Option Activity (Details) - F&G Omnibus Plan - $ / shares	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Options (in shares):
Stock options outstanding at beginning of period (in shares)	100,000	643,623	1,172,607
Exercised (in shares)	(100,000)	(543,623)	(502,414)
Canceled (in shares)		0	(26,570)
Stock options outstanding at end (in shares)	0	100,000	643,623
Weighted Average Exercise Price (in dollars per share):
Stock options outstanding at beginning of period (in dollars per share)	$ 39.10	$ 38.8	$ 35.15
Exercised (in dollars per share)	39.10	38.74	30.31
Cancelled (in dollars per share)		0	38.07
Stock options outstanding at end of period (in dollars per share)	$ 0	$ 39.10	$ 38.8
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Options exercisable (in shares)	0	100,000	643,623	1,172,607

Business and Summary of Significant Accounting Policies - Schedule of Changes in Other Comprehensive Earnings (Details) - USD ($)
$ in Millions

12 Months Ended

Dec. 31, 2025

Dec. 31, 2024

Dec. 31, 2023

Accumulated Other Comprehensive Income (Loss) [Line Items]

Stockholders' equity attributable to parent, beginning balance

$ 7,754

(46)

$ (8)

$ 126

477

759

Stockholders' equity attributable to parent, ending balance

^[1]

(73)

(7)

(134)

7,424

7,754

Unrealized gain (loss) on investments and other financial instruments, net (excluding investments in unconsolidated affiliates)

Accumulated Other Comprehensive Income (Loss) [Line Items]

Stockholders' equity attributable to parent, beginning balance

(2,795)

(2,655)

(3,583)

137

711

(157)

961

Stockholders' equity attributable to parent, ending balance

(116)

(170)

(2,172)

(2,795)

(2,655)

Change in current discount rate - future policy benefits

Accumulated Other Comprehensive Income (Loss) [Line Items]

Stockholders' equity attributable to parent, beginning balance

808

605

763

(235)

224

(189)

Stockholders' equity attributable to parent, ending balance

(21)

613

808

605

Change in instrument-specific credit risk - market risk benefits

Accumulated Other Comprehensive Income (Loss) [Line Items]

Stockholders' equity attributable to parent, beginning balance

(71)

(76)

(48)

(24)

(34)

Stockholders' equity attributable to parent, ending balance

(91)

(71)

(76)

Other

Accumulated Other Comprehensive Income (Loss) [Line Items]

Stockholders' equity attributable to parent, beginning balance

(2)

(58)

(11)

Stockholders' equity attributable to parent, ending balance

(1)

(28)

Total Accumulated Other Comprehensive Earnings (Loss)

Accumulated Other Comprehensive Income (Loss) [Line Items]

Stockholders' equity attributable to parent, beginning balance

(2,052)

(2,119)

(2,870)

Stockholders' equity attributable to parent, ending balance

$ (1,678)

$ (2,052)

$ (2,119)

[1]	Net of income tax benefit of $18 million, $3 million, and $35 million for the years ended December 31, 2025, and 2024, and 2023, respectively.

Goodwill (Tables)

12 Months Ended

Dec. 31, 2025

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Goodwill

A summary of the changes in Goodwill consists of the following:


	Title		F&G		Corporate and Other		Total
	(In millions)
Balance, December 31, 2023	$	2,788	$	1,749	$	293	$	4,830
Goodwill associated with acquisitions	11		430		—		441

Balance, December 31, 2024	$	2,799	$	2,179	$	293	$	5,271
Goodwill associated with acquisitions	—		1		—		1




Balance, December 31, 2025	$	2,799	$	2,180	$	293	$	5,272

Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 24
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482548/350-20-55-24

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1A

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-2

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

12 Months Ended

Dec. 31, 2025

Commitments and Contingencies

Legal and Regulatory Contingencies

In the ordinary course of business, we are involved in various pending and threatened litigation matters related to our operations, some of which include claims for punitive or exemplary damages. With respect to our title insurance operations, this customary litigation includes but is not limited to a wide variety of cases arising out of or related to title and escrow claims, for which we make provisions through our loss reserves. See Note B Summary of Reserve for Title Claim Losses for further discussion. Additionally, like other companies, our ordinary course litigation includes a number of class action and purported class action lawsuits, which make allegations related to aspects of our operations. We believe that no actions, other than the matters discussed below, if any, depart from customary litigation incidental to our business.

We review lawsuits and other legal and regulatory matters (collectively “legal proceedings”) on an ongoing basis when making accrual and disclosure decisions. When assessing reasonably possible and probable outcomes, management bases its decision on its assessment of the ultimate outcome assuming all appeals have been exhausted. For legal proceedings in which it has been determined that a loss is both probable and reasonably estimable, a liability based on known facts and that represents our best estimate has been recorded. Our accrual for legal and regulatory matters was $7 million and $17 million as of December 31, 2025 and 2024, respectively. None of the amounts we have currently recorded are considered to be material to our financial condition individually or in the aggregate. Actual losses may materially differ from the amounts recorded and the ultimate outcome of our pending legal proceedings is generally not yet determinable. While some of these matters could be material to our operating results or cash flows for any particular period if an unfavorable outcome results, at present we do not believe that the ultimate resolution of currently pending legal proceedings, either individually or in the aggregate, will have a material adverse effect on our financial condition.

On June 10, 2025, a stockholder derivative lawsuit styled, Patrick Ayers v. William P. Foley, Douglas K. Ammerman, Halim Dhanidina, Thomas M. Hagerty, Daniel D. Lane, Heather H. Miller, Sandra D. Morgan, John D. Rood, Peter O. Shea, Jr., Cary H. Thompson, and Fidelity National Financial, Inc., C.A. No. 2025-0650-LWW, was filed in the Chancery Court of the State of Delaware against FNF and its non-employee members of its Board of Directors alleging they breached their fiduciary duties related to their compensation in 2022, 2023, and 2024, and were unjustly enriched. Plaintiff seeks disgorgement of any alleged excessive and unfair compensation payments, the recovery of damages on behalf of FNF, and the reformation of certain corporate governance and internal measures to protect FNF and its stockholders going forward. On August 1, 2025, defendants filed a motion to dismiss the lawsuit based on various grounds. A hearing on the motion has been rescheduled for March 9, 2026. At this time, FNF does not believe the lawsuit will have a material impact on its business, operations, or financial results.

Fidelity & Guaranty Life Insurance Company (“FGL Insurance”) is a defendant in a lawsuit filed in U.S. District Court for the Southern District of Texas (the “Southern District of Texas”) styled, Insurance Distribution Consulting, LLC v. Fidelity & Guaranty Life Insurance Company, Case No. 3:23-cv-00126. Plaintiff, which provides consulting services to independent marketing organizations (“IMO”), alleges FGL Insurance failed to pay commissions owed to plaintiff and diverted commissions from one of plaintiff’s IMO customers, Syncis, to another IMO, Freedom Equity Group, LLC (“Freedom Equity”). Further, plaintiff alleges after FGL Insurance purportedly purchased a partial ownership interest in Syncis and Freedom Equity, plaintiff offered to sell its interests in its contracts with Syncis but FGL Insurance declined, leading plaintiff to allege a statutory violation of 42 U.S.C. §1981 for discrimination where plaintiff’s sole member is a racial minority. Plaintiff claims its damages for breach of contract from FGL Insurance’s purported failure to pay commissions are more than $162 million and its damages from FGL Insurance’s declining to purchase plaintiff’s interest in its contracts with Syncis are over $11 million. FGL Insurance denies the allegations and denies any contract or agreement existed with plaintiff to pay commissions. On April 21, 2025, FGL Insurance filed its initial motion for summary judgment. On June 5, 2025, plaintiff amended its complaint to include an additional breach of contract claim, prompting FGL Insurance to file a second motion for summary judgment on July 18, 2025, addressing the new allegation. Both motions for summary judgment were argued on February 20, 2026, and a decision is pending with the court. Additionally, FGL Insurance’s motion to exclude plaintiff’s expert testimony as inadmissible, filed June

9, 2025, remains pending with the Southern District of Texas. On July 18, 2025, Peak Altitude Equity, LLC (“Peak”), a subsidiary of Fidelity & Guaranty Life Holdings, Inc., was served with a new lawsuit filed by Insurance Distribution Consulting, LLC (“IDC”) as a counterclaim in response to a separate breach of contract lawsuit initiated against IDC by Syncis. The case, styled Syncis Insurance Solutions, LLC v. Insurance Distribution Consulting, LLC, Case No. 2:25-cv-03874, is pending in the U.S. District Court for the Central District of California (the “Central District of California”), and certain facts alleged by IDC against Peak overlap with those asserted in the lawsuit filed by IDC against FGL Insurance. On September 8, 2025, Peak filed its motion to dismiss IDC’s counterclaim on various grounds. A decision is pending with the Central District of California. FGL Insurance and Peak will vigorously contest the plaintiff’s claims in the actions. As these cases continue to evolve, it is not possible to reasonably estimate the probability that plaintiff will ultimately prevail on its claims or that FGL Insurance or Peak will be held liable for the dispute. At this time, we do not believe the lawsuit will have a material impact on our business, operations, or financial results.

F&G is a defendant in two putative class action lawsuits related to the alleged compromise of certain customers’ personal information resulting from an alleged vulnerability in the MOVEit file transfer software. F&G’s vendor, Pension Benefit Information, LLC (“PBI”), used the MOVEit software in the course of providing audit and address research services to F&G and many other corporate customers. Miller v. F&G, No. 4:23-cv-00326 was filed against F&G in the Southern District of Iowa on August 31, 2023. Miller alleges that he is a F&G customer whose information was impacted in the MOVEit incident and brings common law tort and implied contract claims. Cooper v. Progress Software Corp., No. 1:23-cv-12067 was filed against F&G and five other defendants in the District of Massachusetts on September 7, 2023. Cooper also alleges that he is a F&G customer and brings similar common law tort claims and alleges claims as a purported third-party beneficiary of an alleged contract.

Well over 150 similar lawsuits have been filed against other entities impacted by the MOVEit incident including a number of such lawsuits related to PBI’s use of MOVEit. On October 4, 2023, the U.S. Judicial Panel on Multidistrict Litigation created a multidistrict litigation (“MDL”) pursuant to 28 U.S.C. § 1407 to handle all litigation brought by individuals whose information was potentially compromised in connection with the alleged MOVEit vulnerability. Both Miller and Cooper have been transferred to the MDL and are consolidated under MDL Case No. 1:23-md-03083-ADB-PGL. The case is proceeding under a modified bellwether structure to decide critical issues and facilitate reciprocal discovery, and plaintiffs’ consolidated class action complaint against all the bellwether Defendants was filed on December 6, 2024. F&G was not selected as a bellwether Defendant, and there is no schedule in place for further proceedings involving the non-bellwether Defendants like F&G. At this time, we do not believe the incident will have a material impact on our business, operations, or financial results.

From time to time, we receive inquiries and requests for information from state insurance departments, attorneys general, and other regulatory agencies about various matters relating to our business. Sometimes these take the form of civil investigative demands or subpoenas. We cooperate with all such inquiries, and we have responded to or are currently responding to inquiries from multiple governmental agencies. Also, regulators and courts have been dealing with issues arising from foreclosures and related processes and documentation. Various governmental entities are studying the title insurance product, market, pricing, and business practices, and potential regulatory and legislative changes, which may materially affect our business and operations. From time to time, we are assessed fines for violations of regulations or other matters or enter into settlements with such authorities, which may require us to pay fines or claims or take other actions. We do not anticipate such fines and settlements, either individually or in the aggregate, will have a material adverse effect on our business, operations, or financial results.

Escrow Balances

In conducting our operations, we routinely hold customers’ assets in escrow, pending completion of real estate transactions, and are responsible for the proper disposition of these balances for our customers. Certain of these amounts are maintained in segregated bank accounts and have not been included in the accompanying Consolidated Balance Sheets, consistent with GAAP and industry practice. These balances amounted to $16.2 billion and $14.4 billion at December 31, 2025 and 2024, respectively. As a result of holding these customers’ assets in escrow, we have ongoing programs for realizing economic benefits during the year through favorable borrowing and vendor arrangements with various banks. There were no investments or loans outstanding as of December 31, 2025 and 2024 related to these arrangements.

F&G Commitments

In our F&G segment, we have unfunded investment commitments as of December 31, 2025 based upon the timing of when investments and agreements are executed or signed compared to when the actual investments and agreements are funded or closed. Some investments require that funding occur over a period of months or years. A summary of unfunded commitments by commitment type is included below:


	December 31, 2025

Commitment Type	(In millions)
Other fixed maturity securities, AFS	$	126
Commercial mortgage loans	74
Residential mortgage loans	300
Other assets	122

Consolidated VIEs:
Other long-term investments	250
Unconsolidated VIEs:
Limited partnerships	$	1,224
Asset-backed lending	263
Fixed maturity securities, asset-backed securities	684
Direct Lending	1,199
Total	$	4,242

Concurrent with the purchase agreement for a prior year acquisition, we executed a separate loan agreement with the sellers for us to lend up to $40 million The loan matures on August 5, 2027. The principal balance outstanding as of December 31, 2025 and 2024 was $24 million and $11 million, respectively. The balance is included in Prepaid expenses and other assets on the Consolidated Balance Sheets. Changes in fair value are reported within Recognized gains and losses, net in the Consolidated Statements of Earnings. Interest income is recorded in Interest and investment income in the Consolidated Statements of Earnings and recognized when earned. The remainder of the unfunded loan commitment is included in the unfunded commitments table above in the “Other assets” line item. Refer to Note C Fair Value of Financial Instruments for information regarding the fair value calculation of this loan receivable.

Contingent Consideration

Under the terms of the purchase agreement for a prior year acquisition, we have agreed to make cash payments of up to approximately $90 million over a three-year period upon the achievement by the acquiree of certain EBITDA milestones. The contingent consideration is recorded at fair value in Accounts payable and accrued liabilities on the Consolidated Balance Sheets. Refer to Note C Fair Value of Financial Instruments for more information regarding the fair value of the contingent consideration.

See Note A Business and Summary of Significant Accounting Policies, for discussion of funding agreements that have been issued pursuant to the FABN Program as well as to the FHLB that are included in Contractholder funds.

The Company has a reinsurance agreement with Kubera to cede certain FIA statutory reserves on a coinsurance funds withheld basis, net of applicable existing reinsurance. To enhance Kubera's ability to pay its obligations under the amended reinsurance agreement, effective October 31, 2021, F&G entered into a Variable Note Purchase Agreement (the “NPA”), whereby F&G agreed to fund a note to Kubera to be used to ultimately settle with F&G, with principal increases up to a maximum amount of $435 million, to the extent a potential funding shortfall (treaty assets are less than the total funding requirement) is projected relative to the business ceded to Kubera from F&G as part of the amended reinsurance agreement. The potential funding shortfall will be determined quarterly and, among other items, is impacted by the market value of the assets in the funds withheld account related to the reinsurance agreement and Kubera's capital as calculated on a Bermuda regulatory basis. The NPA matures on November 30, 2071. Based on the current level of the treaty assets and projections that these policies will be profitable over the lifetime of the agreement, we do not expect significant fundings to occur under the NPA. As of December 31, 2025 and 2024, the amount funded under the NPA was insignificant.

Financial Instruments with Off-Balance Sheet Risk and Concentration of Risk (Details) - Geographic Concentration Risk - Title Insurance Premiums	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Texas
Concentration Risk [Line Items]
Concentration risk percentage	14.10%	13.80%	14.30%
California
Concentration Risk [Line Items]
Concentration risk percentage	12.20%	12.90%	13.00%
Florida
Concentration Risk [Line Items]
Concentration risk percentage	9.40%	10.20%	10.70%
Illinois
Concentration Risk [Line Items]
Concentration risk percentage	5.80%	5.80%	6.00%
Pennsylvania
Concentration Risk [Line Items]
Concentration risk percentage	5.40%	5.20%	4.90%

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-18

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-18

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 20
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-20

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-18

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-18

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-18

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 18
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482836/275-10-55-18

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 20
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-20

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 954
-SubTopic 310
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478785/954-310-50-2

For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.

Investments - Residential Mortgage Loan by State (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Allowance for expected credit loss	$ (86)	$ (70)	$ (66)
Loans, net	7,891	5,926
Residential mortgage
Loans	4,717	3,274
Allowance for expected credit loss	$ (68)	$ (53)	$ (54)
% of Total	100.00%	100.00%
Loans, net	$ 4,649	$ 3,221
California \| Residential mortgage
Loans	$ 288
% of Total	6.00%
Florida \| Residential mortgage
Loans	$ 246	$ 164
% of Total	5.00%	5.00%
New York \| Residential mortgage
Loans	$ 232
% of Total	5.00%
All other states \| Residential mortgage
Loans	$ 3,951	$ 3,110
% of Total	84.00%	95.00%

Employee Benefit Plans - F&G Omnibus Incentive Plan (Details) - shares	Jun. 01, 2020	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock outstanding (in shares)		2,105,535
F&G Omnibus Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized for grant (in shares)	2,096,429
Options outstanding (in shares)		0	100,000	643,623	1,172,607
F&G Omnibus Plan \| Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized for grant (in shares)	2,411,585
Award vesting period	3 years
Expiration period	7 years
F&G Omnibus Plan \| Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock outstanding (in shares)		0

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(v)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iv)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (l)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 35
-Paragraph 1D
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 35
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480483/718-10-35-3

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(01)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(02)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(03)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(04)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(01)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(02)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(03)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Other Intangible Assets - Reconciliation of Other Intangibles to Balance Sheet (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]
VOBA	$ 1,196	$ 1,349	$ 1,446
DAC	3,637	3,036
DSI	891	625	$ 346
Definite lived	917	966
Total	6,641	5,976
Customer relationships and contracts
Finite-Lived Intangible Assets [Line Items]
Definite lived	349	435
Value of distribution asset
Finite-Lived Intangible Assets [Line Items]
Definite lived	62	74
Computer software
Finite-Lived Intangible Assets [Line Items]
Definite lived	289	277
Trademarks, tradenames, and other
Finite-Lived Intangible Assets [Line Items]
Definite lived	$ 217	$ 180

Summary of Reserve for Title Claim Losses (Tables)

12 Months Ended

Dec. 31, 2025

Schedule of the Reserve for Title Claim Losses

A summary of the reserve for title claim losses follows:


	Year Ended December 31,
	2025			2024			2023
	(Dollars in millions)
Beginning balance	$	1,713		$	1,770		$	1,810

Change in insurance recoverable	(6)			(10)			15
Claim loss provision related to:
Current year	262			232			207
Prior years	—			—			—
Total title claim loss provision	262			232			207
Claims paid, net of recoupments related to:
Current year	(21)			(25)			(22)
Prior years	(248)			(254)			(240)
Total title claims paid, net of recoupments	(269)			(279)			(262)
Ending balance of claim loss reserve for title insurance	$	1,700		$	1,713		$	1,770
Provision for title insurance claim losses as a percentage of title insurance premiums	4.5		%	4.5		%	4.5		%

Other Intangible Assets - Definite and Indefinite Lived Intangible Assets (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Finite-Lived Intangible Assets [Line Items]
Net carrying amount	$ 917	$ 966
Customer relationships and contracts
Finite-Lived Intangible Assets [Line Items]
Cost	760	795
Accumulated amortization	(411)	(360)
Net carrying amount	$ 349	$ 435
Customer relationships and contracts \| Minimum
Finite-Lived Intangible Assets [Line Items]
Weighted average useful life (years)	10 years	10 years
Customer relationships and contracts \| Maximum
Finite-Lived Intangible Assets [Line Items]
Weighted average useful life (years)	20 years	20 years
Computer software
Finite-Lived Intangible Assets [Line Items]
Cost	$ 747	$ 723
Accumulated amortization	(458)	(446)
Net carrying amount	$ 289	$ 277
Computer software \| Minimum
Finite-Lived Intangible Assets [Line Items]
Weighted average useful life (years)	2 years	2 years
Computer software \| Maximum
Finite-Lived Intangible Assets [Line Items]
Weighted average useful life (years)	10 years	10 years
Value of distribution asset
Finite-Lived Intangible Assets [Line Items]
Cost	$ 140	$ 140
Accumulated amortization	(78)	(66)
Net carrying amount	$ 62	$ 74
Weighted average useful life (years)	15 years	15 years
Trademarks, tradenames, and other
Finite-Lived Intangible Assets [Line Items]
Cost	$ 289	$ 234
Accumulated amortization	(72)	(54)
Net carrying amount	$ 217	$ 180

Summary of Reserve for Title Claim Losses (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]
Change in insurance recoverable	$ 1	$ 13	$ (78)
Title
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]
Beginning balance	1,713	1,770	1,810
Change in insurance recoverable	(6)	(10)	15
Claim loss provision related to:
Current year	262	232	207
Prior years	0	0	0
Total title claim loss provision	262	232	207
Claims paid, net of recoupments related to:
Current year	(21)	(25)	(22)
Prior years	(248)	(254)	(240)
Total title claims paid, net of recoupments	(269)	(279)	(262)
Ending balance of claim loss reserve for title insurance	$ 1,700	$ 1,713	$ 1,770
Provision for title insurance claim losses as a percentage of title insurance premiums	4.50%	4.50%	4.50%

Income Taxes - Effective Tax Rate Reconciliation (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Effective Income Tax Rate Reconciliation, Percent
Federal statutory rate	21.00%	21.00%	21.00%
State income taxes, net of federal benefit	1.90%	1.80%	2.40%
Stock compensation		(0.50%)	(0.20%)
Tax credits	(0.60%)	(0.70%)	(1.80%)
Valuation allowance for deferred tax assets	(2.00%)	(1.00%)	5.00%
Outside basis difference in F&G	33.70%
Officers Compensation		0.80%	1.20%
Non-deductible expenses and other, net	(0.10%)	(0.30%)	0.10%
Effective tax rate	53.90%	21.10%	27.70%
Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount
Federal statutory rate	$ 293
State income taxes, net of federal income tax effect	26
Tax credits	(8)
Changes in valuation allowances	(28)
Outside basis difference in F&G	471
Nontaxable or nondeductible items and other	(1)
Effective tax rate	753	$ 367	$ 192
Illinois And Florida
Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount
State income taxes, net of federal income tax effect	$ 23

Segment Information (Details) - USD ($) $ in Millions	12 Months Ended
Segment Information (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Segment Reporting Information [Line Items]
Direct title insurance premiums	$ 2,574	$ 2,200	$ 1,982
Agency title insurance premiums	3,250	2,953	2,610
Escrow, title-related and other fees	5,444	5,321	4,717
Interest and investment income	3,237	3,124	2,607
Recognized gains and losses, net	(60)	83	(164)
Total revenues	14,445	13,681	11,752
Personnel costs	3,437	3,148	2,908
Agent commissions	2,518	2,287	2,008
Other operating expenses	1,615	1,558	1,521
Benefits and other changes in policy reserves	3,963	3,791	3,553
Total significant segment expenses	11,533	10,784	9,990
Depreciation and amortization	844	739	593
Provision for title claim losses	262	232	207
Market risk benefit (gains) losses	167	(25)	95
Interest expense	242	209	174
Total other segment items	1,515	1,155	1,069
Total expenses	13,048	11,939	11,059
Earnings (loss) before income taxes and equity in earnings of unconsolidated affiliates	1,397	1,742	693
Income tax expense (benefit)	753	367	192
Earnings before equity in earnings of unconsolidated affiliates	644	1,375	501
Equity in earnings of unconsolidated affiliates	35	16	17
Net earnings from continuing operations	679	1,391	518
Assets	109,014	95,263	80,614
Goodwill	5,272	5,271	4,830
Operating Segments \| Title
Segment Reporting Information [Line Items]
Direct title insurance premiums	2,574	2,200	1,982
Agency title insurance premiums	3,250	2,953	2,610
Escrow, title-related and other fees	2,381	2,196	2,117
Interest and investment income	363	359	338
Recognized gains and losses, net	(78)	(6)	(9)
Total revenues	8,490	7,702	7,038
Personnel costs	2,983	2,695	2,544
Agent commissions	2,518	2,287	2,008
Other operating expenses	1,353	1,251	1,242
Benefits and other changes in policy reserves	0	0	0
Total significant segment expenses	6,854	6,233	5,794
Depreciation and amortization	147	141	154
Provision for title claim losses	262	232	207
Market risk benefit (gains) losses	0	0	0
Interest expense	0	0	0
Total other segment items	409	373	361
Total expenses	7,263	6,606	6,155
Earnings (loss) before income taxes and equity in earnings of unconsolidated affiliates	1,227	1,096	883
Income tax expense (benefit)	283	265	181
Earnings before equity in earnings of unconsolidated affiliates	944	831	702
Equity in earnings of unconsolidated affiliates	39	16	17
Net earnings from continuing operations	983	847	719
Assets	8,093	7,627	7,949
Goodwill	2,799	2,799	2,788
Operating Segments \| F&G
Segment Reporting Information [Line Items]
Direct title insurance premiums	0	0	0
Agency title insurance premiums	0	0	0
Escrow, title-related and other fees	2,884	2,941	2,413
Interest and investment income	2,837	2,719	2,211
Recognized gains and losses, net	10	84	(124)
Total revenues	5,731	5,744	4,500
Personnel costs	293	296	232
Agent commissions	0	0	0
Other operating expenses	156	203	146
Benefits and other changes in policy reserves	3,963	3,791	3,553
Total significant segment expenses	4,412	4,290	3,931
Depreciation and amortization	665	569	412
Provision for title claim losses	0	0	0
Market risk benefit (gains) losses	167	(25)	95
Interest expense	164	132	97
Total other segment items	996	676	604
Total expenses	5,408	4,966	4,535
Earnings (loss) before income taxes and equity in earnings of unconsolidated affiliates	323	778	(35)
Income tax expense (benefit)	52	136	23
Earnings before equity in earnings of unconsolidated affiliates	271	642	(58)
Equity in earnings of unconsolidated affiliates	0	0	0
Net earnings from continuing operations	271	642	(58)
Assets	98,432	84,938	70,186
Goodwill	2,180	2,179	1,749
Operating Segments \| Corporate and Other
Segment Reporting Information [Line Items]
Direct title insurance premiums	0	0	0
Agency title insurance premiums	0	0	0
Escrow, title-related and other fees	179	184	187
Interest and investment income	154	154	123
Recognized gains and losses, net	8	5	(31)
Total revenues	341	343	279
Personnel costs	161	157	132
Agent commissions	0	0	0
Other operating expenses	106	104	133
Benefits and other changes in policy reserves	0	0	0
Total significant segment expenses	267	261	265
Depreciation and amortization	32	29	27
Provision for title claim losses	0	0	0
Market risk benefit (gains) losses	0	0	0
Interest expense	78	77	77
Total other segment items	110	106	104
Total expenses	377	367	369
Earnings (loss) before income taxes and equity in earnings of unconsolidated affiliates	(36)	(24)	(90)
Income tax expense (benefit)	418	(34)	(12)
Earnings before equity in earnings of unconsolidated affiliates	(454)	10	(78)
Equity in earnings of unconsolidated affiliates	(4)	0	0
Net earnings from continuing operations	(458)	10	(78)
Assets	2,489	2,698	2,479
Goodwill	293	293	293
Elimination
Segment Reporting Information [Line Items]
Direct title insurance premiums	0	0	0
Agency title insurance premiums	0	0	0
Escrow, title-related and other fees	0	0	0
Interest and investment income	(117)	(108)	(65)
Recognized gains and losses, net	0	0	0
Total revenues	(117)	(108)	(65)
Personnel costs	0	0	0
Agent commissions	0	0	0
Other operating expenses	0	0	0
Benefits and other changes in policy reserves	0	0	0
Total significant segment expenses	0	0	0
Depreciation and amortization	0	0	0
Provision for title claim losses	0	0	0
Market risk benefit (gains) losses	0	0	0
Interest expense	0	0	0
Total other segment items	0	0	0
Total expenses	0	0	0
Earnings (loss) before income taxes and equity in earnings of unconsolidated affiliates	(117)	(108)	(65)
Income tax expense (benefit)	0	0	0
Earnings before equity in earnings of unconsolidated affiliates	(117)	(108)	(65)
Equity in earnings of unconsolidated affiliates	0	0	0
Net earnings from continuing operations	(117)	(108)	(65)
Assets	0	0	0
Goodwill	$ 0	$ 0	$ 0

Other Intangible Assets - Estimated Amortization Expense for VOBA in Future Fiscal Periods (Detail) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
2026	$ 133
2027	120
2028	109
2029	99
2030	90
Thereafter	645
Total	$ 1,196	$ 1,349	$ 1,446

Regulation and Equity - Narrative (Details) $ in Millions	12 Months Ended
Regulation and Equity - Narrative (Details) $ in Millions	Dec. 31, 2025 USD ($) permitted_practice	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2026 USD ($)
Statutory Accounting Practices [Line Items]
Change in statutory capital surplus (deficit)	$ 32	$ 33
Combined statutory unearned premium reserve required	1,619
Net assets restricted from dividend payments without prior approval	1,141
Statutory capital and surplus	1,273	1,223
Statutory net income	488	587	$ 503
Minimum net worth required for compliance	$ 1
Statutory accounting practices, number of permitted practices \| permitted_practice	2
Corbeau Re (VT)
Statutory Accounting Practices [Line Items]
Change in statutory capital surplus (deficit)	$ 1,489	1,230
Non-permitted statutory accounting practices deficit	(1,253)	(1,052)
F&G Cayman Re Ltd
Statutory Accounting Practices [Line Items]
Permitted practice, statutory surplus	20	(64)
Iowa
Statutory Accounting Practices [Line Items]
Change in statutory capital surplus (deficit)	249	454
Iowa \| F&G
Statutory Accounting Practices [Line Items]
Statutory capital and surplus	1,735	1,654
New York
Statutory Accounting Practices [Line Items]
Statutory account practices, amount available for dividend (maximum)	27
New York \| F&G
Statutory Accounting Practices [Line Items]
Statutory capital and surplus	122	97
Vermont \| Corbeau Re (VT) \| F&G
Statutory Accounting Practices [Line Items]
Statutory capital and surplus	236	178
Vermont \| Raven Re (VT) \| F&G
Statutory Accounting Practices [Line Items]
Statutory capital and surplus	182	168
Vermont \| Raven Re (VT)
Statutory Accounting Practices [Line Items]
Change in statutory capital surplus (deficit)	150	175
Statutory capital and surplus	182	168
Non-permitted statutory accounting practices deficit	$ 29	$ (13)
Forecast
Statutory Accounting Practices [Line Items]
Statutory amount available for distributions without prior approval				$ 437
Forecast \| Iowa
Statutory Accounting Practices [Line Items]
Statutory account practices, amount available for dividend (maximum)				$ 0

Supplemental Cash Flow Information

12 Months Ended

Dec. 31, 2025

Supplemental Cash Flow Elements [Abstract]

Supplemental Cash Flow Information

The following supplemental cash flow information is provided with respect to certain cash payment and non-cash investing and financing activities.


	Year Ended December 31,
	2025		2024		2023

Cash paid for:	(In millions)
Interest	$	229	$	200	$	157
Income taxes	250		237		216
Deferred sales inducements	332		319		168
Non-cash investing and financing activities:

Investments transferred subject to reinsurance agreement	(500)		—		—

Investments received from pension risk transfer premiums	—		129		464
Change in proceeds of sales of investments available for sale receivable in period	20		(59)		32
Change in purchases of investments available for sale payable in period	9		82		20
Lease liabilities recognized in exchange for lease right-of-use assets	45		55		40
Remeasurement of lease liabilities	54		67		75
Liabilities assumed in connection with acquisitions
Fair value of assets acquired	6		789		304
Less: Total Purchase price	3		586		299
Liabilities and noncontrolling interests assumed	$	3	$	203	$	5

Regulation and Equity

12 Months Ended

Dec. 31, 2025

Regulation and Equity

Summary of Reserve for Title Claim Losses

A summary of the reserve for title claim losses follows:


	Year Ended December 31,
	2025			2024			2023
	(Dollars in millions)
Beginning balance	$	1,713		$	1,770		$	1,810

Change in insurance recoverable	(6)			(10)			15
Claim loss provision related to:
Current year	262			232			207
Prior years	—			—			—
Total title claim loss provision	262			232			207
Claims paid, net of recoupments related to:
Current year	(21)			(25)			(22)
Prior years	(248)			(254)			(240)
Total title claims paid, net of recoupments	(269)			(279)			(262)
Ending balance of claim loss reserve for title insurance	$	1,700		$	1,713		$	1,770
Provision for title insurance claim losses as a percentage of title insurance premiums	4.5		%	4.5		%	4.5		%

Regulation and Equity

Regulation

Title

F&G

F&G's non-U.S. insurance subsidiaries, F&G Life Re (Bermuda) and F&G Cayman Re (Cayman Islands), file financial statements with their respective regulators.


	Subsidiary (state of domicile) (a)
	FGL Insurance (IA)		FGL NY Insurance (NY)		Raven Re (VT)		Corbeau Re (VT)
Statutory Net (loss) income:	(In millions)
Year ended December 31, 2025	$	(257)	$	29	$	38	$	(201)
Year ended December 31, 2024	150		8		54		(458)
Year ended December 31, 2023	(462)		5		60		(644)

Statutory Capital and Surplus:
December 31, 2025	$	1,735	$	122	$	182	$	236
December 31, 2024	1,654		97		168		178

(a) FGL NY Insurance, Raven Re and Corbeau Re are subsidiaries of FGL Insurance, and the columns should not be added together. Corbeau Re was incorporated on September 1, 2023.

Regulation - U.S. Companies

FGL Insurance, FGL NY Insurance, Raven Re and Corbeau Re’s respective statutory capital and surplus satisfy the applicable minimum regulatory requirements.

Dividends

The insurance laws of Iowa and New York regulate the amount of dividends that may be paid in any year by FGL Insurance and FGL NY Insurance, respectively.

Prescribed and permitted practices

The prescribed and permitted practices resulted in increases to statutory capital and surplus of $249 million and $454 million at December 31, 2025 and 2024, respectively.

Non-U.S. Companies

F&G Life Re files financial statements based on GAAP.

Net income and capital and surplus of our wholly owned Cayman Islands and Bermuda regulated insurance subsidiaries under SAP and GAAP, respectively, were as follows:


	Subsidiary (country of domicile)
	F&G Cayman Re (Cayman Islands)		F&G Life Re (Bermuda)
Statutory Net (loss) income:	(In millions)
Year ended December 31, 2025	$	(30)	$	160
Year ended December 31, 2024	(11)		139
Year ended December 31, 2023	133		151
Statutory Capital and Surplus (Deficit):
December 31, 2025	$	1,134	$	84
December 31, 2024	734		123

Regulation - Bermuda

F&G Life Re’s ability to pay dividends in 2026 is subject to the limitations described above.

Regulation - Cayman Islands

The prescribed and permitted statutory accounting practices have no impact on our audited Consolidated Financial Statements, which are prepared in accordance with GAAP.

Equity

Property, Plant and Equipment [Abstract]

Property and Equipment

12 Months Ended

Dec. 31, 2025

Property and Equipment


Property and equipment consist of the following:
	December 31,
	2025		2024
	(In millions)
Furniture, fixtures and equipment	$	164	$	161
Data processing equipment	164		155
Leasehold improvements	131		126
Buildings	103		93
Land	17		14
Other	8		8
Total property and equipment, gross	587		557
Accumulated depreciation and amortization	(398)		(384)
Total property and equipment, net	$	189	$	173

Depreciation expense on property and equipment was $53 million, $53 million, and $55 million for the years ended December 31, 2025, 2024, and 2023, respectively.

Supplemental Cash Flow Information (Tables)

12 Months Ended

Dec. 31, 2025

Supplemental Cash Flow Elements [Abstract]

Schedule of Supplemental Cash Flow Information

The following supplemental cash flow information is provided with respect to certain cash payment and non-cash investing and financing activities.


	Year Ended December 31,
	2025		2024		2023

Cash paid for:	(In millions)
Interest	$	229	$	200	$	157
Income taxes	250		237		216
Deferred sales inducements	332		319		168
Non-cash investing and financing activities:

Investments transferred subject to reinsurance agreement	(500)		—		—

Investments received from pension risk transfer premiums	—		129		464
Change in proceeds of sales of investments available for sale receivable in period	20		(59)		32
Change in purchases of investments available for sale payable in period	9		82		20
Lease liabilities recognized in exchange for lease right-of-use assets	45		55		40
Remeasurement of lease liabilities	54		67		75
Liabilities assumed in connection with acquisitions
Fair value of assets acquired	6		789		304
Less: Total Purchase price	3		586		299
Liabilities and noncontrolling interests assumed	$	3	$	203	$	5

Total income taxes paid was allocated as follows:


	Year Ended December 31,
	2025
	(In millions)
Federal	$	198
State & Foreign	52
Total	$	250

Supplemental Cash Flow Information


	Year Ended December 31,
	2025		2024		2023
	(In millions)
Cash paid during the year:
Interest paid	$	73	$	73	$	73
Income tax payments	241		229		213

Business and Summary of Significant Accounting Policies - Recent Developments (Details) - USD ($)		12 Months Ended
	Mar. 24, 2025	Dec. 31, 2025	Jan. 01, 2026	Feb. 01, 2025	Jan. 13, 2025	Dec. 31, 2024	Jun. 04, 2024	Apr. 20, 2018
Business Combination [Line Items]
Share distribution conversion rate (in dollars per share)		0.06
Common stock, par value per share (in dollars per share)		$ 0.0001				$ 0.0001
Subsequent Event \| FGL
Business Combination [Line Items]
Ownership percentage			70.00%
5.50% F&G Senior Notes due May 2025 \| Senior Notes
Business Combination [Line Items]
Debt instrument, interest rate, stated percentage				5.50%			5.50%	5.50%
Repurchased amount				$ 300,000,000
Aggregate principal amount								$ 550,000,000
7.30% Junior Subordinated Notes due 2065 \| Senior Notes
Business Combination [Line Items]
Debt instrument, interest rate, stated percentage					7.30%
Aggregate principal amount					$ 375,000,000
Common equity securities \| F&G Annuities & Life Member
Business Combination [Line Items]
Percentage of outstanding shares		12.00%
Common equity securities \| 2025 F&G Distribution
Business Combination [Line Items]
Number of shares issued in transaction (in shares)		16,000,000
Common equity securities \| Public Stock Offering
Business Combination [Line Items]
Number of shares issued in transaction (in shares)	8,000,000
Common stock, par value per share (in dollars per share)	$ 0.001
Sale of stock underwriter offering period	30 days
Common equity securities \| Public Stock Offering \| Related Party
Business Combination [Line Items]
Number of shares issued in transaction (in shares)	4,500,000
Sale of stock, price per share (in dollars per share)	$ 33.60
Common equity securities \| Over-Allotment Option
Business Combination [Line Items]
Number of shares issued in transaction (in shares)	1,200,000

Future Policy Benefits - Liability For Future Policy Benefit Expected Future Policy Benefit Undiscounted (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Traditional life
Undiscounted
Expected future benefit payments	$ 2,511	$ 2,705
Expected future gross premiums	848	914
Discounted
Expected future benefit payments	1,857	1,948
Expected future gross premiums	630	681
Immediate annuities
Undiscounted
Expected future benefit payments	3,095	3,189
Expected future gross premiums	0	0
Discounted
Expected future benefit payments	1,276	1,297
Expected future gross premiums	0	0
PRT
Undiscounted
Expected future benefit payments	13,074	10,038
Expected future gross premiums	0	0
Discounted
Expected future benefit payments	8,112	6,054
Expected future gross premiums	$ 0	$ 0

Future Policy Benefits (Tables)

12 Months Ended

Dec. 31, 2025

Schedule of Balances and Changes in the Present Value of Expected Net Premiums and Present Value

The following table summarizes balances and changes in the present value of expected net premiums and the present value of the expected FPB for nonparticipating traditional contracts:


	Traditional life
	December 31, 2025		December 31, 2024
Expected net premiums	(In millions)
Balance, beginning of year	$	631	$	722
Beginning balance at original discount rate	780		874

Effect of actual variances from expected experience	1		(4)
Balance adjusted for variances from expectation	781		870

Interest accrual	15		17
Net premiums collected	(96)		(107)

Ending balance at original discount rate	700		780
Effect of changes in discount rate assumptions	(115)		(149)
Balance, end of year	$	585	$	631

Expected FPB
Balance, beginning of year	$	1,933	$	2,071
Beginning balance at original discount rate	2,368		2,492

Effect of actual variances from expected experience	(21)		44
Balance adjusted for variances from expectation	2,347		2,536

Interest accrual	50		54
Benefits payments	(230)		(222)

Ending balance at original discount rate	2,167		2,368
Effect of changes in discount rate assumptions	(312)		(435)
Balance, end of year	$	1,855	$	1,933

Net liability for future policy benefits	$	1,270	$	1,302
Less: Reinsurance recoverable	489		513
Net liability for future policy benefits, after reinsurance recoverable	$	781	$	789

Weighted-average duration of liability for future policyholder benefits (years)	6.84		6.28

The following tables summarize balances and changes in the present value of the expected FPB for limited-payment contracts:


	PRT
	December 31, 2025		December 31, 2024
	(In millions)
Balance, beginning of year	$	6,054	$	4,189
Beginning balance at original discount rate	6,417		4,351
Effect of changes in cash flow assumptions	(36)		(3)
Effect of actual variances from expected experience	13		(11)
Balance adjusted for variances from expectation	6,394		4,337
Issuances	2,206		2,324
Interest accrual	331		240
Benefits payments	(663)		(484)

Ending balance at original discount rate	8,268		6,417
Effect of changes in discount rate assumptions	(156)		(363)
Balance, end of year	$	8,112	$	6,054



Net liability for future policy benefits, after reinsurance recoverable	$	8,112	$	6,054

Weighted-average duration of liability for future policyholder benefits (years)	7.80		7.78


	Immediate annuities
	December 31, 2025		December 31, 2024
	(In millions)
Balance, beginning of year	$	1,297	$	1,415
Beginning balance at original discount rate	1,732		1,788

Effect of actual variances from expected experience	(11)		(27)
Balance adjusted for variances from expectation	1,721		1,761
Issuances	17		30
Interest accrual	54		59
Benefits payments	(113)		(118)

Ending balance at original discount rate	1,679		1,732
Effect of changes in discount rate assumptions	(403)		(435)
Balance, end of year	$	1,276	$	1,297

Net liability for future policy benefits	$	1,276	$	1,297
Less: Reinsurance recoverable	106		109
Net liability for future policy benefits, after reinsurance recoverable	$	1,170	$	1,188

Weighted-average duration of liability for future policyholder benefits (years)	12.32		12.63

Schedule of Changes in Liability for Deferred Profit Liability

The following tables summarize balances and changes in the liability for DPL for limited-payment contracts:


	December 31, 2025				December 31, 2024
	Immediate annuities		PRT		Immediate annuities		PRT
	(In millions)
Balance, beginning of year	$	90	$	6	$	87	$	10

Effect of changes in cash flow assumptions	—		—		—		(8)
Effect of actual variances from expected experience	2		1		8		—
Balance adjusted for variances from expectation	92		7		95		2
Issuances	6		1		3		1
Interest accrual	1		—		1		4
Amortization	(9)		(1)		(9)		(1)
Balance, end of year	$	90	$	7	$	90	$	6

Schedule Of Reconciliation Of Future Policy Benefits To Statement Of Financial Position


	December 31,
	2025		2024
	(In millions)
Traditional life	$	1,270	$	1,302
Immediate annuities	1,276		1,297
PRT	8,112		6,054
Immediate annuities DPL	90		90
PRT DPL	7		6
Total	$	10,755	$	8,749

Schedule of Liability for Future Policy Benefit Expected Future Policy Benefit Undiscounted Before Reinsurance


	Undiscounted					Discounted
	December 31, 2025		December 31, 2024			December 31, 2025		December 31, 2024
Traditional life	(In millions)
Expected future benefit payments	$	2,511	$	2,705		$	1,857	$	1,948
Expected future gross premiums	848		914			630		681
Immediate annuities
Expected future benefit payments	$	3,095	$	3,189		$	1,276	$	1,297
Expected future gross premiums	—		—		—	—		—
PRT
Expected future benefit payments	$	13,074	$	10,038		$	8,112	$	6,054
Expected future gross premiums	—		—			—		—

Schedule of Revenue from External Customers by Products and Services

The following table summarizes the amount of revenue and interest related to nonparticipating traditional and limited-payment contracts recognized in the Consolidated Statements of Earnings:


	Gross Premiums (a)						Interest Expense (b)
	December 31,						December 31,
	2025		2024		2023		2025		2024		2023
	(In millions)
Traditional life	$	99	$	111	$	123	$	35	$	37	$	37
Immediate annuities	17		18		24		54		59		51
PRT	2,107		2,217		1,964		331		240		109
Total	$	2,223	$	2,346	$	2,111	$	420	$	336	$	197

(a) Included in Life insurance premiums and other fees on the Consolidated Statements of Earnings.

(b) Included in Benefits and other changes in policy reserves (remeasurement gains (a)) on the Consolidated Statements of Earnings.

Schedule of Liability for Future Policy Benefit, Weighted Average Discount Rates

The following table presents the weighted-average interest rate:


	December 31,
	2025		2024		2023
Traditional life
Interest accretion rate	2.35	%	2.34	%	2.33	%
Current discount rate	4.77	%	5.44	%	5.03	%
Immediate annuities
Interest accretion rate	3.20	%	3.17	%	3.14	%
Current discount rate	5.29	%	5.45	%	4.98	%
PRT
Interest accretion rate	4.87	%	4.72	%	4.61	%
Current discount rate	4.98	%	5.54	%	5.03	%

Schedule of Liability for Future Policy Benefit, Mortality and Lapse, Actual and Expected Experience

The following tables summarize the actual experience and expected experience for mortality and lapses of the FPB:


	December 31,
	2025						2024						2023
	Traditional life		Immediate annuities		PRT		Traditional life		Immediate annuities		PRT		Traditional life		Immediate annuities		PRT
Mortality
Actual experience	2.4	%	2.4	%	2.6	%	1.4	%	2.7	%	2.7	%	1.7	%	3.2	%	3.2	%
Expected experience	1.6	%	1.7	%	2.5	%	1.5	%	1.9	%	2.5	%	1.4	%	1.8	%	2.3	%
Lapses
Actual experience	—	%	—	%	—	%	0.1	%	—	%	—	%	—	%	—	%	—	%
Expected experience	0.6	%	—	%	—	%	0.5	%	—	%	—	%	0.3	%	—	%	—	%

Schedule of Liability For Future Policy Benefits, Additional Information

The following table provides additional information for periods in which a cohort has a net premium ratio (“NPR”) greater than 100% (and therefore capped at 100%) (dollars in millions):


	December 31, 2025				December 31, 2024
	Cohort X			Description	Cohort X			Description
NPR before capping	104		%	Term with return of premium Non-NY Cohort	108		%	Term with return of premium Non-NY Cohort
Reserves before NPR capping	$	1,145		Term with return of premium Non-NY Cohort	$	1,147		Term with return of premium Non-NY Cohort
Reserves after NPR capping	1,156			Term with return of premium Non-NY Cohort	1,174			Term with return of premium Non-NY Cohort
Loss Expense	11			Term with return of premium Non-NY Cohort	27			Term with return of premium Non-NY Cohort

Business and Summary of Significant Accounting Policies - Earnings Per Share (Details) - shares	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Accounting Policies [Abstract]
Antidilutive securities excluded from computation of EPS (in shares)	0	0

Other Intangible Assets - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
VOBA amortization	$ 153	$ 175	$ 169
DAC amortization	357	280	186
DIS Amortization	66	40	22
Amortization of intangible assets	203	187	152
Expected amortization, 2026	174
Expected amortization, 2027	141
Expected amortization, 2028	109
Expected amortization, 2029	91
Expected amortization, 2030	64
Finite-Lived Intangible Assets [Line Items]
Definite lived	917	966
Depreciation and amortization	844	739	593
Trademarks, Tradenames and Other/Market Risk Benefit Offset
Finite-Lived Intangible Assets [Line Items]
Definite lived	145	94
Depreciation and amortization	$ 9	$ 5	$ 1

Segment Information - Narratives (Details)	12 Months Ended
Segment Information - Narratives (Details)	Dec. 31, 2025 segment
Segment Reporting [Abstract]
Number of reportable segments (segment)	2

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2025

Income Tax Disclosure [Abstract]

Income Tax Expense (Benefit) on Continuing Operations

Income tax expense (benefit) on continuing operations consists of the following:


	Year Ended December 31,
	2025
	(In millions)
Current tax expense
Federal	$	76
State	23
Foreign	16
Total current tax expense	$	115
Deferred tax expense
Federal	599
State	39

Total deferred tax expense	$	638
Total income tax expense on continuing operations	$	753


	Year Ended December 31,
	2024		2023
	(In millions)
Current	$	360	$	241
Deferred	7		(49)
	$	367	$	192

Schedule of Components of Income Tax Expense (Benefit)

Total income tax expense was allocated as follows:


	Year Ended December 31,
	2025
	(In millions)
Net earnings from continuing operations	$	753

Other comprehensive earnings (loss):
Unrealized gain on investments and other financial instruments	160
Unrealized gain on foreign currency translation	4
Changes in current discount rate - future policy benefits	(62)
Changes in instrument - specific credit risk - market risk benefits	(6)
Tax effects of F&G Distribution	(16)
Other comprehensive earnings attributable to non-controlling interest	(18)

Total income tax expense allocated to other comprehensive earnings	62

Total income taxes	$	815


	Year Ended December 31,
	2024		2023
	(In millions)
Net earnings from continuing operations	$	367	$	192

Other comprehensive earnings (loss):
Unrealized (loss) gain on investments and other financial instruments	(35)		275
Unrealized (loss) gain on foreign currency translation	(6)		2
Changes in current discount rate - future policy benefits	59		(50)
Changes in instrument - specific credit risk - market risk benefits	1		(9)
F&G 15% Distribution	(3)		(35)

Total income tax expense) allocated to other comprehensive earnings	16		183

Total income tax expense	$	383	$	375

Schedule of Effective Income Tax Rate Reconciliation

A reconciliation of the federal statutory rate to our effective tax rate is as follows:


	Year Ended December 31, 2025
			(In millions)
Federal statutory rate	21.0	%	$	293
State income taxes, net of federal income tax effect (1)	1.9		26




Tax credits	(0.6)		(8)



Changes in valuation allowances	(2.0)		(28)
Outside basis difference in F&G (2)	33.7		471

Nontaxable or nondeductible items and other	(0.1)		(1)
Effective tax rate	53.9	%	$	753

(1) State taxes in California and Illinois made up the majority (greater than 50 percent) of the tax effect in this category.

(2) State taxes of $23 million are included in this category, of which Illinois and Florida made up the majority (greater than 50 percent).


	Year Ended December 31,
	2024		2023
Federal statutory rate	21.0	%	21.0	%
State income taxes, net of federal benefit	1.8		2.4



Stock compensation	(0.5)		(0.2)
Tax credits	(0.7)		(1.8)



Valuation allowance for deferred tax assets	(1.0)		5.0







Officers Compensation	0.8		1.2
Non-deductible expenses and other, net	(0.3)		0.1
Effective tax rate	21.1	%	27.7	%

Schedule of Income Taxes Paid

The following supplemental cash flow information is provided with respect to certain cash payment and non-cash investing and financing activities.


	Year Ended December 31,
	2025		2024		2023

Cash paid for:	(In millions)
Interest	$	229	$	200	$	157
Income taxes	250		237		216
Deferred sales inducements	332		319		168
Non-cash investing and financing activities:

Investments transferred subject to reinsurance agreement	(500)		—		—

Investments received from pension risk transfer premiums	—		129		464
Change in proceeds of sales of investments available for sale receivable in period	20		(59)		32
Change in purchases of investments available for sale payable in period	9		82		20
Lease liabilities recognized in exchange for lease right-of-use assets	45		55		40
Remeasurement of lease liabilities	54		67		75
Liabilities assumed in connection with acquisitions
Fair value of assets acquired	6		789		304
Less: Total Purchase price	3		586		299
Liabilities and noncontrolling interests assumed	$	3	$	203	$	5

Total income taxes paid was allocated as follows:


	Year Ended December 31,
	2025
	(In millions)
Federal	$	198
State & Foreign	52
Total	$	250

Supplemental Cash Flow Information


	Year Ended December 31,
	2025		2024		2023
	(In millions)
Cash paid during the year:
Interest paid	$	73	$	73	$	73
Income tax payments	241		229		213

Schedule of Deferred Tax Assets and Liabilities

The significant components of deferred tax assets and liabilities consist of the following:


	December 31,
	2025		2024
	(In millions)
Deferred Tax Assets:
Employee benefit accruals	$	138	$	129

Net operating loss carryforwards	119		115





Tax credits	176		204

Investment securities	504		775
Capital loss carryover	2		19

Life insurance and claim related adjustments	539		451
Funds held under reinsurance agreements	1,178		822
Market Risk Benefits	99		56
Bermuda corporate income tax net operating loss carryforward	—		10

Section 263a Costs	30		—
Other	36		42
Total gross deferred tax asset	2,821		2,623
Less: valuation allowance	114		164
Total deferred tax asset	$	2,707	$	2,459
Deferred Tax Liabilities:
Title plant	$	(54)	$	(53)
Amortization of goodwill and intangible assets	(97)		(71)

Other	(7)		(11)

Depreciation	(21)		(24)
Partnerships	(277)		(198)
Value of business acquired	(251)		(283)


Deferred acquisition costs	(677)		(543)

Outside basis difference in F&G	(404)		—
Funds held under reinsurance agreements	(1,261)		(945)
Title Insurance reserve discounting	(17)		(16)


Total deferred tax liability	$	(3,066)	$	(2,144)
Net deferred tax (liability) asset	$	(359)	$	315

Insider Trading Policies and Procedures	12 Months Ended
Insider Trading Policies and Procedures	Dec. 31, 2025
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted	true

Schedule II - Condensed Financial Information (Tables)

12 Months Ended

Dec. 31, 2025

Condensed Financial Information Disclosure [Abstract]

Balance Sheets

SCHEDULE II

FIDELITY NATIONAL FINANCIAL, INC.

(Parent Company)

BALANCE SHEETS

(In millions)


	December 31,
	2025		2024
ASSETS
Cash	$	396	$	534
Short-term investments	262		252


Investment in unconsolidated affiliates	2		3
Notes receivable	142		212
Investments in and amounts due from subsidiaries	9,245		8,882
Property and equipment, net	15		2
Prepaid expenses and other assets	358		433



Total assets	$	10,420	$	10,318
LIABILITIES AND EQUITY
Liabilities:
Accounts payable and other accrued liabilities	$	424	$	385
Income taxes payable	1		51
Deferred tax liability	439		—
Notes payable	2,132		2,128
Total liabilities	2,996		2,564
Equity:

FNF common stock, $0.0001 par value; authorized 600 shares as of December 31, 2025 and 2024; outstanding of 271 and 275 as of December 31, 2025 and 2024, respectively, and issued of 332 and 331 as of December 31, 2025 and 2024, respectively	—		—

Preferred stock, $0.0001 par value; authorized 50,000,000 shares; issued and outstanding, none	—		—
Additional paid-in capital	6,042		5,976
Retained earnings	5,484		5,982
Accumulated other comprehensive earnings	(1,678)		(2,052)
Less: Treasury stock, 61 and 56 shares as of December 31, 2025 and 2024, at cost	(2,424)		(2,152)
Total equity of Fidelity National Financial, Inc. common shareholders	7,424		7,754


Total liabilities and equity	$	10,420	$	10,318

Statement of Earnings and Retained Earnings

SCHEDULE II

FIDELITY NATIONAL FINANCIAL, INC.

(Parent Company)

STATEMENTS OF EARNINGS AND RETAINED EARNINGS


	Year Ended December 31,
	2025		2024		2023
	(In millions, except per share data)
Revenues:
Other fees and revenue	$	39	$	38	$	33
Interest and investment income and realized gains	64		76		74
Recognized gains and losses, net	7		2		(31)
Total revenues	110		116		76
Expenses:
Personnel expenses	100		94		70
Other operating expenses	38		28		47
Interest expense	77		76		77
Total expenses	215		198		194
Losses before income tax benefit and equity in earnings of subsidiaries	(105)		(82)		(118)
Income tax expense (benefit)	419		(20)		(29)
Losses before equity in earnings of subsidiaries	(524)		(62)		(89)
Equity in earnings of subsidiaries	1,126		1,332		606


Net earnings attributable to Fidelity National Financial, Inc. common shareholders	$	602	$	1,270	$	517

Retained earnings, beginning of year	$	5,982	$	5,244	$	5,225
Dividends declared	(549)		(532)		(498)
Distribution of F&G to FNF common shareholders	(551)		—		—



Net earnings attributable to Fidelity National Financial, Inc. common shareholders	602		1,270		517
Retained earnings, end of year	$	5,484	$	5,982	$	5,244

Statements of Cash Flows

SCHEDULE II

FIDELITY NATIONAL FINANCIAL, INC.

(Parent Company)

STATEMENTS OF CASH FLOWS


	Year Ended December 31,
	2025		2024		2023
	(In millions)
Cash Flows From Operating Activities:
Net earnings	$	602	$	1,270	$	517
Adjustments to reconcile net earnings to net cash provided by operating activities:



Equity in earnings of subsidiaries	(1,126)		(1,332)		(606)
Depreciation and amortization	1		1		1
Stock-based compensation	83		82		57

Net change in income taxes	415		5		(262)
Net increase in prepaid expenses and other assets	(3)		(113)		(72)
Net increase in accounts payable and other accrued liabilities	36		27		70
Net cash provided by (used in) operating activities	8		(60)		(295)
Cash Flows From Investing Activities:
Purchase of F&G preferred stock	—		(250)		—
Net (purchases of) proceeds from short-term investment activities	(10)		235		82
Purchase of F&G common stock	(151)		—		—
Additions to notes receivable	(1)		(1)		(12)
Collection of notes receivable	40		55		47


Investments in subsidiaries	(95)		—		—
Net cash provided by (used in) investing activities	(217)		39		117
Cash Flows From Financing Activities:





Dividends paid	(546)		(532)		(500)
Purchases of treasury stock	(251)		—		(6)
Exercise of stock options	4		21		15
Payment for shares withheld for taxes and in treasury	(18)		(22)		(17)

Additional investments in non-controlling interests	(6)		(12)		(12)


Net cash transfers from subsidiaries	888		703		689
Net cash provided by (used in) financing activities	71		158		169
Net change in cash and cash equivalents	(138)		137		(9)
Cash at beginning of year	534		397		406
Cash at end of year	$	396	$	534	$	397
See Notes to Financial Statements

Schedule of Notes Payable

Notes payable consists of the following:


	December 31, 2025		December 31, 2024
	(In millions)
4.50% Notes, net of discount	$	448	$	447

3.40% Notes, net of discount	646		646





2.45% Notes, net of discount	596		595
3.20% Notes, net of discount	445		444
Revolving Credit Facility	(3)		(4)
F&G Credit Agreement	—		—
5.50% F&G Notes	—		301

7.40% F&G Notes, net of discount	498		497
7.30% F&G Notes	364		—




7.95% F&G Notes, net of discount	336		336
6.50% F&G Notes, net of discount	546		545
6.25% F&G Notes, net of discount	493		492
Other	31		22
	$	4,400	$	4,321

B. Notes Payable

Notes payable consist of the following:


	December 31,
	2025		2024
	(In millions)
4.50% Notes, net of discount	$	448	$	447

3.40% Notes, net of discount	646		646
2.45% Notes, net of discount	596		595
3.20% Notes, net of discount	445		444
Revolving credit facility	(3)		(4)

	$	2,132	$	2,128

Schedule of Supplemental Cash Flow Information

The following supplemental cash flow information is provided with respect to certain cash payment and non-cash investing and financing activities.


	Year Ended December 31,
	2025		2024		2023

Cash paid for:	(In millions)
Interest	$	229	$	200	$	157
Income taxes	250		237		216
Deferred sales inducements	332		319		168
Non-cash investing and financing activities:

Investments transferred subject to reinsurance agreement	(500)		—		—

Investments received from pension risk transfer premiums	—		129		464
Change in proceeds of sales of investments available for sale receivable in period	20		(59)		32
Change in purchases of investments available for sale payable in period	9		82		20
Lease liabilities recognized in exchange for lease right-of-use assets	45		55		40
Remeasurement of lease liabilities	54		67		75
Liabilities assumed in connection with acquisitions
Fair value of assets acquired	6		789		304
Less: Total Purchase price	3		586		299
Liabilities and noncontrolling interests assumed	$	3	$	203	$	5

Total income taxes paid was allocated as follows:


	Year Ended December 31,
	2025
	(In millions)
Federal	$	198
State & Foreign	52
Total	$	250

Supplemental Cash Flow Information


	Year Ended December 31,
	2025		2024		2023
	(In millions)
Cash paid during the year:
Interest paid	$	73	$	73	$	73
Income tax payments	241		229		213

Regulation and Equity - Statutory Income and Net Capital (Details) - F&G - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Iowa
Statutory Accounting Practices [Line Items]
Statutory Net (loss) income:	$ (257)	$ 150	$ (462)
Statutory Capital and Surplus:	1,735	1,654
New York
Statutory Accounting Practices [Line Items]
Statutory Net (loss) income:	29	8	5
Statutory Capital and Surplus:	122	97
Vermont \| Raven Re (VT)
Statutory Accounting Practices [Line Items]
Statutory Net (loss) income:	38	54	60
Statutory Capital and Surplus:	182	168
Vermont \| Corbeau Re (VT)
Statutory Accounting Practices [Line Items]
Statutory Net (loss) income:	(201)	(458)	(644)
Statutory Capital and Surplus:	236	178
Cayman Islands
Statutory Accounting Practices [Line Items]
Statutory Net (loss) income:	(30)	(11)	133
Statutory Capital and Surplus:	1,134	734
Bermuda
Statutory Accounting Practices [Line Items]
Statutory Net (loss) income:	160	139	$ 151
Statutory Capital and Surplus:	$ 84	$ 123

Employee Benefit Plans - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Intrinsic value of options exercised	$ 3.0	$ 9.0	$ 8.0
Stock-based compensation cost	$ 88.0	82.0	60.0
Weighted average	1 year 8 months 8 days
Restricted Stock \| Board of Directors Chairman
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of restricted stock awards granted		$ 50.0
Award vesting period		3 years
Restricted Stock \| Board of Directors Chairman \| Vesting Period Immediate
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	25.00%
Fair value of restricted stock awards vested	$ 12.5
Restricted Stock \| Board of Directors Chairman \| Vesting Period One of Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	25.00%
Fair value of restricted stock awards vested	$ 12.5
Restricted Stock \| Board of Directors Chairman \| Vesting Period Two of Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	25.00%
Fair value of restricted stock awards vested	$ 12.5
Restricted Stock \| Board of Directors Chairman \| Vesting Period Three of Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	25.00%
Fair value of restricted stock awards vested	$ 12.5
The Omnibus Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense	91.0
The Omnibus Plan \| Restricted Stock \| FNF Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of restricted stock awards granted	50.0	$ 97.0	43.0
Fair value of restricted stock awards vested	$ 63.0	$ 76.0	$ 51.0

Investments - Fair Value and Gross Unrealized Losses of Available-for-Sale Securities (Details) $ in Millions	Dec. 31, 2025 USD ($) security	Dec. 31, 2024 USD ($) security
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Values, Less than 12 months	$ 9,600	$ 10,420
Gross Unrealized Losses Less than 12 months	(103)	(290)
Fair Value, 12 Months or longer	15,352	16,141
Gross Unrealized Losses, 12 months or longer	(2,966)	(3,485)
Total Fair Value	24,952	26,561
Total Gross Unrealized Losses	$ (3,069)	$ (3,775)
Total number of available-for-sale securities in an unrealized loss position less than twelve months \| security	1,962	2,005
Total number of available-for-sale securities in an unrealized loss position twelve months or longer \| security	2,194	2,305
Total number of available-for-sale securities in an unrealized loss position \| security	4,156	4,310
Asset-backed securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Values, Less than 12 months	$ 4,756	$ 1,164
Gross Unrealized Losses Less than 12 months	(30)	(30)
Fair Value, 12 Months or longer	2,160	2,637
Gross Unrealized Losses, 12 months or longer	(209)	(276)
Total Fair Value	6,916	3,801
Total Gross Unrealized Losses	(239)	(306)
Commercial mortgage-backed securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Values, Less than 12 months	542	727
Gross Unrealized Losses Less than 12 months	(11)	(11)
Fair Value, 12 Months or longer	1,051	1,513
Gross Unrealized Losses, 12 months or longer	(106)	(175)
Total Fair Value	1,593	2,240
Total Gross Unrealized Losses	(117)	(186)
Corporates
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Values, Less than 12 months	3,419	6,831
Gross Unrealized Losses Less than 12 months	(55)	(208)
Fair Value, 12 Months or longer	10,097	9,866
Gross Unrealized Losses, 12 months or longer	(2,312)	(2,624)
Total Fair Value	13,516	16,697
Total Gross Unrealized Losses	(2,367)	(2,832)
Hybrids
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Values, Less than 12 months	61	105
Gross Unrealized Losses Less than 12 months	(1)	(4)
Fair Value, 12 Months or longer	372	380
Gross Unrealized Losses, 12 months or longer	(21)	(25)
Total Fair Value	433	485
Total Gross Unrealized Losses	(22)	(29)
Municipals
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Values, Less than 12 months	201	261
Gross Unrealized Losses Less than 12 months	(3)	(12)
Fair Value, 12 Months or longer	1,050	1,006
Gross Unrealized Losses, 12 months or longer	(212)	(243)
Total Fair Value	1,251	1,267
Total Gross Unrealized Losses	(215)	(255)
Residential mortgage-backed securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Values, Less than 12 months	208	899
Gross Unrealized Losses Less than 12 months	(2)	(16)
Fair Value, 12 Months or longer	390	460
Gross Unrealized Losses, 12 months or longer	(67)	(89)
Total Fair Value	598	1,359
Total Gross Unrealized Losses	(69)	(105)
U.S. Government
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Values, Less than 12 months	353	313
Gross Unrealized Losses Less than 12 months	(1)	(4)
Fair Value, 12 Months or longer	84	122
Gross Unrealized Losses, 12 months or longer	(2)	(5)
Total Fair Value	437	435
Total Gross Unrealized Losses	(3)	(9)
Foreign Governments
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Values, Less than 12 months	60	120
Gross Unrealized Losses Less than 12 months	0	(5)
Fair Value, 12 Months or longer	148	157
Gross Unrealized Losses, 12 months or longer	(37)	(48)
Total Fair Value	208	277
Total Gross Unrealized Losses	$ (37)	$ (53)

Employee Benefit Plans - Stock Purchase Plan (Details) - Employee Stock - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation expense	$ 51	$ 34	$ 30
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
ESPP, annual contributions per employee, percent	3.00%
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
ESPP, annual contributions per employee, percent	15.00%

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Business and Summary of Significant Accounting Policies

Audit Information	12 Months Ended
Audit Information	Dec. 31, 2025
Audit Information [Abstract]
Auditor Firm ID	42
Auditor Name	Ernst & Young LLP
Auditor Location	Jacksonville, Florida

Employee Benefit Plans

12 Months Ended

Dec. 31, 2025

Retirement Benefits [Abstract]

Employee Benefit Plans

Stock Purchase Plan

During the three-year period ended December 31, 2025, our eligible employees could voluntarily participate in our employee stock purchase plan (“ESPP”) sponsored by us. Pursuant to the ESPP, employees may contribute an amount between 3% and 15% of their base salary and certain commissions. We contribute varying amounts as specified in the ESPP.

We contributed $51 million, $34 million, and $30 million to the ESPP in the years ended December 31, 2025, 2024, and 2023, respectively, in accordance with our matching contribution.

FNF 401(k) Profit Sharing Plan

During the three-year period ended December 31, 2025, we have offered our employees the opportunity to participate in our 401(k) profit sharing plan (the “401(k) Plan”), a qualified voluntary contributory savings plan that is available to substantially all of our employees. Eligible employees may contribute up to 40% of their pre-tax annual compensation, up to the amount allowed pursuant to the Internal Revenue Code. During the year ended December 31, 2025, 2024 and 2023, we made an employer match on the 401(k) Plan of $0.50 on each $1.00 contributed up to the first 6% of eligible earnings contributed to the 401(k) Plan by employees. The employer match was $50 million, $46 million, and $45 million for the years ended December 31, 2025, 2024 and 2023, respectively, and was credited based on the participant's individual investment elections in the FNF 401(k) Plan.

Omnibus Incentive Plan

In 2005, we established the FNT 2005 Omnibus Incentive Plan (as amended and restated, the “Omnibus Plan”) authorizing the issuance of up to 8 million shares of common stock, subject to the terms of the Omnibus Plan. On October 23, 2006; May 29, 2008; May 25, 2011; May 22, 2013; and June 15, 2016, the shareholders of FNF approved amendments to increase the number of shares for issuance under the Omnibus Plan by 16 million, 11 million, 6 million, 6 million, and 10 million shares, respectively. The primary purpose of the increases were to assure that we had adequate means to provide equity incentive compensation to our employees on a going-forward basis. The Omnibus Plan provides for the grant of stock options, stock appreciation rights, restricted stock, restricted stock units and performance shares, performance units, other cash and stock-based awards and dividend equivalents. As of December 31, 2025, there were 2,105,535 shares of restricted stock and no stock options outstanding under the Omnibus Plan. Awards granted are approved by the Compensation Committee of the Board of Directors.

F&G Omnibus Incentive Plan

On June 1, 2020, in connection with the acquisition of F&G, we assumed the shares that remained available for future awards under the FGL Holdings 2017 Omnibus Incentive Plan, as amended and restated (the “F&G Omnibus Plan”) and converted such shares into 2,096,429 shares of FNF common stock that may be issued pursuant to future awards granted under the F&G Omnibus Plan and 2,411,585 shares of FNF common stock that may be issued pursuant to outstanding stock options under the F&G Omnibus Plan. Each unvested stock option assumed under the F&G Omnibus Plan was converted into an FNF stock option and vests solely on the passage of time without any ongoing performance-vesting conditions. The options vest over a 3 year period, based on the option's initial grant date, and have a contractual life of 7 years. As of December 31, 2025, there were no shares of restricted stock and no stock options outstanding under the F&G Omnibus Plan.

FNF stock option transactions under the F&G Omnibus Plan for 2025, 2024, and 2023 are as follows:


	Options	Weighted Average Exercise Price		Exercisable
Balance January 1, 2023	1,172,607	$	35.15	1,172,607

Exercised	(502,414)	30.31
Canceled	(26,570)	38.07
Balance, December 31, 2023	643,623	$	38.8	643,623
Exercised	(543,623)	38.74
Canceled	—	—
Balance, December 31, 2024	100,000	$	39.10	100,000

Exercised	(100,000)	39.10

Balance, December 31, 2025	—	$	—	—

FNF restricted stock transactions under the Omnibus Plan in 2025, 2024, and 2023 are as follows:



	Shares	Weighted Average Grant Date Fair Value
Balance, December 31, 2022	1,841,544	$	41.59
Granted	966,093	44.44

Canceled	(23,975)	41.42
Vested	(908,267)	40.26
Balance, December 31, 2023	1,875,395	$	43.69
Granted	1,604,119	60.23
Canceled	(16,603)	45.92
Vested	(1,105,691)	47.21
Balance, December 31, 2024	2,357,220	$	53.28
Granted	862,320	57.50
Canceled	(12,617)	47.55
Vested	(1,101,388)	50.02
Balance, December 31, 2025	2,105,535	$	56.75

FNF restricted stock transactions under the F&G Omnibus Plan in 2025, 2024, and 2023 are as follows:


	Shares	Weighted Average Grant Date Fair Value
Balance, January 1, 2023	501,548	$	42.31
Granted	—	—
Canceled	(15,965)	45.63
Vested	(304,104)	42.87
Balance, December 31, 2023	181,479	$	41.08
Granted	—	—
Canceled	(13,082)	48.28
Vested	(168,397)	40.53
Balance, December 31, 2024	—	$	—
Granted	—	—
Canceled	—	—
Vested	—	—
Balance, December 31, 2025	—	$	—

We account for stock-based compensation plans in accordance with GAAP on share-based payments, which requires that compensation cost relating to share-based payments be recognized in the consolidated financial statements based on the fair value of each award. Using the fair value method of accounting, compensation cost is measured based on the fair value of the award at the grant date and recognized over the service period. Fair value of restricted stock awards and units is based on the grant date value of the underlying stock derived from quoted market prices. In 2024, we issued a $50 million restricted stock grant to our chairman, of which one quarter of the grant vested immediately, with the remaining three quarters vesting in equal installments over a period of three years on each anniversary of the grant date. The total fair value of restricted stock awards granted in the years ended December 31, 2025, 2024, and 2023 was $50 million, $97 million, and $43 million, respectively. The total fair value of restricted stock awards, which vested in the years ended December 31, 2025, 2024, and 2023 was $63 million, $76 million, and $51 million, respectively. Option awards are measured at fair value on the grant date using the Black Scholes Option Pricing Model. The intrinsic value of options exercised in the years ended December 31, 2025, 2024, and 2023 was $3 million, $9 million, and $8 million, respectively. Net earnings attributable to FNF Shareholders reflects stock-based compensation expense amounts of $88 million for the year ended December 31, 2025, $82 million for the year ended

December 31, 2024 and $60 million for the year ended December 31, 2023, which are included in personnel costs in the reported financial results of each period.

At December 31, 2025, the total unrecognized compensation cost related to non-vested stock option grants and restricted stock grants is $91 million, which is expected to be recognized in pre-tax income over a weighted average period of 1.69 years.

Pension Plan

In 2000, FNF merged with Chicago Title Corporation ("CTC"). In connection with the merger, we assumed CTC’s noncontributory defined contribution plan and noncontributory defined benefit pension plan (the “Pension Plan”). The Pension Plan covers certain CTC employees. The benefits are based on years of service and the employee’s average monthly compensation in the highest 60 consecutive calendar months during the 120 months ending at retirement or termination. Effective December 31, 2000, the Pension Plan was frozen and there will be no future credit given for years of service or changes in salary. The accumulated benefit obligation is the same as the projected benefit obligation due to the pension plan being frozen as of December 31, 2000. Pursuant to GAAP on employers’ accounting for defined benefit pension and other post-retirement plans, the measurement date is December 31.

On May 1, 2023, we elected to terminate the Pension Plan, subject to approval by the Pension Benefit Guarantee Corporation and the receipt of a favorable determination letter from the IRS. Upon termination, the account balance of each participant in the Pension Plan shall become fully vested. Each remaining participant or beneficiary in the Pension Plan shall be given one of the following options with respect to termination of the Pension Plan: (i) a lump-sum distribution of the participant's account balance; or (ii) an annuity benefit equal to the participant’s account balance.

During the year ended December 31, 2024, we distributed substantially all of the Pension Plan assets to the participants or beneficiaries of the Pension Plan. As of December 31, 2024, the project benefit obligation and fair value of plan assets were immaterial. The net pension liability and net periodic expense included in our financial position and results of operations relating to the Pension Plan is not considered material for any period presented.

Contractholder Funds - Account Values by Range of Guaranteed Minimum Credit Rating (Details) $ in Millions	Dec. 31, 2025 USD ($)	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)
Policyholder Account Balance [Line Items]
Contractholder funds	$ 62,726	$ 56,404
Indexed annuities
Policyholder Account Balance [Line Items]
Contractholder funds	4,275	4,004
No guaranteed minimum crediting rate	28,951	26,231
Total	33,226	30,235	$ 27,164
Indexed annuities \| At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Contractholder funds	1,419	1,406
Indexed annuities \| Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Contractholder funds	482	597
Indexed annuities \| Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Contractholder funds	931	622
Indexed annuities \| Greater Than 0150
Policyholder Account Balance [Line Items]
Contractholder funds	1,443	1,379
Indexed annuities \| Up to 1.50%
Policyholder Account Balance [Line Items]
Contractholder funds	2,233	2,506
Indexed annuities \| Up to 1.50% \| At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Contractholder funds	659	721
Indexed annuities \| Up to 1.50% \| Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Contractholder funds	464	596
Indexed annuities \| Up to 1.50% \| Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Contractholder funds	298	309
Indexed annuities \| Up to 1.50% \| Greater Than 0150
Policyholder Account Balance [Line Items]
Contractholder funds	812	880
Indexed annuities \| 1.51%-2.50%
Policyholder Account Balance [Line Items]
Contractholder funds	1,828	1,231
Indexed annuities \| 1.51%-2.50% \| At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Contractholder funds	548	432
Indexed annuities \| 1.51%-2.50% \| Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Contractholder funds	17	1
Indexed annuities \| 1.51%-2.50% \| Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Contractholder funds	633	313
Indexed annuities \| 1.51%-2.50% \| Greater Than 0150
Policyholder Account Balance [Line Items]
Contractholder funds	630	485
Indexed annuities \| Greater than 2.50%
Policyholder Account Balance [Line Items]
Contractholder funds	214	267
Indexed annuities \| Greater than 2.50% \| At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Contractholder funds	212	253
Indexed annuities \| Greater than 2.50% \| Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Contractholder funds	1	0
Indexed annuities \| Greater than 2.50% \| Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Contractholder funds	0	0
Indexed annuities \| Greater than 2.50% \| Greater Than 0150
Policyholder Account Balance [Line Items]
Contractholder funds	1	14
Fixed rate annuities
Policyholder Account Balance [Line Items]
Contractholder funds	19,265	17,442
Total	19,265	17,442	13,443
Fixed rate annuities \| At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Contractholder funds	825	865
Fixed rate annuities \| Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Contractholder funds	83	29
Fixed rate annuities \| Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Contractholder funds	813	798
Fixed rate annuities \| Greater Than 0150
Policyholder Account Balance [Line Items]
Contractholder funds	17,544	15,750
Fixed rate annuities \| Up to 1.50%
Policyholder Account Balance [Line Items]
Contractholder funds	16,509	15,257
Fixed rate annuities \| Up to 1.50% \| At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Contractholder funds	94	57
Fixed rate annuities \| Up to 1.50% \| Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Contractholder funds	75	20
Fixed rate annuities \| Up to 1.50% \| Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Contractholder funds	792	773
Fixed rate annuities \| Up to 1.50% \| Greater Than 0150
Policyholder Account Balance [Line Items]
Contractholder funds	15,548	14,407
Fixed rate annuities \| 1.51%-2.50%
Policyholder Account Balance [Line Items]
Contractholder funds	492	493
Fixed rate annuities \| 1.51%-2.50% \| At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Contractholder funds	4	4
Fixed rate annuities \| 1.51%-2.50% \| Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Contractholder funds	6	7
Fixed rate annuities \| 1.51%-2.50% \| Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Contractholder funds	16	20
Fixed rate annuities \| 1.51%-2.50% \| Greater Than 0150
Policyholder Account Balance [Line Items]
Contractholder funds	466	462
Fixed rate annuities \| Greater than 2.50%
Policyholder Account Balance [Line Items]
Contractholder funds	2,264	1,692
Fixed rate annuities \| Greater than 2.50% \| At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Contractholder funds	727	804
Fixed rate annuities \| Greater than 2.50% \| Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Contractholder funds	2	2
Fixed rate annuities \| Greater than 2.50% \| Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Contractholder funds	5	5
Fixed rate annuities \| Greater than 2.50% \| Greater Than 0150
Policyholder Account Balance [Line Items]
Contractholder funds	1,530	881
Universal Life
Policyholder Account Balance [Line Items]
Contractholder funds	3,292	2,817
Total	3,292	2,817	$ 2,391
Universal Life \| At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Contractholder funds	3,251	2,785
Universal Life \| Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Contractholder funds	9	7
Universal Life \| Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Contractholder funds	1	1
Universal Life \| Greater Than 0150
Policyholder Account Balance [Line Items]
Contractholder funds	31	24
Universal Life \| Up to 1.50%
Policyholder Account Balance [Line Items]
Contractholder funds	2,938	2,452
Universal Life \| Up to 1.50% \| At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Contractholder funds	2,898	2,421
Universal Life \| Up to 1.50% \| Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Contractholder funds	9	7
Universal Life \| Up to 1.50% \| Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Contractholder funds	0	0
Universal Life \| Up to 1.50% \| Greater Than 0150
Policyholder Account Balance [Line Items]
Contractholder funds	31	24
Universal Life \| 1.51%-2.50%
Policyholder Account Balance [Line Items]
Contractholder funds	0	0
Universal Life \| 1.51%-2.50% \| At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Contractholder funds	0	0
Universal Life \| 1.51%-2.50% \| Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Contractholder funds	0	0
Universal Life \| 1.51%-2.50% \| Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Contractholder funds	0	0
Universal Life \| 1.51%-2.50% \| Greater Than 0150
Policyholder Account Balance [Line Items]
Contractholder funds	0	0
Universal Life \| Greater than 2.50%
Policyholder Account Balance [Line Items]
Contractholder funds	354	365
Universal Life \| Greater than 2.50% \| At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Contractholder funds	353	364
Universal Life \| Greater than 2.50% \| Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Contractholder funds	0	0
Universal Life \| Greater than 2.50% \| Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Contractholder funds	1	1
Universal Life \| Greater than 2.50% \| Greater Than 0150
Policyholder Account Balance [Line Items]
Contractholder funds	$ 0	$ 0
Minimum \| Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Policyholder account balance, above guaranteed minimum crediting rate	0.0001	0.0001
Minimum \| Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Policyholder account balance, above guaranteed minimum crediting rate	0.0051	0.0051
Minimum \| Greater Than 0150
Policyholder Account Balance [Line Items]
Policyholder account balance, above guaranteed minimum crediting rate	0.0150	0.0150
Maximum \| Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Policyholder account balance, above guaranteed minimum crediting rate	0.0050	0.0050
Maximum \| Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Policyholder account balance, above guaranteed minimum crediting rate	0.0150	0.0150

F&G Reinsurance - Effect of Reinsurance on Premiums Earned, Benefits Incurred and Reserve Changes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Net Premiums Earned
Direct	$ 2,940	$ 3,001	$ 2,567
Ceded	(145)	(141)	(154)
Net	2,795	2,860	2,413
Net Benefits Incurred
Net	262	232	207
Traditional Life Insurance Premiums
Net Premiums Earned
Direct	2,223	2,346	2,112
Ceded	(85)	(94)	(105)
Net	2,138	2,252	2,007
Net Product Fees
Direct	717	655	455
Ceded	(60)	(47)	(49)
Net	657	608	406
Net Benefits Incurred
Direct	4,197	3,987	3,728
Ceded	(234)	(196)	(175)
Net	$ 3,963	$ 3,791	$ 3,553

Business and Summary of Significant Accounting Policies

12 Months Ended

Dec. 31, 2025

Accounting Policies [Abstract]

The following describes the business and significant accounting policies of Fidelity National Financial, Inc. and its subsidiaries (collectively, "we," "us," "our," the "Company" or "FNF"), which have been followed in preparing the accompanying Consolidated Financial Statements.

Description of the Business

We are a leading provider of (i) title insurance, escrow and other title-related services, including trust activities, trustee sales guarantees, recordings and reconveyances and home warranty products; (ii) technology and transaction services to the real estate and mortgage industries; and (iii) annuity and life insurance products. FNF is one of the nation’s largest title insurance companies operating through its title insurance underwriters - Fidelity National Title Insurance Company ("FNTIC"), Chicago Title Insurance Company ("Chicago Title"), Commonwealth Land Title Insurance Company ("Commonwealth Title"), Alamo Title Insurance and National Title Insurance of New York Inc. - which collectively issue more title insurance policies than any other title company in the United States. Through our subsidiary, ServiceLink Holdings, LLC ("ServiceLink"), we provide mortgage transaction services, including title-related services and facilitation of production and management of mortgage loans. We are also a leading provider of insurance solutions serving retail annuity and life customers and institutional clients through our majority owned subsidiary, F&G Annuities & Life ("F&G").

For information about our reporting segments refer to Note J Segment Information.

Recent Developments

F&G Life Re Ltd. (“F&G Life Re”)

On February 19, 2026, F&G announced the expected sale of its Bermuda based subsidiary, F&G Life Re, to Ancient Financial Holdings, LP (“Ancient”). The transaction is expected to be completed on March 1, 2026, subject to satisfaction or waiver of customary closing conditions.

2025 F&G Distribution

On December 31, 2025, we completed our previously announced pro rata distribution of approximately 16 million shares of common stock of F&G owned by FNF, representing approximately 12% of the outstanding shares of F&G's common stock, to all of FNF's shareholders of record as of 4:30 p.m. ET on December 17, 2025 (the "2025 F&G Distribution"). FNF's shareholders received six shares of F&G's common stock for every 100 shares of FNF's common stock.

No fractional shares of F&G's common stock were distributed. Instead, FNF's shareholders received cash in lieu of any fraction of a share of F&G's common stock that they otherwise would have received. The 2025 F&G Distribution is structured as a taxable dividend to FNF shareholders for U.S. federal income tax purposes. Immediately following the 2025 F&G Distribution, FNF owned approximately 70% of the common stock of F&G.

F&G Common Stock Issuance

On March 24, 2025, F&G completed a public offering of 8,000,000 shares of F&G common stock, par value $0.001 per share. In connection with the offering, F&G entered into an underwriting agreement, pursuant to which they granted the underwriters of the offering a 30-day option to purchase up to an additional 1,200,000 shares of common stock. Pursuant to the underwriting agreement, the underwriters agreed to resell to FNF 4,500,000 shares of F&G common stock at the same price per share paid by the underwriters, which was $33.60 per share. The underwriters option expired unexercised. F&G is used the net proceeds from the offering for general corporate purposes, including the support of organic growth opportunities.

Redemption of 5.50% F&G Senior Notes

On February 1, 2025, F&G redeemed the outstanding $300 million aggregate principal amount of its 5.50% Senior Notes due May 1, 2025 (the "5.50% F&G Senior Notes"). The notes were redeemed for a redemption price equal to 100% of the principal amount of the notes plus accrued and unpaid interest to, but excluding, the redemption date.

7.30% F&G Junior Notes

On January 13, 2025, F&G completed its public offering of its 7.30% Junior Subordinated Notes due 2065 with an aggregate principal amount of $375 million (the "7.30% F&G Notes"). F&G used a portion of the net proceeds of this offering to redeem the outstanding $300 million aggregate principal amount of its 5.50% F&G Senior Notes. F&G used the remaining net proceeds for general corporate purposes. The 7.30% F&G Notes were registered under the Securities Act of 1933 (as

amended) (the “Securities Act”).

Principles of Consolidation and Basis of Presentation

The Consolidated Financial Statements are prepared in accordance with generally accepted accounting principles in the United States ("GAAP") and include our accounts as well as our wholly-owned subsidiaries, majority-owned subsidiaries, and variable interest entities (VIEs) for which we are the primary beneficiary. All intercompany profits, transactions, and balances have been eliminated. Non-controlling interests recorded on the Consolidated Statements of Earnings represent the portion of a majority-owned subsidiary's net earnings or loss that is owned by non-controlling shareholders of the subsidiary. Non-controlling interests recorded on the Consolidated Balance Sheets represent the portion of equity in a consolidated subsidiary owned by non-controlling shareholders.

We are involved in certain entities that are considered variable interest entities (“VIEs”) as defined under GAAP. Our involvement with VIEs is primarily to invest in assets that allow us to gain exposure to a broadly diversified portfolio of asset classes. A VIE is an entity that does not have sufficient equity to finance its own activities without additional financial support, where investors lack certain characteristics of a controlling financial interest, or where the entity is structured with non-substantive voting rights. We consolidate VIEs for which we are the primary beneficiary and account for all other VIEs as unconsolidated VIEs. We assess our relationships with VIEs to evaluate if we are the primary beneficiary, which is the party that has both (i) the power to direct the activities that most significantly impact the VIE’s economic performance and (ii) the obligation to absorb losses or the right to receive benefits that could potentially be significant. See Note D Investments for additional information on our investments in VIEs.

Investments

Fixed Maturity Securities

Fixed maturity securities are purchased to support our investment strategies, which are developed based on factors including rate of return, maturity, credit risk, duration, tax considerations and regulatory requirements. Our investments in fixed maturity securities have been designated as available-for-sale ("AFS") and are carried at fair value, net of allowance for expected credit losses, with unrealized gains and losses included within AOCI, net of deferred income taxes. Fair values for fixed maturity securities are principally a function of current market conditions and are primarily valued based on quoted prices in markets that are not active or model inputs that are observable or unobservable. We recognize investment income on fixed maturities based on the effective interest method, which results in the recognition of a constant rate of return on the investment equal to the prevailing rate at the time of purchase or at the time of subsequent adjustments of book value. Realized gains and losses on sales of our fixed maturity securities are determined on the basis of the cost of the specific investments sold and are credited or charged to income on a trade date basis except for private placements, which are recorded on a settlement date basis. Realized gains and losses on sales of fixed maturity securities are reported within Recognized gains and (losses), net in the accompanying Consolidated Statements of Earnings. Fixed maturity securities AFS are subject to an allowance for credit loss and changes in the allowance are reported in net earnings as a component of Recognized gains and (losses), net. For details on our policy around allowance for expected credit losses on AFS securities, refer to Note D Investments.

Equity Securities

Preferred and common equity securities held are carried at fair value as of the balance sheet dates. Changes in fair value and realized gains and losses on sales of our preferred and common equity securities are reported within Recognized gains and losses, net in the Consolidated Statements of Earnings. Realized gains and losses on sales of our preferred and common equity securities are determined on the specific identification basis and are credited or charged to earnings on a trade date basis unless the security is a private placement in which case settlement date basis is used. Interest and dividend income from these investments is reported in Interest and investment income in the Consolidated Statements of Earnings.

Derivative Financial Instruments

Freestanding Derivatives

In our F&G segment, we economically hedge certain portions of our exposure to product related equity market risk by entering into derivative transactions (primarily equity options and, to a lesser degree, futures contracts). We also utilize certain interest rate swaps, to reduce market risks from interest rate changes on our earnings associated with our floating rate investments, and foreign currency swaps, to reduce market risks from fluctuations in foreign exchange rates that impact earnings associated with our foreign currency denominated investments. All such derivative instruments are recognized as either assets or liabilities in the Consolidated Balance Sheets at fair value. The changes in fair value of derivatives not designated to hedge relationships are reported within Recognized gains and losses, net in the Consolidated Statements of Earnings. The change in the fair value of these derivative instruments is included in operating activities in the Consolidated Statements of Cash Flows.

Hedge Accounting

We designate certain derivatives to fair value or cash flow hedge relationships that hedge exposures to interest rates, foreign currency, or both, associated with changes in the fair value of a recognized asset or liability (“fair value hedge”) or a forecasted transaction or variability of cash flows to be received or paid related to a recognized asset or liability (“cash flow hedge”).

When a derivative is designated as a fair value hedge and is determined to be highly effective, changes in the fair value of the derivative included in the assessment of effectiveness are reported in the same line on the Consolidated Statements of Earnings that is used to report the earnings effect of the hedged item.

When a derivative is designated as a cash flow hedge and is determined to be highly effective, changes in the fair value of the derivative included in the assessment of effectiveness are recorded in AOCI until earnings are affected by the variability of cash flows being hedged. At the time the variability of cash flows being hedged impacts net earnings, the related portion of deferred gains or losses on the derivative instrument is reclassified and reported in net earnings in the same line item on the Consolidated Statements of Earnings that is used to report the earnings effect of the hedged item.

Any portion of the change in fair value of a derivative designated to a fair value or cash flow hedge relationship that is excluded from the assessment of effectiveness will be recorded in AOCI and amortized into earnings over the life of the remaining term of the hedge relationship.

To qualify for hedge accounting, at hedge inception we formally document our risk management objective and strategy for entering into hedging relationships, as well as the designation of the hedge. In our hedge documentation, we explain how the hedging instrument is expected to hedge the designated risks related to the hedged item and the method that will be used to test for hedge effectiveness on both a prospective and retrospective basis. A derivative designated as a hedging instrument must be assessed as being highly effective in offsetting the designated risk of the hedged item. Effectiveness of the hedge is formally assessed at inception and at least quarterly throughout the life of the hedging relationship.

We prospectively discontinue hedge accounting when (1) the criteria to qualify for hedge accounting is no longer met; (2) the derivative expires, is sold, terminated, or is exercised; or (3) we de-designate the derivative from being the hedging instrument for a fair value or cash flow hedge.

If a fair value or cash flow hedge is discontinued, the derivative will continue to be carried at fair value on the Consolidated Balance Sheets, with changes in fair value recognized prospectively in Recognized gains and losses in the Consolidated Statements of Earnings.

For discontinued fair value hedges, the hedged item will no longer be adjusted for changes in the hedged risk and any existing basis adjustment will be amortized into the Consolidated Statements of Earnings within the same line item that is used to report other earnings effects of the hedged item. Any amounts remaining in AOCI associated with a component of the change in derivative fair value excluded from the assessment of effectiveness will be amortized into earnings in a manner consistent with how any basis adjustment associated with the hedged item would be amortized.

The component of AOCI related to discontinued cash flow hedges where it is probable the hedged forecasted transaction will not occur, will be immediately reclassified from AOCI into earnings. In all other cases any amounts remaining in AOCI will be amortized into earnings consistent with the earnings impacts expected from the original hedged cash flows.

Embedded Derivatives

We purchase financial instruments and enter into agreements that may contain embedded derivatives. If it is determined that the embedded derivative possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract, and a separate instrument with the same terms would qualify as a derivative instrument, the embedded derivative is bifurcated from the host contract for measurement purposes. For further information, refer to Note E Derivative Financial Instruments.

Mortgage Loans

Our investment in mortgage loans consists of commercial and residential mortgage loans on real estate, which are reported at amortized cost, less allowance for expected credit losses. For details on our policy around allowance for expected credit losses on mortgage loans, refer to Note D Investments.

Commercial mortgage loans ("CMLs") are continuously monitored by reviewing appraisals, operating statements, rent revenues, annual inspection reports, loan specific credit quality, property characteristics, market trends and other factors.

CMLs are rated for the purpose of quantifying the level of risk. Loans are placed on a watch list when the debt service coverage ("DSC") ratio falls below certain thresholds and the loan-to-value ("LTV") ratios exceeds certain thresholds. Loans on

the watchlist are closely monitored for collateral deficiency or other credit events that may lead to a potential loss of principal or interest. We define delinquent mortgage loans as 30 days past due, consistent with industry practice.

Residential mortgage loans ("RMLs") have a primary credit quality indicator of either a performing or nonperforming loan. We define nonperforming RMLs as those that are 90 or more days past due and/or in nonaccrual status, which is assessed monthly. Generally, nonperforming RMLs have a higher risk of experiencing a credit loss. We consider residential mortgage loans that are 90 or more days past due and have an LTV greater than 90% to be foreclosure probable.

Interest on loans is recognized on an accrual basis at the applicable interest rate on the principal amount outstanding. Loan origination fees and direct costs, as well as premiums and discounts, are amortized as level yield adjustments over the respective loan terms. Unamortized net fees or costs are recognized upon early repayment of the loans. Interest income, amortization of premiums and discounts, prepayment fees, and loan commitment fees are reported in Interest and investment income in the accompanying Consolidated Statements of Earnings.

Short-term investments

Short-term investments consist of financial instruments with an original maturity of one year or less when purchased and include short-term fixed maturity securities and money market instruments, which are carried at fair value, and short-term loans, which are carried at amortized cost, which approximates fair value.

Investments in Unconsolidated Affiliates

In our F&G segment, we account for our investments in unconsolidated affiliates using the equity method or by electing the fair value option. Initial investments are recorded at cost. For investments subsequently measured using the equity method (primarily limited partnerships, including those held by consolidated VIEs), adjustments to the carrying amount reflect our pro rata ownership percentage of the operating results as indicated by net asset value ("NAV") in the unconsolidated affiliates’ financial statements, which we may adjust if we determine NAV is not calculated consistent with investment company fair value principles. Our pro rata share of NAV adjustments are reported in Interest and investment income and realized gains and losses on sales are reported in Recognized gains and losses, net in the Consolidated Statements of Earnings. Distributions received from investments measured using the equity method are recorded as a decrease in the investment balance. Recognition of income and adjustments to the carrying amount can be delayed due to the availability of the related financial statements, which are obtained from the general partner or managing member generally on a one to three-month delay. Management inquires quarterly with the general partner or managing member to determine whether any credit or other market events have occurred since prior quarter financial statements to ensure any material events are properly included in current quarter NAV adjustments and investment income.

For investments subsequently measured using the fair value option, adjustments to the carrying amount reflecting the change in fair value of the investment and realized gains and losses on sales are reported in Recognized gains and losses, net in the Consolidated Statements of Earnings. Distributions received from investments measured using the fair value option are reported within Interest and investment income in the Consolidated Statements of Earnings.

For descriptions of the fair value methodologies used for our investments, refer to Note C Fair Value of Financial Instruments.

In our title segment, we account for our investments in unconsolidated affiliates using the equity method of accounting and earnings on our investments in unconsolidated affiliates are recorded within Equity in earnings of unconsolidated affiliates within the Consolidated Statements of Earnings. We classify distributions received from unconsolidated affiliates in our Consolidated Statements of Cash Flows using the cumulative earnings approach. Under the cumulative earnings approach, distributions are considered returns on investment and classified as cash inflows from operating activities unless the Company’s cumulative distributions from an investee received exceed the cumulative equity in earnings of such investee. When cumulative distributions from an investee exceed cumulative equity in earnings of the investee, such excess is considered a return of investment and is classified as a cash inflow from investing activities.

Interest and investment income

Dividends and interest income are recorded in Interest and investment income and recognized when earned. Income or losses upon call or prepayment of fixed maturity securities are recognized in Interest and investment income. Amortization of premiums and accretion of discounts on investments in fixed maturity securities are reflected in Interest and investment income over the contractual terms of the investments, and for callable investments at a premium, based on the earliest call date of the investments, in a manner that produces a constant effective yield.

For mortgage-backed and asset-backed securities, included in the fixed maturity securities portfolios, one of two models may be used to recognize interest income. For higher rated securities, interest income will be estimated based on an effective yield that considers cash flows received to date plus current expectations of future cash flows. For all other securities, interest

income will be estimated based upon an effective yield that considers current expectations of future cash flows. For both interest income models, the estimated future cash flows include assumptions regarding the performance of the underlying collateral pool.

Interest and investment income is presented net of investment expenses and the effects of certain reinsurance contracts.

Cash and Cash Equivalents

Highly liquid instruments purchased as part of cash management with original maturities of three months or less are considered cash equivalents. The carrying amounts reported in the Consolidated Balance Sheets for these instruments approximate fair value.

Trade and Notes Receivables

The carrying values reported in the Consolidated Balance Sheets for trade and notes receivables approximate their fair value.

Premium revenues from agency title operations are recognized when the underlying title order and transaction closing, if applicable, are complete and reported to us. Premium revenues from agency operations and related commissions include an accrual based on estimated historical transaction volume data for policies that have closed in a particular period in which premiums have not yet been reported to us. Historically, the time lag between the closing of these transactions by our agents and the reporting of these policies, or premiums, to us has been up to 15 months, with 48% - 75% reported within three months following closing, an additional 24% - 48% reported within the next three months, and the remainder within seven to fifteen months. In addition to accruing these earned but unreported agency premiums, we also accrue agent commission expense, which was 77.5% of agent premiums earned in 2025, 77.4% of agent premiums earned in 2024, and 76.9% of agent premiums earned in 2023. The amount due from our agents relating to this accrual, i.e., the agent premium less their contractual retained commission, was approximately $42 million and $40 million as of December 31, 2025 and 2024, respectively. Due to the offsetting effects of reversing prior period accruals, the impact of this accrual to our recorded Agency title insurance premiums, Agent commissions, and net earnings in any given period is not considered material.

Fair Value of Financial Instruments

The fair values of financial instruments presented in the Consolidated Financial Statements are estimates of the fair values at the balance sheet date using available market information and appropriate valuation methodologies. These estimates are subjective in nature and involve uncertainties and significant judgment in the interpretation of current market data. See a description of the fair value methodology used in Note C Fair Value of Financial Instruments.

Fair Value of Assets Acquired and Liabilities Assumed in Business Combinations

The Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 805, Business Combinations, requires an acquirer to recognize, separately from goodwill, the identifiable assets acquired, liabilities assumed, and any non-controlling interest in the acquiree, and to measure these items generally at their acquisition date fair values. If the initial accounting for a business combination is incomplete by the end of the reporting period in which the combination occurs, we are required to report provisional amounts in the financial statements for the items for which the accounting is incomplete. Adjustments to provisional amounts initially recorded that are identified during the measurement period are recognized in the reporting period in which the adjustment amounts are determined. This includes any effect on earnings of changes in depreciation, amortization, or other income effects as a result of the change to the provisional amounts, calculated as if the accounting had been completed at the acquisition date. During the measurement period, we are also required to recognize additional assets or liabilities if new information is obtained about facts and circumstances that existed as of the acquisition date that, if known, would have resulted in the recognition of those assets and liabilities as of that date. The measurement period ends the sooner of one year from the acquisition date, or when we receive the information we were seeking about facts and circumstances that existed as of the acquisition date or learn that more information is not obtainable.

Goodwill

Goodwill represents the excess of cost over fair value of identifiable net assets acquired and assumed in a business combination. Goodwill and other intangible assets with indefinite useful lives are reviewed for impairment at the reporting unit level on an annual basis or more frequently if circumstances indicate potential impairment, through a comparison of fair value to the carrying amount. In evaluating the recoverability of goodwill, we perform a qualitative analysis at the reporting unit level to determine whether there are any events or circumstances that would indicate it is more likely than not that the fair value of our recorded goodwill exceeds its carrying value, prior to performing a full fair-value assessment.

We complete annual goodwill impairment analyses in the fourth quarter of each period presented using a September 30 measurement date. For the years ended December 31, 2025, 2024, and 2023, we determined there were no events or circumstances which indicated that the carrying value of a reporting unit exceeded the fair value.

Insurance and Reinsurance Related Intangible Assets

We have insurance and reinsurance related intangible assets, which include the value of insurance and reinsurance contracts acquired (hereafter referred to as “VOBA”), DAC, DSI, and cost of reinsurance (“COR”). VOBA, DAC, and DSI are reported in Other intangible assets, net, on the Consolidated Balance Sheets. COR may be reported in Prepaid expenses and other assets or in Accounts payable and accrued liabilities on the Consolidated Balance Sheets as described below under “Reinsurance - Cost of Reinsurance.”

VOBA is an intangible asset that reflects the amount recorded as insurance contract liabilities less the estimated fair value of in-force contracts (“VIF”) in a life insurance company acquisition. It represents the portion of the purchase price that is allocated to the value of the rights to receive future cash flows from the business inforce at the acquisition date. VOBA is a function of the VIF, current GAAP reserves, GAAP assets, and deferred tax liability. The VIF is determined by the present value of statutory distributable earnings less opening required capital. DAC consists principally of commissions and other acquisition costs that are related directly to the successful sale of new or renewal insurance contracts that are deferred as they are incurred. When insurance contracts are reinsured and reinsurance accounting is applied, acquisition cost reimbursements from reinsurers are recorded as a reduction to DAC. Indirect or unsuccessful acquisition costs, maintenance, product development, and overhead expenses are charged to expense as incurred and are offset by maintenance expense reimbursements within a reinsurance arrangement, when reinsurance accounting is applied to the respective arrangement DSI represents up front bonus credits and persistency or vesting bonuses credited to contractholder fund balances. COR represents net cash flows on reinsurance coverage to ensure no gain or loss is recognized at inception.

VOBA, DAC, DSI, and COR are amortized on a constant level basis for the grouped contracts over the expected term of the related contracts to approximate straight-line amortization. Contracts are grouped by product type, feature and issue year into cohorts consistent with the grouping used in estimating the associated liability, where applicable. The constant level amortization bases of VOBA, DAC, DSI, and COR varies by product type. For universal life and indexed universal life (“IUL”) insurance products, the constant level basis used is face amount inforce. For deferred annuities (indexed annuities and fixed rate annuities), the constant level basis used is initial premium deposit for DAC and DSI and vested account value as of the acquisition date for VOBA and ceded initial premium for COR. For immediate annuity contracts, the VOBA balance is amortized in alignment with the Company’s accounting policy of amortizing the deferred profit liability (“DPL”). All amortization bases are adjusted by full lapses, which includes deaths, full surrenders, annuitizations and maturities, where applicable.

The constant level basis used for amortization are projected using mortality and lapse assumptions that are based on Company’s experience, industry data, and other factors and are consistent with those used for the FPB, where applicable. If those projected assumptions change in future periods, they will be reflected in the cohort level amortization basis at that time. Unexpected contract terminations, due to higher mortality and/or lapse experience than expected, are recognized in the current period as a reduction of the capitalized balances. All balances are reduced for actual experience in excess of expected experience with changes in future estimates recognized prospectively over the remaining expected grouped contract term. The impact of changes in projected assumptions and the impact of actual experience that is different from expectations impact the amortization of these intangible assets, which is reported within Depreciation and amortization for VOBA, DAC DSI and for COR, if the net COR balance is in a deferred gain position is reported within Life insurance premiums and other fees, and if the net COR balance is in a deferred loss position is reported within Other operating expenses in the Consolidated Statements of Earnings.

Some of our IUL policies require payment of fees or other policyholder assessments in advance for services that will be rendered over the estimated lives of the policies or contracts. These payments are established as URL upon receipt and included in Accounts payable and other accrued liabilities in the Consolidated Balance Sheets. URL is amortized like DAC over the estimated lives of these policies.

Other Intangible Assets

We have other intangible assets, not including goodwill, VOBA, DAC or DSI, which consist primarily of customer relationships and contracts, the value of distribution network acquired ("VODA"), trademarks and tradenames, state licenses, and computer software, which are generally recorded in connection with business combinations at their fair value. Intangible assets with estimable lives are amortized over their respective estimated useful lives to their estimated residual values and reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. In general, customer relationships are amortized over their estimated useful lives using an accelerated method, which takes into consideration expected customer attrition rates. VODA is an intangible asset that represents the value of an acquired distribution network and is amortized using the sum of years digits method. Contractual relationships are generally amortized over their contractual life. Trademarks and tradenames are generally amortized over ten years. Capitalized computer software includes the fair value of software acquired in business combinations, purchased software and capitalized software

development costs. Purchased software is recorded at cost and amortized using the straight-line method over its estimated useful life. Software acquired in business combinations is recorded at its fair value and amortized using straight-line or accelerated methods over its estimated useful life. For internal-use computer software products, internal and external costs incurred during the preliminary project stage are expensed as they are incurred. Internal and external costs incurred during the application development stage are capitalized and amortized on a product-by-product basis commencing on the date the software is ready for its intended use. We do not capitalize any costs once the software is ready for its intended use.

We review VOBA, DSI and other intangible assets for impairment annually or when events or circumstances occur that indicate a potential change in the underlying basis. For further information, refer to Note L Intangibles for details of impairment expense.

Title Plants

Title plants are recorded at the cost incurred to construct or obtain and organize historical title information to the point it can be used to perform title searches. Costs incurred to maintain, update and operate title plants are expensed as incurred. Title plants are not amortized as they are considered to have an indefinite life, if maintained. Sales of title plants are reported at the amount received net of the adjusted costs of the title plant sold. Sales of title plant copies are reported at the amount received. No cost is allocated to the sale of copies of title plants unless the carrying value of the title plant is diminished or impaired. Title plants are reviewed for impairment whenever events or circumstances indicate that the carrying amounts may not be recoverable. We reviewed title plants for impairment for the years ended December 31, 2025, 2024, and 2023 and did not record any impairment expense in the years ended December 31, 2025 and 2023. We recorded $2 million of impairment expense related to title plants in the year ended December 31, 2024.

Property and Equipment

Property and equipment are recorded at cost, less accumulated depreciation. Depreciation is computed primarily using the straight-line method based on the estimated useful lives of the related assets: twenty to thirty years for buildings and three to twenty-five years for furniture, fixtures and equipment. Leasehold improvements are amortized on a straight-line basis over the lesser of the term of the applicable lease or the estimated useful lives of such assets. Property and equipment are reviewed for impairment whenever events or circumstances indicate that the carrying amounts may not be recoverable. We did not record any impairment expense related to property and equipment in the years ended December 31, 2025, 2024, and 2023.

Contractholder Funds

Contractholder funds include deferred annuities (indexed annuities and fixed rate annuities), IULs, funding agreements and non-life contingent ("NLC") immediate annuities (which includes NLC pension risk transfer ("PRT") annuities). The liabilities for contractholder funds for fixed rate annuities, funding agreements and NLC immediate annuities consist of contract account balances that accrue to the benefit of the contractholders. The liabilities for indexed annuities and IUL policies consist of the value of the host contract plus the fair value of the indexed crediting feature of the policy, which is accounted for as an embedded derivative. The embedded derivative liability is carried at fair value in Contractholder funds in the Consolidated Balance Sheets with changes in fair value reported in Benefits and other changes in policy reserves in the Consolidated Statements of Earnings. See a description of the fair value methodology used in Note C Fair Value of Financial Instruments.

Future Policy Benefits

The FPB are determined as the present value of future policy benefits and related claims expenses to be paid to or on behalf of the policyholder less the present value of future net premiums to be collected from policyholders. The FPB for traditional life policies and life-contingent immediate annuity policies (which includes life-contingent PRT annuities) are estimated using current assumptions that include discount rate, mortality and surrender/lapse terminations for traditional life insurance policies only, and expenses. The expense assumption is locked-in at contract issuance and not subsequently reviewed or updated. The initial assumptions are based on generally accepted actuarial methods and a combination of internal and industry experience. Policies are terminated through surrenders, lapses and maturities, where surrenders represent the voluntary terminations of policies by policyholders, lapses represent cancellations by us due to nonpayment of premiums, and maturities are determined by policy contract terms.

For traditional life policies and life-contingent immediate annuity policies, contracts are grouped into cohorts by product type, legal entity, and issue year, or acquisition year for cohorts established as of the F&G acquisition date, June 1, 2020. Life-contingent PRT annuities are grouped into cohorts by deal and legal entity. At contract inception, a net premium ratio ("NPR") is determined, which is calculated based on discounted future cash flows projected using best estimate assumptions and is capped at 100%, as net premiums cannot exceed gross premiums. Cohorts with NPRs less than 100% are not used to offset cohorts with NPRs greater than 100%.

The NPR is adjusted for changes in cash flow assumptions and for differences between actual and expected experience. We assess the appropriateness of all future cash flow assumptions, excluding the expense assumption, on a quarterly basis and perform an in-depth review of future cash flow assumptions in the third quarter of each year. Updates are made when evidence suggests a revision is necessary. Updates for actual experience, which includes actual cash flows and insurance in-force, are performed on a quarterly basis. These updated cash flows are used to calculate a revised NPR, which is used to derive an updated liability as of the beginning of the current reporting period, discounted at the original contract issuance date. The updated liability is compared with the carrying amount of the liability as of that same date before the revised NPR. The difference between these amounts is the remeasurement gain or loss, presented parenthetically within Benefits and other changes in policy reserves in the Consolidated Statements of Earnings. In subsequent periods, the revised NPR is used to measure the FPB, subject to future revisions. If the NPR is greater than 100%, and therefore capped at 100%, the liability is increased and expensed immediately to reflect the amount necessary for net premiums to equal gross premiums. As the liability assumptions are reviewed and updated, if deemed necessary, at least annually, if conditions improve whereby the contracts are no longer expected to have net premiums in excess of gross premiums, the improvements would be captured in the remeasurement process and reflected in the Consolidated Statements of Earnings in the period of improvement.

For traditional life policies and life-contingent immediate annuity policies (which includes life-contingent PRT annuities), the discount rate assumption is an equivalent single rate that is derived based on A-credit-rated fixed-income instruments with similar duration to the liability. We selected fixed-income instruments that have been A-rated by Bloomberg. In order to reflect the duration characteristics of the liability, we will use an implied forward yield curve and linear interpolation will be used for durations that have limited or no market observable points on the curve. The discount rate assumption is updated quarterly and used to remeasure the liability at the reporting date, with the resulting change reflected in the accompanying Consolidated Statements of Comprehensive Earnings.

Deferred Profit Liability

For life-contingent immediate annuity policies, gross premiums received in excess of net premiums are deferred at initial recognition as a DPL. Premiums are measured using assumptions consistent with those used in the measurement of the related liability for FPBs, including discount rate, mortality, and expenses.

The DPL is amortized and recognized as premium revenue with the amount of expected future benefit payments, discounted using the same discount rate determined and locked-in at contract issuance that is used in the measurement of the related FPB. Interest is accreted on the balance of the DPL using this same discount rate. We periodically review and update our estimates using the actual historical experience and updated cash flows for the DPL at the same time as the estimates of cash flows for the FPB. When cash flows are updated, the updated estimates are used to recalculate the initial DPL at contract issuance. The recalculated DPL as of the beginning of the current reporting period is compared to the carrying amount of the DPL as of the beginning of the current reporting period, with any differences recognized as a remeasurement gain or loss, presented parenthetically within Benefits and other changes in policy reserves in the Consolidated Statements of Earnings. The DPL is recorded as a component of the Future policy benefits in the Consolidated Balance Sheets.

Market Risk Benefits ("MRBs")

MRBs are contracts or contract features that both provide protection to the contract holder from other-than-nominal capital market risk (equity, interest rate and foreign exchange risk) and expose the Company to other-than-nominal capital market risk. MRBs include certain contract features primarily on indexed annuities products that provide minimum guarantees to policyholders, such as guaranteed minimum death benefit ("GMDB"), guaranteed minimum withdrawal benefit ("GMWB") riders and guaranteed minimum accumulation benefit ("GMAB") riders. In certain reinsurance transactions, the underlying risks ceded to a reinsurer contain MRBs.

MRBs (inclusive of reinsured MRBs) are measured at fair value using an attributed fee measurement approach where attributed fees are explicit rider charges collectible from the policyholder (or paid to the reinsurer) used to cover the excess benefits, which represent expected benefits in excess of the policyholder’s account value. At contract inception, an attributed fee ratio is calculated equal to rider charges over benefits paid in excess of the account value attributable to the MRBs. The attributed fee ratio remains static over the life of the MRBs and is capped at 100%. Each period subsequent to contract inception, the attributed fee ratio is used to calculate the fair value of the MRBs using a risk neutral valuation method and is based on current net amounts at risk, market data, internal and industry experience, and other factors. The balances are computed using assumptions including mortality, full and partial surrender, GMWB utilization, risk-free rates including non-performance spread and risk margin, market value of options and economic scenarios. Policyholder behavior assumptions are reviewed at least annually, typically in the third quarter, for any revisions. Reinsured MRBs are valued using a methodology consistent with direct MRBs, with the exception of the non-performance spread which reflects the credit of the reinsurer. MRBs can either be in an asset or liability position and are presented separately on the Consolidated Balance Sheets as the right of setoff criteria are not met. Changes in fair value, net, are recognized in Market risk benefit (gains) losses in the Consolidated

Statements of Earnings, except for the change in fair value due to a change in the instrument-specific credit risk, which is recognized in the Consolidated Statements of Comprehensive Earnings. See descriptions of the fair value methodology used in Note C Fair Value of Financial Instruments and Note W Market Risk Benefits.

Reserve for Title Claim Losses

Our reserve for title claim losses includes known claims as well as losses we expect to incur, net of recoupments. Each known claim is reserved based on our review as to the estimated amount of the claim and the costs required to settle the claim. Reserves for claims, which are incurred but not reported are established at the time premium revenue is recognized based on historical loss experience and also take into consideration other factors, including industry trends, claim loss history, current legal environment, geographic considerations, and the type of policy written.

The reserve for title claim losses also includes reserves for losses arising from closing and disbursement functions due to fraud or operational error.

If a loss is related to a policy issued by an independent agent, we may proceed against the independent agent pursuant to the terms of the agency agreement. In any event, we may proceed against third parties who are responsible for any loss under the title insurance policy under rights of subrogation.

Secured Trust Deposits

In the state of Illinois, a trust company is permitted to commingle and invest customers’ assets with its own assets, pending completion of real estate transactions. Accordingly, our Consolidated Balance Sheets reflect a secured trust deposit liability of $731 million and $551 million at December 31, 2025 and 2024, respectively, representing customers’ assets held by us and corresponding assets including cash and investments pledged as security for those trust balances.

Income Taxes

We recognize deferred tax assets and liabilities for temporary differences between the financial reporting basis and the tax basis of our assets and liabilities and expected benefits of utilizing net operating loss and credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The impact on deferred taxes of changes in tax rates and laws, if any, is applied to the years during which temporary differences are expected to be settled and reflected in the financial statements in the period enacted.

Reinsurance

Title

In our Title segment, in a limited number of situations, we limit our maximum loss exposure by reinsuring certain risks with other title insurers. We also earn a small amount of additional income, which is reflected in our direct premiums, by assuming reinsurance for certain risks of other title insurers. We cede a portion of certain policy and other liabilities under agent fidelity, excess of loss and case-by-case reinsurance agreements. Reinsurance agreements provide that in the event of a loss (including costs, attorneys’ fees, and expenses) exceeding the retained amounts, the reinsurer is liable for the excess amount assumed. However, the ceding company remains primarily liable in the event the reinsurer does not meet its contractual obligations.

F&G

In our F&G segment, our insurance subsidiaries enter into reinsurance agreements with other companies in the normal course of business. In certain arrangements that are not accounted for as reinsurance, the right of offset may be applied resulting in all balances and activity associated with the agreement being presented on a net basis in the Consolidated Balance Sheets and Statements of Earnings, respectively.

When the right of offset is not applied, the arrangement is reflected on a gross basis in the Consolidated Balance Sheets and Statements of Earnings. This results in the recognition of a Reinsurance recoverable for amounts due from the reinsurer. For arrangements accounted for as reinsurance, the Reinsurance recoverable balance reflects the reserve balance of the policies ceded. For arrangements not accounted for as reinsurance, deposit accounting is applied. As a result, the deposit asset presented as a Reinsurance recoverable on the Consolidated Balance Sheets, is based on the actual and expected cash flows due from the reinsurer where the interest method is used to accrete the deposit asset using an effective yield based on changes in actual and expected cash flows. For coinsurance of FIA and IUL policies, the Reinsurance recoverable will incorporate the fair value of the indexed crediting feature, which is accounted for as an embedded derivative. Changes in the Reinsurance recoverable balance are reported as Benefits and other changes in policy reserves in the Consolidated Statements of Earnings.

Cost of Reinsurance

Amounts received from or paid to reinsurers in excess of reimbursements or liabilities ceded, respectively, represents COR. If the net COR balance is in a deferred gain position, it is included within Accounts payable and accrued liabilities with the related amortization reflected within Life insurance premiums and other fees and, if in a deferred loss position, is included within the Prepaid expenses and other assets with the related amortization reflected within Other operating expenses, in the Consolidated Balance Sheets and Statements of Earnings, respectively. Premiums and expenses are recorded net of reinsurance ceded.

Funds Withheld Arrangements

F&G cedes certain business on a coinsurance funds withheld basis. Assets supporting the arrangements are reported within Funds withheld for reinsurance liabilities on our Consolidated Balance Sheets. All assets within the Funds withheld for reinsurance liabilities are recorded in a manner consistent with each respective item of our accounting policies discussed in this Note A Business and Summary of Significant Accounting Policies. Investment results for the assets that support the coinsurance are segregated within the funds withheld account and are passed directly to the reinsurer pursuant to the contractual terms of the reinsurance agreement, which creates embedded derivatives considered to be total return swaps. These embedded derivatives are not clearly and closely related to the underlying reinsurance agreement and thus require bifurcation. For arrangements reinsuring indexed annuities products, the funds withheld account additionally contains an embedded derivative representing the index credit obligation due the reinsurer, resulting in a compound embedded derivative. Beginning in 2025, these embedded derivatives are reported in Funds withheld for reinsurance liabilities, irrespective if in a net asset position or a net liability position, on the Consolidated Balance Sheets and prior periods have been reclassified from Prepaid expenses and other assets to conform with the current presentation. The related gains or losses are reported in Recognized gains and losses, net, on the Consolidated Statements of Earnings.

See Note N F&G Reinsurance for more details over F&G's reinsurance agreements.

Revenue Recognition

Refer to Note K Revenue Recognition for a description of our accounting for our various revenue streams.

Benefits and Other Changes in Policy Reserves

Benefit expenses for deferred annuities (indexed annuities and fixed rate annuities), IUL policies and funding agreements include interest credited to contractholder account balances. For indexed annuities and IUL, the benefits expense includes the change in fair value of the embedded derivatives associated with the equity crediting rates. Benefit claims in excess of contract account balances, net of reinsurance recoveries, are charged to expense in the period that they are earned by the policyholder based on their selected strategy or strategies.

With the exception of reinsured MRBs discussed above, changes in the Reinsurance recoverable balance that need to be reflected in earnings are included within Benefits and other changes in policy reserves on the Consolidated Statements of Earnings. For reinsurance arrangements that apply reinsurance accounting, this primarily relates to changes in the reserve balance ceded. For reinsurance arrangements that apply deposit accounting, this primarily relates to accretion of the deposit asset balance.

Other changes in policy reserves also include the change in reserves for life insurance products. For traditional life and life-contingent immediate annuities (which includes PRT annuities with life contingencies), policy benefit claims are charged to expense in the period that the claims are incurred, net of reinsurance recoveries. Remeasurement gains or losses on the related FPB and DPL balances are presented parenthetically within Benefits and other changes in policy reserves in the accompanying Consolidated Statements of Earnings.

Stock-Based Compensation Plans

We account for stock-based compensation plans using the fair value method. Using the fair value method of accounting, compensation cost is measured based on the fair value of the award at the grant date using quoted market prices, and recognized over the service period.

Earnings Per Share

Basic earnings per share, as presented on the Consolidated Statement of Earnings, is computed by dividing net earnings available to common shareholders by the weighted average number of common shares outstanding during the period. In periods when earnings are positive, diluted earnings per share is calculated by dividing net earnings available to common shareholders by the weighted average number of common shares outstanding plus the impact of assumed conversions of potentially dilutive

securities. For periods when we recognize a net loss, diluted earnings per share is equal to basic earnings per share as the impact of assumed conversions of potentially dilutive securities is considered to be antidilutive. We have granted certain stock options, shares of restricted stock, convertible debt instruments and certain other convertible share-based payments, which have been treated as common share equivalents for purposes of calculating diluted earnings per share for periods in which positive earnings have been reported.

The net earnings of F&G in our calculation of diluted earnings per share is adjusted for dilution related to certain F&G restricted stock granted to F&G's employees in accordance with ASC 260-10-55-20. We calculate the ratio of the shares of F&G we own to the total weighted average diluted shares of F&G outstanding and multiply the ratio by F&G's net earnings. The result is used for F&G's net earnings attributable to FNF included in our consolidated net earnings in the numerator for our diluted EPS calculation.

Restricted stock, options or other instruments, which provide the ability to acquire shares of our common stock that are antidilutive are excluded from the computation of diluted earnings per share. There were no antidilutive instruments outstanding for the years ended December 31, 2025 and 2024.

Comprehensive Earnings (Loss)

We report Comprehensive earnings (loss) in accordance with GAAP on the Consolidated Statements of Comprehensive Earnings. Total comprehensive earnings are defined as all changes in shareholders' equity during a period, other than those resulting from investments by and distributions to shareholders. While total comprehensive earnings is the activity in a period and is largely driven by net earnings in that period, accumulated other comprehensive earnings or loss represents the cumulative balance of other comprehensive earnings, net of tax, as of the balance sheet date. Amounts reclassified to net earnings relate to the realized gains (losses) on our investments and other financial instruments, excluding investments in unconsolidated affiliates, and are included in Recognized gains and losses, net on the Consolidated Statements of Earnings. The income tax effects are released from AOCI when the related activity is reclassified to net earnings.

Changes in the balance of Other comprehensive earnings (loss) for the years ended December 31, 2025, 2024, and 2023, by component are as follows:


	Unrealized gain (loss) on investments and other financial instruments, net (excluding investments in unconsolidated affiliates)		Change in current discount rate - future policy benefits		Change in instrument-specific credit risk - market risk benefits		Other		Total Accumulated Other Comprehensive Earnings (Loss)
	(In millions)
Balance January 1, 2023	$	(3,583)	$	763	$	(48)	$	(2)	$	(2,870)

Reclassification adjustments	137		—		—		(11)		126
Other comprehensive earnings	961		(189)		(34)		21		759
Non-controlling interest	(170)		31		6		(1)		(134)
Balance December 31, 2023	(2,655)		605		(76)		7		(2,119)

Reclassification adjustments	3		—		—		(11)		(8)
Other comprehensive earnings	(157)		224		5		10		82
Non-controlling interest	14		(21)		—		—		(7)
Balance December 31, 2024	(2,795)		808		(71)		6		(2,052)
Reclassification adjustments	12		—		—		(58)		(46)
Other comprehensive earnings	711		(235)		(24)		25		477
F&G Distribution	16		—		—		—		16
Non-controlling interest	(116)		40		4		(1)		(73)
Balance December 31, 2025	$	(2,172)	$	613	$	(91)	$	(28)	$	(1,678)

Management Estimates

The preparation of these Consolidated Financial Statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Periodically, and at least annually, typically in the third quarter, we review the assumptions associated with reserves for policy benefits and product guarantees. During the third quarter and for the years ended December 31, 2025 and 2024, based on

policyholder behavior, experience and interest rate movements, we reflected updates to surrender assumptions for recent and expected near term policyholder behavior, as well as updated certain indexed annuities assumptions used to calculate the fair value of the embedded derivative component within Contractholder funds. These changes resulted in decreases in total benefits and other changes in policy reserves of approximately $20 million and $89 million for the years ended December 31, 2025 and 2024, respectively.

During the third quarter and for the year ended December 31, 2023, based on increases in interest rates and pricing changes, we updated certain indexed annuities assumptions to calculate the fair value of the embedded derivative component within the contractholder funds and also aligned reserves to actual policyholder behavior. These changes resulted in an increase in total benefits and other changes in policy reserves of approximately $73 million.

Reclassifications

Prior period amounts have been reclassified to conform with the current period presentation. Refer to “Funds Withheld Arrangements” above for further information.

Owned Distribution Investments

For the years ended December 31, 2025, 2024, and 2023, we expensed approximately $55 million, $119 million, and $154 million in commissions on sales through our funded owned distribution investments and their affiliates, respectively, with the acquisition expense deferred and amortized in Depreciation and amortization on the accompanying Consolidated Statements of Earnings.

Fair Value of Financial Instruments - Narrative (Details) $ in Millions	Dec. 31, 2025 USD ($) $ / Contract	Dec. 31, 2024 USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments in unconsolidated affiliates	$ 5,166	$ 3,731
Title
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments in unconsolidated affiliates	$ 288	$ 166
Credit Linked Note \| Income Approach
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative, strike price \| $ / Contract	0

This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.

Investments - Variable Interest Entities (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Investments in unconsolidated affiliates	$ 5,166	$ 3,731
Other long-term investments		0
Cash and cash equivalents	2,636	3,479
Total assets	109,014	95,263	$ 80,614
Variable Interest Entity, Primary Beneficiary
Debt Instrument [Line Items]
Investments in unconsolidated affiliates	262	0
Other long-term investments	248	0
Short-term investments	116	0
Cash and cash equivalents	2	0
Total assets	628	0
Total consolidated VIE investments	$ 628	$ 0

Amount of asset recognized for present right to economic benefit.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-28

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 480
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 64
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481620/480-10-55-64

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 944
-SubTopic 605
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477548/944-605-55-14

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 944
-SubTopic 605
-Name Accounting Standards Codification
-Section 55
-Paragraph 11
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477548/944-605-55-11

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 48
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-48

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 49
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-49

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 13: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 810
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (bb)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481203/810-10-50-3

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 810
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 25
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481231/810-10-45-25

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481687/323-10-50-3

Reference 19: http://www.xbrl.org/2003/role/exampleRef
-Topic 852
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481372/852-10-55-10

Reference 20: http://www.xbrl.org/2003/role/exampleRef
-Topic 946
-SubTopic 830
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479168/946-830-55-12

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(8))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(18))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B

Reference 35: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 852
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481404/852-10-50-7

Reference 36: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(f))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 55
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482949/835-30-55-8

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69E
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E

Reference 12: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69F
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 15: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

Reference 30: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482925/835-30-45-2

Reference 31: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482900/835-30-50-1

Net earnings from continuing operations

Income Taxes - Tax Expense Allocation (Details) - USD ($)
$ in Millions

12 Months Ended

Dec. 31, 2025

Dec. 31, 2024

Dec. 31, 2023

Income Tax Disclosure [Abstract]

$ 753

$ 367

$ 192

Other comprehensive earnings (loss):

Unrealized gain on investments and other financial instruments

160

(35)

275

Unrealized gain on foreign currency translation

(6)

^[1]

Changes in current discount rate - future policy benefits

^[2]

(62)

(50)

Changes in instrument - specific credit risk - market risk benefits

^[3]

(6)

(9)

Cumulative Other Comprehensive Income (Loss), Tax Effects of Distribution

(3)

(35)

Tax effects of F&G Distribution

(16)

Other comprehensive earnings attributable to non-controlling interest

(18)

(3)

(35)

Total income tax expense allocated to other comprehensive earnings

183

Total income taxes

$ 815

$ 383

$ 375

Dividend to shareholders, pro rata percentage of common stock

15.00%

[1]	Net of income tax expense (benefit) of $4 million and $(6) million, and $2 million for the years ended December 31, 2025 and 2024, and 2023, respectively.
[2]	Net of income tax (benefit) expense of $(62) million, $59 million, and $(50) million for the years ended December 31, 2025, 2024, and 2023, respectively
[3]	Net of income tax (benefit) expense of $(6) million, $1 million, and $(9) million for the years ended December 31, 2025, 2024, and 2023, respectively.

Other Intangible Assets - VOBA (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
VOBA
VOBA at beginning of period	$ 1,349	$ 1,446
Amortization	(153)	(160)
Actuarial model updates and refinements		63
VOBA at end of period	1,196	1,349
Amortization	15
Indexed annuities
VOBA
VOBA at beginning of period	892	1,025
Amortization	(122)	(133)
Actuarial model updates and refinements		0
VOBA at end of period	770	892
Fixed rate annuities
VOBA
VOBA at beginning of period	22	27
Amortization	(4)	(5)
Actuarial model updates and refinements		0
VOBA at end of period	18	22
Immediate Annuities
VOBA
VOBA at beginning of period	184	191
Amortization	(6)	(7)
Actuarial model updates and refinements		0
VOBA at end of period	178	184
Universal life
VOBA
VOBA at beginning of period	126	134
Amortization	(7)	(8)
Actuarial model updates and refinements		0
VOBA at end of period	119	126
Traditional life
VOBA
VOBA at beginning of period	125	69
Amortization	(14)	(7)
Actuarial model updates and refinements		63
VOBA at end of period	$ 111	$ 125

Revenue Recognition

12 Months Ended

Dec. 31, 2025

Revenue from Contract with Customer [Abstract]

Revenue Recognition

Disaggregation of Revenue

Our revenue consists of:


			Year Ended December 31,
				2025		2024		2023
Revenue Stream	Income Statement Classification	Segment		Total Revenue
Revenue from insurance contracts:				(In millions)
Direct title insurance premiums	Direct title insurance premiums	Title		$	2,574	$	2,200	$	1,982
Agency title insurance premiums	Agency title insurance premiums	Title		3,250		2,953		2,610
Life insurance premiums, insurance and investment product fees, and other (1)	Escrow, title-related and other fees	F&G		2,884		2,941		2,413
Home warranty	Escrow, title-related and other fees	Title		151		146		143
Total revenue from insurance contracts				8,859		8,240		7,148
Revenue from contracts with customers:
Escrow fees	Escrow, title-related and other fees	Title		915		824		766
Other title-related fees and income	Escrow, title-related and other fees	Title		695		642		633
ServiceLink, excluding title premiums, escrow fees, and subservicing fees	Escrow, title-related and other fees	Title		354		318		313

Real estate technology	Escrow, title-related and other fees	Corporate and other		135		140		151


Total revenue from contracts with customers				2,099		1,924		1,863
Other revenue:
Loan subservicing revenue	Escrow, title-related and other fees	Title		266		266		262
Other	Escrow, title-related and other fees	Corporate and other		44		44		36
Interest and investment income	Interest and investment income	Various		3,237		3,124		2,607
Recognized gains and losses, net	Recognized gains and losses, net	Various		(60)		83		(164)
Total revenues	Total revenues			$	14,445	$	13,681	$	11,752
(1) Includes $2,108, $2,217, and $1,964 of life-contingent pension risk transfer premiums in 2025, 2024, and 2023, respectively.

Our Direct title insurance premiums are recognized as revenue at the time of closing of the underlying transaction as the earnings process is then considered complete. Regulation of title insurance rates varies by state. Premiums are charged to customers based on rates predetermined in coordination with each states' respective Department of Insurance. Cash associated with such revenue is typically collected at closing of the underlying real estate transaction. Premium revenues from agency title operations are recognized when the underlying title order and transaction closing, if applicable, are complete.

Revenues from our home warranty business are generated from contracts with customers to provide warranty for major home appliances. Substantially all of our home warranty contracts are one year in length and revenue is recognized ratably over the term of the contract.

Escrow fees and Other title-related fees and income in our Title segment are closely related to Direct title insurance premiums and are primarily associated with managing the closing of real estate transactions including the processing of funds on behalf of the transaction participants, gathering and recording the required closing documents, providing notary and home inspection services, and other real estate or title-related activities. Revenue is primarily recognized upon closing of the underlying real estate transaction or completion of services. Cash associated with such revenue is typically collected at closing.

Revenues from ServiceLink, excluding its title premiums, escrow fees, and loan subservicing fees, primarily include revenues from real estate appraisal services and foreclosure processing and facilitation services. Revenues from real estate appraisal services are recognized when all appraisal work is complete, a final report is issued to the client and the client is billed. Revenues from foreclosure processing and facilitation services are primarily recognized upon completion of the services and when billing to the client is complete.

Life insurance premiums in our F&G segment reflect premiums for life-contingent PRT, traditional life insurance products and life-contingent immediate annuity products, which are recognized as revenue when due from the policyholder, as well as policy rider fees primarily on indexed annuities policies, the cost of insurance on IUL policies and surrender charges assessed against policy withdrawals in excess of the policyholders' allowable penalty-free amounts. We have ceded the majority of our traditional life business to unaffiliated third-party reinsurers. While the base contract has been reinsured, we continue to retain

the return of premium rider. Other income related to riders is earned when elected by the policyholder. Surrender charges are earned when a policyholder withdraws funds from the contract early or cancels the contract.

Premium and annuity deposit collections for indexed annuities, fixed rate annuities, immediate annuities and PRT without life contingency, and amounts received for funding agreements are reported in the financial statements as deposit liabilities (i.e., contractholder funds) instead of as sales or revenues. Similarly, cash payments to customers are reported as decreases in the liability for contractholder funds and not as expenses. Sources of revenues for products accounted for as deposit liabilities include net investment income, surrender, cost of insurance and other charges deducted from contractholder funds, and net realized gains (losses) on investments. Components of expenses for products accounted for as deposit liabilities are interest-sensitive and index product benefits (primarily interest credited to account balances or the hedging cost of providing index credits to the policyholder), amortization of DAC, DSI, and VOBA, other operating costs and expenses, and income taxes.

Premiums, annuity deposits (net of reinsurance and reinsurance recoverable) and funding agreements, which are not included as revenues in the accompanying Consolidated Statements of Earnings, collected by product type were as follows:


	Year ended
	December 31, 2025		December 31, 2024		December 31, 2023
Product Type	(In millions)
Fixed indexed annuities	$	5,341	$	5,828	$	4,738
Fixed rate annuities	1,637		1,277		1,147
Funding agreements (FABN/FHLB)	3,748		2,404		1,256

Life insurance and other (a)	849		638		646
Total	$	11,575	$	10,147	$	7,787

(a) Life insurance and other primarily includes indexed universal life insurance.

Real estate technology revenues are primarily comprised of subscription fees for use of software provided to real estate professionals. Revenue is recognized in the month services are provided.

Loan subservicing revenues are generated by certain subsidiaries of ServiceLink and are associated with the servicing of mortgage loans on behalf of its customers. Revenue is recognized when the underlying work is performed and billed. Loan subservicing revenues are subject to the recognition requirements of ASC Topic 860.

Interest and investment income consists primarily of interest payments received on fixed maturity security holdings and dividends received on equity and preferred security holdings along with the investment income of limited partnerships.

We do not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less, primarily related to revenue from our home warranty business, and (ii) contracts for which we recognize revenue at the amount to which we have the right to invoice for services performed.

Contract Balances

The following table provides information about trade receivables and deferred revenue:


	December 31, 2025		December 31, 2024
	(In millions)
Trade receivables	$	375	$	362
Deferred revenue (contract liabilities)	95		92

Deferred revenue is recorded primarily for our home warranty contracts. Revenues from home warranty products are recognized over the life of the policy, which is primarily one year. The unrecognized portion is recorded as deferred revenue in Accounts payable and other accrued liabilities in the Consolidated Balance Sheets. During the years ended December 31, 2025 and 2024, we recognized $84 million and $80 million of revenue, respectively, which was included in deferred revenue at the beginning of the respective period.

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-7

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-9

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-10

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-15

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-12

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-13

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Topic 606
-Publisher FASB
-URI https://asc.fasb.org/606/tableOfContent

Goodwill and Intangible Assets Disclosure [Abstract]

Revenue Recognition - Disaggregation of Revenue (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Disaggregation of Revenue [Line Items]
Revenue from contract with customer	$ 2,099	$ 1,924	$ 1,863
Interest and investment income	3,237	3,124	2,607
Recognized gains and losses, net	(60)	83	(164)
Total revenues	14,445	13,681	11,752
Title
Disaggregation of Revenue [Line Items]
Loan subservicing revenue	266	266	262
Title \| Direct title insurance premiums
Disaggregation of Revenue [Line Items]
Revenue from contract with customer	2,574	2,200	1,982
Title \| Agency title insurance premiums
Disaggregation of Revenue [Line Items]
Revenue from contract with customer	3,250	2,953	2,610
Title \| Home warranty
Disaggregation of Revenue [Line Items]
Revenue from contract with customer	151	146	143
Title \| Insurance contracts
Disaggregation of Revenue [Line Items]
Revenue from contract with customer	8,859	8,240	7,148
Title \| Escrow fees
Disaggregation of Revenue [Line Items]
Revenue from contract with customer	915	824	766
Title \| Other title-related fees and income
Disaggregation of Revenue [Line Items]
Revenue from contract with customer	695	642	633
Title \| ServiceLink, excluding title premiums, escrow fees, and subservicing fees
Disaggregation of Revenue [Line Items]
Revenue from contract with customer	354	318	313
F&G \| Life insurance premiums, insurance and investment product fees, and other
Disaggregation of Revenue [Line Items]
Revenue from contract with customer	2,884	2,941	2,413
F&G \| Life insurance premiums, insurance and investment product fees, other, pension risk transfer
Disaggregation of Revenue [Line Items]
Revenue from contract with customer	2,108	2,217	1,964
Corporate and other \| Real estate technology
Disaggregation of Revenue [Line Items]
Revenue from contract with customer	135	140	151
Corporate and other \| Other
Disaggregation of Revenue [Line Items]
Revenue from contract with customer	$ 44	$ 44	$ 36

Derivative Financial Instruments - Schedule of Carrying Amounts of Derivative Instruments (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosures
Gross Notional	$ 37,639	$ 35,048
Assets	1,596	925
Liabilities	6,631	5,121
Designated as Hedging Instrument
Derivative Instruments and Hedging Activities Disclosures
Gross Notional	871	39
Assets	11	2
Liabilities	4	0
Designated as Hedging Instrument \| Interest rate swaps
Derivative Instruments and Hedging Activities Disclosures
Gross Notional	850	0
Assets	11	0
Liabilities	1	0
Designated as Hedging Instrument \| Foreign currency swaps
Derivative Instruments and Hedging Activities Disclosures
Gross Notional	21	39
Assets	0	2
Liabilities	3	0
Not Designated as Hedging Instrument
Derivative Instruments and Hedging Activities Disclosures
Gross Notional	36,768	35,009
Assets	1,585	923
Liabilities	6,627	5,121
Not Designated as Hedging Instrument \| Interest rate swaps
Derivative Instruments and Hedging Activities Disclosures
Gross Notional	6,453	5,145
Assets	83	19
Liabilities	3	10
Not Designated as Hedging Instrument \| Foreign currency swaps
Derivative Instruments and Hedging Activities Disclosures
Gross Notional	503	0
Assets	0	0
Liabilities	6	0
Not Designated as Hedging Instrument \| Equity options
Derivative Instruments and Hedging Activities Disclosures
Gross Notional	29,651	29,594
Assets	1,062	773
Liabilities	0	0
Not Designated as Hedging Instrument \| Futures contracts
Derivative Instruments and Hedging Activities Disclosures
Gross Notional	68	152
Assets	0	0
Liabilities	1	0
Not Designated as Hedging Instrument \| Other derivative investments
Derivative Instruments and Hedging Activities Disclosures
Gross Notional	93	118
Assets	0	1
Liabilities	0	0
Not Designated as Hedging Instrument \| Other embedded derivatives
Derivative Instruments and Hedging Activities Disclosures
Gross Notional	0	0
Assets	41	32
Liabilities	0	0
Not Designated as Hedging Instrument \| Indexed annuities/IUL embedded derivatives
Derivative Instruments and Hedging Activities Disclosures
Gross Notional	0	0
Assets	399	98
Liabilities	6,542	5,220
Not Designated as Hedging Instrument \| Reinsurance related embedded derivatives, included in Funds withheld for reinsurance liabilities
Derivative Instruments and Hedging Activities Disclosures
Gross Notional	0	0
Assets	0	0
Liabilities	$ 75	$ (109)

Derivative Financial Instruments - Narrative (Details)	12 Months Ended
Derivative Financial Instruments - Narrative (Details)	Dec. 31, 2025 USD ($) counterparty contract	Dec. 31, 2024 USD ($) contract
Derivative [Line Items]
Fair value hedging adjustments for hedged assets		$ 0
Fair value hedging adjustments for hedged liabilities	$ 0
Number of counterparties, net exposure threshold set to zero \| counterparty	1
Futures contracts
Derivative [Line Items]
Number of instruments held \| contract	172	527
Collateral held	$ 4,000,000	$ 7,000,000
Derivatives for trading and investment \| Call options and interest rate swaps \| Not Designated as Hedging Instrument
Derivative [Line Items]
Collateral	1,185,000,000	771,000,000
Derivatives for trading and investment \| Call Option [Member] \| Not Designated as Hedging Instrument
Derivative [Line Items]
Net credit risk	34,000,000	34,000,000
Cash and cash equivalents \| Call Option [Member] \| Not Designated as Hedging Instrument
Derivative [Line Items]
Collateral	$ 928,000,000	$ 679,000,000
All counterparties except one
Derivative [Line Items]
Counterparties, collateral required threshold	0.00%

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Dec. 31, 2025
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Market Risk Benefits - Schedule of Balances and Changes in Market Risk Benefit (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Indexed annuities
Market Risk Benefit [Roll Forward]
Balance beginning of period	$ 420	$ 314
Balance, beginning of period, before effect of changes in the instrument-specific credit risk	322	209
Issuances and benefit payments	(147)	(109)
Attributed fees collected and interest accrual	156	147
Actual policyholder behavior different from expected	45	(5)
Changes in assumptions and other	8	24
Effects of market related movements	6	(162)
Balance, end of period, before effect of changes in the instrument-specific credit risk	684	322
Issuances and benefit payments	(147)	(109)
Attributed fees collected and interest accrual	156	147
Actual policyholder behavior different from expected	45	(5)
Changes in assumptions and other	8	24
Effects of market related movements	6	(162)
Effect of changes in the instrument-specific credit risk	128	98
Balance, end of period	812	420
Less: reinsured market risk benefits	195	61
Balance, end of period, net of reinsurance	$ 617	$ 359
Weighted-average attained age of policyholders weighted by total AV (years)	67 years 10 months 2 days	67 years 11 months 23 days
Net amount at risk	$ 1,900	$ 1,327
Fixed rate annuities
Market Risk Benefit [Roll Forward]
Balance beginning of period	1	1
Balance, beginning of period, before effect of changes in the instrument-specific credit risk	1	1
Issuances and benefit payments	0	0
Attributed fees collected and interest accrual	0	0
Actual policyholder behavior different from expected	0	0
Changes in assumptions and other	0	0
Effects of market related movements	0	0
Balance, end of period, before effect of changes in the instrument-specific credit risk	1	1
Issuances and benefit payments	0	0
Attributed fees collected and interest accrual	0	0
Actual policyholder behavior different from expected	0	0
Changes in assumptions and other	0	0
Effects of market related movements	0	0
Effect of changes in the instrument-specific credit risk	0	0
Balance, end of period	1	1
Less: reinsured market risk benefits	0	0
Balance, end of period, net of reinsurance	$ 1	$ 1
Weighted-average attained age of policyholders weighted by total AV (years)	84 years 8 months 8 days	83 years 6 months 3 days
Net amount at risk	$ 2	$ 2

Other Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2025

Schedule of Definite and Indefinite Lived Other Intangible Assets

The following table reconciles to Other intangible assets, net, on the Consolidated Balance Sheets as of December 31, 2025 and 2024:


	December 31, 2025		December 31, 2024
	(In millions)
Customer relationships and contracts	$	349	$	435
VOBA	1,196		1,349
DAC	3,637		3,036
DSI	891		625
Value of distribution asset	62		74
Computer software	289		277
Trademarks, tradenames, and other	217		180
Total Other intangible assets, net	$	6,641	$	5,976

Other intangible assets as of December 31, 2025, consist of the following:


	Cost		Accumulated amortization		Net carrying amount		Weighted average useful life (years)
	(In millions)
Customer relationships and contracts (a)	$	760	$	(411)	$	349	10 to 20
Computer software	747		(458)		289		2 to 10
Value of distribution asset (VODA)	140		(78)		62		15
Trademarks, tradenames, and other	289		(72)		217		Varies
Total					$	917

Other intangible assets as of December 31, 2024, consist of the following:


	Cost		Accumulated amortization		Net carrying amount		Weighted average useful life (years)
	(In millions)
Customer relationships and contracts	$	795	$	(360)	$	435	10 to 20
Computer software	723		(446)		277		2 to 10
Value of distribution Asset (VODA)	140		(66)		74		15
Trademarks, tradenames, and other	234		(54)		180		Varies
Total					$	966

Schedule of Indefinite-Lived Intangible Assets

The following table reconciles to Other intangible assets, net, on the Consolidated Balance Sheets as of December 31, 2025 and 2024:


	December 31, 2025		December 31, 2024
	(In millions)
Customer relationships and contracts	$	349	$	435
VOBA	1,196		1,349
DAC	3,637		3,036
DSI	891		625
Value of distribution asset	62		74
Computer software	289		277
Trademarks, tradenames, and other	217		180
Total Other intangible assets, net	$	6,641	$	5,976

Other intangible assets as of December 31, 2025, consist of the following:


	Cost		Accumulated amortization		Net carrying amount		Weighted average useful life (years)
	(In millions)
Customer relationships and contracts (a)	$	760	$	(411)	$	349	10 to 20
Computer software	747		(458)		289		2 to 10
Value of distribution asset (VODA)	140		(78)		62		15
Trademarks, tradenames, and other	289		(72)		217		Varies
Total					$	917

Other intangible assets as of December 31, 2024, consist of the following:


	Cost		Accumulated amortization		Net carrying amount		Weighted average useful life (years)
	(In millions)
Customer relationships and contracts	$	795	$	(360)	$	435	10 to 20
Computer software	723		(446)		277		2 to 10
Value of distribution Asset (VODA)	140		(66)		74		15
Trademarks, tradenames, and other	234		(54)		180		Varies
Total					$	966

Schedule of Rollforward of Value of Business Acquired

The following tables roll forward VOBA by product for the years ended December 31, 2025 and 2024:


	Indexed Annuities		Fixed Rate Annuities		Immediate Annuities		Universal Life		Traditional Life		Total
	(In millions)
Balance at January 1, 2025	$	892	$	22	$	184	$	126	$	125	$	1,349

Amortization	(122)		(4)		(6)		(7)		(14)		(153)

Balance at December 31, 2025	$	770	$	18	$	178	$	119	$	111	$	1,196


	Indexed Annuities		Fixed Rate Annuities		Immediate Annuities		Universal Life		Traditional Life		Total
	(In millions)
Balance at January 1, 2024	$	1,025	$	27	$	191	$	134	$	69	$	1,446

Amortization	(133)		(5)		(7)		(8)		(7)		(160)
Actuarial model updates and refinements (a)	—		—		—		—		63		63

Balance at December 31, 2024	$	892	$	22	$	184	$	126	$	125	$	1,349

(a)net of amortization of ($15 million).

Schedule of Rollforward of Deferred Policy Acquisition Costs

The following tables roll forward DAC by product for the years ended December 31, 2025 and 2024:


	Indexed Annuities		Fixed Rate Annuities		Universal Life		Total (a)
	(In millions)
Balance at January 1, 2025	$	1,874	$	376	$	781	$	3,031
Capitalization	530		132		292		954
Amortization	(199)		(106)		(52)		(357)

Balance at December 31, 2025	$	2,205	$	402	$	1,021	$	3,628

	Indexed Annuities		Fixed Rate Annuities		Universal Life		Total (a)
	(In millions)
Balance at January 1, 2024	$	1,378	$	288	$	545	$	2,211
Capitalization	652		174		274		1,100
Amortization	(156)		(86)		(38)		(280)

Balance at December 31, 2024	$	1,874	$	376	$	781	$	3,031

(a) Excludes insignificant amounts of DAC related to FABN and PRT.

Schedule of Reconciliation of Deferred Policy Acquisition Cost to Statement of Financial Position

The following table presents a reconciliation of DAC to the table above which is reconciled to the Consolidated Balance Sheets as of December 31, 2025 and 2024:


	December 31, 2025		December 31, 2024
	(In millions)
Indexed Annuities	$	2,205	$	1,874
Fixed Rate Annuities	402		376

Universal Life	1,021		781

FABN	5		4
PRT	4		1
Total	$	3,637	$	3,036

Schedule of Rollforward of Deferred Sale Inducement Cost

The following tables roll forward DSI for our indexed annuity products for the years ended December 31, 2025 and 2024:


	Years Ended December 31,
	2025		2024
	(In millions)
Balance at January 1,	$	625	$	346
Capitalization	332		319
Amortization	(66)		(40)
Balance at December 31,	$	891	$	625

Schedule of Estimated Amortization Expense for VOBA in Future Fiscal Periods

For the in-force liabilities as of December 31, 2025, the estimated amortization expense for VOBA in future fiscal periods is as follows:


	Estimated Amortization Expense
	(In millions)
2026	$	133
2027	120
2028	109
2029	99
2030	90
Thereafter	645
Total	$	1,196

Contractholder Funds

12 Months Ended

Dec. 31, 2025

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Contractholder Funds

Market Risk Benefits

The following table presents the balances of and changes in MRBs associated with indexed annuities and fixed rate annuities for the years ended December 31, 2025 and 2024:


	December 31, 2025				December 31, 2024
	Indexed annuities		Fixed rate annuities		Indexed annuities		Fixed rate annuities
	(In millions)
Balance, beginning of period, net liability	$	420	$	1	$	314	$	1

Balance, beginning of period, before effect of changes in the instrument-specific credit risk	$	322	$	1	$	209	$	1
Issuances and benefit payments	147		—		109		—
Attributed fees collected and interest accrual	156		—		147		—
Actual policyholder behavior different from expected	45		—		(5)		—
Changes in assumptions and other	8		—		24		—


Effects of market related movements	6		—		(162)		—
Balance, end of period, before effect of changes in the instrument-specific credit risk	684		1		322		1
Effect of changes in the instrument-specific credit risk	128		—		98		—
Balance, end of period, net liability	812		1		420		1
Less: reinsured market risk benefits	195		—		61		—
Balance, end of period, net of reinsurance	$	617	$	1	$	359	$	1

Weighted-average attained age of policyholders weighted by total AV (years)	67.84		84.69		67.98		83.51
Net amount at risk	$	1,900	$	2	$	1,327	$	2

The following table reconciles MRBs by amounts in an asset position and amounts in a liability position to the MRBs amounts in the Consolidated Balance Sheets:


	December 31, 2025						December 31, 2024
	Direct		Reinsured		Total		Direct		Reinsured		Total
	(In millions)
MRB asset
Indexed annuities	$	88	$	197	$	285	$	128	$	61	$	189
Fixed rate annuities	—		—		—		—		—		—
Total MRB asset	$	88	$	197	$	285	$	128	$	61	$	189

MRB liability
Indexed annuities	$	900	$	2	$	902	$	548	$	—	$	548
Fixed rate annuities	1		—		1		1		—		1
Total MRB liability	$	901	$	2	$	903	$	549	$	—	$	549

The net MRB liability increased for the year ended December 31, 2025, primarily as a result of collection of attributed fees, interest accrual, and MRB reserves for contracts issued within the period.

For the year ended December 31, 2025, notable changes made to the inputs to the fair value estimates of MRBs calculations included an increase in risk-free rates leading to a favorable change in the MRBs associated with indexed annuities and decreases in the equity market related projections resulted in an increase in the net amount at risk associated with indexed annuities, leading to an unfavorable change in the value of the associated MRBs.

The net MRB liability increased for the year ended December 31, 2024, primarily as a result of collection of attributed fees, interest accrual, MRB reserves for contracts issued within the period, and changes in actuarial assumptions. These increases were partially offset by the effects of market related movements, including the impacts of higher risk-free rates and increases in the equity market related projections.

For the year ended December 31, 2024, notable changes made to the inputs to the fair value estimates of MRBs calculations included an increase in risk-free rates leading to a favorable change in the MRBs associated with indexed annuities and fixed rate annuities; increases in the equity market related projections resulted in a decrease in the net amount at risk associated with indexed annuities, leading to a favorable change in the value of the associated MRBs; and an increase in the rider benefit utilization assumption, leading to an unfavorable change in the value of the associated MRBs.

In addition, the cash flow assumptions used to calculate MRBs reflect the Company’s best estimates for policyholder behavior. F&G reviews cash flow assumptions annually, generally in the third quarter. In 2024 and 2025, F&G undertook a review of all significant assumptions and revised several assumptions relating to their deferred annuities (indexed annuities and fixed rate annuities) with MRBs. For the year ended December 31, 2025, F&G updated assumptions including surrender rates, mortality and mortality improvement, partial withdrawals, projected CPI, and option budgets. All updates to these assumptions brought F&G more in line with internal and overall industry experience since the prior assumption updates. These updates, in total, led to an increase in the net MRB liability for the year ended December 31, 2025. For the year ended December 31, 2024, F&G updated assumptions including surrender rates, rider benefit election utilization, mortality improvement, and option budgets. All updates to these assumptions brought F&G more in line with internal and overall industry experience since the prior assumption updates. These updates, in total, led to an increase in the net MRB liability for the year ended December 31, 2024.

Contractholder Funds

The following tables summarize balances of and changes in contractholder funds’ account balances:


	December 31, 2025
	Indexed annuities			Fixed rate annuities			Universal life			FABN (b)		FHLB (b)
	(In millions)
Balance, beginning of year	$	30,235		$	17,442		$	2,817		$	2,463	$	2,852
Issuances	6,714			3,801			229			1,148		2,241
Premiums received	31			—			593			—		—
Policy charges (a)	(222)			—			(378)			—		—
Surrenders and withdrawals	(3,831)			(2,485)			(130)			—		—
Benefit payments	(536)			(358)			(21)			(395)		(2,298)

Interest credited	830			866			182			107		103
Other	5			(1)			—			1		—
Balance, end of year	33,226			19,265			3,292			3,324		2,898
Reconciling items (c)	321			2			115			11		—
Gross liability, end of year	33,547			19,267			3,407			3,335		2,898
Less: Reinsurance recoverable	3,198			12,863			887			—		—
Net liability, after reinsurance	$	30,349		$	6,404		$	2,520		$	3,335	$	2,898

Weighted-average crediting rate	2.65		%	4.84		%	6.13		%	N/A		N/A
Net amount at risk (d)	N/A			N/A			$	29,581		N/A		N/A
Cash surrender value (e)	$	30,920		$	18,034		$	2,533		N/A		N/A

(a)Contracts included in the contractholder funds are generally charged a premium and/or monthly assessments on the basis of the account balance.

(e)These amounts are gross of reinsurance.


	December 31, 2024
	Indexed annuities			Fixed rate annuities			Universal life			FABN (b)		FHLB (b)
	(In millions)
Balance, beginning of year	$	27,164		$	13,443		$	2,391		$	2,613	$	2,539
Issuances	6,649			5,125			208			600		1,804
Premiums received	120			1			495			—		—
Policy charges (a)	(195)			—			(315)			—		—
Surrenders and withdrawals	(3,832)			(1,479)			(101)			—		—
Benefit payments	(495)			(315)			(18)			(820)		(1,606)

Interest credited	821			667			157			71		117
Other	3			—			—			(1)		(2)
Balance, end of year	30,235			17,442			2,817			2,463		2,852
Embedded derivative adjustment (c)	219			—			79			—		—
Gross liability, end of year	30,454			17,442			2,896			2,463		2,852
Less: Reinsurance recoverable	861			11,009			877			—		—
Net liability, after reinsurance	$	29,593		$	6,433		$	2,019		$	2,463	$	2,852

Weighted-average crediting rate	2.90		%	4.42		%	6.20		%	N/A		N/A
Net amount at risk (d)	N/A			N/A			$	74,279		N/A		N/A
Cash surrender value (e)	$	27,865		$	16,266		$	2,177		N/A		N/A

(a)Contracts included in the contractholder funds are generally charged a premium and/or monthly assessments on the basis of the account balance.

(c)The embedded derivative adjustment reconciles the account balance to the gross GAAP liability and represents the combination of the host contract and the fair value of the embedded derivatives.

(e)These amounts are gross of reinsurance.

The following table reconciles contractholder funds’ account balances to the contractholder funds liability in the Consolidated Balance Sheets:


	December 31,
	2025		2024
	(In millions)
Indexed annuities	$	33,547	$	30,454
Fixed rate annuities	19,267		17,442
Immediate annuities	262		286
Universal life	3,407		2,896
Traditional life	4		5
FABN	3,335		2,463
FHLB	2,898		2,852
PRT	6		6
Total	$	62,726	$	56,404

Annually, typically in the third quarter, F&G reviews assumptions associated with reserves for policy benefits and product guarantees. During the years ended December 31, 2025 and 2024, based on policyholder behavior, experience and interest rate movements, F&G reflected updates to surrender assumptions for recent and expected near term policyholder behavior, as well as updated certain indexed annuities assumptions used to calculate the fair value of the embedded derivative component within Contractholder funds. These changes resulted in a decrease in Contractholder funds of approximately $22 million and $89 million for the years ended December 31, 2025 and December 31, 2024, respectively.


	December 31, 2025
Range of guaranteed minimum crediting rate	At Guaranteed Minimum		1 Basis Point-50 Basis Points Above		51 Basis Points-150 Basis Points Above		Greater Than 150 Basis Points Above		Total
Indexed annuities	(In millions)
Up to 1.50%	$	659	$	464	$	298	$	812	$	2,233
1.51%-2.50%	548		17		633		630		1,828
Greater than 2.50%	212		1		—		1		214
Subtotal	1,419		482		931		1,443		$	4,275
No guaranteed minimum crediting rate									28,951
Total									$	33,226

Fixed rate annuities
Up to 1.50%	$	94	$	75	$	792	$	15,548	$	16,509
1.51%-2.50%	4		6		16		466		492
Greater than 2.50%	727		2		5		1,530		2,264
Total	$	825	$	83	$	813	$	17,544	$	19,265

Universal Life
Up to 1.50%	$	2,898	$	9	$	—	$	31	$	2,938
1.51%-2.50%	—		—		—		—		—
Greater than 2.50%	353		—		1		—		354
Total	$	3,251	$	9	$	1	$	31	$	3,292


	December 31, 2024
Range of guaranteed minimum crediting rate	At Guaranteed Minimum		1 Basis Point-50 Basis Points Above		51 Basis Points-150 Basis Points Above		Greater Than 150 Basis Points Above		Total
Indexed annuities	(In millions)
Up to 1.50%	$	721	$	596	$	309	$	880	$	2,506
1.51%-2.50%	432		1		313		485		1,231
Greater than 2.50%	253		—		—		14		267
Subtotal	$	1,406	$	597	$	622	$	1,379	$	4,004
No guaranteed minimum crediting rate									26,231
Total									$	30,235

Fixed rate annuities
Up to 1.50%	$	57	$	20	$	773	$	14,407	$	15,257
1.51%-2.50%	4		7		20		462		493
Greater than 2.50%	804		2		5		881		1,692
Total	$	865	$	29	$	798	$	15,750	$	17,442

Universal Life
Up to 1.50%	$	2,421	$	7	$	—	$	24	$	2,452
1.51%-2.50%	—		—		—		—		—
Greater than 2.50%	364		—		1		—		365
Total	$	2,785	$	7	$	1	$	24	$	2,817

Future Policy Benefits - Balances and Changes in the Deferred Profit Liability (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Immediate annuities
Deferred Profit Liability Rollforward
Balance, beginning of year	$ 90	$ 87
Effect of changes in cash flow assumptions		0	$ 0
Effect of actual variances from expected experience		2	8
Balance adjusted for variances from expectation		92	95
Issuances	6	3
Interest accrual	1	1
Amortization	(9)	(9)
Balance, end of period	90	90
Effect of changes in cash flow assumptions		0	0
Effect of actual variances from expected experience		2	8
PRT
Deferred Profit Liability Rollforward
Balance, beginning of year	6	10
Effect of changes in cash flow assumptions		0	(8)
Effect of actual variances from expected experience		1	0
Balance adjusted for variances from expectation		7	2
Issuances	1	1
Interest accrual	0	4
Amortization	(1)	(1)
Balance, end of period	$ 7	6
Effect of changes in cash flow assumptions		0	(8)
Effect of actual variances from expected experience		$ 1	$ 0

Commitments and Contingencies - Unfunded Commitments by Invested Asset Class (Details) $ in Millions	Dec. 31, 2025 USD ($)
Other fixed maturity securities, AFS
Other Commitments [Line Items]
Unfunded investment commitment	$ 126
Commercial mortgage loans
Other Commitments [Line Items]
Unfunded investment commitment	74
Residential mortgage loans
Other Commitments [Line Items]
Unfunded investment commitment	300
Other assets
Other Commitments [Line Items]
Unfunded investment commitment	122
Other long-term investments
Other Commitments [Line Items]
Unfunded investment commitment	250
Limited partnerships
Other Commitments [Line Items]
Unfunded investment commitment	1,224
Asset-backed lending
Other Commitments [Line Items]
Unfunded investment commitment	263
Fixed maturity securities, asset-backed securities
Other Commitments [Line Items]
Unfunded investment commitment	684
Direct Lending
Other Commitments [Line Items]
Unfunded investment commitment	1,199
Commitment to Invest
Other Commitments [Line Items]
Unfunded investment commitment	$ 4,242

Derivative Financial Instruments

12 Months Ended

Dec. 31, 2025

Derivative Financial Instruments

Refer to Note A Business and Summary of Significant Accounting Policies, for a description of the Company's accounting policies for derivative financial instruments and Note C Fair Value of Financial Instruments for descriptions of the fair value methodologies used for derivative financial instruments.

The notional and carrying amounts of derivative financial instruments, including derivative instruments embedded in indexed annuities and IUL contracts, and reinsurance are as follows:


	December 31, 2025						December 31, 2024
	Gross Notional		Assets		Liabilities		Gross Notional		Assets		Liabilities
	(In millions)
Derivatives designated as hedging instruments
Interest rate swaps (a)	$	850	$	11	$	1	$	—	$	—	$	—

Foreign currency swaps (a)	21		—		3		39		2		—
Total derivatives designated as hedging instruments	871		11		4		39		2		—

Derivatives not designated as hedging instruments
Equity options (a)	29,651		1,062		—		29,594		773		—
Interest rate swaps (a)	6,453		83		3		5,145		19		10
Foreign currency swaps (a)	503		—		6		—		—		—
Futures contracts (a)	68		—		1		152		—		—
Other derivative investments (a)	93		—		—		118		1		—
Other embedded derivatives (b)	—		41		—		—		32		—
Indexed annuities/IUL embedded derivatives (c)	—		399		6,542		—		98		5,220
Reinsurance related embedded derivatives (d)	—		—		75		—		—		(109)
Total derivatives not designated as hedging instruments	36,768		1,585		6,627		35,009		923		5,121
Total derivatives	$	37,639	$	1,596	$	6,631	$	35,048	$	925	$	5,121

(b)The fair value is included in Other long term investments on the Consolidated Balance Sheets.

(c)The fair value of the liability is included in Contractholder funds and the ceded portion is included in Reinsurance recoverable on the Consolidated Balance Sheets.

(d)The fair value of the embedded derivative asset is included in Funds withheld for reinsurance liabilities as a contra-liability on the Consolidated Balance Sheet as of December 31, 2024.

The amounts and locations of gains losses, net recognized for derivatives items included in the Consolidated Statements of Earnings are as follows:


	Year Ended December 31,
	2025				2024				2023
	Recognized gains losses, net for derivatives		Benefits and other changes in policy reserves for derivatives		Recognized gains losses, net for derivatives		Benefits and other changes in policy reserves for derivatives		Recognized gains losses, net for derivatives		Benefits and other changes in policy reserves for derivatives
	(In millions)
Derivatives designated as hedging instruments
Interest rate swaps	$	—	$	11	$	—	$	—	$	—	$	—

Foreign currency swaps	(3)		—		—		—		—		—
Total derivatives designated as hedging instruments	(3)		11		—		—		—		—

Derivatives not designated as hedging instruments
Equity options	177		—		145		—		92		—
Interest rate swaps	60		—		(103)		—		48		—
Foreign currency swaps	(6)		—		—		—		—		—
Futures contracts	32		—		18		—		9		—
Other derivative investments	(9)		—		10		—		(2)		—
Other embedded derivatives	9		—		4		—		5		—
Indexed annuities/IUL embedded derivatives	—		402		—		47		—		257
Reinsurance related embedded derivatives	(148)		—		(32)		—		(128)		—
Total derivatives not designated as instruments	115		402		42		47		24		257
Total derivatives	$	112	$	413	$	42	$	47	$	24	$	257

The amounts and locations of gains losses, net recognized for hedged items included in the Consolidated Statements of Earnings are as follows:


	Year Ended December 31,
	2025				2024				2023
	Recognized gains losses, net for hedged item		Benefits and other changes in policy reserves for hedged item		Recognized gains losses, net for hedged item		Benefits and other changes in policy reserves for hedged item		Recognized gains losses, net for hedged item		Benefits and other changes in policy reserves for hedged item
	(In millions)
Derivatives designated as hedging instruments
Interest rate swaps	$	—	$	(11)	$	—	$	—	$	—	$	—

Foreign currency swaps	3		—		—		—		—		—
Total derivatives designated as hedging instruments	$	3	$	(11)	$	—	$	—	$	—	$	—


	Year Ended December 31,
	2025				2024
Line Item in the Consolidated Balance Sheet that includes hedged item	Carrying Amount of Hedged Assets (Liabilities)		Cumulative Amount of Fair Value Hedging Adjustment included in the Carrying Amount of the Hedged Assets (Liabilities)		Carrying Amount of Hedged Assets (Liabilities)		Cumulative Amount of Fair Value Hedging Adjustment included in the Carrying Amount of the Hedged Assets (Liabilities)
	(In millions)
Fixed maturity securities, AFS, at amortized cost	$	21	$	—	$	—	$	—
Contractholder funds	(862)		(11)		—		—

For the years ended December 31, 2025, 2024, and 2023, the derivative instruments’ gains losses, net excluded from the assessment of hedge effectiveness was immaterial.

There were no cumulative fair value hedging adjustments for hedged assets and liabilities for which hedge accounting was discontinued as of December 31, 2025 and 2024.

Derivatives designated as hedging instruments

We utilize interest rate swaps and foreign currency swaps that are designated and accounted for as fair value hedges to reduce interest rate risk for certain funding agreements and to reduce the risk of certain exposures to foreign currency risk for foreign AFS fixed maturity securities. For fair value hedges of funding agreements, changes in fair value are reported in Benefits and other changes in policy reserves. For fair value hedges of AFS fixed maturity securities, changes in fair value included in the assessment of effectiveness are reported in Recognized gains and losses, net in the Consolidated Statement of Earnings. The change in the fair value of components excluded from the assessment of hedge effectiveness is recorded in OCI and is recognized in net income through periodic settlements.

Derivatives not designated as hedging instruments

Indexed Annuities/IUL Embedded Derivative, Equity Options and Futures

We have indexed annuities and IUL contracts that permit the holder to elect an interest rate return or an equity index linked component, where interest credited to the contracts is linked to the performance of various equity indices, such as the S&P 500 Index. This feature represents an embedded derivative under GAAP. The indexed annuities/IUL embedded derivatives are valued at fair value and included in the liability for Contractholder funds in the Consolidated Balance Sheets with the ceded portion of the reinsured indexed crediting feature embedded derivatives, recorded as a component of the Reinsurance recoverable in the Consolidated Balance Sheets. Changes in fair value are included as a component of Benefits and other changes in policy reserves in the Consolidated Statements of Earnings.

We purchase derivatives consisting of a combination of equity options and futures contracts (specifically for indexed annuity contracts) on the applicable market indices to fund the index credits due to indexed annuity/IUL contractholders. The equity options are one, two, three, five and six year options purchased to match the funding requirements of the underlying policies. On the respective anniversary dates of the indexed policies, the index used to compute the interest credit is reset and we purchase new equity options to fund the next index credit. We manage the cost of these purchases through the terms of our indexed annuities/IUL contracts, which permit us to change caps, spreads or participation rates, subject to guaranteed minimums, on each contract’s anniversary date. The change in the fair value of the equity options and futures contracts is generally designed to offset the portion of the change in the fair value of the indexed annuities/IUL embedded derivatives related to index performance through the current credit period. The equity options and futures contracts are marked to fair value with the change in fair value included as a component of Recognized gains and losses, net, in the Consolidated Statements of Earnings. The change in fair value of the equity options and futures contracts includes the gains and losses recognized at the expiration of the instrument term or upon early termination and the changes in fair value of open positions.

Other market exposures are hedged periodically depending on market conditions and our risk tolerance. Our indexed annuities/IUL hedging strategy economically hedges the equity returns and exposes us to the risk that unhedged market exposures result in divergence between changes in the fair value of the liabilities and the hedging assets. We use a variety of techniques, including direct estimation of market sensitivities, to monitor this risk daily. We intend to continue to adjust the hedging strategy as market conditions and our risk tolerance changes.

Interest Rate Swaps

We utilize interest rate swaps to reduce market risks from interest rate changes on our earnings associated with our floating rate investments. With an interest rate swap, we agree with another party to exchange, at specified intervals, the difference between fixed-rate and floating-rate interest amounts tied to an agreed upon notional principal.

The interest rate swaps are marked to fair value with the change in fair value, including accrued interest and related periodic cash flows received or paid, included as a component of Recognized gains and losses, net, in the Consolidated Statements of Earnings.

Foreign Currency Swaps

We utilize foreign currency swaps to reduce market risks from fluctuations in foreign exchange rates that impact earnings associated with our foreign currency denominated investments. Through a foreign currency swap, we agree with another party to exchange, at specified intervals, principal and interest payments in one currency for principal and interest payments in another currency, based on an agreed-upon notional amount.

The foreign currency swaps are marked to fair value with the change in fair value, including accrued interest and related periodic cash flows received or paid, included as a component of Recognized gains and losses, net, in the Consolidated Statements of Earnings.

Reinsurance Related Embedded Derivatives

F&G cedes certain business on a coinsurance funds withheld basis. Investment results for the assets that support the coinsurance are segregated within the funds withheld account and are passed directly to the reinsurer pursuant to the contractual terms of the reinsurance agreement, which creates embedded derivatives considered to be total return swaps. These total return swaps are not clearly and closely related to the underlying reinsurance agreement and thus require bifurcation. For arrangements reinsuring indexed annuities products, the funds withheld account additionally contains an embedded derivative representing the index credit obligation due the reinsurer, resulting in a compound embedded derivative. Beginning in 2025, these embedded derivatives are reported in Funds withheld for reinsurance liabilities, irrespective if in a net asset position or a net liability position, on the Consolidated Balance Sheets and prior periods have been reclassified from Prepaid expenses and other assets to conform with the current presentation. The related gains or losses are reported in Recognized gains and losses, net, on the Consolidated Statements of Earnings.

Credit Risk

We are exposed to credit loss in the event of non-performance by our counterparties and reflect assumptions regarding this non-performance risk in the fair value of our derivatives. The non-performance risk is the net counterparty exposure based on the fair value of the open contracts less collateral held. We maintain a policy of requiring all derivative contracts to be governed by an International Swaps and Derivatives Association (“ISDA”) Master Agreement.

We manage credit risk related to non-performance by our counterparties by (i) entering into derivative transactions with creditworthy counterparties; (ii) obtaining collateral, such as cash and securities when appropriate; and (iii) establishing counterparty exposure limits, which are subject to periodic management review.

Information regarding our exposure to credit loss on the derivative instruments we hold, excluding futures contracts, is presented below:


		Fair Value		Collateral		Net Credit Risk
	(In millions)
December 31, 2025		$	1,137	$	1,185	$	34
December 31, 2024		782		771		34

Collateral Agreements

We are required to maintain minimum ratings as a matter of routine practice as part of our over-the-counter derivative agreements on ISDA forms. Under some ISDA agreements, we have agreed to maintain certain financial strength ratings. A downgrade below these levels provides the counterparty under the agreement the right to terminate the open derivative contracts between the parties, at which time any amounts payable by us or the counterparty would be dependent on the market value of the underlying contracts. Our current rating does not allow any counterparty the right to terminate ISDA agreements. In certain transactions, both us and the counterparty have entered into a collateral support agreement requiring either party to post collateral when the net exposures exceed pre-determined thresholds. For all counterparties, except one, the threshold is set to zero. As of December 31, 2025 and 2024, counterparties posted collateral of $1,185 million and $771 million, respectively. This included cash collateral of $928 million and $679 million, respectively, for which we record an associated payable included in Accounts payable and accrued liabilities on the Consolidated Balance Sheets. Cash collateral received is not legally segregated and may be used by the Company in the normal course of business. The Company is obligated to return an equivalent amount of collateral upon settlement or termination of the related derivative contracts, or otherwise in accordance with the collateral provisions of such agreements, including in circumstances where changes in market conditions cause the Company’s mark-to-market position to decline. The remaining collateral represents securities collateral received that is not reported on the Consolidated Balance Sheets. Accordingly, the maximum amount of loss due to credit risk that we would incur if parties to the derivatives failed completely to perform according to the terms of the contracts, after giving effect to cash and securities collateral held, was $34 million at both December 31, 2025 and 2024.

We are required to pay our counterparties the effective federal funds interest rate each day for cash collateral posted to us. Cash collateral is reinvested in overnight investment sweep products, which are included in Cash and cash equivalents on the Consolidated Balance Sheets, to reduce the interest cost. Changes in cash collateral are included in the Change in derivative collateral liabilities in the Consolidated Statements of Cash Flows.

We held 172 and 527 futures contracts at December 31, 2025 and 2024, respectively. The fair value of the futures contracts represents the cumulative unsettled variation margin (open trade equity, net of cash settlements). We provide cash collateral to the counterparties for the initial and variation margin on the futures contracts, which is included in Cash and cash equivalents in the Consolidated Balance Sheets. The amount of cash collateral held by the counterparties for such contracts was $4 million and $7 million at December 31, 2025 and 2024, respectively.

The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 182
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480401/815-10-55-182

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 185
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480401/815-10-55-185

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 184
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480401/815-10-55-184

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 181
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480401/815-10-55-181

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4K
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4K

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4K
-Subparagraph (a)(5)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4K

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4K
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4K

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4K
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4K

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4K
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4K

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4H
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4H

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4H
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4H

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 15
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480960/815-15-50-3

Reference 13: http://www.xbrl.org/2003/role/exampleRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 183
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480401/815-10-55-183

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4K
-Subparagraph (a)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4K

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4K
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4K

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4K
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4K

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4I
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4I

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4F
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4F

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-2

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-2

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(1)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-2

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(1)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-2

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(1)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-2

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-1B

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1A
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1A
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1A
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/815/tableOfContent

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480237/815-40-50-5

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5C
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-5C

Schedule of Stock Options Transactions

Employee Benefit Plans (Tables)

12 Months Ended

Dec. 31, 2025

Retirement Benefits [Abstract]

FNF stock option transactions under the F&G Omnibus Plan for 2025, 2024, and 2023 are as follows:


	Options	Weighted Average Exercise Price		Exercisable
Balance January 1, 2023	1,172,607	$	35.15	1,172,607

Exercised	(502,414)	30.31
Canceled	(26,570)	38.07
Balance, December 31, 2023	643,623	$	38.8	643,623
Exercised	(543,623)	38.74
Canceled	—	—
Balance, December 31, 2024	100,000	$	39.10	100,000

Exercised	(100,000)	39.10

Balance, December 31, 2025	—	$	—	—

Schedule of Restricted Stock Transactions

FNF restricted stock transactions under the Omnibus Plan in 2025, 2024, and 2023 are as follows:



	Shares	Weighted Average Grant Date Fair Value
Balance, December 31, 2022	1,841,544	$	41.59
Granted	966,093	44.44

Canceled	(23,975)	41.42
Vested	(908,267)	40.26
Balance, December 31, 2023	1,875,395	$	43.69
Granted	1,604,119	60.23
Canceled	(16,603)	45.92
Vested	(1,105,691)	47.21
Balance, December 31, 2024	2,357,220	$	53.28
Granted	862,320	57.50
Canceled	(12,617)	47.55
Vested	(1,101,388)	50.02
Balance, December 31, 2025	2,105,535	$	56.75

FNF restricted stock transactions under the F&G Omnibus Plan in 2025, 2024, and 2023 are as follows:


	Shares	Weighted Average Grant Date Fair Value
Balance, January 1, 2023	501,548	$	42.31
Granted	—	—
Canceled	(15,965)	45.63
Vested	(304,104)	42.87
Balance, December 31, 2023	181,479	$	41.08
Granted	—	—
Canceled	(13,082)	48.28
Vested	(168,397)	40.53
Balance, December 31, 2024	—	$	—
Granted	—	—
Canceled	—	—
Vested	—	—
Balance, December 31, 2025	—	$	—

Investments (Tables)

12 Months Ended

Dec. 31, 2025

Investments, Debt and Equity Securities [Abstract]

Schedule of Consolidated Investments

Our preferred and equity securities investments are carried at fair value with unrealized gains and losses included in net earnings.


	December 31, 2025
	Amortized Cost		Allowance for Expected Credit Losses		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
AFS securities	(In millions)
Asset-backed securities	$	18,853	$	(25)	$	166	$	(256)	$	18,738
Commercial mortgage-backed securities	5,341		(61)		58		(139)		5,199
Corporates	26,538		(25)		302		(2,368)		24,447
Hybrids	625		—		6		(22)		609
Municipals	1,604		—		4		(215)		1,393
Residential mortgage-backed securities	2,846		(1)		76		(70)		2,851
U.S. Government	954		—		5		(3)		956
Foreign Governments	400		—		5		(37)		368
Total AFS securities	$	57,161	$	(112)	$	622	$	(3,110)	$	54,561


	December 31, 2024
	Amortized Cost		Allowance for Expected Credit Losses		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
AFS securities	(In millions)
Asset-backed securities	$	15,784	$	(13)	$	202	$	(317)	$	15,656
Commercial mortgage-backed securities	5,379		(49)		53		(201)		5,182
Corporates	24,425		(5)		108		(2,832)		21,696
Hybrids	604		—		6		(29)		581
Municipals	1,638		—		3		(255)		1,386
Residential mortgage-backed securities	2,869		—		32		(105)		2,796
U.S. Government	645		—		2		(10)		637
Foreign Governments	337		—		—		(53)		284
Total AFS securities	$	51,681	$	(67)	$	406	$	(3,802)	$	48,218

Schedule of Investments Classified by Contractual Maturity Date


	December 31, 2025				December 31, 2024
	(in millions)				(in millions)
	Amortized Cost		Fair Value		Amortized Cost		Fair Value
Corporates, Non-structured Hybrids, Municipal, Foreign and U.S. Government Securities:
Due in one year or less	$	623	$	619	$	961	$	955
Due after one year through five years	5,597		5,626		4,616		4,544
Due after five years through ten years	5,811		5,812		5,311		5,126
Due after ten years	18,090		15,716		16,761		13,959
Subtotal	30,121		27,773		27,649		24,584
Other securities, which provide for periodic payments:
Asset-backed securities	18,853		18,738		15,784		15,656
Commercial mortgage-backed securities	5,341		5,199		5,379		5,182

Residential mortgage-backed securities	2,846		2,851		2,869		2,796
Subtotal	27,040		26,788		24,032		23,634
Total fixed maturity AFS securities	$	57,161	$	54,561	$	51,681	$	48,218

Schedule of Fair Value and Gross Unrealized Losses of Available-for-sale Securities


	December 31, 2025
	Less than 12 months				12 months or longer				Total
	Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses
AFS securities	(Dollars in millions)
Asset-backed securities	$	4,756	$	(30)	$	2,160	$	(209)	$	6,916	$	(239)
Commercial mortgage-backed securities	542		(11)		1,051		(106)		1,593		(117)
Corporates	3,419		(55)		10,097		(2,312)		13,516		(2,367)
Hybrids	61		(1)		372		(21)		433		(22)
Municipals	201		(3)		1,050		(212)		1,251		(215)
Residential mortgage-backed securities	208		(2)		390		(67)		598		(69)
U.S. Government	353		(1)		84		(2)		437		(3)
Foreign Government	60		—		148		(37)		208		(37)
Total AFS securities	$	9,600	$	(103)	$	15,352	$	(2,966)	$	24,952	$	(3,069)
Total number of available-for-sale securities in an unrealized loss position less than twelve months											1,962
Total number of available-for-sale securities in an unrealized loss position twelve months or longer											2,194
Total number of available-for-sale securities in an unrealized loss position											4,156


	December 31, 2024
	Less than 12 months				12 months or longer				Total
	Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses
AFS securities
Asset-backed securities	$	1,164	$	(30)	$	2,637	$	(276)	$	3,801	$	(306)
Commercial mortgage-backed securities	727		(11)		1,513		(175)		2,240		(186)
Corporates	6,831		(208)		9,866		(2,624)		16,697		(2,832)
Hybrids	105		(4)		380		(25)		485		(29)
Municipals	261		(12)		1,006		(243)		1,267		(255)
Residential mortgage-backed securities	899		(16)		460		(89)		1,359		(105)
U.S. Government	313		(4)		122		(5)		435		(9)
Foreign Government	120		(5)		157		(48)		277		(53)
Total AFS securities	$	10,420	$	(290)	$	16,141	$	(3,485)	$	26,561	$	(3,775)
Total number of available-for-sale securities in an unrealized loss position less than twelve months											2,005
Total number of available-for-sale securities in an unrealized loss position twelve months or longer											2,305
Total number of available-for-sale securities in an unrealized loss position											4,310

Schedule of Distribution of CMLs, Gross Valuation by Property Type and Geographic Region

The distribution of CMLs, gross of valuation allowances, by property type and geographic region is reflected in the following tables:


	December 31, 2025				December 31, 2024
	Gross Carrying Value		% of Total		Gross Carrying Value		% of Total
Property Type:	(Dollars in millions)


Hotel	$	9	—	%	$	17	1	%
Industrial	671		21		657		24
Mixed Use	21		1		11		—
Multifamily	1,150		35		1,006		37
Office	345		11		349		13
Retail	327		10		98		4
Student Housing	83		3		83		3
Other	654		19		501		18
Total CMLs, gross of valuation allowance	$	3,260	100	%	$	2,722	100	%
Allowance for expected credit loss	(18)				(17)
Total CMLs, net of valuation allowance	$	3,242			$	2,705

U.S. Region:
East North Central	$	124	4	%	$	98	4	%
East South Central	86		3		75		3
Middle Atlantic	356		11		354		13
Mountain	396		12		409		15
New England	183		6		164		6
Pacific	709		22		706		26
South Atlantic	1,157		34		683		25
West North Central	69		2		62		2
West South Central	180		6		171		6

Total CMLs, gross of valuation allowance	$	3,260	100	%	$	2,722	100	%
Allowance for expected credit loss	(18)				(17)
Total CMLs, net of valuation allowance	$	3,242			$	2,705

Schedule of Loans Segregated by Risk Rating Exposure


	December 31, 2025

	Amortized Cost by Origination Year
	2025		2024		2023		2022		2021		Prior		Total
CMLs	(In millions)
Current (less than 30 days past due)	$	646	$	295	$	194	$	292	$	1,252	$	569	$	3,248
30-89 days past due	—		—		—		—		—		—		—
90 days or more past due	—		—		—		—		—		12		12
Total CMLs	$	646	$	295	$	194	$	292	$	1,252	$	581	$	3,260


	December 31, 2024

	Amortized Cost by Origination Year
	2024		2023		2022		2021		2020		Prior		Total
CMLs	(In millions)
Current (less than 30 days past due)	$	273	$	227	$	290	$	1,253	$	469	$	201	$	2,713
30-89 days past due	—		—		—		—		—		—		—
90 days or more past due	—		—		—		—		—		9		9
Total CMLs	$	273	$	227	$	290	$	1,253	$	469	$	210	$	2,722


	December 31, 2025

	Amortized Cost by Origination Year
	2025		2024		2023		2022		2021		Prior		Total
RMLs	(In millions)
Current (less than 30 days past due)	$	1,568	$	736	$	327	$	798	$	731	$	419	$	4,579
30-89 days past due	15		2		17		29		4		3		70
90 days or more past due	2		4		4		12		21		25		68
Total RMLS	$	1,585	$	742	$	348	$	839	$	756	$	447	$	4,717


	December 31, 2024

	Amortized Cost by Origination Year
	2024		2023		2022		2021		2020		Prior		Total
RMLs	(In millions)
Current (less than 30 days past due)	$	610	$	368	$	911	$	805	$	162	$	312	$	3,168
30-89 days past due	1		6		4		6		1		3		21
90 days or more past due	3		2		13		29		13		25		85
Total RMLS	$	614	$	376	$	928	$	840	$	176	$	340	$	3,274

Schedule of Investment in Mortgage Loans by Loan to Value and Debt Service Coverage Ratios

The following tables present the recorded investment in CMLs by LTV and DSC ratio categories and estimated fair value by the indicated LTV ratios, gross of valuation allowances:


	Debt-Service Coverage Ratios						Total Amount	% of Total		Estimated Fair Value		% of Total
	>1.25		1.00 - 1.25		<1.00
December 31, 2025	(Dollars in millions)
LTV Ratios:
Less than 50.00%	$	594	$	16	$	—		$	610	19	%	$	596	19	%
50.00% to 59.99%	850		36		37			923		28		852		28
60.00% to 74.99%	1,415		288		6			1,709		52		1,560		52
75.00% to 84.99%	—		9		9			18		1		17		1
Total CMLs	$	2,859	$	349	$	52		$	3,260	100	%	$	3,025	100	%

December 31, 2024
LTV Ratios:
Less than 50.00%	$	490	$	34	$	—		$	524	19	%	$	501	21	%
50.00% to 59.99%	803		112		12			927		34		826		34
60.00% to 74.99%	1,238		16		—			1,254		46		1,060		44
75.00% to 84.99%	4		4		9			17		1		17		1
Total CMLs	$	2,535	$	166	$	21		$	2,722	100	%	$	2,404	100	%


	December 31, 2025

	Amortized Cost by Origination Year
	2025		2024		2023		2022		2021		Prior		Total
LTV Ratios:	(In millions)
Less than 50.00%	$	148	$	49	$	66	$	21	$	75	$	251	$	610
50.00% to 59.99%	157		36		53		149		320		208		923
60.00% to 74.99%	341		206		70		113		857		122		1,709
75.00% to 84.99%	—		4		5		9		—		—		18

Total CMLs	$	646	$	295	$	194	$	292	1,252		$	581	3,260
DSC Ratios
Greater than 1.25x	$	469	$	140	$	182	$	283	$	1,240	$	545	$	2,859
1.00x - 1.25x	169		155		12		—		—		13		349
Less than 1.00x	8		—		—		9		12		23		52
Total CMLs	$	646	$	295	$	194	$	292	$	1,252	$	581	$	3,260


	December 31, 2024

	Amortized Cost by Origination Year
	2024		2023		2022		2021		2020		Prior		Total
LTV Ratios:	(In millions)
Less than 50.00%	$	66	$	99	$	19	$	74	$	189	$	77	$	524
50.00% to 59.99%	112		53		149		321		159		133		927
60.00% to 74.99%	91		71		113		858		121		—		1,254
75.00% to 84.99%	4		4		9		—		—		—		17
Total CMLs	$	273	$	227	$	290	$	1,253	$	469	$	210	$	2,722
DSC Ratios
Greater than 1.25x	$	140	$	215	$	278	$	1,241	$	469	$	192	$	2,535
1.00x - 1.25x	133		12		3		—		—		18		166
Less than 1.00x	—		—		9		12		—		—		21
Total CMLs	$	273	$	227	$	290	$	1253	$	469	$	210	$	2,722

Schedule of Residential Mortgage Loans by State

The distribution of RMLs by state with highest-to-lowest concentration are reflected in the following tables, gross of valuation allowances:


	December 31, 2025
U.S. States:	Amortized Cost (In millions)		% of Total
California	$	288	6	%
Florida	246		5
New York	232		5




All other states (a)	3,951		84
Total RMLs, gross of valuation allowance	$	4,717	100	%
Allowance for expected credit loss	(68)
Total RMLs, net of valuation allowance	$	4,649

(a) The individual concentration of each state is less than 5% as of December 31, 2025.


	December 31, 2024
U.S. States:	Amortized Cost (In millions)		% of Total
Florida	$	164	5	%






All other states (a)	3,110		95
Total RMLs, gross of valuation allowance	$	3,274	100	%
Allowance for expected credit loss	(53)
Total RMLs, net of valuation allowance	$	3,221

(a) The individual concentration of each state is less than 5% as of December 31, 2024.

Schedule of Loans with Credit Quality Indicators, Performing or Nonperforming

The credit quality of RMLs was as follows:


	December 31, 2025				December 31, 2024
	Amortized Cost		% of Total		Amortized Cost		% of Total
Performance indicators:	(In millions)						(In millions)
Performing	$	4,650	99	%	$	3,188	97	%
Non-performing	67		1		86		3
Total RMLs, gross of valuation allowance	$	4,717	100	%	$	3,274	100	%
Allowance for expected loan loss	(68)				(53)
Total RMLs, net of valuation allowance	$	4,649			$	3,221

Schedule of Nonaccrual Loans by Amortized Cost

Non-accrual loans by amortized cost as of December 31, 2025 and 2024 were as follows:


	December 31, 2025		December 31, 2024
	(In millions)
Residential mortgage	$	67	$	85
Commercial mortgage	12		9
Total non-accrual mortgages	$	79	$	94

Schedule of Changes in Allowance for Expected Credit Losses on Loans

The allowances for our mortgage loan portfolio are summarized as follows:


	Year ended December 31, 2025			Year ended December 31, 2024
	( In millions)			( In millions)
		Residential Mortgage		Commercial Mortgage		Total		Residential Mortgage		Commercial Mortgage		Total
Beginning Balance		$	(53)	$	(17)	$	(70)	$	(54)	$	(12)	$	(66)
Provision (expense) benefit for loan losses		(15)		(1)		(16)		1		(5)		(4)




Ending Balance		$	(68)	$	(18)	$	(86)	$	(53)	$	(17)	$	(70)

Schedule of Sources of Net Investment Income Reported

The major sources of Interest and investment income reported on the Consolidated Statements of Earnings were as follows:


	Year ended
		December 31, 2025		December 31, 2024		December 31, 2023
		(In millions)
Fixed maturity securities, available-for-sale		$	2,329	$	2,261	$	1,911
Preferred equity securities		26		34		52
Common equity securities		36		33		33
Mortgage loans		374		273		229

Invested cash and short-term investments		180		238		151

Limited partnerships		305		326		231
Tax deferred property exchange income		122		133		166
Other investments		136		125		91
Gross investment income		3,508		3,423		2,864
Investment expense		(271)		(299)		(257)
Interest and investment income		$	3,237	$	3,124	$	2,607

Schedule of Recognized Gains and Losses, net

Details underlying Recognized gains and losses, net reported on the Consolidated Statements of Earnings were as follows:


	Year ended
		December 31, 2025		December 31, 2024		December 31, 2023
		(In millions)
Net realized (losses) on fixed maturity available-for-sale securities		$	(10)	$	(9)	$	(155)
Net realized/unrealized (losses) gains on preferred equity securities (a)		(167)		2		23
Net realized/unrealized (losses) gains on common equity securities (b)		(4)		12		(1)
Net realized gains (losses) on other invested assets		70		61		(25)
Change in allowance for expected credit losses		(60)		(33)		(36)
Derivatives and embedded derivatives:
Realized (losses) gains on certain derivative instruments		(62)		254		(211)
Unrealized gains (losses) on certain derivative instruments		312		(184)		358
Change in fair value of reinsurance related embedded derivatives (c)		(148)		(32)		(128)
Change in fair value of other derivatives and embedded derivatives		9		12		11
Net realized/unrealized gains on derivatives and embedded derivatives		111		50		30
Recognized gains and losses, net		$	(60)	$	83	$	(164)

(a) Includes net valuation (losses) gains of $(8) million, $(131) million, and $47 million for the years ended December 31, 2025, 2024, and 2023, respectively.

(b) Includes net valuation gains (losses) of $(1) million, $13 million, and $80 million for the years ended December 31, 2025, 2024, and 2023, respectively

(c) Change in fair value of reinsurance related embedded derivatives is due to activity related to the reinsurance treaties.

Schedule of Proceeds from Sale of Fixed Maturity Available-for-sale Securities

The proceeds from the sale of fixed-maturity securities and the gross gains and losses associated with those transactions were as follows:


	Year ended
		December 31, 2025		December 31, 2024		December 31, 2023
		(In millions)
Proceeds		$	5,720	$	4,414	$	2,698
Gross gains		30		45		18
Gross losses		(27)		(80)		(145)

Schedule of Variable Interest Entities

Asset and liability information held by consolidated VIEs included on the Consolidated Balance Sheets are as follows:


	December 31,
	2025		2024

Assets	(In millions)

Investments in unconsolidated affiliates	$	262		$	—
Other long-term investments	248			—
Short-term investments	116			—
Cash and cash equivalents	2			—
Total assets	$	628		$	—




Total consolidated VIE investments	$	628		$	—

Schedule of Carrying Value and Maximum Loss Exposure, Unconsolidated VIEs

The following table summarizes the carrying value and the maximum loss exposure of our unconsolidated VIEs:


	December 31, 2025				December 31, 2024
	Carrying Value		Maximum Loss Exposure		Carrying Value		Maximum Loss Exposure
	(In millions)
Investment in unconsolidated affiliates	$	5,145	$	6,389	$	3,565	$	4,703
Fixed maturity securities	26,419		28,803		23,242		24,242
Total unconsolidated VIE investments	$	31,564	$	35,192	$	26,807	$	28,945

Business and Summary of Significant Accounting Policies - Management Estimates (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Accounting Policies [Abstract]
Change in total benefits and other changes in policy reserves (decrease) increase	$ (20)	$ (89)	$ 73

Income Taxes - Tax Expense (Benefit) on Continuing Operations (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Current tax expense
Federal	$ 76
State	23
Foreign	16
Total current tax expense	115	$ 360	$ 241
Deferred tax expense
Federal	599
State	39
Total deferred tax expense	638	7	(49)
Effective tax rate	$ 753	$ 367	$ 192

Future Policy Benefits - Reconciliation of Net FPB to the Condensed Consolidated Balance Sheets (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Liability for Future Policy Benefit, Activity
Future policy benefits	$ 10,755	$ 8,749
Traditional life
Liability for Future Policy Benefit, Activity
Future policy benefits	1,270	1,302
Immediate annuities
Liability for Future Policy Benefit, Activity
Future policy benefits	1,276	1,297
Deferred profit liability	90	90	$ 87
PRT
Liability for Future Policy Benefit, Activity
Future policy benefits	8,112	6,054
Immediate annuities DPL
Liability for Future Policy Benefit, Activity
Deferred profit liability	90	90
PRT DPL
Liability for Future Policy Benefit, Activity
Deferred profit liability	$ 7	$ 6

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480081/944-40-50-6

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (b)(6)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480081/944-40-50-6

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (b)(5)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480081/944-40-50-6

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (b)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480081/944-40-50-6

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (b)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480081/944-40-50-6

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480081/944-40-50-6

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480016/944-40-65-2

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480081/944-40-50-6

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 29E
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480046/944-40-55-29E

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480081/944-40-50-6

Supplemental Cash Flow Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Cash paid for:
Interest	$ 229	$ 200	$ 157
Income taxes	250	237	216
Deferred sales inducements	332	319	168
Non-cash investing and financing activities:
Investments transferred subject to reinsurance agreement	(500)	0	0
Investments received from pension risk transfer premiums	0	129	464
Change in proceeds of sales of investments available for sale receivable in period	20	(59)	32
Change in purchases of investments available for sale payable in period	9	82	20
Lease liabilities recognized in exchange for lease right-of-use assets	45	55	40
Remeasurement of lease liabilities	54	67	75
Liabilities assumed in connection with acquisitions
Fair value of assets acquired	6	789	304
Less: Total Purchase price	3	586	299
Liabilities and noncontrolling interests assumed	$ 3	$ 203	$ 5

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Statement of Financial Position [Abstract]
Available-for-sale securities, amortized cost, net	$ 57,161	$ 51,681
Available for sale securities, allowance for credit losses	112	67
Available-for-sale securities, pledged securities, secured trust deposits	446	495
Mortgage loans, allowance for credit loss	86	70
Cash, pledged, secured trust deposits	261	69
Allowance for doubtful accounts, premiums and other receivables	31	32
Expected credit losses on reinsurance recoverable	$ 18	$ 20
Common stock, par value per share (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	600,000,000	600,000,000
Common stock, shares outstanding (in shares)	271,000,000	275,000,000
Common stock, shares issued (in shares)	332,000,000	331,000,000
Preferred stock, par or stated value per share (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	50,000,000	50,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Treasury stock (in shares)	61,000,000	56,000,000

Investments - Amortized Costs of Non-accrual Loans (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Financing Receivable, Credit Quality Indicator [Line Items]
Total non-accrual mortgages	$ 79	$ 94
Residential mortgage
Financing Receivable, Credit Quality Indicator [Line Items]
Total non-accrual mortgages	67	85
Commercial mortgage
Financing Receivable, Credit Quality Indicator [Line Items]
Total non-accrual mortgages	$ 12	$ 9

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 326
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479294/326-20-55-12

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 326
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479294/326-20-55-12

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 326
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479294/326-20-55-12

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 326
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Subparagraph (d)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479294/326-20-55-12

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 326
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Subparagraph (d)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479294/326-20-55-12

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 326
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Subparagraph (d)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479294/326-20-55-12

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 326
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479294/326-20-55-12

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 326
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479294/326-20-55-12

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 326
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 15
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479294/326-20-55-15

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 326
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479319/326-20-50-5

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Topic 326
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 15
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479294/326-20-55-15

Reference 12: http://www.xbrl.org/2003/role/exampleRef
-Topic 326
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479294/326-20-55-12

Reference 13: http://www.xbrl.org/2003/role/exampleRef
-Topic 326
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479294/326-20-55-12

Reference 14: http://www.xbrl.org/2003/role/exampleRef
-Topic 326
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Subparagraph (e)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479294/326-20-55-12

Reference 15: http://www.xbrl.org/2003/role/exampleRef
-Topic 326
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479294/326-20-55-12

Reference 16: http://www.xbrl.org/2003/role/exampleRef
-Topic 326
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Subparagraph (b)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479294/326-20-55-12

Reference 17: http://www.xbrl.org/2003/role/exampleRef
-Topic 326
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Subparagraph (b)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479294/326-20-55-12

Reference 18: http://www.xbrl.org/2003/role/exampleRef
-Topic 326
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 12
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479294/326-20-55-12

Reference 19: http://www.xbrl.org/2003/role/exampleRef
-Topic 326
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 15
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479294/326-20-55-15

Reference 20: http://www.xbrl.org/2003/role/exampleRef
-Topic 326
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 15
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479294/326-20-55-15

Reference 21: http://www.xbrl.org/2003/role/exampleRef
-Topic 326
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 15
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479294/326-20-55-15

Reference 22: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 310
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 29
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481962/310-10-50-29

Reference 23: http://www.xbrl.org/2003/role/exampleRef
-Topic 326
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 79
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479294/326-20-55-79

Schedules of Title Insurance Premiums as a Percentage of Total Title Insurance Premiums Written

Investments - Consolidated Investments (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
AFS securities
Amortized Cost	$ 57,161	$ 51,681
Allowance for Expected Credit Losses	(112)	(67)
Gross Unrealized Gains	622	406
Gross Unrealized Losses	(3,110)	(3,802)
Fair Value	54,561	48,218
Asset-backed securities
AFS securities
Amortized Cost	18,853	15,784
Allowance for Expected Credit Losses	(25)	(13)
Gross Unrealized Gains	166	202
Gross Unrealized Losses	(256)	(317)
Fair Value	18,738	15,656
Commercial mortgage-backed securities
AFS securities
Amortized Cost	5,341	5,379
Allowance for Expected Credit Losses	(61)	(49)
Gross Unrealized Gains	58	53
Gross Unrealized Losses	(139)	(201)
Fair Value	5,199	5,182
Corporates
AFS securities
Amortized Cost	26,538	24,425
Allowance for Expected Credit Losses	(25)	(5)
Gross Unrealized Gains	302	108
Gross Unrealized Losses	(2,368)	(2,832)
Fair Value	24,447	21,696
Hybrids
AFS securities
Amortized Cost	625	604
Allowance for Expected Credit Losses	0	0
Gross Unrealized Gains	6	6
Gross Unrealized Losses	(22)	(29)
Fair Value	609	581
Municipals
AFS securities
Amortized Cost	1,604	1,638
Allowance for Expected Credit Losses	0	0
Gross Unrealized Gains	4	3
Gross Unrealized Losses	(215)	(255)
Fair Value	1,393	1,386
Residential mortgage-backed securities
AFS securities
Amortized Cost	2,846	2,869
Allowance for Expected Credit Losses	(1)	0
Gross Unrealized Gains	76	32
Gross Unrealized Losses	(70)	(105)
Fair Value	2,851	2,796
U.S. Government
AFS securities
Amortized Cost	954	645
Allowance for Expected Credit Losses	0	0
Gross Unrealized Gains	5	2
Gross Unrealized Losses	(3)	(10)
Fair Value	956	637
Foreign Governments
AFS securities
Amortized Cost	400	337
Allowance for Expected Credit Losses	0	0
Gross Unrealized Gains	5	0
Gross Unrealized Losses	(37)	(53)
Fair Value	$ 368	$ 284

Financial Instruments with Off-Balance Sheet Risk and Concentration of Risk (Tables)

12 Months Ended

Dec. 31, 2025

Risks and Uncertainties [Abstract]

Title insurance premiums as a percentage of the total title insurance premiums written from those five states are detailed as follows:


	2025		2024		2023
Texas	14.1	%	13.8	%	14.3	%
California	12.2	%	12.9	%	13.0	%
Florida	9.4	%	10.2	%	10.7	%
Illinois	5.8	%	5.8	%	6.0	%
Pennsylvania	5.4	%	5.2	%	4.9	%

Fair Value of Financial Instruments - Changes to Fair Value of Financial Instruments Level 3 (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	$ 11,832	$ 9,697
Balance at End of Period	14,530	11,832
Liabilities
Balance at Beginning of Period	5,843	4,661
Balance at End of Period	7,526	5,843
Indexed annuities/ IUL embedded derivatives, included in Contractholder funds
Liabilities
Balance at Beginning of Period	5,220	4,258
Liabilities, Total Gains (Losses) Included in Earnings	450	45
Liabilities, Total Gains (Losses) Included in AOCI	0	0
Liabilities, Purchases	1,357	1,351
Liabilities, Sales	0	0
Liabilities, Settlements	(485)	(434)
Liabilities, Net transfer In (Out) of Level 3	0	0
Balance at End of Period	6,542	5,220
Change in Unrealized Incl in OCI	0	0
Interest rate swaps
Liabilities
Balance at Beginning of Period	0	0
Liabilities, Total Gains (Losses) Included in Earnings	9	28
Liabilities, Total Gains (Losses) Included in AOCI	0	0
Liabilities, Purchases	0	0
Liabilities, Sales	0	0
Liabilities, Settlements	0	0
Liabilities, Net transfer In (Out) of Level 3	0	(28)
Balance at End of Period	9	0
Change in Unrealized Incl in OCI	0	0
Contingent consideration, included in Accounts payable and accrued liabilities
Liabilities
Balance at Beginning of Period	74	0
Liabilities, Total Gains (Losses) Included in Earnings	10	26
Liabilities, Total Gains (Losses) Included in AOCI	0	0
Liabilities, Purchases	0	48
Liabilities, Sales	0	0
Liabilities, Settlements	(12)	0
Liabilities, Net transfer In (Out) of Level 3	0	0
Balance at End of Period	72	74
Change in Unrealized Incl in OCI	0	0
Asset-backed securities
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	8,143	7,122
Assets, Total Gains (Losses) Included in Earnings	(5)	19
Assets, Total Gains (Losses) Included in AOCI	80	128
Assets, Purchases	3,688	5,104
Assets, Sales	(433)	(2,825)
Assets, Settlements	(1,228)	(1,210)
Assets, Net transfer In (Out) of Level 3	(151)	(195)
Balance at End of Period	10,094	8,143
Change in Unrealized Incl in OCI	73	130
Commercial mortgage-backed securities
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	0	18
Assets, Total Gains (Losses) Included in Earnings	0	0
Assets, Total Gains (Losses) Included in AOCI	0	0
Assets, Purchases	46	58
Assets, Sales	0	0
Assets, Settlements	0	0
Assets, Net transfer In (Out) of Level 3	(46)	(76)
Balance at End of Period	0	0
Change in Unrealized Incl in OCI	0	0
Corporates
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	2,957	1,979
Assets, Total Gains (Losses) Included in Earnings	(12)	(3)
Assets, Total Gains (Losses) Included in AOCI	72	81
Assets, Purchases	1,490	1,148
Assets, Sales	(889)	(100)
Assets, Settlements	(407)	(139)
Assets, Net transfer In (Out) of Level 3	(66)	(9)
Balance at End of Period	3,145	2,957
Change in Unrealized Incl in OCI	73	80
Hybrids
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	0
Assets, Total Gains (Losses) Included in Earnings	0
Assets, Total Gains (Losses) Included in AOCI	0
Assets, Purchases	15
Assets, Sales	0
Assets, Settlements	0
Assets, Net transfer In (Out) of Level 3	0
Balance at End of Period	15	0
Change in Unrealized Incl in OCI	0
Municipals
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	0	49
Assets, Total Gains (Losses) Included in Earnings	0	0
Assets, Total Gains (Losses) Included in AOCI	0	1
Assets, Purchases	4	0
Assets, Sales	0	(50)
Assets, Settlements	(1)	0
Assets, Net transfer In (Out) of Level 3	0	0
Balance at End of Period	3	0
Change in Unrealized Incl in OCI	0	1
Residential mortgage-backed securities
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	3	3
Assets, Total Gains (Losses) Included in Earnings	0	0
Assets, Total Gains (Losses) Included in AOCI	0	0
Assets, Purchases	2	1
Assets, Sales	0	0
Assets, Settlements	0	0
Assets, Net transfer In (Out) of Level 3	(2)	(1)
Balance at End of Period	3	3
Change in Unrealized Incl in OCI	0	0
Foreign Governments
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	4	16
Assets, Total Gains (Losses) Included in Earnings	0	0
Assets, Total Gains (Losses) Included in AOCI	2	(1)
Assets, Purchases	19	0
Assets, Sales	0	0
Assets, Settlements	(2)	(11)
Assets, Net transfer In (Out) of Level 3	0	0
Balance at End of Period	23	4
Change in Unrealized Incl in OCI	1	(1)
Preferred equity securities
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	8	8
Assets, Total Gains (Losses) Included in Earnings	(1)	0
Assets, Total Gains (Losses) Included in AOCI	1	0
Assets, Purchases	0	0
Assets, Sales	0	0
Assets, Settlements	0	0
Assets, Net transfer In (Out) of Level 3	0	0
Balance at End of Period	8	8
Change in Unrealized Incl in OCI	0	0
Common equity securities
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	10
Assets, Total Gains (Losses) Included in Earnings	2
Assets, Total Gains (Losses) Included in AOCI	0
Assets, Purchases	5
Assets, Sales	0
Assets, Settlements	0
Assets, Net transfer In (Out) of Level 3	0
Balance at End of Period	17	10
Change in Unrealized Incl in OCI	0
Equity securities
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	10	15
Assets, Total Gains (Losses) Included in Earnings		(5)
Assets, Total Gains (Losses) Included in AOCI		0
Assets, Purchases		0
Assets, Sales		0
Assets, Settlements		0
Assets, Net transfer In (Out) of Level 3		0
Balance at End of Period		10
Change in Unrealized Incl in OCI		0
Derivative investments
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	3	57
Assets, Total Gains (Losses) Included in Earnings		(50)
Assets, Total Gains (Losses) Included in AOCI		3
Assets, Purchases		0
Assets, Sales		0
Assets, Settlements		0
Assets, Net transfer In (Out) of Level 3		(7)
Balance at End of Period		3
Change in Unrealized Incl in OCI		1
Interest rate swaps
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	3
Assets, Total Gains (Losses) Included in Earnings	(2)
Assets, Total Gains (Losses) Included in AOCI	(2)
Assets, Purchases	1
Assets, Sales	0
Assets, Settlements	0
Assets, Net transfer In (Out) of Level 3	0
Balance at End of Period	0	3
Change in Unrealized Incl in OCI	(2)
Investment in unconsolidated affiliates
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	272	285
Assets, Total Gains (Losses) Included in Earnings	(2)	79
Assets, Total Gains (Losses) Included in AOCI	0	0
Assets, Purchases	0	0
Assets, Sales	0	0
Assets, Settlements	0	0
Assets, Net transfer In (Out) of Level 3	0	(92)
Balance at End of Period	270	272
Change in Unrealized Incl in OCI	0	0
Other assets
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	65	0
Assets, Total Gains (Losses) Included in Earnings	(4)	0
Assets, Total Gains (Losses) Included in AOCI	0	0
Assets, Purchases	85	65
Assets, Sales	(17)	0
Assets, Settlements	0	0
Assets, Net transfer In (Out) of Level 3	0	0
Balance at End of Period	129	65
Change in Unrealized Incl in OCI	0	0
Short-term investments
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	37	0
Assets, Total Gains (Losses) Included in Earnings	0	0
Assets, Total Gains (Losses) Included in AOCI	0	0
Assets, Purchases	75	236
Assets, Sales	0	(190)
Assets, Settlements	(38)	(9)
Assets, Net transfer In (Out) of Level 3	0	0
Balance at End of Period	74	37
Change in Unrealized Incl in OCI	0	0
Available-for-sale embedded derivative
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	32	27
Assets, Total Gains (Losses) Included in Earnings	0	0
Assets, Total Gains (Losses) Included in AOCI	9	5
Assets, Purchases	0	0
Assets, Sales	0	0
Assets, Settlements	0	0
Assets, Net transfer In (Out) of Level 3	0	0
Balance at End of Period	41	32
Change in Unrealized Incl in OCI	9	5
Credit linked note
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	0	10
Assets, Total Gains (Losses) Included in Earnings		1
Assets, Total Gains (Losses) Included in AOCI		0
Assets, Purchases		0
Assets, Sales		0
Assets, Settlements		(11)
Assets, Net transfer In (Out) of Level 3		0
Balance at End of Period		0
Change in Unrealized Incl in OCI		0
Indexed annuities/IUL ceded embedded derivatives
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	98	20
Assets, Total Gains (Losses) Included in Earnings	48	(2)
Assets, Total Gains (Losses) Included in AOCI	0	0
Assets, Purchases	256	81
Assets, Sales	0	0
Assets, Settlements	(3)	(1)
Assets, Net transfer In (Out) of Level 3	0	0
Balance at End of Period	399	98
Change in Unrealized Incl in OCI	0	0
Loan receivable
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	11	0
Assets, Total Gains (Losses) Included in Earnings	0	0
Assets, Total Gains (Losses) Included in AOCI	0	0
Assets, Purchases	13	11
Assets, Sales	0	0
Assets, Settlements	0	0
Assets, Net transfer In (Out) of Level 3	0	0
Balance at End of Period	24	11
Change in Unrealized Incl in OCI	0	0
Subtotal Level 3 assets at fair value
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	11,643	9,609
Assets, Total Gains (Losses) Included in Earnings	24	39
Assets, Total Gains (Losses) Included in AOCI	162	217
Assets, Purchases	5,699	6,704
Assets, Sales	(1,339)	(3,165)
Assets, Settlements	(1,679)	(1,381)
Assets, Net transfer In (Out) of Level 3	(265)	(380)
Balance at End of Period	14,245	11,643
Change in Unrealized Incl in OCI	$ 154	$ 216
Liabilities
Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Asset, Gain (Loss), Statement of Other Comprehensive Income or Comprehensive Income [Extensible Enumeration]	Unrealized gain (loss) on investments and other financial instruments, net of adjustments to intangible assets and unearned revenue (excluding investments in unconsolidated affiliates)	Unrealized gain (loss) on investments and other financial instruments, net of adjustments to intangible assets and unearned revenue (excluding investments in unconsolidated affiliates)
Market risk benefits asset
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	$ 189	$ 88
Balance at End of Period	285	189
Subtotal Level 3 liabilities at fair value
Liabilities
Balance at Beginning of Period	5,294	4,258
Liabilities, Total Gains (Losses) Included in Earnings	469	99
Liabilities, Total Gains (Losses) Included in AOCI	0	0
Liabilities, Purchases	1,357	1,399
Liabilities, Sales	0	0
Liabilities, Settlements	(497)	(434)
Liabilities, Net transfer In (Out) of Level 3	0	(28)
Balance at End of Period	6,623	5,294
Change in Unrealized Incl in OCI	$ 0	$ 0
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Recognized gains and losses, net	Recognized gains and losses, net
Market risk benefits liability
Liabilities
Balance at Beginning of Period	$ 549	$ 403
Balance at End of Period	$ 903	$ 549

Schedule III - F&G Supplementary Insurance Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Abstract]
Deferred acquisition costs	$ 3,637	$ 3,036	$ 2,215
Future policy benefits, losses, claims and loss expenses	10,755	8,749	7,050
Other policy claims and benefits payable	100	102	92
Life insurance premiums and other fees	2,795	2,860	2,413
Interest and investment income	2,837	2,719	2,211
Benefits, claims, losses and settlement expenses	(3,963)	(3,791)	(3,553)
Amortization of deferred policy acquisition costs	(357)	(280)	(191)
Other operating expenses, net of deferrals	$ (156)	$ (203)	$ (146)

Fair Value of Financial Instruments (Tables)

12 Months Ended

Dec. 31, 2025

Fair Value Disclosures [Abstract]

Schedule of Carrying Amounts of Assets and Liabilities and Estimated at Fair Value on Recurring Basis

Our assets and liabilities measured and carried at fair value on a recurring basis, summarized according to the hierarchy previously described, are as follows:


	December 31, 2025
	Level 1		Level 2		Level 3		NAV		Fair Value
Assets	(In millions)
Cash and cash equivalents	$	2,636	$	—	$	—	$	—	$	2,636
Fixed maturity securities, available-for-sale:
Asset-backed securities	—		8,644		10,094		—		18,738
Commercial mortgage-backed securities	—		5,200		—		—		5,200
Corporates	40		21,263		3,145		—		24,448
Hybrids	36		558		15		—		609
Municipals	—		1,390		3		—		1,393
Residential mortgage-backed securities	—		2,848		3		—		2,851
U.S. Government	938		15		—		—		953
Foreign Governments	107		238		23		—		368
Equity securities:
Preferred equity securities	174		254		8		—		436
Common equity securities	441		—		17		35		493
Derivative investments	—		1,156		—		—		1,156
Investments in unconsolidated affiliates	—		—		270		—		270
Other long-term investments (a)	—		248		41		—		289
Short term investments	1,764		82		74		—		1,920
Indexed annuities/IUL ceded embedded derivatives, included in Reinsurance recoverable	—		—		399		—		399
Loan receivable, included in Prepaid expenses and other assets	—		—		24		—		24


Market risk benefits asset	—		—		285		—		285
Other assets	—		—		129		—		129

Total financial assets at fair value	$	6,136	$	41,896	$	14,530	$	35	$	62,597
Liabilities

Derivatives:
Indexed annuities/indexed universal life insurance ("IUL") embedded derivatives, included in Contractholder funds	$	—	$	—	$	6,542	$	—	$	6,542
Interest rate and foreign currency swaps, included in Accounts payable and accrued liabilities	—		3		9		—		12
Reinsurance related embedded derivatives, included in Funds withheld for reinsurance liabilities	—		75		—		—		75
Equity options	1		—		—		—		1
Contingent consideration, included in Accounts payable and accrued liabilities	—		—		72		—		72
Market risk benefits liability	—		—		903		—		903

Total financial liabilities at fair value	$	1	$	78	$	7,526	$	—	$	7,605

(a) Includes certain interests in VIEs for which the fair value option has been elected. Refer to Note D - Investments for further details.


	December 31, 2024
	Level 1		Level 2		Level 3		NAV		Fair Value
Assets	(In millions)
Cash and cash equivalents	$	3,479	$	—	$	—	$	—	$	3,479
Fixed maturity securities, available-for-sale:
Asset-backed securities	—		7,513		8,143		—		15,656
Commercial mortgage-backed securities	—		5,182		—		—		5,182
Corporates	41		18,698		2,957		—		21,696
Hybrids	35		546		—		—		581
Municipals	—		1,386		—		—		1,386
Residential mortgage-backed securities	—		2,793		3		—		2,796
U.S. Government	631		6		—		—		637
Foreign Governments	—		280		4		—		284



Equity securities:
Preferred equity securities	189		246		8		—		443
Common equity securities	575		—		10		57		642
Derivative investments	—		791		3		—		794

Investments in unconsolidated affiliates	—		—		272		—		272
Other long-term investments	—		—		32		—		32
Short term investments	2,995		18		37		—		3,050
Indexed annuities/IUL ceded embedded derivatives, included in Reinsurance recoverable	—		—		98		—		98
Loan receivable, included in Prepaid expenses and other asset	—		—		11		—		11
Market risk benefits asset	—		—		189		—		189
Other assets	—		—		65		—		65

Total financial assets at fair value	$	7,945	$	37,459	$	11,832	$	57	$	57,293
Liabilities

Derivatives:
Indexed annuities/IUL embedded derivatives, included in Contractholder funds	$	—	$	—	$	5,220	$	—	$	5,220
Interest rate swaps, included in Accounts payable and accrued liabilities	—		10		—		—		10
Equity options	1		—		—		—		1
Reinsurance related embedded derivatives, included in Funds withheld for reinsurance liabilities	—		(109)		—		—		(109)
Contingent consideration, included in Accounts payable and accrued liabilities	—		—		74		—		74
Market risk benefits liability	—		—		549		—		549


Total financial liabilities at fair value	$	1	$	(99)	$	5,843	$	—	$	5,745


	December 31, 2025
	(in millions)
	Level 1		Level 2		Level 3		NAV		Total Estimated Fair Value		Carrying Amount
Assets
FHLB common stock	$	—	$	155	$	—	$	—	$	155	$	155
Commercial mortgage loans	—		—		3,025		—		3,025		3,242
Residential mortgage loans	—		—		4,424		—		4,424		4,649
Investments in unconsolidated affiliates	—		—		—		4,608		4,608		4,608
Policy loans	—		—		147		—		147		147
Other invested assets	18		—		—		75		93		93
Company-owned life insurance	—		—		887		—		887		887

Trade and notes receivables, net of allowance	—		—		473		—		473		473
Total	$	18	$	155	$	8,956	$	4,683	$	13,812	$	14,254

Liabilities
Investment contracts, included in Contractholder funds	$	—	$	—	$	51,027	$	—	$	51,027	$	56,184
Debt	—		4,204		—		—		4,204		4,400

Total	$	—	$	4,204	$	51,027	$	—	$	55,231	$	60,584



	December 31, 2024
	(in millions)
	Level 1		Level 2		Level 3		NAV		Total Estimated Fair Value		Carrying Amount
Assets
FHLB common stock	$	—	$	153	$	—	$	—	$	153	$	153
Commercial mortgage loans	—		—		2,404		—		2,404		2,705
Residential mortgage loans	—		—		2,916		—		2,916		3,221
Investments in unconsolidated affiliates	—		—		5		3,288		3,293		3,293
Policy loans	—		—		104		—		104		104
Other invested assets	42		—		—		48		90		90
Company-owned life insurance	—		—		431		—		431		431
Trade and notes receivables, net of allowance	—		—		471		—		471		471
Total	$	42	$	153	$	6,331	$	3,336	$	9,862	$	10,468

Liabilities
Investment contracts, included in Contractholder funds	$	—	$	—	$	46,339	$	—	$	46,339	$	51,184
Debt	—		3,781		—		—		3,781		4,321
Total	$	—	$	3,781	$	46,339	$	—	$	50,120	$	55,505

Schedule of Unobservable Inputs Used for Level Three Fair Value Measurements of Financial Instruments on Recurring Basis

Fair Value at

Valuation Technique

Unobservable Input(s)

Range (Weighted average)

December 31, 2025

(in millions)

December 31, 2025

Assets

Asset-backed securities

Third-Party Valuation

Discount Rate

4.36% - 7.15% (5.80%)

Corporates

Discounted Cash Flow

Discount Rate

5.50% - 100.00% (98.73%)

Corporates

661

Third-Party Valuation

Discount Rate

3.45% - 8.68% (5.84%)

Residential mortgage-backed securities

Third-Party Valuation

Discount Rate

5.41%-5.41% (5.41%)

Foreign Governments

Third-Party Valuation

Discount Rate

5.73% - 5.73% (5.73%)

Municipals

Third-Party Valuation

Discount Rate

4.94% - 4.94% (4.94%)

Investments in unconsolidated affiliates

270

Market Comparable Company Analysis

EBITDA Multiple

7.4x - 15.5x (12.10x)

Equity securities:

Preferred equity securities

Discounted Cash Flow

Discount rate

100.00% - 100.00% (100.00%)

Common equity securities

Discounted Cash Flow

Discount rate

8.10% - 14.00% (14.29%)

Market Comparable Company Analysis

EBITDA multiple

4.8x - 6.7x (5.5x)

MSRs

129

Discounted Cash Flow

Discount Rate

6.38% - 10.69% (8.00%)

Conditional Prepayment Rate

5.85% -13.65% (7.77%)

Other long-term investments:

Available-for-sale embedded derivative

Black Scholes Model

Market Value of AnchorPath Fund

100.00%

Reinsurance recoverable:

Indexed annuities/IUL ceded embedded derivatives

399

Discounted Cash Flow

Market Value of Option

0.00% - 31.77% (2.74%)

Mortality Multiplier

80.00% - 115.00% (100.00%)

Surrender Rates

0.25% - 50.00% (3.33%)

Partial Withdrawals

2.00% - 6.50% (2.22%)

Non-Performance Spread

0.53% - 1.15% (0.90%)

Option Cost

1.39% - 5.30% (1.98%)

Prepaid expenses and other assets:

Loan receivable

Discounted Cash Flow

Risk-Adjusted Discount Rate

6.35% - 6.35% (6.35%)

Collateral Volatility

35.00% - 35.00% (35.00%)

Market risk benefits asset

285

Discounted Cash Flow

Mortality

80.00% - 115.00% (100.00%)

Surrender Rates

0.25% - 30.00% (5.33%)

Partial Withdrawal Rates

0.00% - 25.64% (2.47%)

Non-Performance Spread

0.43% - 0.85% (0.64%)

GMWB Utilization

50.00% - 75.00% (63.03%)

Total financial assets at fair value (a)

1,933

Liabilities

Derivatives:

Indexed annuities/ IUL embedded derivatives, included in Contractholder funds

6,542

Discounted Cash Flow

Market Value of Option

0.00% - 40.13% (3.84%)

Mortality Multiplier

80.00% - 115.00% (100.00%)

Surrender Rates

0.25% - 50.00% (6.68%)

Partial Withdrawals

2.00% - 35.71% (2.69%)

Non-Performance Spread

0.43% - 0.85% (0.64%)


				Option Cost	0.50% - 6.09% (2.78%)


Contingent consideration	72		Discounted Cash Flow	Risk-Adjusted Discount Rate	11.50% - 11.50% (11.50%)
				EBITDA Volatility	35% - 35% (35%)
				Counterparty Discount Rate	6.30% - 6.30% (6.30%)
Market risk benefits liability	903		Discounted Cash Flow	Mortality	80.00% - 115.00% (100.00%)
				Surrender Rates	0.25% - 30.00% (5.33%)
				Partial Withdrawal Rates	0.00% - 25.64% (2.47%)
				Non-Performance Spread	0.43% - 0.85% (0.64%)
				GMWB Utilization	50.00% - 75.00% (63.03%)
Total financial liabilities at fair value	$	7,517

Fair Value at

Valuation Technique

Unobservable Input(s)

Range (Weighted average)

December 31, 2024

(In millions)

December 31, 2024

Assets

Asset-backed securities

Third-Party Valuation

Discount Rate

4.83% - 7.15% (6.33%)

Corporates

750

Third-Party Valuation

Discount Rate

2.00% - 22.53% (6.76%)

Corporates

Discounted Cash Flow

Discount Rate

13.33% - 100.00% (96.45%)

Residential mortgage-backed securities

Third-Party Valuation

Discount Rate

5.89% - 5.89% (5.89%)

Foreign Governments

Third-Party Valuation

Discount Rate

12.14% - 12.14% (12.14%)

Investments in unconsolidated affiliates

272

Market Comparable Company Analysis

EBITDA Multiple

8.7x - 23.6x (14.6x)

Equity securities:

Preferred equity securities

Discounted Cash Flow

Discount rate

100.00% -100.00% (100.00%)

Common equity securities

Discounted Cash Flow

Discount rate

4.80% - 14.10% (9.40%)

Market Comparable Company Analysis

EBITDA multiple

5.8x - 7.5x (7.0x)

Other assets

Discounted Cash Flow

Discount Rate

10.60% - 12.00% (11.30%)

Conditional Prepayment Rate

6.24% - 11.99% (9.12%)

Other long-term investments:

Available-for-sale embedded derivative

Black Scholes Model

Market Value of AnchorPath Fund

100%

Reinsurance recoverable:

Indexed annuities/IUL ceded embedded derivatives

Discounted Cash Flow

Market Value of Option

0.35% - 2.53% (1.39%)

Mortality Multiplier

80.00% - 115.00% (100.00%)

Surrender Rates

0.25% - 50.00% (3.24%)

Partial Withdrawals

2.00% - 5.00% (2.13%)

Non-Performance Spread

0.48% - 0.95% (0.75%)

Option Cost

1.40% - 1.40% (1.40%)

Prepaid expenses and other assets:

Loan receivable

Discounted Cash Flow

Risk-Adjusted Discount Rate

7.22% - 7.22% (7.22%)

Collateral Volatility

35.00% -35.00% (35.00%)

Market risk benefits asset

189

Discounted Cash Flow

Mortality

80.00% - 115.00% (100.00%)

Surrender Rates

0.25% - 30.00% (5.05%)


				Partial Withdrawal Rates	2.00% - 24.39% (2.48%)
				Non-Performance Spread	0.48% - 0.95% (0.75%)
				GMWB Utilization	50.00% - 75.00% (61.77%)
Total financial assets at fair value (a)	$	1,531
Liabilities
Derivatives:
Indexed annuities/IUL embedded derivatives, included in Contractholder funds	$	5,220	Discounted Cash Flow	Market Value of Option	0.00% - 20.81% (2.92%)

				Mortality Multiplier	80.00% - 115.00% (100.00%)
				Surrender Rates	0.25% - 50.00% (6.94%)
				Partial Withdrawals	2.00% - 35.71% (2.72%)
				Non-Performance Spread	0.48% - 0.95% (0.75%)
				Option Cost	0.07% - 5.70% (2.68%)
Contingent consideration	74		Discounted Cash Flow	Risk-Adjusted Discount Rate	13.50% - 13.50% (13.50%)
				EBITDA Volatility	35.00% - 35.00% (35.00%)
				Counterparty Discount Rate	6.50% - 6.50% (6.50%)
Market risk benefits liability	549		Discounted Cash Flow	Mortality	80.00% - 115.00% (100.00%)
				Surrender Rates	0.25% - 30.00% (5.05%)
				Partial Withdrawal Rates	2.00% - 24.39% 2.48%
				Non-Performance Spread	0.48% - 0.95% (0.75%)
				GMWB Utilization	50.00% - 75.00% (61.77%)
Total financial liabilities at fair value	$	5,843

Schedule of Changes in Fair Value of Financial Instruments - Assets


	Year ended December 31, 2025
	(in millions)
	Balance at Beginning of Period			Total Gains (Losses)					Purchases		Sales		Settlements		Net transfer In (Out) of Level 3 (a)		Balance at End of Period		Change in Unrealized Incl in OCI
			Included in Earnings			Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	8,143		$	(5)		$	80	$	3,688	$	(433)	$	(1,228)	$	(151)	$	10,094	$	73
Commercial mortgage-backed securities	—			—			—		46		—		—		(46)		—		—
Corporates	2,957			(12)			72		1,490		(889)		(407)		(66)		3,145		73
Hybrids	—			—			—		15		—		—		—		15		—
Municipals	—			—			—		4		—		(1)		—		3		—
Residential mortgage-backed securities	3			—			—		2		—		—		(2)		3		—
Foreign Governments	4			—			2		19		—		(2)		—		23		1
Equity securities:
Preferred equity securities	8			(1)			1		—		—		—		—		8		—
Common equity securities	10			2			—		5		—		—		—		17		—
Derivative investments	3			(2)			(2)		1		—		—		—		—		(2)
Investments in unconsolidated affiliates	272			(2)			—		—		—		—		—		270		—
Other assets	65			(4)			—		85		(17)		—		—		129		—
Short-term investments	37			—			—		75		—		(38)		—		74		—

Other long-term assets:

Available-for-sale embedded derivative	32			—			9		—		—		—		—		41		9





Reinsurance recoverable:
Indexed annuities/IUL ceded embedded derivatives	98			48			—		256		—		(3)		—		399		—
Prepaid expenses and other assets:
Loan receivable (b)	11			—			—		13		—		—		—		24		—
Subtotal Level 3 assets at fair value	$	11,643		$	24		$	162	$	5,699	$	(1,339)	$	(1,679)	$	(265)	$	14,245	$	154
Market risk benefits asset (c)	189																285
Total Level 3 assets at fair value	$	11,832															$	14,530
Liabilities
Indexed annuities/ IUL embedded derivatives, included in Contractholder funds	$	5,220		$	450		$	—	$	1,357	$	—	$	(485)	$	—	$	6,542	$	—
Foreign currency swaps, included in Accounts payable and accrued liabilities	—			9			—		—		—		—		—		9		—
Contingent consideration, included in Accounts payable and accrued liabilities	74			10			—		—		—		(12)		—		72		—

Subtotal Level 3 liabilities at fair value	$	5,294		$	469		$	—	$	1,357	$	—	$	(497)	$	—	$	6,623	$	—
Market Risk benefits liability (c)	549																903
Total Level 3 liabilities at fair value	$	5,843															$	7,526

(a)The net transfers out of Level 3 during the year ended December 31, 2025 were exclusively to Level 2.

(b)Purchases represent advances on the loan commitment to Roar. Refer to Note G Commitments and Contingencies for further details.

(c)Refer to Note W Market Risk Benefits for roll forward activity of the net Market Risk Benefits Asset and Liability.



	Year ended December 31, 2024
	Balance at Beginning of Period		Total Gains (Losses)				Purchases		Sales		Settlements		Net transfer In (Out) of Level 3 (a)		Balance at End of Period		Change in Unrealized Incl in OCI
			Included in Earnings		Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	7,122	$	19	$	128	$	5,104	$	(2,825)	$	(1,210)	$	(195)	$	8,143	$	130
Commercial mortgage-backed securities	18		—		—		58		—		—		(76)		—		—
Corporates	1,979		(3)		81		1,148		(100)		(139)		(9)		2,957		80

Municipals	49		—		1		—		(50)		—		—		—		1
Residential mortgage-backed securities	3		—		—		1		—		—		(1)		3		—
Foreign Governments	16		—		(1)		—		—		(11)		—		4		(1)
Preferred securities	8		—		—		—		—		—		—		8		—
Equity securities	15		(5)		—		—		—		—		—		10		—
Derivative investments	57		(50)		3		—		—		—		(7)		3		1
Investments in unconsolidated affiliates	285		79		—		—		—		—		(92)		272		—
Other assets	—		—		—		65		—		—		—		65		—
Short-term investments	—		—		—		236		(190)		(9)		—		37		—
Other long-term assets:

Available-for-sale embedded derivative	27		—		5		—		—		—		—		32		5

Credit linked note	10		1		—		—		—		(11)		—		—		—
Reinsurance recoverable:
Indexed annuities/IUL ceded embedded derivatives	20		(2)		—		81		—		(1)		—		98		—
Prepaid expenses and other assets:
Loan receivable (b)	—		—		—		11		—		—		—		11		—
Subtotal Level 3 assets at fair value	$	9,609	$	39	$	217	$	6,704	$	(3,165)	$	(1,381)	$	(380)	$	11,643	$	216
Market risk benefits asset (c)	88														189
Total Level 3 assets at fair value	$	9,697													$	11,832
Liabilities

Indexed annuities embedded derivatives, included in Contractholder funds	$	4,258	$	45	$	—	$	1,351	$	—	$	(434)	$	—	$	5,220	$	—
Interest rate swaps	—		28		—		—		—		—		(28)		—		—
Contingent consideration, included in Accounts payable and accrued liabilities	—		26		—		48		—		—		—		74		—
Subtotal Total liabilities at Level 3 fair value	$	4,258	$	99	$	—	$	1,399	$	—	$	(434)	$	(28)	$	5,294	$	—
Market risk benefits liability (c)	403														549
Total Level 3 liabilities at fair value	$	4,661													$	5,843

(a) The net transfers out of Level 3 during the year ended December 31, 2024 were exclusively to Level 2.

(b) Purchases represent advances on the loan commitment to Roar. Refer to Note G Commitments and Contingencies for further details.

Schedule of Fair Value Option

The following table presents information regarding the assets for which the fair value option was elected.


	December 31,
	2025		2024

Assets

Investments in unconsolidated affiliates	$	270		$	272
Other loans, within other long-term investments (a)
Fair Value	$	248		$	—
Aggregate unpaid principal	250			—
Loan receivable, within prepaid expenses and other assets (a)
Fair Value	$	24		$	11
Aggregate unpaid principal	24			11

(a) No loans are 90 days or more past due or on nonaccrual status


	December 31,
	2025	2024


Investments in unconsolidated affiliates	(2)		79

Schedule of Changes in Fair Value of Financial Instruments - Liabilities


	Year ended December 31, 2025
	(in millions)
	Balance at Beginning of Period			Total Gains (Losses)					Purchases		Sales		Settlements		Net transfer In (Out) of Level 3 (a)		Balance at End of Period		Change in Unrealized Incl in OCI
			Included in Earnings			Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	8,143		$	(5)		$	80	$	3,688	$	(433)	$	(1,228)	$	(151)	$	10,094	$	73
Commercial mortgage-backed securities	—			—			—		46		—		—		(46)		—		—
Corporates	2,957			(12)			72		1,490		(889)		(407)		(66)		3,145		73
Hybrids	—			—			—		15		—		—		—		15		—
Municipals	—			—			—		4		—		(1)		—		3		—
Residential mortgage-backed securities	3			—			—		2		—		—		(2)		3		—
Foreign Governments	4			—			2		19		—		(2)		—		23		1
Equity securities:
Preferred equity securities	8			(1)			1		—		—		—		—		8		—
Common equity securities	10			2			—		5		—		—		—		17		—
Derivative investments	3			(2)			(2)		1		—		—		—		—		(2)
Investments in unconsolidated affiliates	272			(2)			—		—		—		—		—		270		—
Other assets	65			(4)			—		85		(17)		—		—		129		—
Short-term investments	37			—			—		75		—		(38)		—		74		—

Other long-term assets:

Available-for-sale embedded derivative	32			—			9		—		—		—		—		41		9





Reinsurance recoverable:
Indexed annuities/IUL ceded embedded derivatives	98			48			—		256		—		(3)		—		399		—
Prepaid expenses and other assets:
Loan receivable (b)	11			—			—		13		—		—		—		24		—
Subtotal Level 3 assets at fair value	$	11,643		$	24		$	162	$	5,699	$	(1,339)	$	(1,679)	$	(265)	$	14,245	$	154
Market risk benefits asset (c)	189																285
Total Level 3 assets at fair value	$	11,832															$	14,530
Liabilities
Indexed annuities/ IUL embedded derivatives, included in Contractholder funds	$	5,220		$	450		$	—	$	1,357	$	—	$	(485)	$	—	$	6,542	$	—
Foreign currency swaps, included in Accounts payable and accrued liabilities	—			9			—		—		—		—		—		9		—
Contingent consideration, included in Accounts payable and accrued liabilities	74			10			—		—		—		(12)		—		72		—

Subtotal Level 3 liabilities at fair value	$	5,294		$	469		$	—	$	1,357	$	—	$	(497)	$	—	$	6,623	$	—
Market Risk benefits liability (c)	549																903
Total Level 3 liabilities at fair value	$	5,843															$	7,526

(a)The net transfers out of Level 3 during the year ended December 31, 2025 were exclusively to Level 2.

(b)Purchases represent advances on the loan commitment to Roar. Refer to Note G Commitments and Contingencies for further details.

(c)Refer to Note W Market Risk Benefits for roll forward activity of the net Market Risk Benefits Asset and Liability.



	Year ended December 31, 2024
	Balance at Beginning of Period		Total Gains (Losses)				Purchases		Sales		Settlements		Net transfer In (Out) of Level 3 (a)		Balance at End of Period		Change in Unrealized Incl in OCI
			Included in Earnings		Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	7,122	$	19	$	128	$	5,104	$	(2,825)	$	(1,210)	$	(195)	$	8,143	$	130
Commercial mortgage-backed securities	18		—		—		58		—		—		(76)		—		—
Corporates	1,979		(3)		81		1,148		(100)		(139)		(9)		2,957		80

Municipals	49		—		1		—		(50)		—		—		—		1
Residential mortgage-backed securities	3		—		—		1		—		—		(1)		3		—
Foreign Governments	16		—		(1)		—		—		(11)		—		4		(1)
Preferred securities	8		—		—		—		—		—		—		8		—
Equity securities	15		(5)		—		—		—		—		—		10		—
Derivative investments	57		(50)		3		—		—		—		(7)		3		1
Investments in unconsolidated affiliates	285		79		—		—		—		—		(92)		272		—
Other assets	—		—		—		65		—		—		—		65		—
Short-term investments	—		—		—		236		(190)		(9)		—		37		—
Other long-term assets:

Available-for-sale embedded derivative	27		—		5		—		—		—		—		32		5

Credit linked note	10		1		—		—		—		(11)		—		—		—
Reinsurance recoverable:
Indexed annuities/IUL ceded embedded derivatives	20		(2)		—		81		—		(1)		—		98		—
Prepaid expenses and other assets:
Loan receivable (b)	—		—		—		11		—		—		—		11		—
Subtotal Level 3 assets at fair value	$	9,609	$	39	$	217	$	6,704	$	(3,165)	$	(1,381)	$	(380)	$	11,643	$	216
Market risk benefits asset (c)	88														189
Total Level 3 assets at fair value	$	9,697													$	11,832
Liabilities

Indexed annuities embedded derivatives, included in Contractholder funds	$	4,258	$	45	$	—	$	1,351	$	—	$	(434)	$	—	$	5,220	$	—
Interest rate swaps	—		28		—		—		—		—		(28)		—		—
Contingent consideration, included in Accounts payable and accrued liabilities	—		26		—		48		—		—		—		74		—
Subtotal Total liabilities at Level 3 fair value	$	4,258	$	99	$	—	$	1,399	$	—	$	(434)	$	(28)	$	5,294	$	—
Market risk benefits liability (c)	403														549
Total Level 3 liabilities at fair value	$	4,661													$	5,843

(a) The net transfers out of Level 3 during the year ended December 31, 2024 were exclusively to Level 2.

(b) Purchases represent advances on the loan commitment to Roar. Refer to Note G Commitments and Contingencies for further details.

Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.

Notes Payable - Schedule of Principal Maturities of Notes Payable (Details) $ in Millions	Dec. 31, 2025 USD ($)
Maturities of Long-term Debt [Abstract]
2026	$ 32
2027	0
2028	950
2029	550
2030	650
Thereafter	2,270
Total long term debt	$ 4,452

Business and Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2025
Accounting Policies [Abstract]
Principles of Consolidation and Basis of Presentation	Principles of Consolidation and Basis of Presentation The Consolidated Financial Statements are prepared in accordance with generally accepted accounting principles in the United States ("GAAP") and include our accounts as well as our wholly-owned subsidiaries, majority-owned subsidiaries, and variable interest entities (VIEs) for which we are the primary beneficiary. All intercompany profits, transactions, and balances have been eliminated. Non-controlling interests recorded on the Consolidated Statements of Earnings represent the portion of a majority-owned subsidiary's net earnings or loss that is owned by non-controlling shareholders of the subsidiary. Non-controlling interests recorded on the Consolidated Balance Sheets represent the portion of equity in a consolidated subsidiary owned by non-controlling shareholders. We are involved in certain entities that are considered variable interest entities (“VIEs”) as defined under GAAP. Our involvement with VIEs is primarily to invest in assets that allow us to gain exposure to a broadly diversified portfolio of asset classes. A VIE is an entity that does not have sufficient equity to finance its own activities without additional financial support, where investors lack certain characteristics of a controlling financial interest, or where the entity is structured with non-substantive voting rights. We consolidate VIEs for which we are the primary beneficiary and account for all other VIEs as unconsolidated VIEs. We assess our relationships with VIEs to evaluate if we are the primary beneficiary, which is the party that has both (i) the power to direct the activities that most significantly impact the VIE’s economic performance and (ii) the obligation to absorb losses or the right to receive benefits that could potentially be significant. See Note D Investments for additional information on our investments in VIEs.
Investments	Investments Fixed Maturity Securities Fixed maturity securities are purchased to support our investment strategies, which are developed based on factors including rate of return, maturity, credit risk, duration, tax considerations and regulatory requirements. Our investments in fixed maturity securities have been designated as available-for-sale ("AFS") and are carried at fair value, net of allowance for expected credit losses, with unrealized gains and losses included within AOCI, net of deferred income taxes. Fair values for fixed maturity securities are principally a function of current market conditions and are primarily valued based on quoted prices in markets that are not active or model inputs that are observable or unobservable. We recognize investment income on fixed maturities based on the effective interest method, which results in the recognition of a constant rate of return on the investment equal to the prevailing rate at the time of purchase or at the time of subsequent adjustments of book value. Realized gains and losses on sales of our fixed maturity securities are determined on the basis of the cost of the specific investments sold and are credited or charged to income on a trade date basis except for private placements, which are recorded on a settlement date basis. Realized gains and losses on sales of fixed maturity securities are reported within Recognized gains and (losses), net in the accompanying Consolidated Statements of Earnings. Fixed maturity securities AFS are subject to an allowance for credit loss and changes in the allowance are reported in net earnings as a component of Recognized gains and (losses), net. For details on our policy around allowance for expected credit losses on AFS securities, refer to Note D Investments. Equity Securities Preferred and common equity securities held are carried at fair value as of the balance sheet dates. Changes in fair value and realized gains and losses on sales of our preferred and common equity securities are reported within Recognized gains and losses, net in the Consolidated Statements of Earnings. Realized gains and losses on sales of our preferred and common equity securities are determined on the specific identification basis and are credited or charged to earnings on a trade date basis unless the security is a private placement in which case settlement date basis is used. Interest and dividend income from these investments is reported in Interest and investment income in the Consolidated Statements of Earnings.
Derivative Financial Instruments	Derivative Financial Instruments Freestanding Derivatives In our F&G segment, we economically hedge certain portions of our exposure to product related equity market risk by entering into derivative transactions (primarily equity options and, to a lesser degree, futures contracts). We also utilize certain interest rate swaps, to reduce market risks from interest rate changes on our earnings associated with our floating rate investments, and foreign currency swaps, to reduce market risks from fluctuations in foreign exchange rates that impact earnings associated with our foreign currency denominated investments. All such derivative instruments are recognized as either assets or liabilities in the Consolidated Balance Sheets at fair value. The changes in fair value of derivatives not designated to hedge relationships are reported within Recognized gains and losses, net in the Consolidated Statements of Earnings. The change in the fair value of these derivative instruments is included in operating activities in the Consolidated Statements of Cash Flows. Hedge Accounting We designate certain derivatives to fair value or cash flow hedge relationships that hedge exposures to interest rates, foreign currency, or both, associated with changes in the fair value of a recognized asset or liability (“fair value hedge”) or a forecasted transaction or variability of cash flows to be received or paid related to a recognized asset or liability (“cash flow hedge”). When a derivative is designated as a fair value hedge and is determined to be highly effective, changes in the fair value of the derivative included in the assessment of effectiveness are reported in the same line on the Consolidated Statements of Earnings that is used to report the earnings effect of the hedged item. When a derivative is designated as a cash flow hedge and is determined to be highly effective, changes in the fair value of the derivative included in the assessment of effectiveness are recorded in AOCI until earnings are affected by the variability of cash flows being hedged. At the time the variability of cash flows being hedged impacts net earnings, the related portion of deferred gains or losses on the derivative instrument is reclassified and reported in net earnings in the same line item on the Consolidated Statements of Earnings that is used to report the earnings effect of the hedged item. Any portion of the change in fair value of a derivative designated to a fair value or cash flow hedge relationship that is excluded from the assessment of effectiveness will be recorded in AOCI and amortized into earnings over the life of the remaining term of the hedge relationship. To qualify for hedge accounting, at hedge inception we formally document our risk management objective and strategy for entering into hedging relationships, as well as the designation of the hedge. In our hedge documentation, we explain how the hedging instrument is expected to hedge the designated risks related to the hedged item and the method that will be used to test for hedge effectiveness on both a prospective and retrospective basis. A derivative designated as a hedging instrument must be assessed as being highly effective in offsetting the designated risk of the hedged item. Effectiveness of the hedge is formally assessed at inception and at least quarterly throughout the life of the hedging relationship. We prospectively discontinue hedge accounting when (1) the criteria to qualify for hedge accounting is no longer met; (2) the derivative expires, is sold, terminated, or is exercised; or (3) we de-designate the derivative from being the hedging instrument for a fair value or cash flow hedge. If a fair value or cash flow hedge is discontinued, the derivative will continue to be carried at fair value on the Consolidated Balance Sheets, with changes in fair value recognized prospectively in Recognized gains and losses in the Consolidated Statements of Earnings. For discontinued fair value hedges, the hedged item will no longer be adjusted for changes in the hedged risk and any existing basis adjustment will be amortized into the Consolidated Statements of Earnings within the same line item that is used to report other earnings effects of the hedged item. Any amounts remaining in AOCI associated with a component of the change in derivative fair value excluded from the assessment of effectiveness will be amortized into earnings in a manner consistent with how any basis adjustment associated with the hedged item would be amortized. The component of AOCI related to discontinued cash flow hedges where it is probable the hedged forecasted transaction will not occur, will be immediately reclassified from AOCI into earnings. In all other cases any amounts remaining in AOCI will be amortized into earnings consistent with the earnings impacts expected from the original hedged cash flows. Embedded Derivatives We purchase financial instruments and enter into agreements that may contain embedded derivatives. If it is determined that the embedded derivative possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract, and a separate instrument with the same terms would qualify as a derivative instrument, the embedded derivative is bifurcated from the host contract for measurement purposes. For further information, refer to Note E Derivative Financial Instruments.
Mortgage Loans	Mortgage Loans Our investment in mortgage loans consists of commercial and residential mortgage loans on real estate, which are reported at amortized cost, less allowance for expected credit losses. For details on our policy around allowance for expected credit losses on mortgage loans, refer to Note D Investments. Commercial mortgage loans ("CMLs") are continuously monitored by reviewing appraisals, operating statements, rent revenues, annual inspection reports, loan specific credit quality, property characteristics, market trends and other factors. CMLs are rated for the purpose of quantifying the level of risk. Loans are placed on a watch list when the debt service coverage ("DSC") ratio falls below certain thresholds and the loan-to-value ("LTV") ratios exceeds certain thresholds. Loans on the watchlist are closely monitored for collateral deficiency or other credit events that may lead to a potential loss of principal or interest. We define delinquent mortgage loans as 30 days past due, consistent with industry practice. Residential mortgage loans ("RMLs") have a primary credit quality indicator of either a performing or nonperforming loan. We define nonperforming RMLs as those that are 90 or more days past due and/or in nonaccrual status, which is assessed monthly. Generally, nonperforming RMLs have a higher risk of experiencing a credit loss. We consider residential mortgage loans that are 90 or more days past due and have an LTV greater than 90% to be foreclosure probable. Interest on loans is recognized on an accrual basis at the applicable interest rate on the principal amount outstanding. Loan origination fees and direct costs, as well as premiums and discounts, are amortized as level yield adjustments over the respective loan terms. Unamortized net fees or costs are recognized upon early repayment of the loans. Interest income, amortization of premiums and discounts, prepayment fees, and loan commitment fees are reported in Interest and investment income in the accompanying Consolidated Statements of Earnings.
Short-term Investments	Short-term investments Short-term investments consist of financial instruments with an original maturity of one year or less when purchased and include short-term fixed maturity securities and money market instruments, which are carried at fair value, and short-term loans, which are carried at amortized cost, which approximates fair value.
Investments in Unconsolidated Affiliates	Investments in Unconsolidated Affiliates In our F&G segment, we account for our investments in unconsolidated affiliates using the equity method or by electing the fair value option. Initial investments are recorded at cost. For investments subsequently measured using the equity method (primarily limited partnerships, including those held by consolidated VIEs), adjustments to the carrying amount reflect our pro rata ownership percentage of the operating results as indicated by net asset value ("NAV") in the unconsolidated affiliates’ financial statements, which we may adjust if we determine NAV is not calculated consistent with investment company fair value principles. Our pro rata share of NAV adjustments are reported in Interest and investment income and realized gains and losses on sales are reported in Recognized gains and losses, net in the Consolidated Statements of Earnings. Distributions received from investments measured using the equity method are recorded as a decrease in the investment balance. Recognition of income and adjustments to the carrying amount can be delayed due to the availability of the related financial statements, which are obtained from the general partner or managing member generally on a one to three-month delay. Management inquires quarterly with the general partner or managing member to determine whether any credit or other market events have occurred since prior quarter financial statements to ensure any material events are properly included in current quarter NAV adjustments and investment income. For investments subsequently measured using the fair value option, adjustments to the carrying amount reflecting the change in fair value of the investment and realized gains and losses on sales are reported in Recognized gains and losses, net in the Consolidated Statements of Earnings. Distributions received from investments measured using the fair value option are reported within Interest and investment income in the Consolidated Statements of Earnings. For descriptions of the fair value methodologies used for our investments, refer to Note C Fair Value of Financial Instruments. In our title segment, we account for our investments in unconsolidated affiliates using the equity method of accounting and earnings on our investments in unconsolidated affiliates are recorded within Equity in earnings of unconsolidated affiliates within the Consolidated Statements of Earnings. We classify distributions received from unconsolidated affiliates in our Consolidated Statements of Cash Flows using the cumulative earnings approach. Under the cumulative earnings approach, distributions are considered returns on investment and classified as cash inflows from operating activities unless the Company’s cumulative distributions from an investee received exceed the cumulative equity in earnings of such investee. When cumulative distributions from an investee exceed cumulative equity in earnings of the investee, such excess is considered a return of investment and is classified as a cash inflow from investing activities.
Interest and Investment Income	Interest and investment income Dividends and interest income are recorded in Interest and investment income and recognized when earned. Income or losses upon call or prepayment of fixed maturity securities are recognized in Interest and investment income. Amortization of premiums and accretion of discounts on investments in fixed maturity securities are reflected in Interest and investment income over the contractual terms of the investments, and for callable investments at a premium, based on the earliest call date of the investments, in a manner that produces a constant effective yield. For mortgage-backed and asset-backed securities, included in the fixed maturity securities portfolios, one of two models may be used to recognize interest income. For higher rated securities, interest income will be estimated based on an effective yield that considers cash flows received to date plus current expectations of future cash flows. For all other securities, interest income will be estimated based upon an effective yield that considers current expectations of future cash flows. For both interest income models, the estimated future cash flows include assumptions regarding the performance of the underlying collateral pool. Interest and investment income is presented net of investment expenses and the effects of certain reinsurance contracts.
Cash and Cash Equivalents	Cash and Cash Equivalents Highly liquid instruments purchased as part of cash management with original maturities of three months or less are considered cash equivalents.
Trade and Notes Receivables	Trade and Notes Receivables The carrying values reported in the Consolidated Balance Sheets for trade and notes receivables approximate their fair value. Premium revenues from agency title operations are recognized when the underlying title order and transaction closing, if applicable, are complete and reported to us. Premium revenues from agency operations and related commissions include an accrual based on estimated historical transaction volume data for policies that have closed in a particular period in which premiums have not yet been reported to us. Historically, the time lag between the closing of these transactions by our agents and the reporting of these policies, or premiums, to us has been up to 15 months, with 48% - 75% reported within three months following closing, an additional 24% - 48% reported within the next three months, and the remainder within seven to fifteen months. In addition to accruing these earned but unreported agency premiums, we also accrue agent commission expense, which was 77.5% of agent premiums earned in 2025, 77.4% of agent premiums earned in 2024, and 76.9% of agent premiums earned in 2023. The amount due from our agents relating to this accrual, i.e., the agent premium less their contractual retained commission, was approximately $42 million and $40 million as of December 31, 2025 and 2024, respectively. Due to the offsetting effects of reversing prior period accruals, the impact of this accrual to our recorded Agency title insurance premiums, Agent commissions, and net earnings in any given period is not considered material.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair values of financial instruments presented in the Consolidated Financial Statements are estimates of the fair values at the balance sheet date using available market information and appropriate valuation methodologies. These estimates are subjective in nature and involve uncertainties and significant judgment in the interpretation of current market data. See a description of the fair value methodology used in Note C Fair Value of Financial Instruments.
Fair Value of Assets Acquired and Liabilities Assumed in Business Combinations	Fair Value of Assets Acquired and Liabilities Assumed in Business Combinations The Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 805, Business Combinations, requires an acquirer to recognize, separately from goodwill, the identifiable assets acquired, liabilities assumed, and any non-controlling interest in the acquiree, and to measure these items generally at their acquisition date fair values. If the initial accounting for a business combination is incomplete by the end of the reporting period in which the combination occurs, we are required to report provisional amounts in the financial statements for the items for which the accounting is incomplete. Adjustments to provisional amounts initially recorded that are identified during the measurement period are recognized in the reporting period in which the adjustment amounts are determined. This includes any effect on earnings of changes in depreciation, amortization, or other income effects as a result of the change to the provisional amounts, calculated as if the accounting had been completed at the acquisition date. During the measurement period, we are also required to recognize additional assets or liabilities if new information is obtained about facts and circumstances that existed as of the acquisition date that, if known, would have resulted in the recognition of those assets and liabilities as of that date. The measurement period ends the sooner of one year from the acquisition date, or when we receive the information we were seeking about facts and circumstances that existed as of the acquisition date or learn that more information is not obtainable.
Goodwill	Goodwill Goodwill represents the excess of cost over fair value of identifiable net assets acquired and assumed in a business combination. Goodwill and other intangible assets with indefinite useful lives are reviewed for impairment at the reporting unit level on an annual basis or more frequently if circumstances indicate potential impairment, through a comparison of fair value to the carrying amount. In evaluating the recoverability of goodwill, we perform a qualitative analysis at the reporting unit level to determine whether there are any events or circumstances that would indicate it is more likely than not that the fair value of our recorded goodwill exceeds its carrying value, prior to performing a full fair-value assessment. We complete annual goodwill impairment analyses in the fourth quarter of each period presented using a September 30 measurement date. For the years ended December 31, 2025, 2024, and 2023, we determined there were no events or circumstances which indicated that the carrying value of a reporting unit exceeded the fair value.
VOBA, DAC, DSI, URL and Other Intangible Assets	Other Intangible Assets We have other intangible assets, not including goodwill, VOBA, DAC or DSI, which consist primarily of customer relationships and contracts, the value of distribution network acquired ("VODA"), trademarks and tradenames, state licenses, and computer software, which are generally recorded in connection with business combinations at their fair value. Intangible assets with estimable lives are amortized over their respective estimated useful lives to their estimated residual values and reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. In general, customer relationships are amortized over their estimated useful lives using an accelerated method, which takes into consideration expected customer attrition rates. VODA is an intangible asset that represents the value of an acquired distribution network and is amortized using the sum of years digits method. Contractual relationships are generally amortized over their contractual life. Trademarks and tradenames are generally amortized over ten years. Capitalized computer software includes the fair value of software acquired in business combinations, purchased software and capitalized software development costs. Purchased software is recorded at cost and amortized using the straight-line method over its estimated useful life. Software acquired in business combinations is recorded at its fair value and amortized using straight-line or accelerated methods over its estimated useful life. For internal-use computer software products, internal and external costs incurred during the preliminary project stage are expensed as they are incurred. Internal and external costs incurred during the application development stage are capitalized and amortized on a product-by-product basis commencing on the date the software is ready for its intended use. We do not capitalize any costs once the software is ready for its intended use. We review VOBA, DSI and other intangible assets for impairment annually or when events or circumstances occur that indicate a potential change in the underlying basis. For further information, refer to Note L Intangibles for details of impairment expense. Title Plants Title plants are recorded at the cost incurred to construct or obtain and organize historical title information to the point it can be used to perform title searches. Costs incurred to maintain, update and operate title plants are expensed as incurred. Title plants are not amortized as they are considered to have an indefinite life, if maintained. Sales of title plants are reported at the amount received net of the adjusted costs of the title plant sold. Sales of title plant copies are reported at the amount received. No cost is allocated to the sale of copies of title plants unless the carrying value of the title plant is diminished or impaired. Title plants are reviewed for impairment whenever events or circumstances indicate that the carrying amounts may not be recoverable.
Property and Equipment	Property and Equipment Property and equipment are recorded at cost, less accumulated depreciation. Depreciation is computed primarily using the straight-line method based on the estimated useful lives of the related assets: twenty to thirty years for buildings and three to twenty-five years for furniture, fixtures and equipment. Leasehold improvements are amortized on a straight-line basis over the lesser of the term of the applicable lease or the estimated useful lives of such assets. Property and equipment are reviewed for impairment whenever events or circumstances indicate that the carrying amounts may not be recoverable. We did not record any impairment expense related to property and equipment in the years ended December 31, 2025, 2024, and 2023.
Contractholder Funds	Contractholder Funds Contractholder funds include deferred annuities (indexed annuities and fixed rate annuities), IULs, funding agreements and non-life contingent ("NLC") immediate annuities (which includes NLC pension risk transfer ("PRT") annuities). The liabilities for contractholder funds for fixed rate annuities, funding agreements and NLC immediate annuities consist of contract account balances that accrue to the benefit of the contractholders. The liabilities for indexed annuities and IUL policies consist of the value of the host contract plus the fair value of the indexed crediting feature of the policy, which is accounted for as an embedded derivative. The embedded derivative liability is carried at fair value in Contractholder funds in the Consolidated Balance Sheets with changes in fair value reported in Benefits and other changes in policy reserves in the Consolidated Statements of Earnings. See a description of the fair value methodology used in Note C Fair Value of Financial Instruments.
Future Policy Benefits	Future Policy Benefits The FPB are determined as the present value of future policy benefits and related claims expenses to be paid to or on behalf of the policyholder less the present value of future net premiums to be collected from policyholders. The FPB for traditional life policies and life-contingent immediate annuity policies (which includes life-contingent PRT annuities) are estimated using current assumptions that include discount rate, mortality and surrender/lapse terminations for traditional life insurance policies only, and expenses. The expense assumption is locked-in at contract issuance and not subsequently reviewed or updated. The initial assumptions are based on generally accepted actuarial methods and a combination of internal and industry experience. Policies are terminated through surrenders, lapses and maturities, where surrenders represent the voluntary terminations of policies by policyholders, lapses represent cancellations by us due to nonpayment of premiums, and maturities are determined by policy contract terms. For traditional life policies and life-contingent immediate annuity policies, contracts are grouped into cohorts by product type, legal entity, and issue year, or acquisition year for cohorts established as of the F&G acquisition date, June 1, 2020. Life-contingent PRT annuities are grouped into cohorts by deal and legal entity. At contract inception, a net premium ratio ("NPR") is determined, which is calculated based on discounted future cash flows projected using best estimate assumptions and is capped at 100%, as net premiums cannot exceed gross premiums. Cohorts with NPRs less than 100% are not used to offset cohorts with NPRs greater than 100%. The NPR is adjusted for changes in cash flow assumptions and for differences between actual and expected experience. We assess the appropriateness of all future cash flow assumptions, excluding the expense assumption, on a quarterly basis and perform an in-depth review of future cash flow assumptions in the third quarter of each year. Updates are made when evidence suggests a revision is necessary. Updates for actual experience, which includes actual cash flows and insurance in-force, are performed on a quarterly basis. These updated cash flows are used to calculate a revised NPR, which is used to derive an updated liability as of the beginning of the current reporting period, discounted at the original contract issuance date. The updated liability is compared with the carrying amount of the liability as of that same date before the revised NPR. The difference between these amounts is the remeasurement gain or loss, presented parenthetically within Benefits and other changes in policy reserves in the Consolidated Statements of Earnings. In subsequent periods, the revised NPR is used to measure the FPB, subject to future revisions. If the NPR is greater than 100%, and therefore capped at 100%, the liability is increased and expensed immediately to reflect the amount necessary for net premiums to equal gross premiums. As the liability assumptions are reviewed and updated, if deemed necessary, at least annually, if conditions improve whereby the contracts are no longer expected to have net premiums in excess of gross premiums, the improvements would be captured in the remeasurement process and reflected in the Consolidated Statements of Earnings in the period of improvement. For traditional life policies and life-contingent immediate annuity policies (which includes life-contingent PRT annuities), the discount rate assumption is an equivalent single rate that is derived based on A-credit-rated fixed-income instruments with similar duration to the liability. We selected fixed-income instruments that have been A-rated by Bloomberg. In order to reflect the duration characteristics of the liability, we will use an implied forward yield curve and linear interpolation will be used for durations that have limited or no market observable points on the curve. The discount rate assumption is updated quarterly and used to remeasure the liability at the reporting date, with the resulting change reflected in the accompanying Consolidated Statements of Comprehensive Earnings. Deferred Profit Liability For life-contingent immediate annuity policies, gross premiums received in excess of net premiums are deferred at initial recognition as a DPL. Premiums are measured using assumptions consistent with those used in the measurement of the related liability for FPBs, including discount rate, mortality, and expenses. The DPL is amortized and recognized as premium revenue with the amount of expected future benefit payments, discounted using the same discount rate determined and locked-in at contract issuance that is used in the measurement of the related FPB. Interest is accreted on the balance of the DPL using this same discount rate. We periodically review and update our estimates using the actual historical experience and updated cash flows for the DPL at the same time as the estimates of cash flows for the FPB. When cash flows are updated, the updated estimates are used to recalculate the initial DPL at contract issuance. The recalculated DPL as of the beginning of the current reporting period is compared to the carrying amount of the DPL as of the beginning of the current reporting period, with any differences recognized as a remeasurement gain or loss, presented parenthetically within Benefits and other changes in policy reserves in the Consolidated Statements of Earnings. The DPL is recorded as a component of the Future policy benefits in the Consolidated Balance Sheets. Market Risk Benefits ("MRBs") MRBs are contracts or contract features that both provide protection to the contract holder from other-than-nominal capital market risk (equity, interest rate and foreign exchange risk) and expose the Company to other-than-nominal capital market risk. MRBs include certain contract features primarily on indexed annuities products that provide minimum guarantees to policyholders, such as guaranteed minimum death benefit ("GMDB"), guaranteed minimum withdrawal benefit ("GMWB") riders and guaranteed minimum accumulation benefit ("GMAB") riders. In certain reinsurance transactions, the underlying risks ceded to a reinsurer contain MRBs. MRBs (inclusive of reinsured MRBs) are measured at fair value using an attributed fee measurement approach where attributed fees are explicit rider charges collectible from the policyholder (or paid to the reinsurer) used to cover the excess benefits, which represent expected benefits in excess of the policyholder’s account value. At contract inception, an attributed fee ratio is calculated equal to rider charges over benefits paid in excess of the account value attributable to the MRBs. The attributed fee ratio remains static over the life of the MRBs and is capped at 100%. Each period subsequent to contract inception, the attributed fee ratio is used to calculate the fair value of the MRBs using a risk neutral valuation method and is based on current net amounts at risk, market data, internal and industry experience, and other factors. The balances are computed using assumptions including mortality, full and partial surrender, GMWB utilization, risk-free rates including non-performance spread and risk margin, market value of options and economic scenarios. Policyholder behavior assumptions are reviewed at least annually, typically in the third quarter, for any revisions. Reinsured MRBs are valued using a methodology consistent with direct MRBs, with the exception of the non-performance spread which reflects the credit of the reinsurer. MRBs can either be in an asset or liability position and are presented separately on the Consolidated Balance Sheets as the right of setoff criteria are not met. Changes in fair value, net, are recognized in Market risk benefit (gains) losses in the Consolidated Statements of Earnings, except for the change in fair value due to a change in the instrument-specific credit risk, which is recognized in the Consolidated Statements of Comprehensive Earnings. See descriptions of the fair value methodology used in Note C Fair Value of Financial Instruments and Note W Market Risk Benefits.
Reserve for Title Claims Losses	Reserve for Title Claim Losses Our reserve for title claim losses includes known claims as well as losses we expect to incur, net of recoupments. Each known claim is reserved based on our review as to the estimated amount of the claim and the costs required to settle the claim. Reserves for claims, which are incurred but not reported are established at the time premium revenue is recognized based on historical loss experience and also take into consideration other factors, including industry trends, claim loss history, current legal environment, geographic considerations, and the type of policy written. The reserve for title claim losses also includes reserves for losses arising from closing and disbursement functions due to fraud or operational error. If a loss is related to a policy issued by an independent agent, we may proceed against the independent agent pursuant to the terms of the agency agreement. In any event, we may proceed against third parties who are responsible for any loss under the title insurance policy under rights of subrogation.
Secured Trust Deposits	Secured Trust Deposits In the state of Illinois, a trust company is permitted to commingle and invest customers’ assets with its own assets, pending completion of real estate transactions. Accordingly, our Consolidated Balance Sheets reflect a secured trust deposit liability of $731 million and $551 million at December 31, 2025 and 2024, respectively, representing customers’ assets held by us and corresponding assets including cash and investments pledged as security for those trust balances.
Income Taxes	Income Taxes We recognize deferred tax assets and liabilities for temporary differences between the financial reporting basis and the tax basis of our assets and liabilities and expected benefits of utilizing net operating loss and credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The impact on deferred taxes of changes in tax rates and laws, if any, is applied to the years during which temporary differences are expected to be settled and reflected in the financial statements in the period enacted.
Reinsurance	Reinsurance Title In our Title segment, in a limited number of situations, we limit our maximum loss exposure by reinsuring certain risks with other title insurers. We also earn a small amount of additional income, which is reflected in our direct premiums, by assuming reinsurance for certain risks of other title insurers. We cede a portion of certain policy and other liabilities under agent fidelity, excess of loss and case-by-case reinsurance agreements. Reinsurance agreements provide that in the event of a loss (including costs, attorneys’ fees, and expenses) exceeding the retained amounts, the reinsurer is liable for the excess amount assumed. However, the ceding company remains primarily liable in the event the reinsurer does not meet its contractual obligations. F&G In our F&G segment, our insurance subsidiaries enter into reinsurance agreements with other companies in the normal course of business. In certain arrangements that are not accounted for as reinsurance, the right of offset may be applied resulting in all balances and activity associated with the agreement being presented on a net basis in the Consolidated Balance Sheets and Statements of Earnings, respectively. When the right of offset is not applied, the arrangement is reflected on a gross basis in the Consolidated Balance Sheets and Statements of Earnings. This results in the recognition of a Reinsurance recoverable for amounts due from the reinsurer. For arrangements accounted for as reinsurance, the Reinsurance recoverable balance reflects the reserve balance of the policies ceded. For arrangements not accounted for as reinsurance, deposit accounting is applied. As a result, the deposit asset presented as a Reinsurance recoverable on the Consolidated Balance Sheets, is based on the actual and expected cash flows due from the reinsurer where the interest method is used to accrete the deposit asset using an effective yield based on changes in actual and expected cash flows. For coinsurance of FIA and IUL policies, the Reinsurance recoverable will incorporate the fair value of the indexed crediting feature, which is accounted for as an embedded derivative. Changes in the Reinsurance recoverable balance are reported as Benefits and other changes in policy reserves in the Consolidated Statements of Earnings. Cost of Reinsurance Amounts received from or paid to reinsurers in excess of reimbursements or liabilities ceded, respectively, represents COR. If the net COR balance is in a deferred gain position, it is included within Accounts payable and accrued liabilities with the related amortization reflected within Life insurance premiums and other fees and, if in a deferred loss position, is included within the Prepaid expenses and other assets with the related amortization reflected within Other operating expenses, in the Consolidated Balance Sheets and Statements of Earnings, respectively. Premiums and expenses are recorded net of reinsurance ceded. Funds Withheld Arrangements F&G cedes certain business on a coinsurance funds withheld basis. Assets supporting the arrangements are reported within Funds withheld for reinsurance liabilities on our Consolidated Balance Sheets. All assets within the Funds withheld for reinsurance liabilities are recorded in a manner consistent with each respective item of our accounting policies discussed in this Note A Business and Summary of Significant Accounting Policies. Investment results for the assets that support the coinsurance are segregated within the funds withheld account and are passed directly to the reinsurer pursuant to the contractual terms of the reinsurance agreement, which creates embedded derivatives considered to be total return swaps. These embedded derivatives are not clearly and closely related to the underlying reinsurance agreement and thus require bifurcation. For arrangements reinsuring indexed annuities products, the funds withheld account additionally contains an embedded derivative representing the index credit obligation due the reinsurer, resulting in a compound embedded derivative. Beginning in 2025, these embedded derivatives are reported in Funds withheld for reinsurance liabilities, irrespective if in a net asset position or a net liability position, on the Consolidated Balance Sheets and prior periods have been reclassified from Prepaid expenses and other assets to conform with the current presentation. The related gains or losses are reported in Recognized gains and losses, net, on the Consolidated Statements of Earnings.
Benefits and Other Changes in Policy Reserves	Benefits and Other Changes in Policy Reserves Benefit expenses for deferred annuities (indexed annuities and fixed rate annuities), IUL policies and funding agreements include interest credited to contractholder account balances. For indexed annuities and IUL, the benefits expense includes the change in fair value of the embedded derivatives associated with the equity crediting rates. Benefit claims in excess of contract account balances, net of reinsurance recoveries, are charged to expense in the period that they are earned by the policyholder based on their selected strategy or strategies. With the exception of reinsured MRBs discussed above, changes in the Reinsurance recoverable balance that need to be reflected in earnings are included within Benefits and other changes in policy reserves on the Consolidated Statements of Earnings. For reinsurance arrangements that apply reinsurance accounting, this primarily relates to changes in the reserve balance ceded. For reinsurance arrangements that apply deposit accounting, this primarily relates to accretion of the deposit asset balance. Other changes in policy reserves also include the change in reserves for life insurance products. For traditional life and life-contingent immediate annuities (which includes PRT annuities with life contingencies), policy benefit claims are charged to expense in the period that the claims are incurred, net of reinsurance recoveries. Remeasurement gains or losses on the related FPB and DPL balances are presented parenthetically within Benefits and other changes in policy reserves in the accompanying Consolidated Statements of Earnings.
Stock-Based Compensation Plans	Stock-Based Compensation Plans We account for stock-based compensation plans using the fair value method. Using the fair value method of accounting, compensation cost is measured based on the fair value of the award at the grant date using quoted market prices, and recognized over the service period.
Earnings Per Share	Earnings Per Share Basic earnings per share, as presented on the Consolidated Statement of Earnings, is computed by dividing net earnings available to common shareholders by the weighted average number of common shares outstanding during the period. In periods when earnings are positive, diluted earnings per share is calculated by dividing net earnings available to common shareholders by the weighted average number of common shares outstanding plus the impact of assumed conversions of potentially dilutive securities. For periods when we recognize a net loss, diluted earnings per share is equal to basic earnings per share as the impact of assumed conversions of potentially dilutive securities is considered to be antidilutive. We have granted certain stock options, shares of restricted stock, convertible debt instruments and certain other convertible share-based payments, which have been treated as common share equivalents for purposes of calculating diluted earnings per share for periods in which positive earnings have been reported. The net earnings of F&G in our calculation of diluted earnings per share is adjusted for dilution related to certain F&G restricted stock granted to F&G's employees in accordance with ASC 260-10-55-20. We calculate the ratio of the shares of F&G we own to the total weighted average diluted shares of F&G outstanding and multiply the ratio by F&G's net earnings. The result is used for F&G's net earnings attributable to FNF included in our consolidated net earnings in the numerator for our diluted EPS calculation. Restricted stock, options or other instruments, which provide the ability to acquire shares of our common stock that are antidilutive are excluded from the computation of diluted earnings per share.
Comprehensive Earnings (Loss)	Comprehensive Earnings (Loss) We report Comprehensive earnings (loss) in accordance with GAAP on the Consolidated Statements of Comprehensive Earnings. Total comprehensive earnings are defined as all changes in shareholders' equity during a period, other than those resulting from investments by and distributions to shareholders. While total comprehensive earnings is the activity in a period and is largely driven by net earnings in that period, accumulated other comprehensive earnings or loss represents the cumulative balance of other comprehensive earnings, net of tax, as of the balance sheet date. Amounts reclassified to net earnings relate to the realized gains (losses) on our investments and other financial instruments, excluding investments in unconsolidated affiliates, and are included in Recognized gains and losses, net on the Consolidated Statements of Earnings. The income tax effects are released from AOCI when the related activity is reclassified to net earnings.
Reclassifications	Reclassifications Prior period amounts have been reclassified to conform with the current period presentation. Refer to “Funds Withheld Arrangements” above for further information.
Revenue Recognition	Our Direct title insurance premiums are recognized as revenue at the time of closing of the underlying transaction as the earnings process is then considered complete. Regulation of title insurance rates varies by state. Premiums are charged to customers based on rates predetermined in coordination with each states' respective Department of Insurance. Cash associated with such revenue is typically collected at closing of the underlying real estate transaction. Premium revenues from agency title operations are recognized when the underlying title order and transaction closing, if applicable, are complete. Revenues from our home warranty business are generated from contracts with customers to provide warranty for major home appliances. Substantially all of our home warranty contracts are one year in length and revenue is recognized ratably over the term of the contract.
Revenue Recognition, Other	Interest and investment income consists primarily of interest payments received on fixed maturity security holdings and dividends received on equity and preferred security holdings along with the investment income of limited partnerships. We do not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less, primarily related to revenue from our home warranty business, and (ii) contracts for which we recognize revenue at the amount to which we have the right to invoice for services performed.
Revenue Recognition, Services, Real Estate Transactions	Escrow fees and Other title-related fees and income in our Title segment are closely related to Direct title insurance premiums and are primarily associated with managing the closing of real estate transactions including the processing of funds on behalf of the transaction participants, gathering and recording the required closing documents, providing notary and home inspection services, and other real estate or title-related activities. Revenue is primarily recognized upon closing of the underlying real estate transaction or completion of services. Cash associated with such revenue is typically collected at closing. Revenues from ServiceLink, excluding its title premiums, escrow fees, and loan subservicing fees, primarily include revenues from real estate appraisal services and foreclosure processing and facilitation services. Revenues from real estate appraisal services are recognized when all appraisal work is complete, a final report is issued to the client and the client is billed. Revenues from foreclosure processing and facilitation services are primarily recognized upon completion of the services and when billing to the client is complete. Life insurance premiums in our F&G segment reflect premiums for life-contingent PRT, traditional life insurance products and life-contingent immediate annuity products, which are recognized as revenue when due from the policyholder, as well as policy rider fees primarily on indexed annuities policies, the cost of insurance on IUL policies and surrender charges assessed against policy withdrawals in excess of the policyholders' allowable penalty-free amounts. We have ceded the majority of our traditional life business to unaffiliated third-party reinsurers. While the base contract has been reinsured, we continue to retain the return of premium rider. Other income related to riders is earned when elected by the policyholder. Surrender charges are earned when a policyholder withdraws funds from the contract early or cancels the contract. Premium and annuity deposit collections for indexed annuities, fixed rate annuities, immediate annuities and PRT without life contingency, and amounts received for funding agreements are reported in the financial statements as deposit liabilities (i.e., contractholder funds) instead of as sales or revenues. Similarly, cash payments to customers are reported as decreases in the liability for contractholder funds and not as expenses. Sources of revenues for products accounted for as deposit liabilities include net investment income, surrender, cost of insurance and other charges deducted from contractholder funds, and net realized gains (losses) on investments. Components of expenses for products accounted for as deposit liabilities are interest-sensitive and index product benefits (primarily interest credited to account balances or the hedging cost of providing index credits to the policyholder), amortization of DAC, DSI, and VOBA, other operating costs and expenses, and income taxes. Real estate technology revenues are primarily comprised of subscription fees for use of software provided to real estate professionals. Revenue is recognized in the month services are provided. Loan subservicing revenues are generated by certain subsidiaries of ServiceLink and are associated with the servicing of mortgage loans on behalf of its customers. Revenue is recognized when the underlying work is performed and billed. Loan subservicing revenues are subject to the recognition requirements of ASC Topic 860.
Recent Accounting Pronouncements Adopted and Not Yet Adopted	Adopted Pronouncements In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amendments in this update enhance the transparency of the income tax disclosures by expanding on the disclosures required annually. The amendments require entities to disclose in their rate reconciliation table additional categories of information about federal, state, and foreign income taxes, in addition to providing details about the reconciling items in some categories if above a quantitative threshold. Additionally, the amendments require annual disclosure of income taxes paid (net of refunds received) disaggregated by jurisdiction based on a quantitative threshold. We adopted this standard as of December 31, 2025 and are applying this guidance on a prospective basis. Refer to Note S Income Taxes for further information. Pronouncements Not Yet Adopted In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. The amendments in this update enhance transparency of certain expense captions by disclosing more granular information of specific expenses within those captions such as personnel costs, depreciation, and amortization. The amendments also require disclosure of qualitative description of amounts remaining in relevant expense captions that are not separately disaggregated. The amendments in this update are effective for all public companies for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted, and the amendments should be applied either prospectively to financial statements issued for reporting periods after the effective date or retrospectively to all prior periods presented in the financial statements. We do not expect to early adopt this standard and are in the process of assessing its impact on our disclosures upon adoption. In September 2025, the FASB issued ASU 2025-06, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software. The amendments in this update refine capitalization thresholds by removing all references to project stages. The amendments require that an entity capitalize software costs when management has authorized and committed to funding the software project and when it is probable that the project will be completed and the software will be used to perform the function intended (“probable-to-complete recognition threshold”). Additionally, the amendments clarify the disclosure requirements for internal-use software costs. The amendments in this update are effective for all companies for annual and interim reporting periods beginning after December 15, 2027. Early adoption is permitted, and the amendments should be applied using a prospective, retrospective, or modified transition approach. We are in the process of assessing this standard and its impact upon adoption. In November 2025, the FASB issued ASU 2025-09, Derivatives and Hedging (Topic 815): Hedge Accounting Improvements. The amendments in this update make improvements to the hedge accounting guidance, with the overall goal of simplifying the application of hedge accounting guidance. The main amendments in this Update include: Issue 1) Similar Risk Assessment for Cash Flow Hedges: expands the hedged risks permitted to be aggregated in a group of individual forecasted transactions in a cash flow hedge, enabling entities to apply hedge accounting to potentially broader portfolios of forecasted transactions, Issue 2) Hedging Forecasted Interest Payments on Choose-Your-Rate Debt Instruments: establishes a model that enables hedge accounting to be applied more broadly to choose-your-rate debt and address existing diversity in practice, Issue 3) Cash Flow Hedges of Nonfinancial Forecasted Transactions: expands hedge accounting for forecasted purchases and sales of nonfinancial assets subject to certain criteria, Issue 4) Net Written Options as Hedging Instruments: accommodates differences in the loan and swap markets that resulted from reference rate reform, eliminating the requirement for the net written option test in certain instances, and Issue 5) Foreign-Currency-Denominated Debt Instrument as Hedging Instrument and Hedged Item (Dual Hedge): eliminates the recognition and presentation mismatch related to a dual hedge strategy. The amendments in this update are effective for public companies for annual and interim reporting periods beginning after December 15, 2026. Early adoption is permitted, and the amendments should be applied using a prospective basis for all hedging relationships. We are in the process of assessing this standard and its impact upon adoption.

Future Policy Benefits - Weighted Average Rates (Details)	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Traditional life
Liability for Future Policy Benefit, Activity
Interest accretion rate	2.35%	2.34%	2.33%
Current discount rate	4.77%	5.44%	5.03%
Immediate annuities
Liability for Future Policy Benefit, Activity
Interest accretion rate	3.20%	3.17%	3.14%
Current discount rate	5.29%	5.45%	4.98%
PRT
Liability for Future Policy Benefit, Activity
Interest accretion rate	4.87%	4.72%	4.61%
Current discount rate	4.98%	5.54%	5.03%

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Revenue from Contract with Customer [Abstract]

Accounts Payable and Other Accrued Liabilities - Schedule of Accounts Payable and Other Accrued Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Accounts Payable [Line Items]
Salaries and incentives	$ 469	$ 433
Accrued benefits	491	454
Contract with Customer, Liability, Current	95	92
Contingent consideration - acquisitions	95	110
Trade accounts payable	246	191
Accrued recording fees and transfer taxes	8	7
Accrued premium taxes	37	30
Liability for policy and contract claims	100	102
Retained asset account	48	60
Remittances and items not allocated	267	224
Option collateral liabilities	928	680
Other accrued liabilities	493	465
Accounts payable and accrued liabilities	3,828	3,249
URL
Accounts Payable [Line Items]
URL/Deferred revenue	$ 551	$ 401

Revenue Recognition (Tables)

12 Months Ended

Dec. 31, 2025

Schedule of Disaggregation of Revenue

Our revenue consists of:


			Year Ended December 31,
				2025		2024		2023
Revenue Stream	Income Statement Classification	Segment		Total Revenue
Revenue from insurance contracts:				(In millions)
Direct title insurance premiums	Direct title insurance premiums	Title		$	2,574	$	2,200	$	1,982
Agency title insurance premiums	Agency title insurance premiums	Title		3,250		2,953		2,610
Life insurance premiums, insurance and investment product fees, and other (1)	Escrow, title-related and other fees	F&G		2,884		2,941		2,413
Home warranty	Escrow, title-related and other fees	Title		151		146		143
Total revenue from insurance contracts				8,859		8,240		7,148
Revenue from contracts with customers:
Escrow fees	Escrow, title-related and other fees	Title		915		824		766
Other title-related fees and income	Escrow, title-related and other fees	Title		695		642		633
ServiceLink, excluding title premiums, escrow fees, and subservicing fees	Escrow, title-related and other fees	Title		354		318		313

Real estate technology	Escrow, title-related and other fees	Corporate and other		135		140		151


Total revenue from contracts with customers				2,099		1,924		1,863
Other revenue:
Loan subservicing revenue	Escrow, title-related and other fees	Title		266		266		262
Other	Escrow, title-related and other fees	Corporate and other		44		44		36
Interest and investment income	Interest and investment income	Various		3,237		3,124		2,607
Recognized gains and losses, net	Recognized gains and losses, net	Various		(60)		83		(164)
Total revenues	Total revenues			$	14,445	$	13,681	$	11,752
(1) Includes $2,108, $2,217, and $1,964 of life-contingent pension risk transfer premiums in 2025, 2024, and 2023, respectively.

Schedule of Premium, Annuity Deposits and Funding Agreements (Net of Reinsurance) By Type


	Year ended
	December 31, 2025		December 31, 2024		December 31, 2023
Product Type	(In millions)
Fixed indexed annuities	$	5,341	$	5,828	$	4,738
Fixed rate annuities	1,637		1,277		1,147
Funding agreements (FABN/FHLB)	3,748		2,404		1,256

Life insurance and other (a)	849		638		646
Total	$	11,575	$	10,147	$	7,787

(a) Life insurance and other primarily includes indexed universal life insurance.

Schedule of Information about Trade Receivables and Deferred Revenue

The following table provides information about trade receivables and deferred revenue:


	December 31, 2025		December 31, 2024
	(In millions)
Trade receivables	$	375	$	362
Deferred revenue (contract liabilities)	95		92

Tabular disclosure of type of deposit liability.

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name Regulation S-K (SK)
-Number 229
-Section 1406
-Paragraph e
-Publisher SEC

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Name Regulation S-K (SK)
-Number 229
-Section 1406
-Paragraph d
-Publisher SEC

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Name Regulation S-K (SK)
-Number 229
-Section 1406
-Paragraph c
-Publisher SEC

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Name Regulation S-K (SK)
-Number 229
-Section 1406
-Paragraph a
-Subparagraph (5)
-Publisher SEC

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Name Regulation S-K (SK)
-Number 229
-Section 1406
-Paragraph a
-Subparagraph (4)
-Publisher SEC

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Name Regulation S-K (SK)
-Number 229
-Section 1406
-Paragraph a
-Subparagraph (3)
-Publisher SEC

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Name Regulation S-K (SK)
-Number 229
-Section 1406
-Paragraph a
-Subparagraph (2)
-Publisher SEC

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Name Regulation S-K (SK)
-Number 229
-Section 1406
-Paragraph a
-Subparagraph (1)
-Publisher SEC

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Name Regulation S-K (SK)
-Number 229
-Section 1406
-Paragraph a
-Publisher SEC

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Name Regulation S-K (SK)
-Number 229
-Section 1406
-Paragraph f
-Subparagraph (1)
-Publisher SEC

Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef
-Name Regulation S-K (SK)
-Number 229
-Section 1406
-Paragraph f
-Subparagraph (2)
-Publisher SEC

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Name Regulation S-K (SK)
-Number 229
-Section 1406
-Paragraph f
-Subparagraph (2)(i)
-Publisher SEC

Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef
-Name Regulation S-K (SK)
-Number 229
-Section 1406
-Paragraph f
-Subparagraph (2)(iv)
-Publisher SEC

Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef
-Name Regulation S-K (SK)
-Number 229
-Section 1406
-Paragraph f
-Subparagraph (2)(iii)
-Publisher SEC

Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef
-Name Regulation S-K (SK)
-Number 229
-Section 1406
-Paragraph f
-Subparagraph (2)(ii)
-Publisher SEC

SEC Schedule, 12-17, Insurance Companies, Reinsurance [Abstract]

Schedule IV - F&G Reinsurance

12 Months Ended

Dec. 31, 2025

Schedule IV - F&G Reinsurance

Schedule IV

FIDELITY NATIONAL FINANCIAL, INC.

F&G Reinsurance

(In millions)


For the Year Ended December 31, 2025	Gross Amount		Ceded to other companies		Assumed from other companies		Net Amount		Percentage of amount assumed to net
Life insurance in force	$	13,148	$	(1,306)	$	—	$	11,842	—	%

Premiums and other considerations:
Traditional life insurance premiums	115		(85)		—		30		—
Life-contingent PRT premiums	2,108		—		—		2,108		—
Annuity product charges and other fees	717		(60)		—		657		—
Total premiums and other considerations	$	2,940	$	(145)	$	—	$	2,795	—	%

For the Year Ended December 31, 2024	Gross Amount		Ceded to other companies		Assumed from other companies		Net Amount		Percentage of amount assumed to net
Life insurance in force	$	10,906	$	(1,370)	$	—	$	9,536	—	%

Premiums and other considerations:
Traditional life insurance premiums	129		(94)		—		35		—
Life-contingent PRT premiums	2,217		—		—		2,217		—
Annuity product charges and other fees	655		(47)		—		608		—
Total premiums and other considerations	$	3,001	$	(141)	$	—	$	2,860	—	%

For the Year Ended December 31, 2023	Gross Amount		Ceded to other companies		Assumed from other companies		Net Amount		Percentage of amount assumed to net
Life insurance in force	$	8,448	$	(1,436)	$	—	$	7,012	—	%

Premiums and other considerations:
Traditional life insurance premiums	148		(105)		—		43		—
Life-contingent PRT premiums	1,964		—		—		1,964		—
Annuity product charges and other fees	455		(49)		—		406		—
Total premiums and other considerations	$	2,567	$	(154)	$	—	$	2,413	—	%

Investments - Commercial Mortgage Loans Segregated by Aging of Loans and Charge Offs by Year of Origination (Details) - Commercial mortgage - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Credit Quality Indicator Current Year [Abstract]
Year one	$ 646	$ 273
Year two	295	227
Year three	194	290
Year four	292	1,253
Year five	1,252	469
Prior	581	210
Total	3,260	2,722
Credit Quality Indicator Prior Year [Abstract]
Year one	646	273
Year two	295	227
Year three	194	290
Year four	292	1,253
Year five	1,252	469
Prior	581	210
Total	3,260	2,722
Current (less than 30 days past due)
Credit Quality Indicator Current Year [Abstract]
Year one	646	273
Year two	295	227
Year three	194	290
Year four	292	1,253
Year five	1,252	469
Prior	569	201
Total	3,248	2,713
Credit Quality Indicator Prior Year [Abstract]
Year one	646	273
Year two	295	227
Year three	194	290
Year four	292	1,253
Year five	1,252	469
Prior	569	201
Total	3,248	2,713
30-89 days past due
Credit Quality Indicator Current Year [Abstract]
Year one	0	0
Year two	0	0
Year three	0	0
Year four	0	0
Year five	0	0
Prior	0	0
Total	0	0
Credit Quality Indicator Prior Year [Abstract]
Year one	0	0
Year two	0	0
Year three	0	0
Year four	0	0
Year five	0	0
Prior	0	0
Total	0	0
90 days or more past due
Credit Quality Indicator Current Year [Abstract]
Year one	0	0
Year two	0	0
Year three	0	0
Year four	0	0
Year five	0	0
Prior	12	9
Total	12	9
Credit Quality Indicator Prior Year [Abstract]
Year one	0	0
Year two	0	0
Year three	0	0
Year four	0	0
Year five	0	0
Prior	12	9
Total	$ 12	$ 9

Income Taxes

12 Months Ended

Dec. 31, 2025

Income Tax Disclosure [Abstract]

Income Taxes

Income tax expense (benefit) on continuing operations consists of the following:


	Year Ended December 31,
	2025
	(In millions)
Current tax expense
Federal	$	76
State	23
Foreign	16
Total current tax expense	$	115
Deferred tax expense
Federal	599
State	39

Total deferred tax expense	$	638
Total income tax expense on continuing operations	$	753


	Year Ended December 31,
	2024		2023
	(In millions)
Current	$	360	$	241
Deferred	7		(49)
	$	367	$	192

Total income tax expense was allocated as follows:


	Year Ended December 31,
	2025
	(In millions)
Net earnings from continuing operations	$	753

Other comprehensive earnings (loss):
Unrealized gain on investments and other financial instruments	160
Unrealized gain on foreign currency translation	4
Changes in current discount rate - future policy benefits	(62)
Changes in instrument - specific credit risk - market risk benefits	(6)
Tax effects of F&G Distribution	(16)
Other comprehensive earnings attributable to non-controlling interest	(18)

Total income tax expense allocated to other comprehensive earnings	62

Total income taxes	$	815


	Year Ended December 31,
	2024		2023
	(In millions)
Net earnings from continuing operations	$	367	$	192

Other comprehensive earnings (loss):
Unrealized (loss) gain on investments and other financial instruments	(35)		275
Unrealized (loss) gain on foreign currency translation	(6)		2
Changes in current discount rate - future policy benefits	59		(50)
Changes in instrument - specific credit risk - market risk benefits	1		(9)
F&G 15% Distribution	(3)		(35)

Total income tax expense) allocated to other comprehensive earnings	16		183

Total income tax expense	$	383	$	375

A reconciliation of the federal statutory rate to our effective tax rate is as follows:


	Year Ended December 31, 2025
			(In millions)
Federal statutory rate	21.0	%	$	293
State income taxes, net of federal income tax effect (1)	1.9		26




Tax credits	(0.6)		(8)



Changes in valuation allowances	(2.0)		(28)
Outside basis difference in F&G (2)	33.7		471

Nontaxable or nondeductible items and other	(0.1)		(1)
Effective tax rate	53.9	%	$	753

(1) State taxes in California and Illinois made up the majority (greater than 50 percent) of the tax effect in this category.

(2) State taxes of $23 million are included in this category, of which Illinois and Florida made up the majority (greater than 50 percent).


	Year Ended December 31,
	2024		2023
Federal statutory rate	21.0	%	21.0	%
State income taxes, net of federal benefit	1.8		2.4



Stock compensation	(0.5)		(0.2)
Tax credits	(0.7)		(1.8)



Valuation allowance for deferred tax assets	(1.0)		5.0







Officers Compensation	0.8		1.2
Non-deductible expenses and other, net	(0.3)		0.1
Effective tax rate	21.1	%	27.7	%

Total income taxes paid was allocated as follows:


	Year Ended December 31,
	2025
	(In millions)
Federal	$	198
State & Foreign	52
Total	$	250

The significant components of deferred tax assets and liabilities consist of the following:


	December 31,
	2025		2024
	(In millions)
Deferred Tax Assets:
Employee benefit accruals	$	138	$	129

Net operating loss carryforwards	119		115





Tax credits	176		204

Investment securities	504		775
Capital loss carryover	2		19

Life insurance and claim related adjustments	539		451
Funds held under reinsurance agreements	1,178		822
Market Risk Benefits	99		56
Bermuda corporate income tax net operating loss carryforward	—		10

Section 263a Costs	30		—
Other	36		42
Total gross deferred tax asset	2,821		2,623
Less: valuation allowance	114		164
Total deferred tax asset	$	2,707	$	2,459
Deferred Tax Liabilities:
Title plant	$	(54)	$	(53)
Amortization of goodwill and intangible assets	(97)		(71)

Other	(7)		(11)

Depreciation	(21)		(24)
Partnerships	(277)		(198)
Value of business acquired	(251)		(283)


Deferred acquisition costs	(677)		(543)

Outside basis difference in F&G	(404)		—
Funds held under reinsurance agreements	(1,261)		(945)
Title Insurance reserve discounting	(17)		(16)


Total deferred tax liability	$	(3,066)	$	(2,144)
Net deferred tax (liability) asset	$	(359)	$	315

Our net deferred tax (liability) asset was $(359) million and $315 million as of December 31, 2025 and 2024, respectively. The significant changes in the deferred taxes are as follows: the deferred tax asset for investment securities decreased by $271 million primarily due to unrealized gains recorded for investment securities, of which $29 million was related to unrealized gains in our Title segment and $242 million was related to unrealized gains in our F&G segment's life insurance business. The deferred tax liability related to deferred acquisition costs increased by $134 million, which is consistent with the growth in sales in our F&G segment. The reinsurance receivable deferred tax asset increased by $356 million and the reinsurance receivable deferred tax liability increased by $316 million, both due to the increase in modified coinsurance reinsurance in the F&G segment. The deferred tax asset relating to life insurance receivables increased by $88 million primarily due to GAAP reserves increasing more than tax reserves by F&G. The deferred tax liability relating to partnerships increased by $79 million, of which $30 million relates to partnerships in our Title segment and $49 million relates to partnerships in our F&G segment. In connection with the 2025 F&G distribution, we recorded a deferred tax liability of $404 million for our outside basis difference in F&G. This deferred tax liability represents the difference between the book basis and tax basis of the retained F&G shares as of December 31, 2025, as we can no longer recover our investment tax free. $471 million was recorded through continuing operations, with the remaining movement in the deferred tax liability recorded through other comprehensive income and equity, following the accounting guidance regarding intraperiod allocation under ASC 740 and ASC 810. As a

result of the 2025 F&G distribution, certain F&G subsidiaries who have historically filed a consolidated tax return with FNF will no longer be eligible to file a consolidated tax return after the 2025 tax year.

As of December 31, 2025, we have net operating losses ("NOLs") on a pretax basis of $548 million, of which $42 million relates to our Title segment and $506 million relates to our F&G segment's life insurance business, which are available to carryforward and offset future federal taxable income. The Title segment NOLs are U.S. federal NOLs arising from acquisitions made since 2012, including Buyers Protection Group, Inc., Digital Insurance Holdings, Inc. and THL Corporations (ServiceLink). Most of the NOLs are subject to an annual Internal Revenue Code Section 382 limitation. These losses will begin to expire in year 2034 and we fully anticipate utilizing the Title segment losses prior to expiration with the exception of $25 million of gross net operating losses that are offset by a $25 million valuation allowance in the Title segment. The F&G NOLs are indefinite life U.S. federal NOLs arising from the life insurance business.

As of December 31, 2025 and 2024, we had $176 million and $204 million of tax credits, respectively, some of which have expiration dates and will begin to expire between 2029 and 2044. The credits primarily consist of general business credits and corporate alternative minimum tax credits, including $124 million associated with our F&G segment's life insurance business. Our corporate alternative minimum tax credit has an indefinite life. We anticipate the remainder of the credits will be utilized prior to expiration with the exception of $31 million relating primarily to general business credits in our Title segment which have a corresponding $31 million valuation allowance recorded.

As of December 31, 2025, a valuation allowance of $71 million on the net deferred tax asset for capital losses was recorded, of which $34 million related to the Title segment and $37 million related to the F&G segment. The net change in the capital loss valuation allowance was a $48 million decrease for the year ended December 31, 2025. This decrease to the valuation allowance was primarily due to fluctuations in the bond and equity markets, and to capital gains and losses generated in 2025.

As of December 31, 2025 and 2024, there were no unrecognized tax benefits.

F&G's life insurance subsidiaries, as well as certain F&G non-life subsidiaries file separate tax returns from the FNF consolidated group. Prepaid expenses and other assets in the accompanying Consolidated Balance Sheets as of December 31, 2025, includes: $82 million of deferred tax assets as well as $84 million of tax receivables related to F&G subsidiaries who file separate tax returns. As of December 31, 2024, prepaid expenses and other assets included $20 million of deferred tax assets related to the FNF consolidated group as well as $6 million of tax receivables and $295 million of deferred tax assets related to F&G subsidiaries who file separate tax returns.

We continue to be a participant in the Internal Revenue Service (“IRS”) Compliance Assurance Process that is a real-time audit. The 2025 U.S. federal income tax return remains open to examination by the IRS. We file income tax returns in various foreign and US state jurisdictions. Our state income tax returns for the 2021 through 2025 tax years remain subject to examination by state jurisdictions. The F&G life insurance group files a separate consolidated return with the IRS. The F&G federal income tax returns for 2020 through the current period remain open to examination by the IRS.

The Organization for Economic Cooperation and Development has developed guidance known as the Global Anti-Base Erosion Pillar Two minimum tax rules, or Pillar Two, which generally provide for a minimum effective tax rate of 15% and are intended to apply to tax years beginning in 2024. As of December 31, 2025, based on the countries in which we do business that have enacted legislation, the Company does not expect these rules to have a material impact on our income tax provision.

On July 4, 2025, the One Big Beautiful Bill Act ("OBBBA") was signed into law. The application of the OBBBA tax provisions did not result in material changes to the Company's total income tax expense or effective tax rate for the year ended December 31, 2025.

The Company considers its non-U.S. earnings to be indefinitely reinvested outside of the U.S. to the extent these earnings are not subject to the U.S. income tax under an anti-deferral tax regime. Given our intent to reinvest these earnings for an indefinite period of time, the Company has not accrued a deferred tax liability on these earnings. A determination of an unrecognized deferred tax liability related to these earnings is not practicable.

The entire disclosure for income tax.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 740
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477617/942-740-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 740
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478822/944-740-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 231
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482663/740-10-55-231

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 270
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477891/740-270-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.5.Q1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-13

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/740/tableOfContent

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-14

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-21

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 17
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-17

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482603/740-30-50-2

Employee Benefit Plans - Restricted Stock Activity (Details) - Restricted Stock - FNF Common Stock - $ / shares	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
The Omnibus Plan
Shares:
Restricted shares outstanding at beginning of period (in shares)	2,357,220	1,875,395	1,841,544
Granted (in shares)	862,320	1,604,119	966,093
Canceled (in shares)	(12,617)	(16,603)	(23,975)
Vested (in shares)	(1,101,388)	(1,105,691)	(908,267)
Restricted shares outstanding at end of period (in shares)	2,105,535	2,357,220	1,875,395
Weighted Average Grant Date Fair Value (in dollars per share):
Weighted average grant date fair value outstanding at beginning of period (in dollars per share)	$ 53.28	$ 43.69	$ 41.59
Granted (in dollars per share)	57.50	60.23	44.44
Canceled (in dollars per share)	47.55	45.92	41.42
Vested (in dollars per share)	50.02	47.21	40.26
Weighted average grant date fair value outstanding at end of period (in dollars per share)	$ 56.75	$ 53.28	$ 43.69
F&G Omnibus Plan
Shares:
Restricted shares outstanding at beginning of period (in shares)	0	181,479	501,548
Granted (in shares)	0	0	0
Canceled (in shares)	0	(13,082)	(15,965)
Vested (in shares)	0	(168,397)	(304,104)
Restricted shares outstanding at end of period (in shares)	0	0	181,479
Weighted Average Grant Date Fair Value (in dollars per share):
Weighted average grant date fair value outstanding at beginning of period (in dollars per share)	$ 0	$ 41.08	$ 42.31
Granted (in dollars per share)	0	0	0
Canceled (in dollars per share)	0	48.28	45.63
Vested (in dollars per share)	0	40.53	42.87
Weighted average grant date fair value outstanding at end of period (in dollars per share)	$ 0	$ 0	$ 41.08

Goodwill (Details) - USD ($) $ in Millions	12 Months Ended
Goodwill (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Goodwill [Roll Forward]
Goodwill, beginning balance	$ 5,271	$ 4,830
Goodwill associated with acquisitions	1	441
Goodwill, ending balance	5,272	5,271
Title \| Operating Segments
Goodwill [Roll Forward]
Goodwill, beginning balance	2,799	2,788
Goodwill associated with acquisitions	0	11
Goodwill, ending balance	2,799	2,799
F&G \| Operating Segments
Goodwill [Roll Forward]
Goodwill, beginning balance	2,179	1,749
Goodwill associated with acquisitions	1	430
Goodwill, ending balance	2,180	2,179
Corporate and Other
Goodwill [Roll Forward]
Goodwill, beginning balance	293	293
Goodwill associated with acquisitions	0	0
Goodwill, ending balance	$ 293	$ 293

Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 24
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482548/350-20-55-24

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-8

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 41
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-41

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 740
-Name Accounting Standards Codification
-Section 55
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478064/805-740-55-13

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 39
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-39

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 49
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-49

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 100
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482078/820-10-55-100

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 852
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481372/852-10-55-10

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(15))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482598/350-20-45-1

Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(10)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-4

Fair Value of Financial Instruments - Carrying Amounts of Assets and Liabilities at Estimated Fair Value Measured on a Recurring Basis (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Assets
Fixed maturity securities available-for-sale	$ 54,561	$ 48,218
Derivative investments/Reinsurance related embedded derivative, included in other assets	1,156	794
Market risk benefits asset	285	189
Total financial assets at fair value	1,933	1,531
Derivatives:
Contingent consideration, included in Accounts payable and accrued liabilities	95	110
Market risk benefits liability	903	549
Level 1
Assets
Cash and cash equivalents	2,636	3,479
Derivative investments/Reinsurance related embedded derivative, included in other assets	0	0
Investments in unconsolidated affiliates	0	0
Other long-term investments/Other assets	0	0
Short term investments	1,764	2,995
Indexed annuities/IUL ceded embedded derivatives, included in Reinsurance recoverable	0	0
Loan receivable, included in Prepaid expenses and other assets	0
Market risk benefits asset	0	0
Total financial assets at fair value	6,136	7,945
Derivatives:
Contingent consideration, included in Accounts payable and accrued liabilities	0	0
Market risk benefits liability	0	0
Total financial liabilities at fair value	1	1
Level 2
Assets
Cash and cash equivalents	0	0
Derivative investments/Reinsurance related embedded derivative, included in other assets	1,156	791
Investments in unconsolidated affiliates	0	0
Other long-term investments/Other assets	0	0
Short term investments	82	18
Indexed annuities/IUL ceded embedded derivatives, included in Reinsurance recoverable	0	0
Loan receivable, included in Prepaid expenses and other assets	0
Market risk benefits asset	0	0
Total financial assets at fair value	41,896	37,459
Derivatives:
Contingent consideration, included in Accounts payable and accrued liabilities	0	0
Market risk benefits liability	0	0
Total financial liabilities at fair value	78
Financial Liabilities, Net Fair Value Disclosure		(99)
Level 3
Assets
Cash and cash equivalents	0	0
Derivative investments/Reinsurance related embedded derivative, included in other assets	0	3
Investments in unconsolidated affiliates	270	272
Other long-term investments/Other assets	129	65
Short term investments	74	37
Indexed annuities/IUL ceded embedded derivatives, included in Reinsurance recoverable	399	98
Loan receivable, included in Prepaid expenses and other assets	24	11
Market risk benefits asset	285	189
Total financial assets at fair value	14,530	11,832
Derivatives:
Contingent consideration, included in Accounts payable and accrued liabilities	72	74
Market risk benefits liability	903	549
Total financial liabilities at fair value	7,526	5,843
NAV
Assets
Total financial assets at fair value	35	57
Total Estimated Fair Value
Assets
Cash and cash equivalents	2,636	3,479
Derivative investments/Reinsurance related embedded derivative, included in other assets	1,156	794
Investments in unconsolidated affiliates	270	272
Other long-term investments/Other assets	129	65
Short term investments	1,920	3,050
Indexed annuities/IUL ceded embedded derivatives, included in Reinsurance recoverable	399	98
Loan receivable, included in Prepaid expenses and other assets	24	11
Market risk benefits asset	285	189
Total financial assets at fair value	62,597	57,293
Derivatives:
Contingent consideration, included in Accounts payable and accrued liabilities	72	74
Market risk benefits liability	903	549
Total financial liabilities at fair value	7,605	5,745
Indexed annuities/ IUL embedded derivatives, included in Contractholder funds \| Level 1
Derivatives:
Derivative liability	0	0
Indexed annuities/ IUL embedded derivatives, included in Contractholder funds \| Level 2
Derivatives:
Derivative liability	0	0
Indexed annuities/ IUL embedded derivatives, included in Contractholder funds \| Level 3
Derivatives:
Derivative liability	6,542	5,220
Indexed annuities/ IUL embedded derivatives, included in Contractholder funds \| Total Estimated Fair Value
Derivatives:
Derivative liability	6,542	5,220
Foreign currency swaps \| Level 1
Derivatives:
Derivative liability	0	0
Foreign currency swaps \| Level 2
Derivatives:
Derivative liability	3	10
Foreign currency swaps \| Level 3
Derivatives:
Derivative liability	9	0
Foreign currency swaps \| Total Estimated Fair Value
Derivatives:
Derivative liability	12	10
Reinsurance related embedded derivatives, included in Funds withheld for reinsurance liabilities \| Level 1
Derivatives:
Derivative liability	0
Reinsurance related embedded derivatives, included in Funds withheld for reinsurance liabilities \| Level 2
Derivatives:
Derivative liability	75
Reinsurance related embedded derivatives, included in Funds withheld for reinsurance liabilities \| Level 3
Derivatives:
Derivative liability	0
Reinsurance related embedded derivatives, included in Funds withheld for reinsurance liabilities \| Total Estimated Fair Value
Derivatives:
Derivative liability	75
Equity options \| Level 1
Derivatives:
Derivative liability	1	1
Equity options \| Level 2
Derivatives:
Derivative liability	0	0
Equity options \| Level 3
Derivatives:
Derivative liability	0	0
Equity options \| Total Estimated Fair Value
Derivatives:
Derivative liability	1	1
Reinsurance related embedded derivatives, included in Funds withheld for reinsurance liabilities \| Level 1
Derivatives:
Reinsurance related embedded derivatives, included in Funds withheld for reinsurance liabilities		0
Reinsurance related embedded derivatives, included in Funds withheld for reinsurance liabilities \| Level 2
Derivatives:
Reinsurance related embedded derivatives, included in Funds withheld for reinsurance liabilities		(109)
Reinsurance related embedded derivatives, included in Funds withheld for reinsurance liabilities \| Level 3
Derivatives:
Reinsurance related embedded derivatives, included in Funds withheld for reinsurance liabilities		0
Reinsurance related embedded derivatives, included in Funds withheld for reinsurance liabilities \| Total Estimated Fair Value
Derivatives:
Reinsurance related embedded derivatives, included in Funds withheld for reinsurance liabilities		(109)
Asset-backed securities
Assets
Fixed maturity securities available-for-sale	18,738	15,656
Asset-backed securities \| Level 1
Assets
Fixed maturity securities available-for-sale	0	0
Asset-backed securities \| Level 2
Assets
Fixed maturity securities available-for-sale	8,644	7,513
Asset-backed securities \| Level 3
Assets
Fixed maturity securities available-for-sale	10,094	8,143
Asset-backed securities \| Total Estimated Fair Value
Assets
Fixed maturity securities available-for-sale	18,738	15,656
Commercial mortgage-backed securities
Assets
Fixed maturity securities available-for-sale	5,199	5,182
Commercial mortgage-backed securities \| Level 1
Assets
Fixed maturity securities available-for-sale	0	0
Commercial mortgage-backed securities \| Level 2
Assets
Fixed maturity securities available-for-sale	5,200	5,182
Commercial mortgage-backed securities \| Level 3
Assets
Fixed maturity securities available-for-sale	0	0
Commercial mortgage-backed securities \| Total Estimated Fair Value
Assets
Fixed maturity securities available-for-sale	5,200	5,182
Corporates
Assets
Fixed maturity securities available-for-sale	24,447	21,696
Corporates \| Level 1
Assets
Fixed maturity securities available-for-sale	40	41
Corporates \| Level 2
Assets
Fixed maturity securities available-for-sale	21,263	18,698
Corporates \| Level 3
Assets
Fixed maturity securities available-for-sale	3,145	2,957
Corporates \| Total Estimated Fair Value
Assets
Fixed maturity securities available-for-sale	24,448	21,696
Hybrids
Assets
Fixed maturity securities available-for-sale	609	581
Hybrids \| Level 1
Assets
Fixed maturity securities available-for-sale	36	35
Hybrids \| Level 2
Assets
Fixed maturity securities available-for-sale	558	546
Hybrids \| Level 3
Assets
Fixed maturity securities available-for-sale	15	0
Hybrids \| Total Estimated Fair Value
Assets
Fixed maturity securities available-for-sale	609	581
Municipals
Assets
Fixed maturity securities available-for-sale	1,393	1,386
Municipals \| Level 1
Assets
Fixed maturity securities available-for-sale	0	0
Municipals \| Level 2
Assets
Fixed maturity securities available-for-sale	1,390	1,386
Municipals \| Level 3
Assets
Fixed maturity securities available-for-sale	3	0
Municipals \| Total Estimated Fair Value
Assets
Fixed maturity securities available-for-sale	1,393	1,386
Residential mortgage-backed securities
Assets
Fixed maturity securities available-for-sale	2,851	2,796
Residential mortgage-backed securities \| Level 1
Assets
Fixed maturity securities available-for-sale	0	0
Residential mortgage-backed securities \| Level 2
Assets
Fixed maturity securities available-for-sale	2,848	2,793
Residential mortgage-backed securities \| Level 3
Assets
Fixed maturity securities available-for-sale	3	3
Residential mortgage-backed securities \| Total Estimated Fair Value
Assets
Fixed maturity securities available-for-sale	2,851	2,796
U.S. Government
Assets
Fixed maturity securities available-for-sale	956	637
U.S. Government \| Level 1
Assets
Fixed maturity securities available-for-sale	938	631
U.S. Government \| Level 2
Assets
Fixed maturity securities available-for-sale	15	6
U.S. Government \| Level 3
Assets
Fixed maturity securities available-for-sale	0	0
U.S. Government \| Total Estimated Fair Value
Assets
Fixed maturity securities available-for-sale	953	637
Foreign Governments
Assets
Fixed maturity securities available-for-sale	368	284
Foreign Governments \| Level 1
Assets
Fixed maturity securities available-for-sale	107	0
Foreign Governments \| Level 2
Assets
Fixed maturity securities available-for-sale	238	280
Foreign Governments \| Level 3
Assets
Fixed maturity securities available-for-sale	23	4
Foreign Governments \| Total Estimated Fair Value
Assets
Fixed maturity securities available-for-sale	368	284
Preferred equity securities
Assets
Equity securities	436	443
Preferred equity securities \| Level 1
Assets
Equity securities	174	189
Preferred equity securities \| Level 2
Assets
Equity securities	254	246
Preferred equity securities \| Level 3
Assets
Equity securities	8	8
Preferred equity securities \| Total Estimated Fair Value
Assets
Equity securities	436	443
Common equity securities \| Level 1
Assets
Equity securities	441	575
Common equity securities \| Level 2
Assets
Equity securities	0	0
Common equity securities \| Level 3
Assets
Equity securities	17	10
Common equity securities \| NAV
Assets
Equity securities	35	57
Common equity securities \| Total Estimated Fair Value
Assets
Equity securities	493	642
Other long-term investments \| Level 1
Assets
Other long-term investments/Other assets	0	0
Other long-term investments \| Level 2
Assets
Other long-term investments/Other assets	248	0
Other long-term investments \| Level 3
Assets
Other long-term investments/Other assets	41	32
Other long-term investments \| Total Estimated Fair Value
Assets
Other long-term investments/Other assets	$ 289	$ 32

Fair Value of Financial Instruments - Fair Value Option (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Fair Value, Option, Quantitative Disclosures [Line Items]
Other loans, within other long-term investments, Fair value		$ 0
Other loans within other long-term investments, Aggregate unpaid principal	$ 250	0
Loan receivable, within prepaid expenses and other assets, Fair value	24	11
Loan receivable, within prepaid expenses and other assets, Aggregate unpaid principal	24	11
Investments in unconsolidated affiliates	5,166	3,731
Fair Value Option, Other Eligible Items
Fair Value, Option, Quantitative Disclosures [Line Items]
Investments in unconsolidated affiliates	(2)	79
Level 3
Fair Value, Option, Quantitative Disclosures [Line Items]
Investments in unconsolidated affiliates	270	272
Investments in unconsolidated affiliates	0	5
Level 3 \| Investments in unconsolidated affiliates
Fair Value, Option, Quantitative Disclosures [Line Items]
Investments in unconsolidated affiliates	$ 270	$ 272

Market Risk Benefits (Tables)

12 Months Ended

Dec. 31, 2025

Schedule of Balances and Changes in Market Risk Benefit

The following table presents the balances of and changes in MRBs associated with indexed annuities and fixed rate annuities for the years ended December 31, 2025 and 2024:


	December 31, 2025				December 31, 2024
	Indexed annuities		Fixed rate annuities		Indexed annuities		Fixed rate annuities
	(In millions)
Balance, beginning of period, net liability	$	420	$	1	$	314	$	1

Balance, beginning of period, before effect of changes in the instrument-specific credit risk	$	322	$	1	$	209	$	1
Issuances and benefit payments	147		—		109		—
Attributed fees collected and interest accrual	156		—		147		—
Actual policyholder behavior different from expected	45		—		(5)		—
Changes in assumptions and other	8		—		24		—


Effects of market related movements	6		—		(162)		—
Balance, end of period, before effect of changes in the instrument-specific credit risk	684		1		322		1
Effect of changes in the instrument-specific credit risk	128		—		98		—
Balance, end of period, net liability	812		1		420		1
Less: reinsured market risk benefits	195		—		61		—
Balance, end of period, net of reinsurance	$	617	$	1	$	359	$	1

Weighted-average attained age of policyholders weighted by total AV (years)	67.84		84.69		67.98		83.51
Net amount at risk	$	1,900	$	2	$	1,327	$	2

Schedule of Market Risk Benefit, Asset And Liability

The following table reconciles MRBs by amounts in an asset position and amounts in a liability position to the MRBs amounts in the Consolidated Balance Sheets:


	December 31, 2025						December 31, 2024
	Direct		Reinsured		Total		Direct		Reinsured		Total
	(In millions)
MRB asset
Indexed annuities	$	88	$	197	$	285	$	128	$	61	$	189
Fixed rate annuities	—		—		—		—		—		—
Total MRB asset	$	88	$	197	$	285	$	128	$	61	$	189

MRB liability
Indexed annuities	$	900	$	2	$	902	$	548	$	—	$	548
Fixed rate annuities	1		—		1		1		—		1
Total MRB liability	$	901	$	2	$	903	$	549	$	—	$	549

Leases

12 Months Ended

Dec. 31, 2025

Leases [Abstract]

Leases

Right-of-use assets and lease liabilities related to operating leases under ASC Topic 842 are recorded when we are party to a contract, which conveys the right for us to control an asset for a specified period of time. Substantially all of our operating lease arrangements relate to rented office space and real estate for our title operations. We generally are not a party to any material contracts considered finance leases. Right-of-use assets and lease liabilities under ASC Topic 842 are recorded as Lease assets and Lease liabilities, respectively, on the Consolidated Balance Sheet as of December 31, 2025.

Our operating leases range in term from one to ten years. As of December 31, 2025, the weighted-average remaining lease term of our operating leases was 4.2 years.

Our lease agreements do not contain material variable lease payments, buyout options, residual value guarantees, or restrictive covenants.

Most of our leases include one or more options to renew, with renewal terms that can extend the lease term by varying amounts. The exercise of lease renewal options is at our sole discretion. We do not include options to renew in our measurement of lease assets and lease liabilities as they are not considered reasonably assured of exercise.

Our operating lease liability is determined by discounting future lease payments using a discount rate based on our incremental borrowing rate for similar collateralized borrowing. The discount rate is calculated as an average of the current yield on our unsecured notes payable and 140 basis points in excess of the current five year SOFR swap rate. As of December 31, 2025, the weighted-average discount rate used to determine our operating lease liability was 5.0%.

We do not separate lease components from non-lease components for any of our right-of-use assets.

Our lease costs are included in Other operating expenses on the Consolidated Statements of Earnings and was $130 million, $134 million, and $137 million for the years ended December 31, 2025, 2024, and 2023, respectively. We do not have any material short term lease costs, variable lease costs, or sublease income.

Future payments under operating lease arrangements accounted for under ASC Topic 842 as of December 31, 2025, are as follows (in millions):


2026	$	130
2027	101
2028	76
2029	52
2030	29
Thereafter	20
Total operating lease payments, undiscounted	$	408
Less: present value discount	40
Lease liability, at present value	$	368

See Note J Supplementary Cash Flow Information for certain information on noncash investing and financing activities related to our operating lease arrangements.

Contractholder Funds - Balances and Changes in Contractholder Funds (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Policyholder Account Balance [Roll Forward]
Reconciling items	$ 9	$ 12	$ 11
Gross liability, end of year	62,726	56,404
Less: Reinsurance recoverable	17,551	13,380
Net amount at risk	29,581	74,279
Indexed annuities
Policyholder Account Balance [Roll Forward]
Balance, beginning of year	30,235	27,164
Issuances	6,714	6,649
Premiums received	31	120
Policy charge	(222)	(195)
Surrenders and withdrawals	(3,831)	(3,832)
Benefit payments	(536)	(495)
Interest credited	830	821
Other	5	3
Balance, end of year	33,226	30,235	27,164
Issuances	6,714	6,649
Premiums received	31	120
Policy charge	(222)	(195)
Surrenders and withdrawals	(3,831)	(3,832)
Benefit payments	(536)	(495)
Interest credited	830	821
Other	5	3
Reconciling items	321	219
Gross liability, end of year	33,547	30,454
Less: Reinsurance recoverable	3,198	861
Net liability, after reinsurance	$ 30,349	$ 29,593
Weighted-average crediting rate	2.65%	2.90%
Cash surrender value	$ 30,920	$ 27,865
Fixed rate annuities
Policyholder Account Balance [Roll Forward]
Balance, beginning of year	17,442	13,443
Issuances	3,801	5,125
Premiums received	0	1
Policy charge	0	0
Surrenders and withdrawals	(2,485)	(1,479)
Benefit payments	(358)	(315)
Interest credited	866	667
Other	(1)	0
Balance, end of year	19,265	17,442	13,443
Issuances	3,801	5,125
Premiums received	0	1
Policy charge	0	0
Surrenders and withdrawals	(2,485)	(1,479)
Benefit payments	(358)	(315)
Interest credited	866	667
Other	(1)	0
Reconciling items	2	0
Gross liability, end of year	19,267	17,442
Less: Reinsurance recoverable	12,863	11,009
Net liability, after reinsurance	$ 6,404	$ 6,433
Weighted-average crediting rate	4.84%	4.42%
Cash surrender value	$ 18,034	$ 16,266
Universal Life
Policyholder Account Balance [Roll Forward]
Balance, beginning of year	2,817	2,391
Issuances	229	208
Premiums received	593	495
Policy charge	(378)	(315)
Surrenders and withdrawals	(130)	(101)
Benefit payments	(21)	(18)
Interest credited	182	157
Other	0	0
Balance, end of year	3,292	2,817	2,391
Issuances	229	208
Premiums received	593	495
Policy charge	(378)	(315)
Surrenders and withdrawals	(130)	(101)
Benefit payments	(21)	(18)
Interest credited	182	157
Other	0	0
Reconciling items	115	79
Gross liability, end of year	3,407	2,896
Less: Reinsurance recoverable	887	877
Net liability, after reinsurance	$ 2,520	$ 2,019
Weighted-average crediting rate	6.13%	6.20%
Cash surrender value	$ 2,533	$ 2,177
FABN
Policyholder Account Balance [Roll Forward]
Balance, beginning of year	2,463	2,613
Issuances	1,148	600
Premiums received	0	0
Policy charge	0	0
Surrenders and withdrawals	0	0
Benefit payments	(395)	(820)
Interest credited	107	71
Other	1	(1)
Balance, end of year	3,324	2,463	2,613
Issuances	1,148	600
Premiums received	0	0
Policy charge	0	0
Surrenders and withdrawals	0	0
Benefit payments	(395)	(820)
Interest credited	107	71
Other	1	(1)
Reconciling items	11	0
Gross liability, end of year	3,335	2,463
Less: Reinsurance recoverable	0	0
Net liability, after reinsurance	3,335	2,463
FHLB
Policyholder Account Balance [Roll Forward]
Balance, beginning of year	2,852	2,539
Issuances	2,241	1,804
Premiums received	0	0
Policy charge	0	0
Surrenders and withdrawals	0	0
Benefit payments	(2,298)	(1,606)
Interest credited	103	117
Other	0	(2)
Balance, end of year	2,898	2,852	$ 2,539
Issuances	2,241	1,804
Premiums received	0	0
Policy charge	0	0
Surrenders and withdrawals	0	0
Benefit payments	(2,298)	(1,606)
Interest credited	103	117
Other	0	(2)
Reconciling items	0	0
Gross liability, end of year	2,898	2,852
Less: Reinsurance recoverable	0	0
Net liability, after reinsurance	$ 2,898	$ 2,852

Employee Benefit Plans - 401(k) Profit Sharing Plan (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Retirement Benefits [Abstract]
Maximum annual contributions per employee, percent	40.00%	40.00%	40.00%
Employer matching contribution, percent of match, amount per dollar	0.50	0.50	0.50
Employer matching contribution, percent of employees' gross pay	6.00%	6.00%	6.00%
Defined contribution plan, cost recognized	$ 50	$ 46	$ 45

CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS - USD ($)
$ in Millions

12 Months Ended

Dec. 31, 2025

Dec. 31, 2024

Dec. 31, 2023

Statement of Comprehensive Income [Abstract]

Unrealized gain (loss) on investments and other financial instruments, net of adjustments to intangible assets and unearned revenue (excluding investments in unconsolidated affiliates)

$ 679

$ 1,391

$ 518

Other comprehensive earnings:

^[1]

709

(157)

961

Unrealized gain on investments in unconsolidated affiliates

^[2]

Unrealized gain (loss) on foreign currency translation

^[3]

(22)

Reclassification adjustments for unrealized gains and losses included in net earnings

^[4]

(46)

(8)

126

Changes in current discount rate - future policy benefits

^[5]

(234)

224

(189)

Changes in instrument-specific credit risk - market risk benefits

^[6]

(24)

(34)

Other comprehensive loss attributable to non-controlling interest

^[7]

(73)

(7)

(134)

Minimum pension liability adjustment

Tax effects of F&G Distribution

Less: Comprehensive earnings attributable to non-controlling interests

374

751

Comprehensive earnings

1,053

1,458

1,269

121

Comprehensive earnings attributable to Fidelity National Financial, Inc. common shareholders

$ 976

$ 1,337

$ 1,268

[1]	Net of income tax expense (benefit) of $171 million, $(43) million, and $238 million for the years ended December 31, 2025, 2024, and 2023, respectively.
[2]	Net of income tax expense of $2 million, $9 million, and $3 million for the years ended December 31, 2025, 2024, and 2023, respectively.
[3]	Net of income tax expense (benefit) of $4 million and $(6) million, and $2 million for the years ended December 31, 2025 and 2024, and 2023, respectively.
[4]	Net of income tax (benefit) expense of $(13) million, $(1) million, and $34 million for the years ended December 31, 2025, 2024, and 2023, respectively.
[5]	Net of income tax (benefit) expense of $(62) million, $59 million, and $(50) million for the years ended December 31, 2025, 2024, and 2023, respectively
[6]	Net of income tax (benefit) expense of $(6) million, $1 million, and $(9) million for the years ended December 31, 2025, 2024, and 2023, respectively.
[7]	Net of income tax benefit of $18 million, $3 million, and $35 million for the years ended December 31, 2025, and 2024, and 2023, respectively.

Employee Benefit Plans - Pension Plans (Details) - Pension Plan - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2000	Dec. 31, 2024
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Consecutive months with highest compensation in which benefits are based	60 months
Months ending at retirement or termination in which benefits are based	120 months
Benefit obligation		$ 0
Fair value of plan assets		$ 0

Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (c)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (c)(iv)(01)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (c)(iv)(01)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (c)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 17
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480482/715-20-55-17

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)(iv)(02)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)(iv)(01)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 12: http://www.xbrl.org/2003/role/exampleRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)(iv)(01)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Future Policy Benefits - Gross Premium Income and Interest Expense (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Liability for Future Policy Benefit, Activity
Gross premium income	$ 2,223	$ 2,346	$ 2,111
Interest expense	420	336	197
Traditional life
Liability for Future Policy Benefit, Activity
Gross premium income	99	111	123
Interest expense	35	37	37
Immediate annuities
Liability for Future Policy Benefit, Activity
Gross premium income	17	18	24
Interest expense	54	59	51
PRT
Liability for Future Policy Benefit, Activity
Gross premium income	2,107	2,217	1,964
Interest expense	$ 331	$ 240	$ 109

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Investments - Credit Quality of RMLs (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Financing Receivable, Credit Quality Indicator [Line Items]
Allowance for expected credit loss	$ (86)	$ (70)	$ (66)
Loans, net	7,891	5,926
Residential mortgage
Financing Receivable, Credit Quality Indicator [Line Items]
Gross Carrying Value	4,717	3,274
Allowance for expected credit loss	(68)	(53)	$ (54)
Loans, net	$ 4,649	$ 3,221
% of Total	100.00%	100.00%
Residential mortgage \| Performing
Financing Receivable, Credit Quality Indicator [Line Items]
Gross Carrying Value	$ 4,650	$ 3,188
% of Total	99.00%	97.00%
Residential mortgage \| Non-performing
Financing Receivable, Credit Quality Indicator [Line Items]
Gross Carrying Value	$ 67	$ 86
% of Total	1.00%	3.00%

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Employee Benefit Plans - Omnibus Incentive Plan (Details) - shares	Jun. 15, 2016	May 22, 2013	May 25, 2011	May 29, 2008	Oct. 23, 2006	Dec. 31, 2025	Dec. 31, 2005
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock outstanding (in shares)						2,105,535
The Omnibus Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized for grant (in shares)							8,000,000
Number of additional shares authorized (in shares)	10,000,000	6,000,000	6,000,000	11,000,000	16,000,000
Options outstanding (in shares)						0

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Revenue Recognition - Contract Balances, Information about Receivables and Deferred Revenue (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Revenue from Contract with Customer [Abstract]
Trade receivables	$ 375	$ 362
Deferred revenue (contract liabilities)	$ 95	92
Policy period	1 year
Revenue recognized	$ 84	$ 80

Leases - Narrative (Details) $ in Millions	12 Months Ended
Leases - Narrative (Details) $ in Millions	Dec. 31, 2025 USD ($) optionsToRenew	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)
Debt Instrument [Line Items]
Operating leases weighted average remaining lease term	4 years 2 months 12 days
Options to renew \| optionsToRenew	1
Weighted average discount rate, percent	5.00%
Operating lease costs \| $	$ 130	$ 134	$ 137
Line of Credit \| Revolving Credit Facility \| Revolving Credit Facility, due April 2022
Debt Instrument [Line Items]
Basis spread on variable rate	1.40%
Minimum
Debt Instrument [Line Items]
Operating lease, term	1 year
Maximum
Debt Instrument [Line Items]
Operating lease, term	10 years

Future Policy Benefits - Actual Experience and Expected Experience for Mortality and Lapses (Details)	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Actual experience \| Traditional life
Liability for Future Policy Benefit, Activity
Mortality	2.40%	1.40%	1.70%
Lapses	0.00%	0.10%	0.00%
Actual experience \| Immediate annuities
Liability for Future Policy Benefit, Activity
Mortality	2.40%	2.70%	3.20%
Lapses	0.00%	0.00%	0.00%
Actual experience \| PRT
Liability for Future Policy Benefit, Activity
Mortality	2.60%	2.70%	3.20%
Lapses	0.00%	0.00%	0.00%
Expected experience \| Traditional life
Liability for Future Policy Benefit, Activity
Mortality	1.60%	1.50%	1.40%
Lapses	0.60%	0.50%	0.30%
Expected experience \| Immediate annuities
Liability for Future Policy Benefit, Activity
Mortality	1.70%	1.90%	1.80%
Lapses	0.00%	0.00%	0.00%
Expected experience \| PRT
Liability for Future Policy Benefit, Activity
Mortality	2.50%	2.50%	2.30%
Lapses	0.00%	0.00%	0.00%

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Regulation and Equity (Tables)

12 Months Ended

Dec. 31, 2025

Schedule of Statutory Accounting Practices Disclosure

Statutory net income and statutory capital and surplus of our wholly owned U.S. regulated insurance subsidiaries were as follows:


	Subsidiary (state of domicile) (a)
	FGL Insurance (IA)		FGL NY Insurance (NY)		Raven Re (VT)		Corbeau Re (VT)
Statutory Net (loss) income:	(In millions)
Year ended December 31, 2025	$	(257)	$	29	$	38	$	(201)
Year ended December 31, 2024	150		8		54		(458)
Year ended December 31, 2023	(462)		5		60		(644)

Statutory Capital and Surplus:
December 31, 2025	$	1,735	$	122	$	182	$	236
December 31, 2024	1,654		97		168		178

(a) FGL NY Insurance, Raven Re and Corbeau Re are subsidiaries of FGL Insurance, and the columns should not be added together. Corbeau Re was incorporated on September 1, 2023.

Net income and capital and surplus of our wholly owned Cayman Islands and Bermuda regulated insurance subsidiaries under SAP and GAAP, respectively, were as follows:


	Subsidiary (country of domicile)
	F&G Cayman Re (Cayman Islands)		F&G Life Re (Bermuda)
Statutory Net (loss) income:	(In millions)
Year ended December 31, 2025	$	(30)	$	160
Year ended December 31, 2024	(11)		139
Year ended December 31, 2023	133		151
Statutory Capital and Surplus (Deficit):
December 31, 2025	$	1,134	$	84
December 31, 2024	734		123

Tabular disclosure of how the entity's reporting under GAAP as of the balance sheet date differs from the results based on prescribed and permitted accounting practices of the state or country of domicile in which a relevant statutory filing is made, or differences in results based on the National Association of Insurance Commissioners (NAIC) prescribed practices, or a combination thereof. Describes the accounting practices used and the related monetary effect on statutory surplus, net income, and risk-based capital. If an insurance enterprise's risk-based capital would have triggered a regulatory event had it not used a permitted practice, that fact is disclosed in the financial statements. Permitted statutory accounting practices include practices not prescribed but allowed by the domiciliary state insurance department regulatory authority.

Market Risk Benefits

12 Months Ended

Dec. 31, 2025